data_6do7_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6do7 _Structure_validation_residue.Date_analyzed 2018-12-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.568 1.321 . . . . 74.34 114.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 115.7 6.7 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.992 1.317 . . . . 73.1 112.359 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.18 173.4 35.38 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 110.283 -1.127 . . . . 70.14 110.283 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -117.62 145.45 44.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.044 0.937 . . . . 73.53 109.046 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -135.82 172.77 12.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.144 2.178 . . . . 74.21 110.579 -169.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -151.69 119.66 6.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.582 1.153 . . . . 74.2 108.04 -164.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 37' ' ' GLY . 46.7 tp -57.57 122.98 14.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.975 1.31 . . . . 64.31 112.177 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -100.22 -49.69 4.19 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 124.921 1.388 . . . . 75.31 110.436 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -161.41 159.77 28.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.57 1.148 . . . . 61.25 110.6 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -160.56 142.37 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.34 1.056 . . . . 74.33 110.661 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -127.65 148.59 50.38 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.233 1.813 . . . . 74.05 108.799 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.17 16.13 6.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.886 1.675 . . . . 73.45 113.509 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.54 -56.68 18.27 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.188 1.395 . . . . 74.31 112.909 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -60.99 -48.23 82.8 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.397 1.061 . . . . 62.3 112.767 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.85 -42.64 76.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.727 1.211 . . . . 74.32 113.794 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -68.6 -46.86 68.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.256 1.422 . . . . 72.24 113.241 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mmt -66.13 -41.23 90.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.646 1.178 . . . . 72.2 113.144 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.89 -40.78 94.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.39 1.076 . . . . 74.34 112.226 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.59 66.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.885 1.439 . . . . 74.22 114.885 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 pt -86.84 0.96 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 113.214 0.82 . . . . 75.3 113.214 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.91 22.57 38.43 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.381 -1.233 . . . . 54.2 113.774 166.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.16 145.93 70.07 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 119.278 1.539 . . . . 72.53 110.859 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 149.65 58.45 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.25 . . . . 74.4 111.998 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -55.52 -29.18 58.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.366 1.466 . . . . 71.15 114.693 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.31 -54.08 51.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.475 1.51 . . . . 75.2 113.257 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.69 -22.75 66.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.892 1.277 . . . . 72.51 113.698 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -78.25 -49.56 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.444 1.098 . . . . 72.31 111.366 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -65.74 -36.56 83.92 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.247 1.203 . . . . 73.04 114.247 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -27.67 55.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 118.524 -0.75 . . . . 72.32 112.28 171.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.3 -29.38 56.32 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.754 -1.026 . . . . 51.5 112.361 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.19 -30.12 18.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.436 1.095 . . . . 73.53 112.797 175.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.34 -59.86 2.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.738 0.815 . . . . 73.22 110.436 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.64 109.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.451 1.094 . . . . 60.01 108.822 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.14 115.77 8.82 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 124.12 0.887 . . . . 71.21 110.191 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.422 ' H ' HD23 ' A' ' 9' ' ' LEU . . . -77.43 179.66 50.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.974 1.421 . . . . 64.02 111.674 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 t -116.93 160.01 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.613 1.565 . . . . 75.42 106.81 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 t -148.15 149.83 32.7 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 108.713 -0.847 . . . . 71.4 108.713 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -147.07 139.56 24.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.628 -0.878 . . . . 73.42 108.628 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.5 mt -136.29 140.41 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.306 -1.368 . . . . 73.42 107.306 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.25 107.56 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.192 -1.04 . . . . 70.04 108.192 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -76.89 131.6 38.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.309 -0.997 . . . . 74.35 108.309 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -130.41 51.21 2.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.988 1.315 . . . . 73.01 108.79 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.25 -115.56 5.17 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.667 -1.773 . . . . 75.11 108.667 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 74.42 112.908 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.33 155.29 39.57 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.972 1.309 . . . . 74.42 112.134 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -147.36 128.27 14.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.621 1.569 . . . . 75.01 107.78 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -106.26 136.0 46.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.657 1.583 . . . . 72.52 108.707 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.74 134.48 55.22 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.083 -1.451 . . . . 73.22 107.083 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.89 122.94 15.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.059 1.343 . . . . 72.25 107.991 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.22 113.7 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.873 -1.158 . . . . 75.43 107.873 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -90.94 104.77 17.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.552 1.141 . . . . 73.34 109.695 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.61 174.99 11.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.644 1.178 . . . . 75.44 110.658 166.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.79 21.15 0.98 Allowed Glycine 0 CA--C 1.544 1.859 0 C-N-CA 125.714 1.626 . . . . 72.42 115.174 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.8 p -158.22 -30.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.578 1.689 . . . . 72.4 113.459 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -151.23 165.07 35.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.195 0.998 . . . . 74.54 110.742 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -108.73 139.72 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 124.462 1.101 . . . . 72.31 108.723 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 117.33 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 106.666 -1.605 . . . . 72.03 106.666 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.66 140.91 39.97 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.348 1.03 . . . . 71.21 109.016 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -144.42 158.97 43.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.954 1.702 . . . . 74.13 109.043 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -145.35 146.82 31.74 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.273 0.983 . . . . 64.34 109.563 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -148.4 171.27 16.3 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.436 1.494 . . . . 74.31 109.474 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.2 m -118.07 132.7 56.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.46 -1.311 . . . . 75.33 107.46 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.91 129.87 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 73.42 110.876 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.21 -7.96 49.16 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 118.179 -1.345 . . . . 55.35 113.821 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -101.62 152.37 20.89 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.202 1.501 . . . . 75.42 109.032 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.63 104.41 16.34 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.098 0.959 . . . . 64.11 110.879 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.7 m -125.18 -162.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.483 1.913 . . . . 72.2 109.067 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.06 155.74 49.76 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.707 1.203 . . . . 62.11 111.522 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.9 mt -132.03 139.04 48.44 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.792 1.637 . . . . 74.32 108.647 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.03 132.86 44.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.069 1.347 . . . . 74.0 109.892 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 m -83.72 162.41 20.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.432 1.493 . . . . 73.14 110.439 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.8 mtt -56.75 -30.1 63.22 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.94 1.459 . . . . 74.13 114.94 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.9 t -71.84 -11.33 60.75 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.427 1.491 . . . . 73.52 114.211 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.49 1.97 70.87 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.88 1.229 . . . . 72.12 112.028 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.89 132.52 47.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.303 1.441 . . . . 72.11 110.881 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -101.29 128.64 47.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.431 1.492 . . . . 62.42 108.375 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.97 126.15 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 124.038 0.836 . . . . 74.43 111.228 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.24 144.52 40.33 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.827 1.651 . . . . 75.41 111.729 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -171.88 179.59 2.69 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.113 1.365 . . . . 74.23 111.069 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.49 145.8 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 126.52 1.928 . . . . 75.14 107.557 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.21 143.33 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.111 0.964 . . . . 72.03 109.474 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -125.06 166.44 16.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.305 1.842 . . . . 70.34 111.216 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.11 135.77 41.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.659 1.584 . . . . 72.31 107.112 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.71 18.99 7.97 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.642 1.177 . . . . 74.41 113.74 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.48 9.18 64.27 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.991 1.758 . . . . 74.32 113.893 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -132.05 46.09 2.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.88 1.272 . . . . 73.41 109.574 -166.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.288 0.9 OUTLIER 49.65 32.06 4.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.071 2.148 . . . . 73.4 114.884 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -137.48 119.82 15.79 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.044 1.738 . . . . 74.12 108.572 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.22 146.42 23.73 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.204 0.94 . . . . 73.5 109.496 171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.72 138.0 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.914 1.286 . . . . 74.34 108.501 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 t -153.43 146.38 24.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.964 0.906 . . . . 75.43 109.51 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.9 p -120.14 174.29 6.58 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.758 1.223 . . . . 73.32 109.007 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.85 -85.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.412 -0.958 . . . . 64.5 108.412 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -51.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.809 1.244 . . . . 75.14 109.11 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.6 12.87 1.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.128 1.771 . . . . 75.11 111.601 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.7 mt -112.21 118.98 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.451 1.9 . . . . 64.22 106.683 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -111.08 102.08 10.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.611 1.164 . . . . 75.22 108.736 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.7 m -99.48 129.18 45.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.293 1.437 . . . . 74.44 110.344 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -133.06 108.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.589 1.156 . . . . 73.31 108.608 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.7 m -85.92 148.49 25.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.456 1.102 . . . . 75.43 109.221 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.85 118.01 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.999 1.32 . . . . 74.33 109.262 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.92 127.28 41.8 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.522 -0.918 . . . . 75.11 108.522 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.14 81.52 2.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.279 1.832 . . . . 74.43 107.729 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.95 -110.38 3.45 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.927 1.251 . . . . 71.31 110.922 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.81 21.24 9.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.562 1.545 . . . . 74.01 111.99 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -129.4 141.38 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.747 1.219 . . . . 75.34 108.646 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.07 107.97 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.941 1.296 . . . . 71.12 107.89 172.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 m -85.9 144.2 27.79 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.835 1.254 . . . . 75.51 108.283 165.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -149.3 122.43 8.89 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.209 -1.404 . . . . 72.52 107.209 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.93 120.33 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.513 1.133 . . . . 71.42 108.87 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.4 mtp -118.43 142.59 47.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.894 1.678 . . . . 65.42 109.216 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -133.71 95.74 3.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 63.04 109.905 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -96.08 106.37 18.54 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 125.038 1.335 . . . . 75.53 108.287 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.47 -109.84 3.08 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 110.218 -1.153 . . . . 65.23 110.218 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.78 -9.06 20.3 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.527 1.531 . . . . 74.43 112.014 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.24 130.87 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.05 1.34 . . . . 72.41 108.956 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.49 82.24 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 124.168 0.918 . . . . 72.05 109.621 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.96 131.91 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.434 1.093 . . . . 65.45 112.534 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -127.97 152.24 48.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.038 1.335 . . . . 74.32 109.577 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -155.79 130.22 8.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.605 1.162 . . . . 74.15 109.401 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.43 131.69 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.096 1.358 . . . . 74.43 107.497 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m -131.02 159.29 37.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.412 1.485 . . . . 71.2 108.924 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -129.2 131.57 47.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.558 1.143 . . . . 73.22 110.016 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -69.33 119.96 14.4 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.852 2.061 . . . . 75.52 110.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 124.098 1.904 . . . . 74.44 108.425 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 114.447 1.277 . . . . 74.34 114.447 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -57.01 120.78 8.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.329 2.252 . . . . 73.1 112.837 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.62 169.8 21.02 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 109.944 -1.262 . . . . 70.14 109.944 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -121.22 133.03 55.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.974 1.309 . . . . 73.53 108.88 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -134.04 122.92 23.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.198 1.399 . . . . 74.21 110.217 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.68 153.31 37.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.264 1.025 . . . . 74.2 110.061 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.65 137.02 49.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.195 0.309 . . . . 64.31 110.726 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -109.17 -48.57 3.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.744 1.277 . . . . 75.31 110.095 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.55 160.24 25.74 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 124.255 0.972 . . . . 61.25 111.786 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.27 153.45 50.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.826 1.65 . . . . 74.33 107.628 172.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -129.87 142.03 50.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.968 0.907 . . . . 74.05 109.613 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 58.86 25.37 13.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.346 1.858 . . . . 73.45 113.495 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -53.83 -55.15 29.19 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.159 1.384 . . . . 74.31 112.794 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.37 -45.24 76.87 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 124.791 1.307 . . . . 62.3 112.946 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.75 86.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.359 1.064 . . . . 74.32 113.577 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.98 -45.4 67.43 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.698 1.199 . . . . 72.24 112.815 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 16.3 mmt -65.82 -40.44 91.83 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.514 1.134 . . . . 72.2 112.945 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -59.34 -39.48 83.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.436 1.094 . . . . 74.34 113.014 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.68 72.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.614 1.339 . . . . 74.22 114.614 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.16 -1.54 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 113.682 0.993 . . . . 75.3 113.682 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.56 38.07 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.83 -0.983 . . . . 54.2 113.146 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.57 142.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 118.581 1.19 . . . . 72.53 109.276 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.02 149.49 77.18 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.58 2.187 . . . . 74.4 111.565 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.74 -24.85 64.37 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.1 1.519 . . . . 71.15 115.1 -174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.97 -46.39 78.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.575 0.954 . . . . 75.2 113.575 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -67.97 -25.7 65.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.352 -0.832 . . . . 72.51 113.001 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -72.73 -53.16 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 117.86 -1.067 . . . . 72.31 111.009 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -62.96 -43.13 99.64 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.025 1.12 . . . . 73.04 114.025 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -23.22 63.3 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.735 0.647 . . . . 72.32 111.926 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.57 -28.36 47.8 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.127 -1.374 . . . . 51.5 112.469 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.37 -28.34 16.96 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 116.756 -1.592 . . . . 73.53 113.79 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -80.35 -34.95 36.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.865 1.212 . . . . 73.22 110.942 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.3 mt -93.47 122.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.361 1.065 . . . . 60.01 108.883 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.71 144.91 29.05 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.983 0.802 . . . . 71.21 110.668 165.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.3 -162.75 26.42 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 124.603 1.19 . . . . 64.02 110.725 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -143.86 152.64 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.607 1.963 . . . . 75.42 107.5 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -132.88 149.21 52.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.841 0.856 . . . . 71.4 109.598 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.14 136.91 54.98 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.023 -1.103 . . . . 73.42 108.023 166.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.63 128.42 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.509 -2.034 . . . . 73.42 105.509 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.92 99.11 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 124.162 0.914 . . . . 70.04 108.738 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -78.51 120.31 23.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.574 1.15 . . . . 74.35 109.685 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -117.45 54.83 0.87 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.381 1.472 . . . . 73.01 109.831 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -118.1 6.47 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.526 -1.83 . . . . 75.11 108.526 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -31.58 60.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.262 1.025 . . . . 74.42 112.829 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 161.92 29.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.339 1.056 . . . . 74.42 111.078 169.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -155.55 138.31 15.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.584 -1.265 . . . . 75.01 107.584 -175.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.98 144.7 48.37 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 125.53 1.532 . . . . 72.52 109.894 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.59 123.41 27.85 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.864 -1.902 . . . . 73.22 105.864 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -116.6 135.52 53.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.313 1.845 . . . . 72.25 108.525 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.52 105.26 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.325 -0.991 . . . . 75.43 108.325 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -97.02 114.84 26.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.824 1.649 . . . . 73.34 109.125 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.86 147.97 17.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.584 0.754 . . . . 75.44 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.63 -105.58 1.96 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 107.608 -2.197 . . . . 72.42 107.608 -173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -147.79 34.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.017 1.327 . . . . 72.4 110.912 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.03 164.4 30.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.0 1.72 . . . . 74.54 109.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.31 129.91 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.977 0.798 . . . . 72.31 109.0 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.27 133.8 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.396 -1.335 . . . . 72.03 107.396 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.82 124.38 43.17 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.245 -1.391 . . . . 71.21 107.245 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.501 HD22 ' HB3' ' A' ' 72' ' ' GLU . 25.3 m120 -123.33 150.71 43.27 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 124.645 1.216 . . . . 74.13 109.014 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.66 142.27 41.15 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 125.205 1.566 . . . . 64.34 108.99 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.81 162.3 40.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.063 1.345 . . . . 74.31 109.756 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.5 m -109.51 135.46 50.48 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 166.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.5 130.46 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.953 0.901 . . . . 73.42 111.032 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.88 -7.97 64.48 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 117.941 -1.477 . . . . 55.35 114.092 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -98.75 136.09 39.29 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.538 1.669 . . . . 75.42 110.08 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.66 136.12 45.58 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.364 1.04 . . . . 64.11 111.068 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -167.63 159.17 11.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.853 1.261 . . . . 72.2 109.403 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -100.94 124.23 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.236 0.96 . . . . 62.11 110.915 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.67 168.66 8.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.941 2.096 . . . . 74.32 109.787 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB3' HD22 ' A' ' 61' ' ' ASN . 35.0 tt0 -129.79 157.96 40.74 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.954 1.301 . . . . 74.0 110.545 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.6 p -124.11 173.09 8.52 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.093 1.757 . . . . 73.14 109.703 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -59.82 -20.39 56.61 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.509 1.67 . . . . 74.13 115.509 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 p -78.57 -14.88 59.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.159 1.783 . . . . 73.52 113.842 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.15 -2.08 83.35 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.996 1.284 . . . . 72.12 112.653 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -65.2 135.74 55.8 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 119.121 1.46 . . . . 72.11 112.559 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -103.93 143.14 33.26 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 125.126 1.516 . . . . 62.42 110.93 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.48 123.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.747 1.219 . . . . 74.43 111.272 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -71.43 137.92 48.66 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.738 1.215 . . . . 75.41 111.582 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -167.41 169.67 12.07 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.677 1.236 . . . . 74.23 110.315 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.71 132.2 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.866 1.266 . . . . 75.14 107.998 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.41 140.88 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 124.11 0.881 . . . . 72.03 109.524 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -131.59 168.58 17.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 70.34 111.373 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -122.44 127.2 49.35 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.006 -1.479 . . . . 72.31 107.006 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -84.9 18.55 2.4 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.596 1.332 . . . . 74.41 114.596 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 18.16 78.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.98 1.276 . . . . 74.32 113.719 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -143.43 48.14 1.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.605 1.162 . . . . 73.41 109.47 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.29 0.7 OUTLIER 47.21 37.58 5.79 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.695 1.998 . . . . 73.4 114.178 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -137.47 121.34 17.61 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.862 1.665 . . . . 74.12 109.072 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.58 140.77 29.44 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.556 1.16 . . . . 73.5 109.725 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.22 138.68 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.326 1.45 . . . . 74.34 108.476 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -160.11 143.62 13.99 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.959 0.787 . . . . 75.43 110.85 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.4 p -129.17 117.35 20.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.243 1.417 . . . . 73.32 107.343 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -69.33 -52.3 28.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.268 1.027 . . . . 64.5 110.604 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -149.26 -101.71 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.828 -2.286 . . . . 75.14 104.828 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -76.72 -20.23 56.79 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.481 2.312 . . . . 75.11 113.674 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.69 102.31 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.312 1.045 . . . . 64.22 108.636 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.84 146.89 24.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.105 1.362 . . . . 75.22 109.838 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 m -138.71 126.89 22.73 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.462 1.505 . . . . 74.44 107.43 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.59 97.71 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.173 -1.418 . . . . 73.31 107.173 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 m -94.54 152.91 18.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.157 1.383 . . . . 75.43 110.156 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -141.32 139.48 33.62 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.7 2.0 . . . . 74.33 108.545 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.11 137.38 47.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 75.11 107.556 162.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -142.11 77.22 1.57 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.927 1.691 . . . . 74.43 106.8 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.88 -98.31 0.48 Allowed Glycine 0 C--N 1.346 1.115 0 C-N-CA 125.435 1.493 . . . . 71.31 110.752 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -87.76 -13.69 41.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.335 1.454 . . . . 74.01 113.133 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.89 140.23 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 119.798 1.181 . . . . 75.34 110.754 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.7 mm -119.5 107.66 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.088 1.355 . . . . 71.12 107.855 168.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -96.04 138.23 33.97 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.154 -1.054 . . . . 75.51 108.154 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -147.0 91.45 2.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.389 0.676 . . . . 72.52 109.252 -170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -82.97 144.24 30.12 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.7 1.25 . . . . 71.42 110.616 173.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 92.9 mtp -130.64 153.09 49.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.519 1.527 . . . . 65.42 108.491 168.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 m -141.03 114.03 8.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.842 0.857 . . . . 63.04 108.737 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -123.95 125.08 43.97 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.568 1.547 . . . . 75.53 107.915 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.22 -101.44 0.38 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 124.983 1.427 . . . . 65.23 110.674 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.2 0.18 12.23 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.586 1.955 . . . . 74.43 112.951 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.76 137.79 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.878 1.271 . . . . 72.41 109.817 -172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.16 102.24 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.544 1.138 . . . . 72.05 109.324 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -84.85 150.99 24.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.539 1.536 . . . . 65.45 111.515 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -136.52 157.24 47.25 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.946 0.898 . . . . 74.32 110.199 167.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -137.46 143.64 41.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.531 1.533 . . . . 74.15 108.645 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.72 123.25 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.428 -1.693 . . . . 74.43 106.428 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -130.32 152.56 49.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.365 1.466 . . . . 71.2 108.988 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -133.29 138.28 46.35 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.85 0.86 . . . . 73.22 110.665 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -64.27 135.99 56.76 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.856 2.062 . . . . 75.52 112.526 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--N 1.343 0.319 0 N-CA-C 103.369 -2.826 . . . . 74.44 103.369 -177.414 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 109.581 -0.526 . . . . 74.34 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.3 p -128.56 124.86 37.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.763 1.225 . . . . 73.1 109.05 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.42 174.21 27.82 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 109.63 -1.388 . . . . 70.14 109.63 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.25 134.01 46.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 73.53 108.98 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.27 130.7 33.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.509 1.524 . . . . 74.21 110.04 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.73 152.47 21.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.273 1.029 . . . . 74.2 110.009 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.62 149.3 50.31 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.838 1.255 . . . . 64.31 112.011 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -125.99 -46.11 1.69 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.697 1.199 . . . . 75.31 111.126 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -162.43 155.71 20.27 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.303 1.041 . . . . 61.25 111.405 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -137.48 140.38 41.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.239 1.415 . . . . 74.33 108.522 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -116.33 149.33 39.48 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.084 0.954 . . . . 74.05 109.208 167.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.93 26.22 14.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.321 1.848 . . . . 73.45 113.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.34 -61.4 2.6 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 124.583 1.153 . . . . 74.31 113.373 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.43 -32.99 74.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.151 -0.928 . . . . 62.3 113.284 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.78 95.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.101 0.961 . . . . 74.32 113.112 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -68.56 -51.01 47.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.419 1.488 . . . . 72.24 113.42 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 mmt -63.37 -42.74 98.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.006 1.322 . . . . 72.2 112.966 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -74.91 -26.54 59.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.036 -0.983 . . . . 74.34 113.071 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.28 66.47 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 118.21 -0.9 . . . . 74.22 113.327 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.24 -13.31 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.968 0.792 . . . . 75.3 112.77 170.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.34 17.88 27.91 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 117.998 -1.446 . . . . 54.2 113.849 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.3 mt -61.56 142.22 94.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 119.694 1.747 . . . . 72.53 112.112 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.15 143.51 90.26 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.502 2.135 . . . . 74.4 111.742 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.73 -24.43 64.01 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.839 1.422 . . . . 71.15 114.839 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.09 -47.39 83.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.418 1.487 . . . . 75.2 113.397 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.6 -27.43 66.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.83 1.252 . . . . 72.51 112.642 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.15 -54.72 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 117.764 -1.112 . . . . 72.31 111.085 168.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -60.96 -42.92 99.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.6 1.333 . . . . 73.04 114.6 -175.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -13.23 59.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.36 -0.829 . . . . 72.32 112.986 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.09 -35.67 9.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.847 -0.974 . . . . 51.5 111.443 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -33.39 23.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.451 1.125 . . . . 73.53 112.874 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -71.96 -60.1 2.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.833 0.853 . . . . 73.22 110.542 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.48 114.99 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 124.339 1.024 . . . . 60.01 109.371 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.97 110.82 3.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.68 1.592 . . . . 71.21 109.415 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.29 -178.68 45.54 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.756 1.169 . . . . 64.02 111.893 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.97 158.3 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.241 1.416 . . . . 75.42 108.846 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -144.32 146.39 32.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.107 1.363 . . . . 71.4 109.76 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -128.38 138.22 52.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.75 1.22 . . . . 73.42 108.318 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -126.46 130.9 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.671 -1.603 . . . . 73.42 106.671 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.31 90.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.844 0.715 . . . . 70.04 109.729 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -76.36 136.32 39.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.325 0.65 . . . . 74.35 110.241 167.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.98 79.07 1.68 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.617 1.567 . . . . 73.01 107.477 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 -126.05 12.53 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.28 -1.528 . . . . 75.11 109.28 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -68.4 -29.35 68.02 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.558 1.318 . . . . 74.42 114.558 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 151.5 39.11 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.913 0.758 . . . . 74.42 111.493 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.06 137.35 23.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.164 1.786 . . . . 75.01 107.382 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -121.75 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.547 1.154 . . . . 72.52 108.85 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.61 103.4 5.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.75 -1.945 . . . . 73.22 105.75 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -92.93 138.7 31.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.698 1.199 . . . . 72.25 108.466 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.78 111.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.786 1.234 . . . . 75.43 107.774 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -86.64 107.3 18.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.873 1.269 . . . . 73.34 108.59 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 -173.63 1.68 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.825 1.65 . . . . 75.44 111.872 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.66 -31.54 63.98 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.783 1.182 . . . . 72.42 114.621 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -162.11 46.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.99 1.316 . . . . 72.4 109.324 167.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.34 160.85 43.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.495 1.518 . . . . 74.54 108.53 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.48 128.79 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.311 -0.996 . . . . 72.31 108.311 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -127.71 141.89 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.748 -1.575 . . . . 72.03 106.748 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.32 137.52 37.47 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.898 0.749 . . . . 71.21 110.766 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -124.17 158.13 33.09 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 125.475 1.734 . . . . 74.13 108.872 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.62 141.71 28.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 124.759 1.287 . . . . 64.34 108.972 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.69 160.67 42.44 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.48 1.112 . . . . 74.31 110.635 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 m -109.48 130.61 55.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.869 -1.16 . . . . 75.33 107.869 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.4 117.21 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.893 0.877 . . . . 73.42 110.242 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.68 56.58 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.74 -1.589 . . . . 55.35 112.759 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -119.16 150.77 39.48 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.502 1.651 . . . . 75.42 110.063 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.8 122.09 24.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.766 1.226 . . . . 64.11 110.732 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.7 m -144.97 151.9 39.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.966 1.306 . . . . 72.2 109.712 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -100.09 134.4 43.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.665 1.186 . . . . 62.11 110.857 -165.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.48 106.65 9.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.013 1.325 . . . . 74.32 109.67 -165.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.78 125.75 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.494 1.518 . . . . 74.0 111.664 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.7 m -82.3 166.38 19.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.728 1.611 . . . . 73.14 111.179 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.12 -27.42 14.14 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.579 1.952 . . . . 74.13 115.488 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -86.44 -17.19 34.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.266 1.826 . . . . 73.52 114.255 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.34 -16.08 45.69 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.785 1.183 . . . . 72.12 112.123 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -62.19 136.7 58.05 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.501 1.52 . . . . 72.11 110.4 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -133.65 153.76 51.43 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 124.382 1.051 . . . . 62.42 111.25 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -150.58 140.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.565 1.946 . . . . 74.43 108.517 -168.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -109.17 134.57 51.56 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.485 1.116 . . . . 75.41 109.867 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 t -168.21 161.05 12.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.327 1.051 . . . . 74.23 111.124 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.78 117.94 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.867 1.267 . . . . 75.14 109.302 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.52 138.15 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.906 0.883 . . . . 72.03 108.818 171.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -129.92 153.93 47.84 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.979 1.312 . . . . 70.34 111.821 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -97.74 132.41 43.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.929 1.292 . . . . 72.31 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -93.54 27.28 2.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.757 1.623 . . . . 74.41 113.607 -170.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.9 6.13 54.96 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.88 1.705 . . . . 74.32 115.304 171.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.26 57.36 0.89 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.329 1.565 . . . . 73.41 109.012 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.341 0.0 OUTLIER 49.4 32.6 4.72 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.337 1.855 . . . . 73.4 114.92 178.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -124.43 138.62 54.34 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 126.532 1.933 . . . . 74.12 108.641 -174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.5 mt -114.34 125.15 53.54 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 124.342 1.026 . . . . 73.5 108.896 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.0 141.7 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.425 1.49 . . . . 74.34 108.718 173.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.8 t -150.78 140.53 21.76 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.212 0.945 . . . . 75.43 110.141 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 76.6 p -135.74 160.09 39.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.347 1.859 . . . . 73.32 108.743 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -127.71 -56.81 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.005 -0.739 . . . . 64.5 109.005 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -140.62 -63.1 0.48 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.697 1.599 . . . . 75.14 109.414 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -127.13 -26.36 3.13 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.633 1.208 . . . . 75.11 112.068 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.1 mt -74.07 100.58 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 124.032 0.933 . . . . 64.22 109.58 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -74.57 148.97 40.35 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.595 1.184 . . . . 75.22 109.01 165.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -149.75 125.11 10.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.812 -1.551 . . . . 74.44 106.812 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.2 t -127.06 100.43 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.82 -1.548 . . . . 73.31 106.82 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 96.1 m -77.99 147.75 34.73 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.463 1.102 . . . . 75.43 108.578 165.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -149.33 114.61 5.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.555 1.142 . . . . 74.33 109.498 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.7 124.25 38.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.439 1.496 . . . . 75.11 109.145 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -129.78 67.65 1.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.235 -1.765 . . . . 74.43 106.235 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.78 -106.4 1.55 Allowed Glycine 0 C--N 1.348 1.202 0 C-N-CA 125.394 1.474 . . . . 71.31 110.278 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.72 -10.82 59.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.459 1.281 . . . . 74.01 114.459 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.58 137.0 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.199 1.0 . . . . 75.34 109.847 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.9 mm -124.77 104.82 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.023 1.329 . . . . 71.12 107.861 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.5 m -94.74 135.31 36.37 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.564 -1.273 . . . . 75.51 107.564 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.73 95.74 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.81 -0.811 . . . . 72.52 108.81 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.1 m -88.96 138.89 31.0 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.618 1.199 . . . . 71.42 109.653 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.7 mtp -130.67 154.37 47.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.425 1.49 . . . . 65.42 109.195 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.1 m -147.64 88.17 1.68 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.819 0.447 . . . . 63.04 111.474 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.09 107.48 16.46 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.502 1.121 . . . . 75.53 108.373 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.23 -99.14 0.22 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.782 1.182 . . . . 65.23 111.685 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.33 -3.81 15.98 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.22 1.808 . . . . 74.43 111.95 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.71 102.29 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.159 1.383 . . . . 72.41 109.075 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.69 84.34 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.498 1.119 . . . . 72.05 109.681 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -70.8 148.55 47.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.633 1.173 . . . . 65.45 112.261 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.28 156.02 49.17 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.722 0.809 . . . . 74.32 110.323 167.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -141.26 136.46 31.68 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.045 1.738 . . . . 74.15 107.339 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.38 132.77 70.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.129 -1.804 . . . . 74.43 106.129 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -139.64 155.26 47.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.616 1.567 . . . . 71.2 109.284 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -142.15 145.57 34.36 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.069 0.948 . . . . 73.22 110.883 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpt85 -51.4 141.09 16.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.023 2.929 . . . . 75.52 113.993 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.1 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 104.103 -2.555 . . . . 74.44 104.103 176.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 115.504 1.668 . . . . 74.34 115.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -59.01 127.2 31.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.929 1.692 . . . . 73.1 113.725 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.11 174.58 27.0 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.9 -0.88 . . . . 70.14 110.9 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -125.23 137.01 54.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.863 1.665 . . . . 73.53 108.094 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.47 127.88 26.5 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.397 1.479 . . . . 74.21 110.527 -166.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.96 152.0 28.23 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.734 0.814 . . . . 74.2 110.046 168.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.39 146.94 50.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.194 0.598 . . . . 64.31 110.409 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -120.39 -60.63 1.66 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.442 1.097 . . . . 75.31 109.779 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 m -143.17 157.28 44.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.69 1.196 . . . . 61.25 110.982 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -142.86 149.97 39.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.289 1.435 . . . . 74.33 109.36 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -125.7 148.96 48.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.059 0.944 . . . . 74.05 109.38 165.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 54.33 33.1 17.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.819 2.048 . . . . 73.45 112.402 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -61.51 -64.61 0.89 Allowed 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.572 1.149 . . . . 74.31 111.318 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.85 -38.99 90.31 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 124.446 1.091 . . . . 62.3 113.062 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.45 78.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.546 1.139 . . . . 74.32 113.476 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -74.39 -40.79 61.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.541 1.136 . . . . 72.24 113.322 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.1 mmt -68.08 -36.64 80.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.492 1.117 . . . . 72.2 113.395 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -65.0 -40.66 95.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.846 0.858 . . . . 74.34 112.313 167.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.85 -33.18 70.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.081 1.511 . . . . 74.22 115.081 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -75.87 -14.12 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 113.371 0.878 . . . . 75.3 113.371 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.7 20.69 39.43 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.593 -1.115 . . . . 54.2 112.719 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.7 135.55 96.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 118.909 1.354 . . . . 72.53 109.296 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.77 153.25 78.73 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.338 2.025 . . . . 74.4 112.268 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -56.97 -27.66 61.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.131 1.53 . . . . 71.15 115.131 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.78 -52.99 61.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.087 -0.958 . . . . 75.2 112.546 169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.62 -22.9 67.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.643 1.177 . . . . 72.51 114.059 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -75.04 -56.65 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 72.31 110.197 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -66.08 -36.38 83.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.702 1.371 . . . . 73.04 114.702 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -13.78 49.44 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.722 0.638 . . . . 72.32 112.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.74 -21.5 76.65 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 118.698 -1.056 . . . . 51.5 111.424 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -103.35 -22.33 13.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 116.365 -1.778 . . . . 73.53 113.86 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.25 20.0 p-10 -70.46 -51.68 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.127 1.33 . . . . 73.22 110.778 -173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.4 mm -97.96 122.98 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.606 1.562 . . . . 60.01 107.418 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.1 126.46 29.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.392 1.057 . . . . 71.21 109.553 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.79 -168.76 10.31 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 124.598 1.186 . . . . 64.02 112.172 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.2 153.86 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 107.801 -1.185 . . . . 75.42 107.801 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -135.98 148.99 48.68 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.11 1.364 . . . . 71.4 108.79 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -138.47 135.78 35.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.9 0.88 . . . . 73.42 108.727 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.96 130.84 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.358 -1.349 . . . . 73.42 107.358 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -136.23 97.81 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.329 -0.989 . . . . 70.04 108.329 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -76.28 143.12 41.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.873 0.869 . . . . 74.35 109.808 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -145.24 83.07 1.67 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.87 -1.159 . . . . 73.01 107.87 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.72 -120.3 10.92 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.292 -1.523 . . . . 75.11 109.292 -175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -77.67 -24.79 49.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 74.42 114.243 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.69 154.13 36.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.305 1.042 . . . . 74.42 111.678 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.78 119.8 6.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.775 1.23 . . . . 75.01 108.39 -173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -99.69 137.48 38.1 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.413 1.071 . . . . 72.52 108.901 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.71 140.86 51.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.336 -1.727 . . . . 73.22 106.336 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 m -140.09 136.95 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.966 1.706 . . . . 72.25 107.929 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.26 114.15 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.635 1.574 . . . . 75.43 106.806 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.3 m -96.8 130.63 44.03 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.296 1.439 . . . . 73.34 109.608 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.39 172.55 8.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.615 1.566 . . . . 75.44 109.365 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.23 7.5 8.02 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 118.249 -1.306 . . . . 72.42 114.638 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -36.9 1.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.23 1.515 . . . . 72.4 112.062 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.5 168.92 22.77 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.967 1.307 . . . . 74.54 110.401 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.73 138.31 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 124.56 1.163 . . . . 72.31 108.242 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.58 127.41 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.197 1.799 . . . . 72.03 106.778 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.18 144.3 30.79 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.737 0.648 . . . . 71.21 111.41 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -146.45 161.18 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.597 1.959 . . . . 74.13 108.857 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -133.81 144.46 49.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.033 0.933 . . . . 64.34 109.88 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.08 171.41 18.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.24 1.416 . . . . 74.31 110.122 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.8 m -112.83 132.09 55.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.59 1.156 . . . . 75.33 108.204 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.39 133.28 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.163 0.985 . . . . 73.42 110.307 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.15 -26.84 13.11 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.59 -1.117 . . . . 55.35 111.593 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.37 153.12 21.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.972 1.309 . . . . 75.42 110.172 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.26 158.0 24.96 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.408 1.067 . . . . 64.11 110.721 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.33 165.01 27.13 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.755 1.222 . . . . 72.2 110.145 -165.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.99 117.23 30.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.736 1.214 . . . . 62.11 109.187 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.06 166.36 11.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 74.32 110.645 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -115.38 148.13 39.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.5 1.92 . . . . 74.0 109.481 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p -111.79 173.88 6.14 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.715 1.606 . . . . 73.14 110.361 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -55.3 -28.73 55.53 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 116.52 2.044 . . . . 74.13 116.52 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.7 p -85.75 -15.87 40.73 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.371 1.068 . . . . 73.52 113.411 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.16 65.35 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 118.339 -1.256 . . . . 72.12 111.542 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.18 129.69 41.94 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 119.261 1.531 . . . . 72.11 109.868 164.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -108.43 150.4 27.46 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 124.792 1.308 . . . . 62.42 110.5 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.31 127.11 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.088 -1.415 . . . . 74.43 109.317 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -74.87 143.14 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.084 0.865 . . . . 75.41 110.663 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 t -160.74 161.0 32.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.12 1.368 . . . . 74.23 109.588 -166.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.36 144.61 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.918 -1.141 . . . . 75.14 107.918 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.18 132.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.098 0.959 . . . . 72.03 109.472 -174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -134.53 150.73 50.79 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.232 1.413 . . . . 70.34 110.751 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 12.9 tp -80.05 137.85 36.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.275 1.03 . . . . 72.31 110.267 171.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -85.59 6.49 27.07 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.769 1.228 . . . . 74.41 112.441 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.436 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 73.6 5.07 67.29 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.695 1.617 . . . . 74.32 113.42 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -127.41 42.31 3.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.356 1.862 . . . . 73.41 108.922 -169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.337 0.2 OUTLIER 47.15 38.52 6.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.456 1.902 . . . . 73.4 113.904 -172.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -134.14 138.94 45.55 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.677 1.991 . . . . 74.12 108.993 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 mt -101.28 143.42 31.37 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 124.632 1.207 . . . . 73.5 108.618 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -121.84 134.38 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.098 -1.445 . . . . 74.34 107.098 170.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -151.09 150.17 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 75.43 110.898 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.1 p -140.87 126.28 18.75 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.241 1.416 . . . . 73.32 108.216 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.54 -87.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.885 1.366 . . . . 64.5 109.493 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.19 -43.44 1.79 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.245 1.418 . . . . 75.14 111.181 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -157.22 26.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.588 1.155 . . . . 75.11 111.533 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.6 mt -130.41 102.74 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.489 -1.3 . . . . 64.22 107.489 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -65.55 132.85 49.89 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.819 0.7 . . . . 75.22 109.518 167.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -142.27 108.81 5.33 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 124.683 1.239 . . . . 74.44 108.129 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -116.98 131.53 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.669 1.188 . . . . 73.31 108.67 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.6 m -113.53 151.83 31.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.251 1.821 . . . . 75.43 108.713 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.87 144.34 37.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.853 1.661 . . . . 74.33 108.534 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -117.92 124.29 47.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.789 2.035 . . . . 75.11 106.725 167.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.17 85.44 2.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.28 1.832 . . . . 74.43 106.844 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.28 -106.69 2.09 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.767 -1.333 . . . . 71.31 109.767 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.46 -20.68 19.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.92 1.288 . . . . 74.01 112.452 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.18 135.02 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.231 1.013 . . . . 75.34 110.52 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mm -119.54 95.1 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.01 1.324 . . . . 71.12 107.707 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.5 m -86.26 127.36 34.75 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.182 0.926 . . . . 75.51 108.858 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.11 141.26 51.81 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.732 -0.84 . . . . 72.52 108.732 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 m -140.93 120.6 13.36 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.715 1.206 . . . . 71.42 108.723 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 83.3 mtp -116.53 156.27 27.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 65.42 109.289 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.4 m -143.76 114.26 7.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.319 1.048 . . . . 63.04 109.557 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.67 105.03 11.17 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.506 1.922 . . . . 75.53 107.162 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.01 -128.91 43.13 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 110.483 -1.047 . . . . 65.23 110.483 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -73.75 -13.83 61.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.83 1.652 . . . . 74.43 114.139 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.4 mt -97.69 132.71 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.854 1.262 . . . . 72.41 109.469 -171.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.63 85.63 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 124.383 1.052 . . . . 72.05 109.458 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -68.47 139.6 55.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.078 1.351 . . . . 65.45 113.052 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 152.45 50.27 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.62 1.168 . . . . 74.32 111.104 173.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -130.45 151.18 51.22 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.663 1.585 . . . . 74.15 108.659 161.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 124.44 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.246 -2.131 . . . . 74.43 105.246 160.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -122.86 157.45 32.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 71.2 108.332 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -134.49 142.08 46.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.862 0.865 . . . . 73.22 110.45 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.7 ttp85 -61.73 138.21 58.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.692 1.997 . . . . 75.52 112.627 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 125.04 2.352 . . . . 74.44 107.996 -178.1 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 112.175 0.435 . . . . 74.34 112.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -132.77 114.1 13.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.172 1.789 . . . . 73.1 109.183 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 165.97 18.6 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 109.187 -1.565 . . . . 70.14 109.187 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tmmt? -120.29 138.46 53.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 73.53 109.744 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -133.64 151.35 51.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.337 1.855 . . . . 74.21 110.59 -164.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.38 149.98 30.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.936 1.294 . . . . 74.2 109.086 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.26 49.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.883 0.873 . . . . 64.31 110.398 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -102.48 -67.86 0.86 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.849 1.26 . . . . 75.31 109.117 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -141.56 167.88 21.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.649 1.18 . . . . 61.25 111.397 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.805 1.242 . . . . 74.33 110.133 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.85 146.46 50.27 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.681 1.592 . . . . 74.05 108.694 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 59.3 20.56 8.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.909 1.684 . . . . 73.45 113.679 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -57.96 -62.07 2.08 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.735 1.214 . . . . 74.31 112.793 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.89 -36.33 82.97 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.332 1.02 . . . . 62.3 112.987 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.16 78.71 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.368 1.067 . . . . 74.32 113.057 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -66.79 -47.06 73.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.266 1.426 . . . . 72.24 113.618 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.6 mmt -66.19 -36.58 83.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.874 1.269 . . . . 72.2 113.346 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -75.7 -28.99 58.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.383 1.073 . . . . 74.34 112.746 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.22 -38.96 71.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.134 0.973 . . . . 74.22 113.135 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.16 -9.73 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 113.174 0.805 . . . . 75.3 113.174 172.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 30.34 22.36 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.48 -1.178 . . . . 54.2 113.968 164.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.46 152.73 95.93 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 119.135 1.467 . . . . 72.53 111.367 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.11 145.74 68.0 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.516 2.144 . . . . 74.4 112.221 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -33.14 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.333 1.853 . . . . 71.15 114.801 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -53.54 -55.46 25.33 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.979 1.712 . . . . 75.2 113.18 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.64 -28.48 68.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.827 1.251 . . . . 72.51 113.87 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.56 -52.06 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 118.085 -0.96 . . . . 72.31 111.526 170.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -67.02 -36.41 82.08 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.696 1.369 . . . . 73.04 114.696 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -23.93 49.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.183 -0.913 . . . . 72.32 111.809 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.03 -32.43 32.24 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.765 -1.02 . . . . 51.5 111.972 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -29.11 30.87 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 118.442 1.121 . . . . 73.53 112.96 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -85.12 -60.36 2.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.062 0.945 . . . . 73.22 109.98 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.4 mm -85.21 128.24 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.141 0.976 . . . . 60.01 109.31 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -81.79 138.57 35.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.339 1.056 . . . . 71.21 110.737 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.32 -171.09 47.58 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 124.586 1.179 . . . . 64.02 111.065 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.1 t -136.78 152.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.852 1.661 . . . . 75.42 107.123 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -144.23 147.63 33.85 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.515 0.726 . . . . 71.4 109.794 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.57 146.15 50.92 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 108.348 -0.982 . . . . 73.42 108.348 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 mt -123.2 138.01 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 105.667 -1.975 . . . . 73.42 105.667 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.84 137.97 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.099 -1.074 . . . . 70.04 108.099 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -129.04 128.9 44.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.988 1.315 . . . . 74.35 108.601 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -137.57 78.63 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.816 1.322 . . . . 73.01 107.759 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.05 -126.64 13.76 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 109.212 -1.555 . . . . 75.11 109.212 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -66.8 -24.73 66.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.512 1.525 . . . . 74.42 114.535 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 146.4 37.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.349 1.06 . . . . 74.42 112.036 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.11 136.69 36.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.65 1.98 . . . . 75.01 107.801 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -125.42 149.22 48.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.67 1.988 . . . . 72.52 108.298 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.92 101.11 3.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.391 0.676 . . . . 73.22 109.544 -174.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -83.44 135.53 34.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.209 1.404 . . . . 72.25 109.878 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.7 mt -137.73 99.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.615 -1.254 . . . . 75.43 107.615 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -92.97 138.15 31.74 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.861 2.064 . . . . 73.34 110.373 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.13 -145.96 0.4 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 75.44 109.401 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.2 85.79 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.2 -0.778 . . . . 72.42 112.52 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -140.9 -62.03 0.48 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.055 1.342 . . . . 72.4 109.477 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -61.68 143.74 55.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.516 1.526 . . . . 74.54 114.157 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.89 144.15 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.767 1.292 . . . . 72.31 108.886 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.5 mt -122.57 127.07 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.868 -1.53 . . . . 72.03 106.868 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 91.36 3.27 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.903 0.881 . . . . 71.21 110.433 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -84.48 155.01 22.38 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.126 1.37 . . . . 74.13 111.42 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.99 138.91 28.76 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 124.851 1.345 . . . . 64.34 110.09 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.91 167.98 27.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.624 1.17 . . . . 74.31 111.032 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.7 m -118.89 128.36 54.36 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 124.704 1.253 . . . . 75.33 107.797 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.92 128.93 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.135 0.974 . . . . 73.42 111.801 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -3.38 86.19 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-O 117.979 -1.456 . . . . 55.35 113.303 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -117.42 147.05 43.04 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.304 1.552 . . . . 75.42 110.936 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.37 119.5 14.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.317 1.847 . . . . 64.11 111.901 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -140.13 169.57 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.047 1.739 . . . . 72.2 109.254 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.6 127.71 55.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.146 0.978 . . . . 62.11 110.33 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.39 141.86 47.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.695 1.598 . . . . 74.32 110.002 -170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -122.27 142.09 50.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.466 1.907 . . . . 74.0 110.383 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -116.7 -178.96 3.55 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.638 1.575 . . . . 73.14 111.132 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -65.94 -24.23 66.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.423 1.489 . . . . 74.13 114.983 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.3 p -81.47 -11.58 59.17 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.261 1.424 . . . . 73.52 112.045 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.85 88.09 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.114 1.34 . . . . 72.12 112.615 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.89 120.18 10.24 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 125.401 1.481 . . . . 72.11 111.364 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -97.8 126.94 43.43 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 124.953 1.408 . . . . 62.42 110.37 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.53 123.57 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.924 1.69 . . . . 74.43 108.801 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -76.01 137.11 40.03 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 124.206 0.941 . . . . 75.41 111.495 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -165.24 -175.94 3.85 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 124.993 1.433 . . . . 74.23 109.834 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.18 144.61 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.716 1.606 . . . . 75.14 107.765 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.02 133.09 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.861 0.864 . . . . 72.03 108.707 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -115.34 174.96 5.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.193 1.797 . . . . 70.34 111.509 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 13.2 tp -124.96 136.04 53.37 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 72.31 107.178 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -89.0 9.23 25.92 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.231 1.197 . . . . 74.41 114.231 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.426 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 84.79 3.3 88.17 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-O 118.147 -1.363 . . . . 74.32 113.86 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -124.64 50.28 1.73 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.08 1.44 . . . . 73.41 108.817 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.333 0.1 OUTLIER 51.19 27.3 3.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.648 1.979 . . . . 73.4 115.297 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -121.73 111.97 17.82 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.329 1.852 . . . . 74.12 109.446 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.53 143.61 46.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.743 1.277 . . . . 73.5 110.336 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.4 135.01 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.515 1.126 . . . . 74.34 108.73 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -158.36 161.57 37.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.935 0.894 . . . . 75.43 110.716 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.8 p -135.37 -178.87 5.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.178 1.791 . . . . 73.32 108.297 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -139.3 -76.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 64.5 109.284 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -133.4 -50.2 0.86 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.72 1.608 . . . . 75.14 109.406 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -148.29 1.86 0.64 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 75.11 111.923 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -105.76 120.46 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.841 1.656 . . . . 64.22 107.155 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -108.27 113.46 26.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.818 1.247 . . . . 75.22 108.661 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -113.26 129.41 56.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.842 1.339 . . . . 74.44 109.835 -174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.97 120.2 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.98 -1.119 . . . . 73.31 107.98 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.9 m -102.74 156.15 17.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.794 1.238 . . . . 75.43 109.205 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.82 142.25 38.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.7 2.0 . . . . 74.33 108.812 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 tt -120.48 119.8 34.03 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.451 -1.685 . . . . 75.11 106.451 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -129.45 83.56 2.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.535 1.534 . . . . 74.43 107.156 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.85 -111.88 3.95 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.913 1.244 . . . . 71.31 110.538 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -79.59 -24.2 42.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.18 1.392 . . . . 74.01 112.974 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -87.62 136.75 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.126 0.97 . . . . 75.34 110.709 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.23 107.62 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.895 1.278 . . . . 71.12 107.83 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -99.02 151.74 20.6 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 124.214 0.946 . . . . 75.51 109.328 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -146.7 141.46 26.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.926 1.29 . . . . 72.52 108.288 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 93.1 m -132.5 132.23 42.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.012 1.725 . . . . 71.42 108.239 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.2 mtp -131.12 119.07 21.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.444 1.497 . . . . 65.42 108.911 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -104.26 110.41 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.257 0.973 . . . . 63.04 109.116 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.8 tp -116.16 98.55 6.67 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 106.816 -1.55 . . . . 75.53 106.816 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.49 -130.59 40.69 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 109.768 -1.333 . . . . 65.23 109.768 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.45 8.74 20.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 74.43 114.013 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 74.3 mt -108.88 123.0 64.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 108.511 -0.922 . . . . 72.41 108.511 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.57 85.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.524 1.14 . . . . 72.05 108.366 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.32 137.81 58.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.821 1.248 . . . . 65.45 111.753 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -134.03 148.5 51.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.012 1.325 . . . . 74.32 109.715 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -143.78 141.54 30.46 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.633 1.173 . . . . 74.15 108.83 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.91 134.1 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.665 -1.235 . . . . 74.43 107.665 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.5 m -133.1 161.02 35.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.782 1.633 . . . . 71.2 109.516 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.73 142.73 33.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.467 1.107 . . . . 73.22 110.741 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -63.44 138.39 58.5 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.222 1.809 . . . . 75.52 113.681 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 104.595 -2.372 . . . . 74.44 104.595 -179.086 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.913 0.708 . . . . 74.34 112.913 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -60.44 112.78 2.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.296 1.839 . . . . 73.1 112.69 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.96 173.44 32.63 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.092 -1.603 . . . . 70.14 109.092 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -127.03 138.96 53.32 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.875 0.87 . . . . 73.53 109.322 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -134.55 139.94 45.76 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.463 1.505 . . . . 74.21 109.634 -168.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.99 152.8 18.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.46 1.104 . . . . 74.2 109.36 171.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.34 140.82 57.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.839 0.856 . . . . 64.31 110.031 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -118.18 -48.1 2.54 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.95 1.3 . . . . 75.31 110.887 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -152.15 152.23 32.03 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.761 1.224 . . . . 61.25 109.868 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -149.6 136.58 19.62 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.356 1.062 . . . . 74.33 110.142 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -128.64 147.07 50.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.965 1.706 . . . . 74.05 110.046 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 55.94 24.91 8.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.305 1.842 . . . . 73.45 112.712 -167.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.61 -62.66 1.63 Allowed 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.556 1.142 . . . . 74.31 112.136 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.87 -43.1 99.52 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.298 0.998 . . . . 62.3 113.173 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.31 75.82 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.685 1.194 . . . . 74.32 113.602 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.06 -46.93 76.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.456 1.502 . . . . 72.24 113.271 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.92 -40.05 79.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.563 1.145 . . . . 72.2 113.183 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.65 -37.67 88.38 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 74.34 112.419 169.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.6 74.03 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.235 1.198 . . . . 74.22 114.235 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.9 pt -79.72 -5.19 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.262 0.838 . . . . 75.3 113.262 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.34 22.52 26.75 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.239 -1.312 . . . . 54.2 113.79 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -69.96 146.11 94.85 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.478 1.639 . . . . 72.53 111.38 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 146.96 77.12 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.474 2.116 . . . . 74.4 111.864 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -30.23 64.04 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.829 1.418 . . . . 71.15 114.829 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.2 -51.52 69.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.387 1.075 . . . . 75.2 112.995 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.8 -24.42 67.75 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.616 1.167 . . . . 72.51 113.207 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.99 -45.55 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 118.005 -0.998 . . . . 72.31 111.073 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -67.28 -33.19 74.78 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.498 1.295 . . . . 73.04 114.498 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HZ1' ' HA3' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -83.8 -11.15 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.123 0.969 . . . . 72.32 112.56 173.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 -28.0 8.82 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.75 -1.028 . . . . 51.5 111.549 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -32.68 37.53 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.49 1.145 . . . . 73.53 113.366 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -83.61 -51.9 6.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.783 0.833 . . . . 73.22 111.301 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.26 113.04 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.411 1.084 . . . . 60.01 108.854 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -67.55 130.35 42.77 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.584 1.178 . . . . 71.21 110.561 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.63 31.25 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 124.834 1.334 . . . . 64.02 111.403 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 t -141.02 154.09 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.398 -1.334 . . . . 75.42 107.398 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -142.72 120.19 11.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.351 1.061 . . . . 71.4 109.922 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -99.8 131.27 45.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 124.302 1.001 . . . . 73.42 108.704 167.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.1 133.58 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.669 -1.604 . . . . 73.42 106.669 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.4 128.56 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 123.485 0.49 . . . . 70.04 109.823 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -88.94 128.6 35.69 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.725 -1.213 . . . . 74.35 107.725 165.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.83 53.11 1.4 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.896 1.278 . . . . 73.01 109.942 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.26 -119.82 5.27 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.035 -2.026 . . . . 75.11 108.035 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -77.2 -29.82 54.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.441 0.696 . . . . 74.42 111.923 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -69.37 164.25 23.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.417 1.087 . . . . 74.42 112.266 169.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -156.32 140.96 16.93 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.133 -1.803 . . . . 75.01 106.133 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -118.07 134.05 55.35 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.75 1.22 . . . . 72.52 109.957 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.59 112.93 18.59 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 125.115 1.509 . . . . 73.22 107.485 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -114.15 124.78 52.92 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.145 -1.428 . . . . 72.25 107.145 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.46 143.52 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.517 1.127 . . . . 75.43 108.601 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -133.74 153.86 51.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 73.34 110.821 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.94 139.66 19.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.096 1.758 . . . . 75.44 108.807 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' HZ1' ' A' ' 31' ' ' LYS . . . 70.44 -98.66 0.68 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.057 -1.617 . . . . 72.42 109.057 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -149.66 39.05 0.78 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.897 1.279 . . . . 72.4 111.314 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -142.2 135.47 28.95 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.121 0.968 . . . . 74.54 110.921 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.61 144.63 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.269 1.428 . . . . 72.31 109.938 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.51 139.32 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.683 1.593 . . . . 72.03 108.095 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.55 132.36 55.13 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.805 1.242 . . . . 71.21 108.075 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.37 158.45 42.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.887 1.275 . . . . 74.13 109.952 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -137.9 148.56 45.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 125.181 1.551 . . . . 64.34 108.853 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.46 157.52 41.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.329 1.452 . . . . 74.31 109.867 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.11 53.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.637 1.175 . . . . 75.33 108.084 171.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.76 113.06 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.648 1.179 . . . . 73.42 110.494 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.02 -11.45 60.52 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.118 -1.379 . . . . 55.35 112.994 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -97.62 144.02 27.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.248 1.524 . . . . 75.42 110.08 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -73.67 134.59 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.572 1.149 . . . . 64.11 110.74 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.568 ' HG ' HD23 ' A' ' 71' ' ' LEU . 27.0 p -164.62 160.0 19.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.979 1.312 . . . . 72.2 109.619 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.44 114.97 28.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.376 1.07 . . . . 62.11 109.972 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.568 HD23 ' HG ' ' A' ' 69' ' ' CYS . 3.7 mm? -103.65 136.22 43.76 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.797 1.639 . . . . 74.32 110.339 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.56 154.88 26.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.869 1.268 . . . . 74.0 111.267 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -117.17 169.34 9.52 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.647 1.979 . . . . 73.14 109.286 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -54.13 -32.75 56.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.145 1.535 . . . . 74.13 115.145 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 p -77.6 -11.15 59.83 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.293 2.237 . . . . 73.52 113.976 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.36 81.2 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.431 -1.205 . . . . 72.12 112.361 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.81 126.23 27.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.276 1.83 . . . . 72.11 110.668 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -112.89 119.33 37.58 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.165 0.916 . . . . 62.42 108.931 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.78 130.09 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.118 1.367 . . . . 74.43 111.928 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -73.93 142.19 45.95 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.194 1.397 . . . . 75.41 113.536 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -174.35 177.11 2.29 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 125.394 1.684 . . . . 74.23 110.615 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.95 148.72 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.773 2.029 . . . . 75.14 107.866 166.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.2 t -112.66 139.43 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.707 -0.849 . . . . 72.03 108.707 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -128.31 155.76 44.11 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.452 1.501 . . . . 70.34 111.102 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.18 117.48 31.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 72.31 107.148 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.67 14.15 4.96 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.058 1.503 . . . . 74.41 115.058 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.11 -7.0 64.86 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.423 1.487 . . . . 74.32 113.816 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -110.78 38.1 2.59 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.004 1.721 . . . . 73.41 111.568 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.312 0.2 OUTLIER 52.75 40.65 30.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.275 1.83 . . . . 73.4 112.96 -177.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -137.95 127.07 24.33 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.438 1.495 . . . . 74.12 109.553 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.1 mt -91.64 144.4 25.57 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.71 1.256 . . . . 73.5 109.11 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -130.97 138.39 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.204 1.402 . . . . 74.34 108.61 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -160.01 159.57 32.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.479 1.111 . . . . 75.43 109.971 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 73.9 p -130.85 -179.25 5.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 73.32 108.443 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -143.53 -55.02 0.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.645 0.657 . . . . 64.5 111.621 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -157.02 -54.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.524 1.13 . . . . 75.14 109.003 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -146.68 2.58 0.83 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.687 1.595 . . . . 75.11 111.699 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.31 102.08 13.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 C-N-CA 125.591 1.557 . . . . 64.22 107.582 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -76.01 144.69 40.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.525 -0.916 . . . . 75.22 108.525 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -143.31 106.61 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.312 1.045 . . . . 74.44 108.466 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -115.12 110.0 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 124.866 1.354 . . . . 73.31 108.018 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -97.67 152.48 19.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.845 1.258 . . . . 75.43 109.539 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.14 146.89 39.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.997 1.719 . . . . 74.33 109.697 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -119.78 137.8 53.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.093 2.157 . . . . 75.11 107.788 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -138.35 64.46 1.5 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.122 2.169 . . . . 74.43 106.561 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.47 -105.0 1.32 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.795 1.188 . . . . 71.31 111.014 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.01 -7.95 59.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.784 1.234 . . . . 74.01 113.095 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.39 146.46 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.579 1.152 . . . . 75.34 109.146 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.4 mm -130.39 143.61 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.478 1.511 . . . . 71.12 108.39 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -127.94 148.76 50.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.398 1.061 . . . . 75.51 108.315 168.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -140.17 117.27 11.18 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.347 -1.723 . . . . 72.52 106.347 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.2 m -120.95 102.01 8.07 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.858 1.349 . . . . 71.42 107.845 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 mtm -93.76 155.39 17.25 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.25 0.969 . . . . 65.42 110.45 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -134.6 97.2 3.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.507 1.123 . . . . 63.04 108.846 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt -85.99 95.06 9.38 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.526 1.13 . . . . 75.53 108.047 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.55 -108.57 1.73 Allowed Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.678 1.132 . . . . 65.23 111.523 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.53 -2.72 57.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.871 2.068 . . . . 74.43 115.5 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.34 137.46 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.079 -1.082 . . . . 72.41 108.079 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.65 88.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 123.944 0.778 . . . . 72.05 109.298 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -67.4 139.58 57.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.217 1.007 . . . . 65.45 112.073 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -133.61 148.83 51.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.564 1.545 . . . . 74.32 109.955 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -157.32 108.88 2.35 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.811 1.244 . . . . 74.15 108.715 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -100.98 135.09 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.304 1.442 . . . . 74.43 107.773 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.7 m -136.11 159.01 43.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 71.2 109.971 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -143.66 144.12 31.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.982 0.913 . . . . 73.22 110.697 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -65.48 136.92 57.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.704 2.002 . . . . 75.52 113.933 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 124.915 2.293 . . . . 74.44 107.798 178.367 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 117.101 2.26 . . . . 74.34 117.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -63.18 147.42 50.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.114 1.524 . . . . 73.1 115.114 -170.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.66 168.0 12.14 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.467 1.508 . . . . 70.14 110.646 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -89.71 152.86 21.12 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.902 1.281 . . . . 73.53 112.369 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -143.78 134.71 25.37 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.963 1.705 . . . . 74.21 107.782 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.25 154.02 22.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.919 0.781 . . . . 74.2 109.458 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.24 130.17 40.16 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.615 0.572 . . . . 64.31 109.649 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -103.57 -61.38 1.43 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.292 1.037 . . . . 75.31 110.797 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 m -143.62 155.08 44.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.384 1.073 . . . . 61.25 110.902 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.57 147.66 48.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 74.33 109.062 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -129.85 136.98 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.829 1.652 . . . . 74.05 108.333 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 56.44 28.18 13.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.861 1.665 . . . . 73.45 112.54 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.78 -63.33 1.28 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.514 1.126 . . . . 74.31 112.608 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -64.02 -37.49 87.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.543 1.152 . . . . 62.3 113.128 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.21 -44.31 88.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.414 1.086 . . . . 74.32 113.171 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.12 -43.46 67.59 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.241 1.416 . . . . 72.24 114.032 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.4 mmt -67.83 -38.27 82.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.177 0.991 . . . . 72.2 112.683 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -64.79 -40.38 95.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.867 0.867 . . . . 74.34 112.721 167.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.28 -27.92 64.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.963 1.468 . . . . 74.22 114.963 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -84.97 -8.3 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.104 0.779 . . . . 75.3 113.104 171.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.7 24.73 22.62 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.07 -1.406 . . . . 54.2 113.54 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.98 149.75 97.77 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.675 1.737 . . . . 72.53 111.29 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.96 152.22 62.91 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.329 2.019 . . . . 74.4 111.847 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -52.66 -34.45 51.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.025 1.33 . . . . 71.15 114.31 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -49.55 -54.83 15.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.73 2.012 . . . . 75.2 113.258 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.11 -26.13 62.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.506 1.523 . . . . 72.51 112.857 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.13 -45.94 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.125 0.97 . . . . 72.31 111.849 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.24 -37.41 74.97 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.307 1.225 . . . . 73.04 114.307 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -18.25 49.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.648 -0.692 . . . . 72.32 112.506 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -38.0 11.07 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.732 -1.038 . . . . 51.5 111.517 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -36.02 61.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.592 1.196 . . . . 73.53 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.81 -65.74 0.79 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.104 1.361 . . . . 73.22 110.661 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -76.83 121.36 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.563 1.165 . . . . 60.01 109.234 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -78.42 127.91 32.86 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.231 0.957 . . . . 71.21 109.716 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.06 -156.86 28.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.791 1.307 . . . . 64.02 111.127 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.89 164.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.865 1.266 . . . . 75.42 108.745 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.12 155.75 47.65 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.017 1.727 . . . . 71.4 107.819 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.13 145.53 31.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.905 -1.517 . . . . 73.42 106.905 167.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.8 mt -126.78 135.74 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.505 -1.665 . . . . 73.42 106.505 166.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.2 87.06 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.965 -1.124 . . . . 70.04 107.965 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -71.5 131.23 43.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.511 -0.768 . . . . 74.35 109.205 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.65 74.16 1.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.36 -1.348 . . . . 73.01 107.36 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.54 -125.27 9.22 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 108.993 -1.643 . . . . 75.11 108.993 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -72.22 -29.14 63.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.216 1.406 . . . . 74.42 114.266 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.95 152.63 42.37 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.117 0.885 . . . . 74.42 110.975 169.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -152.94 133.87 14.0 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.354 -1.35 . . . . 75.01 107.354 -171.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -119.29 148.06 43.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.106 1.362 . . . . 72.52 108.245 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.7 102.8 3.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.94 -1.504 . . . . 73.22 106.94 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.2 m -109.48 92.26 3.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.762 0.825 . . . . 72.25 109.397 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.6 mt -102.85 129.61 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.07 0.948 . . . . 75.43 109.093 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -126.29 150.07 48.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.501 1.12 . . . . 73.34 110.745 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.64 -152.32 0.4 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.374 1.87 . . . . 75.44 109.812 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.12 -0.92 82.53 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.98 -1.456 . . . . 72.42 113.191 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -157.93 9.3 0.16 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.681 1.74 . . . . 72.4 114.094 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -167.41 155.27 9.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.943 0.897 . . . . 74.54 111.928 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.75 144.78 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.598 1.559 . . . . 72.31 109.512 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -119.2 140.44 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.371 1.868 . . . . 72.03 106.48 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.2 123.85 39.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.742 0.817 . . . . 71.21 109.323 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -120.98 150.43 41.12 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.144 1.378 . . . . 74.13 108.983 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -147.56 143.14 27.56 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.707 1.255 . . . . 64.34 108.713 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.65 167.56 29.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.021 1.328 . . . . 74.31 110.55 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -119.25 128.34 54.09 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.419 -1.326 . . . . 75.33 107.419 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.36 103.78 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.436 1.094 . . . . 73.42 110.281 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.0 -7.07 11.97 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 117.85 -1.528 . . . . 55.35 112.621 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -123.95 156.66 35.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.374 1.587 . . . . 75.42 111.518 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -74.36 123.09 23.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.614 1.565 . . . . 64.11 110.717 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.9 m -142.02 156.34 45.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.333 1.453 . . . . 72.2 108.4 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.95 124.24 42.31 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.004 0.921 . . . . 62.11 110.14 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.26 125.42 51.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.985 1.714 . . . . 74.32 108.981 -172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -78.89 128.32 33.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.586 1.154 . . . . 74.0 110.876 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -90.45 166.18 13.4 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.253 1.821 . . . . 73.14 110.329 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 mtt -49.47 -38.16 28.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.954 1.835 . . . . 74.13 115.954 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 p -80.71 -7.37 59.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.965 1.706 . . . . 73.52 113.978 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.05 86.85 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 118.552 -1.138 . . . . 72.12 111.549 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.94 148.25 50.0 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.033 1.333 . . . . 72.11 110.043 163.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -135.57 142.96 45.42 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.768 0.668 . . . . 62.42 109.487 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.96 131.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.576 1.151 . . . . 74.43 110.826 -173.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -81.91 142.84 32.11 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.383 1.073 . . . . 75.41 112.004 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -169.86 160.74 8.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.634 1.574 . . . . 74.23 109.044 -176.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.6 t -104.4 125.21 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.709 -1.219 . . . . 75.14 107.709 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.03 138.64 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.118 0.886 . . . . 72.03 108.792 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -125.74 173.85 8.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.023 1.729 . . . . 70.34 111.204 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.45 127.34 19.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.414 1.485 . . . . 72.31 107.414 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.02 26.19 2.56 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.618 1.34 . . . . 74.41 114.618 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.8 -0.29 78.23 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.258 1.409 . . . . 74.32 114.586 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.05 61.38 1.65 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.35 1.575 . . . . 73.41 108.519 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.99 34.99 3.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.196 2.198 . . . . 73.4 115.331 171.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -128.26 109.76 11.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.875 1.67 . . . . 74.12 108.598 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -83.2 131.4 35.11 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.767 1.292 . . . . 73.5 109.587 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -124.34 137.47 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.761 1.224 . . . . 74.34 109.143 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -157.3 146.41 19.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.611 0.764 . . . . 75.43 110.644 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -138.14 110.09 7.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.398 1.479 . . . . 73.32 107.84 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -72.42 -59.6 2.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.312 1.045 . . . . 64.5 111.79 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -145.97 -61.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.974 1.31 . . . . 75.14 109.314 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -141.27 7.98 2.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.213 1.805 . . . . 75.11 111.64 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 mt -115.73 113.79 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.021 1.728 . . . . 64.22 106.795 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.241 0.963 . . . . 75.22 108.853 168.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -143.31 119.66 10.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.384 -1.339 . . . . 74.44 107.384 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -127.59 97.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 124.983 1.427 . . . . 73.31 107.376 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.3 m -78.17 146.35 35.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.614 1.166 . . . . 75.43 109.257 168.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -138.82 112.14 8.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.915 1.686 . . . . 74.33 108.193 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 tp -83.44 124.17 30.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.624 1.17 . . . . 75.11 108.521 165.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.45 83.14 2.05 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.301 1.84 . . . . 74.43 106.135 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.4 -109.73 3.07 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 109.999 -1.241 . . . . 71.31 109.999 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.3 2.85 56.42 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 74.01 113.846 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -113.96 136.08 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.03 0.932 . . . . 75.34 109.326 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mm -118.17 105.09 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.974 1.31 . . . . 71.12 108.267 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 m -86.17 144.64 27.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.05 -1.093 . . . . 75.51 108.05 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -144.45 95.6 2.74 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 107.83 -1.174 . . . . 72.52 107.83 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.1 m -82.17 137.91 34.83 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 125.205 1.566 . . . . 71.42 109.509 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 mtm -127.56 155.83 43.19 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.275 1.03 . . . . 65.42 109.562 168.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.1 m -140.34 101.85 4.22 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.097 0.873 . . . . 63.04 110.03 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.98 110.31 22.63 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.731 1.212 . . . . 75.53 107.888 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.33 -89.68 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.183 1.373 . . . . 65.23 112.943 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -132.2 36.97 3.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.444 1.898 . . . . 74.43 109.847 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.4 mm -133.92 137.98 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.947 1.699 . . . . 72.41 106.972 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.8 90.25 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 124.06 0.85 . . . . 72.05 108.932 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -78.76 143.79 35.81 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.052 1.341 . . . . 65.45 111.406 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.79 152.73 51.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.183 0.993 . . . . 74.32 109.587 164.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -146.08 126.33 13.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.236 1.414 . . . . 74.15 107.988 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -116.17 128.3 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 125.025 1.453 . . . . 74.43 107.397 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 56.3 m -127.82 157.68 39.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.755 . . . . 71.2 108.83 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -141.91 143.23 33.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.277 1.031 . . . . 73.22 110.875 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -51.32 140.96 16.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.42 2.288 . . . . 75.52 113.558 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 125.181 2.42 . . . . 74.44 108.334 -179.446 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.914 1.079 . . . . 74.34 113.914 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.0 p -60.7 110.16 1.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.371 1.868 . . . . 73.1 114.454 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.81 169.26 34.41 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 110.08 -1.208 . . . . 70.14 110.08 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -119.0 141.93 48.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.405 1.482 . . . . 73.53 108.542 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -137.18 159.1 42.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.228 1.811 . . . . 74.21 110.559 -168.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -121.27 143.41 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.287 1.435 . . . . 74.2 108.257 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 37' ' ' GLY . 37.5 tp -61.1 139.57 58.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.845 1.258 . . . . 64.31 111.608 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -122.79 -43.97 2.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.65 1.18 . . . . 75.31 111.334 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -155.49 156.14 34.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.295 1.038 . . . . 61.25 111.336 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -135.33 155.25 50.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.103 1.361 . . . . 74.33 109.332 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -131.31 144.42 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.707 1.203 . . . . 74.05 108.34 171.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 57.23 22.51 7.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.165 1.786 . . . . 73.45 114.227 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -56.32 -59.22 5.26 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.518 1.127 . . . . 74.31 113.478 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.61 -39.28 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.228 0.955 . . . . 62.3 112.909 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.84 76.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.561 1.144 . . . . 74.32 112.81 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.65 -49.24 74.0 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.321 1.448 . . . . 72.24 113.489 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.17 -37.19 85.03 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 124.512 1.132 . . . . 72.2 113.768 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -73.37 -27.46 61.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.272 -0.87 . . . . 74.34 112.768 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.67 63.75 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.454 1.102 . . . . 74.22 113.839 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.4 pt -80.67 -6.57 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 113.457 0.91 . . . . 75.3 113.457 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.75 28.95 27.78 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 118.759 -1.023 . . . . 54.2 113.379 167.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.84 147.26 88.72 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 118.774 1.287 . . . . 72.53 110.541 175.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.29 149.55 63.65 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.742 2.295 . . . . 74.4 112.588 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.74 -35.54 22.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.242 1.817 . . . . 71.15 114.988 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -51.07 -60.71 2.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.872 1.669 . . . . 75.2 112.614 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.5 -26.13 67.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.71 1.604 . . . . 72.51 113.917 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.6 -58.51 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 CA-C-O 118.233 -0.889 . . . . 72.31 110.691 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -63.98 -34.14 77.31 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.078 1.51 . . . . 73.04 115.078 -173.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -20.23 35.17 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.175 -0.917 . . . . 72.32 112.513 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -34.67 21.05 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.104 -0.831 . . . . 51.5 111.603 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -26.18 42.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.593 1.157 . . . . 73.53 112.769 170.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.67 -67.53 0.63 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.28 1.032 . . . . 73.22 110.52 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.79 108.74 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.572 1.17 . . . . 60.01 109.794 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -63.84 116.2 5.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.425 1.89 . . . . 71.21 109.908 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' H ' HD22 ' A' ' 9' ' ' LEU . . . -75.68 171.98 54.11 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 124.557 1.161 . . . . 64.02 111.834 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.96 149.24 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.189 -1.412 . . . . 75.42 107.189 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.2 t -142.66 149.65 39.17 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.566 0.746 . . . . 71.4 109.71 -172.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.56 140.54 26.19 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.215 1.006 . . . . 73.42 108.298 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -140.4 140.28 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.583 -1.636 . . . . 73.42 106.583 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.4 t -141.69 120.94 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.661 -0.866 . . . . 70.04 108.661 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -95.46 136.35 35.95 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.069 0.856 . . . . 74.35 108.987 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.72 49.57 2.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.155 1.382 . . . . 73.01 110.251 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -70.99 3.0 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.835 1.207 . . . . 75.11 110.858 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -120.74 -34.39 3.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.861 1.664 . . . . 74.42 110.794 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.99 165.45 24.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.316 1.046 . . . . 74.42 111.28 169.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -158.98 136.58 10.13 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.095 -1.446 . . . . 75.01 107.095 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -118.49 152.2 36.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.035 1.334 . . . . 72.52 110.795 168.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.24 137.69 39.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.394 -2.076 . . . . 73.22 105.394 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -143.35 127.13 17.15 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.667 1.187 . . . . 72.25 107.916 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.6 122.43 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.641 -0.874 . . . . 75.43 108.641 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -95.66 114.35 26.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.449 1.5 . . . . 73.34 109.67 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.83 -179.73 6.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.455 1.502 . . . . 75.44 110.487 167.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 17.6 1.59 Allowed Glycine 0 CA--C 1.545 1.939 0 C-N-CA 125.27 1.414 . . . . 72.42 114.99 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -150.03 -40.13 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 72.4 112.261 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 170.56 17.5 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.838 1.255 . . . . 74.54 110.749 -161.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.8 130.43 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.516 1.135 . . . . 72.31 108.825 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.67 144.01 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.525 1.13 . . . . 72.03 108.257 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.42 149.41 45.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 71.21 110.618 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -135.67 163.14 30.82 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.335 1.454 . . . . 74.13 109.44 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -145.39 139.09 26.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.263 -1.335 . . . . 64.34 108.539 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.73 167.18 31.23 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 124.229 0.956 . . . . 74.31 111.343 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.2 126.66 54.84 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.706 1.254 . . . . 75.33 108.271 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.44 123.8 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.093 0.957 . . . . 73.42 111.02 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.5 73.18 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.163 -1.354 . . . . 55.35 113.243 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -125.93 153.17 44.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.01 1.405 . . . . 75.42 109.825 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -72.76 136.92 45.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.096 0.959 . . . . 64.11 112.561 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 m -152.8 153.18 32.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.115 1.766 . . . . 72.2 108.343 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.66 113.55 25.64 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.244 0.965 . . . . 62.11 110.641 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.27 146.72 23.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.573 1.549 . . . . 74.32 109.267 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -112.44 130.58 55.93 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.262 1.025 . . . . 74.0 110.463 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.9 m -78.09 158.91 28.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.47 1.908 . . . . 73.14 110.747 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.38 -18.29 58.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.785 1.772 . . . . 74.13 115.785 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.9 p -76.23 -40.4 52.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.489 1.515 . . . . 73.52 112.38 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.38 2.26 13.49 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.535 -1.703 . . . . 72.12 112.052 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.36 125.72 26.52 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.291 2.046 . . . . 72.11 110.119 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -107.95 120.24 41.73 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.617 1.198 . . . . 62.42 108.617 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.49 127.95 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.337 1.455 . . . . 74.43 111.278 -167.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -80.1 141.42 35.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.091 1.357 . . . . 75.41 112.656 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -167.89 170.94 10.25 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.28 1.432 . . . . 74.23 110.034 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -108.84 137.78 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.454 1.502 . . . . 75.14 108.459 170.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.72 142.15 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 124.082 0.864 . . . . 72.03 108.912 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -126.98 173.04 9.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.811 2.044 . . . . 70.34 111.213 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.39 132.2 35.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 72.31 107.275 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.07 16.73 6.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.706 1.203 . . . . 74.41 113.889 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.29 5.73 77.87 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.042 1.782 . . . . 74.32 114.019 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -131.32 50.53 2.22 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.843 1.322 . . . . 73.41 109.625 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.32 0.4 OUTLIER 41.43 35.95 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 73.4 115.694 -174.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -137.92 122.84 18.95 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 126.021 1.728 . . . . 74.12 107.859 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.86 152.04 22.39 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.35 1.031 . . . . 73.5 109.586 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.53 139.28 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.928 1.291 . . . . 74.34 107.834 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -154.7 165.37 36.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.515 0.726 . . . . 75.43 109.703 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.472 HG21 ' H ' ' A' ' 95' ' ' PHE . 2.5 m -139.06 -176.57 4.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.956 1.302 . . . . 73.32 108.476 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' H ' HG21 ' A' ' 94' ' ' THR . 93.7 m-85 -135.62 -106.47 0.21 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.128 -1.804 . . . . 64.5 106.128 165.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.84 -40.16 6.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.775 1.23 . . . . 75.14 111.259 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -149.11 5.4 0.65 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.144 1.378 . . . . 75.11 112.78 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -124.16 107.79 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.59 -1.263 . . . . 64.22 107.59 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -80.09 165.07 22.86 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 123.975 0.797 . . . . 75.22 110.209 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.4 t -152.74 133.17 13.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.225 1.81 . . . . 74.44 108.483 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -139.03 105.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.941 1.697 . . . . 73.31 106.791 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.8 m -88.52 154.8 20.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.008 1.323 . . . . 75.43 109.746 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -137.19 143.32 42.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.863 1.265 . . . . 74.33 108.786 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.6 tp -120.39 117.46 27.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.33 1.852 . . . . 75.11 106.375 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 86.93 2.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.715 -1.587 . . . . 74.43 106.715 173.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.99 -106.43 2.02 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.385 -1.486 . . . . 71.31 109.385 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -96.7 -19.68 18.8 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 74.01 112.605 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -80.76 133.16 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.475 1.11 . . . . 75.34 109.776 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.6 ' HB ' ' HG ' ' A' ' 124' ' ' SER . 38.8 mm -121.29 103.49 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.03 -1.1 . . . . 71.12 108.03 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.5 m -104.53 97.37 7.29 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.169 0.918 . . . . 75.51 109.845 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.21 143.96 25.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.852 1.261 . . . . 72.52 110.226 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.1 m -145.67 122.8 11.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.655 1.182 . . . . 71.42 109.493 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.04 162.56 16.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.366 1.466 . . . . 65.42 110.091 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 m -144.85 92.2 2.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.566 0.746 . . . . 63.04 110.812 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.6 tp -88.36 114.17 24.71 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 124.28 1.032 . . . . 75.53 109.135 168.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.59 -103.06 0.23 Allowed Glycine 0 CA--C 1.535 1.29 0 O-C-N 125.158 1.536 . . . . 65.23 111.904 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.95 -13.24 25.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.901 2.08 . . . . 74.43 113.835 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.0 mt -119.07 121.98 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.068 0.849 . . . . 72.41 110.863 -166.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.6 96.48 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 O-C-N 124.727 1.267 . . . . 72.05 109.089 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.61 145.63 43.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.444 1.098 . . . . 65.45 111.853 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 154.33 51.27 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 123.411 0.684 . . . . 74.32 110.925 168.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -139.87 125.47 19.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.336 1.454 . . . . 74.15 108.384 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.72 133.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.924 1.289 . . . . 74.43 107.96 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.6 ' HG ' ' HB ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -140.41 162.5 35.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.979 1.312 . . . . 71.2 110.2 -175.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -138.87 146.93 41.77 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.308 1.443 . . . . 73.22 109.449 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -60.25 145.02 48.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.473 1.509 . . . . 75.52 114.239 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 105.818 -1.919 . . . . 74.44 105.818 174.743 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 114.823 1.416 . . . . 74.34 114.823 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 m -65.53 120.69 13.34 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.846 1.259 . . . . 73.1 113.352 -174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.94 175.98 28.49 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.398 0.999 . . . . 70.14 110.701 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -115.7 144.72 43.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.958 1.303 . . . . 73.53 109.951 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -139.84 141.17 36.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.158 1.783 . . . . 74.21 110.207 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -97.72 152.58 18.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.037 1.335 . . . . 74.2 109.66 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.85 143.5 57.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.248 0.619 . . . . 64.31 111.782 170.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -119.21 -61.45 1.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.383 1.473 . . . . 75.31 108.767 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 m -135.5 158.69 43.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.669 1.188 . . . . 61.25 110.521 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -144.12 162.42 36.32 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.779 1.632 . . . . 74.33 108.589 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.75 138.48 14.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.422 -0.585 . . . . 74.05 109.422 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.93 30.05 19.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.475 1.91 . . . . 73.45 112.559 -165.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.97 -57.17 13.76 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.106 0.962 . . . . 74.31 112.433 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.77 -43.68 95.64 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.606 1.191 . . . . 62.3 112.253 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.73 -47.67 76.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.827 1.251 . . . . 74.32 113.491 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.72 -47.0 73.7 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.005 1.322 . . . . 72.24 113.348 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.0 mmt -67.91 -35.56 78.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.909 1.077 . . . . 72.2 113.909 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -71.03 -30.67 66.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.282 -0.866 . . . . 74.34 112.115 171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.71 -37.77 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.515 1.126 . . . . 74.22 113.605 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.4 pt -83.86 -1.25 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 113.623 0.972 . . . . 75.3 113.623 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 27.96 50.46 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.738 -1.034 . . . . 54.2 114.088 164.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 147.32 99.0 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.683 1.242 . . . . 72.53 111.055 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.26 141.3 81.57 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 74.4 111.556 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -55.21 -30.41 59.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.909 1.284 . . . . 71.15 114.194 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -51.72 -54.04 32.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 75.2 113.568 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.31 -25.84 66.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.422 1.489 . . . . 72.51 113.004 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.9 mt -75.18 -49.73 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.02 0.928 . . . . 72.31 111.168 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -62.61 -42.78 99.78 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.972 0.909 . . . . 73.04 113.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.18 -13.49 58.55 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.37 1.044 . . . . 72.32 113.057 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.99 -18.83 45.36 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-O 118.263 -1.298 . . . . 51.5 112.183 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -35.01 11.2 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 116.913 -1.518 . . . . 73.53 113.549 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -78.15 -56.04 4.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.72 1.145 . . . . 73.22 111.085 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.4 124.99 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.436 1.494 . . . . 60.01 107.725 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.52 131.22 34.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 124.461 1.101 . . . . 71.21 109.375 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.06 -176.35 34.4 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 124.697 1.248 . . . . 64.02 111.574 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.96 156.38 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.816 1.646 . . . . 75.42 107.283 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -148.56 141.39 24.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.054 0.941 . . . . 71.4 109.162 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -124.24 144.0 50.21 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.242 -1.021 . . . . 73.42 108.242 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -129.54 139.01 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 106.442 -1.688 . . . . 73.42 106.442 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.07 112.32 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 107.321 -1.363 . . . . 70.04 107.321 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.32 121.47 40.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.153 1.381 . . . . 74.35 109.116 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -122.56 44.01 2.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 73.01 110.36 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -117.52 5.37 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.963 -2.055 . . . . 75.11 107.963 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -73.84 -29.52 62.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.555 1.317 . . . . 74.42 114.555 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 154.51 35.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.524 0.602 . . . . 74.42 110.526 169.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -151.94 137.76 18.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.575 -1.268 . . . . 75.01 107.575 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -125.01 150.4 46.77 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 124.587 1.18 . . . . 72.52 110.128 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 128.24 20.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.491 -1.67 . . . . 73.22 106.491 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 m -111.05 129.91 55.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.291 -1.374 . . . . 72.25 107.291 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.61 109.38 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.974 -1.861 . . . . 75.43 105.974 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 47.4 m -113.87 105.45 13.28 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.375 1.047 . . . . 73.34 109.414 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.04 -173.21 0.99 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 75.44 111.931 169.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.6 46.38 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.277 1.417 . . . . 72.42 114.915 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.1 p -159.04 20.2 0.19 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.201 1.4 . . . . 72.4 113.101 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 153.67 41.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.204 1.402 . . . . 74.54 109.562 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.54 129.81 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.331 1.052 . . . . 72.31 108.302 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -124.23 131.15 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.928 1.691 . . . . 72.03 107.404 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.06 130.54 50.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.252 1.021 . . . . 71.21 109.312 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.79 145.07 39.7 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.183 1.393 . . . . 74.13 109.46 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 146.35 51.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.763 1.625 . . . . 64.34 109.041 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -160.21 162.08 33.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.312 1.045 . . . . 74.31 111.663 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.2 m -96.84 128.28 43.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.564 1.165 . . . . 75.33 108.448 168.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.4 t -66.08 134.02 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.725 1.61 . . . . 73.42 110.737 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.13 -13.14 60.39 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.04 1.305 . . . . 55.35 113.049 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -105.67 145.93 30.4 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.461 1.504 . . . . 75.42 109.639 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.55 139.38 58.26 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.727 1.211 . . . . 64.11 112.244 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.08 161.53 42.38 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 124.792 1.307 . . . . 72.2 109.728 -170.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.84 118.05 30.98 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 124.358 1.036 . . . . 62.11 108.628 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.04 148.64 29.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.66 1.584 . . . . 74.32 109.097 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.67 125.25 43.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.588 1.155 . . . . 74.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -74.83 162.82 28.31 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.817 1.647 . . . . 73.14 110.626 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.05 -26.83 62.99 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.253 1.575 . . . . 74.13 115.253 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 -13.46 61.11 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.224 1.81 . . . . 73.52 113.901 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.98 -3.15 82.6 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.122 -1.377 . . . . 72.12 111.773 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.24 116.07 8.42 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 119.541 1.67 . . . . 72.11 111.087 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -87.12 123.77 32.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 124.809 1.318 . . . . 62.42 110.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.59 129.37 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.071 1.748 . . . . 74.43 109.966 -168.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -74.4 141.61 45.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.355 1.062 . . . . 75.41 111.741 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 t -166.07 166.65 17.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.185 1.394 . . . . 74.23 110.015 -168.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.07 146.54 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 75.14 107.643 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.75 145.41 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.23 1.012 . . . . 72.03 108.92 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.82 149.85 51.4 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.414 1.485 . . . . 70.34 109.837 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -106.21 124.63 49.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.24 1.416 . . . . 72.31 107.524 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -86.55 12.44 10.44 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.945 1.298 . . . . 74.41 114.428 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.5 -10.49 55.25 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.224 1.869 . . . . 74.32 113.872 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.9 49.77 1.14 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.517 1.527 . . . . 73.41 110.973 -169.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.291 0.6 OUTLIER 46.9 43.12 13.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.003 2.121 . . . . 73.4 114.054 -177.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -143.39 141.17 30.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.324 1.85 . . . . 74.12 108.642 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -115.94 148.07 40.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.539 1.535 . . . . 73.5 108.14 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -130.03 133.56 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.867 -1.16 . . . . 74.34 107.867 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -148.77 143.95 26.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.36 1.064 . . . . 75.43 111.219 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 p -139.51 127.91 22.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.363 1.465 . . . . 73.32 108.834 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.5 -98.88 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.495 1.918 . . . . 64.5 108.588 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -106.01 -53.13 2.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.827 1.251 . . . . 75.14 110.51 167.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -143.06 13.94 1.86 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.878 1.271 . . . . 75.11 112.7 -170.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.0 mt -113.65 99.15 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.074 -1.454 . . . . 64.22 107.074 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -87.83 105.58 17.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.071 0.948 . . . . 75.22 109.236 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 t -112.79 117.72 32.96 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.172 1.389 . . . . 74.44 110.631 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.34 128.31 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.227 -1.397 . . . . 73.31 107.227 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 m -109.11 146.19 34.45 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -142.24 148.41 38.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.808 0.843 . . . . 74.33 110.743 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.89 122.47 38.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.992 2.117 . . . . 75.11 107.486 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.14 79.74 1.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 74.43 107.376 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.67 -116.85 6.27 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 109.402 -1.479 . . . . 71.31 109.402 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.1 -10.09 51.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.319 1.448 . . . . 74.01 114.187 172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.25 139.86 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.698 0.799 . . . . 75.34 109.052 175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.31 144.72 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.283 1.433 . . . . 71.12 108.599 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -127.21 148.79 50.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.442 1.897 . . . . 75.51 108.23 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.94 145.79 33.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.922 0.889 . . . . 72.52 109.121 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.7 m -144.77 86.73 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.674 1.59 . . . . 71.42 107.927 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mtm -84.66 139.34 32.11 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.016 0.927 . . . . 65.42 109.747 170.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.1 m -130.82 103.08 6.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.662 1.185 . . . . 63.04 108.277 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.5 tp -118.36 119.56 34.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.334 1.454 . . . . 75.53 108.775 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.79 -105.49 1.34 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.138 -1.585 . . . . 65.23 109.138 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.4 0.05 10.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.681 1.993 . . . . 74.43 112.292 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.6 mt -99.3 142.59 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.96 1.704 . . . . 72.41 109.291 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -121.67 92.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.791 0.837 . . . . 72.05 109.574 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.87 112.09 7.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 65.45 112.307 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -94.5 146.6 23.98 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.289 1.435 . . . . 74.32 110.62 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -134.85 148.93 50.26 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.816 1.322 . . . . 74.15 108.019 161.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.82 131.06 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 105.954 -1.869 . . . . 74.43 105.954 169.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.2 m -131.93 165.3 24.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.16 1.384 . . . . 71.2 109.682 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -147.64 143.11 27.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.823 0.849 . . . . 73.22 110.799 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -54.5 140.09 35.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.629 2.372 . . . . 75.52 113.133 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 124.605 2.145 . . . . 74.44 107.263 178.642 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 115.083 1.512 . . . . 74.34 115.083 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -59.83 116.25 3.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.165 1.786 . . . . 73.1 113.715 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.82 170.86 29.32 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.627 -0.989 . . . . 70.14 110.627 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -112.92 140.46 47.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.981 1.312 . . . . 73.53 107.993 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.41 125.52 26.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.165 1.386 . . . . 74.21 110.34 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.58 152.36 30.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.973 0.909 . . . . 74.2 110.318 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.67 126.64 30.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.712 0.805 . . . . 64.31 109.033 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -95.79 -56.52 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.37 1.068 . . . . 75.31 110.917 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -156.89 163.36 39.26 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.079 1.352 . . . . 61.25 110.39 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -160.09 151.12 19.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.518 1.127 . . . . 74.33 109.59 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.59 143.95 43.86 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.204 1.401 . . . . 74.05 109.18 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.11 16.84 10.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.555 1.942 . . . . 73.45 114.783 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.79 -50.65 69.91 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.669 1.588 . . . . 74.31 113.189 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.17 -59.51 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.296 1.838 . . . . 62.3 112.782 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.5 83.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.213 1.405 . . . . 74.32 113.787 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.69 -52.71 49.26 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.987 1.315 . . . . 72.24 112.835 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 mmt -68.08 -35.35 78.05 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.373 1.046 . . . . 72.2 113.702 -176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -44.42 97.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.644 0.777 . . . . 74.34 112.314 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.45 79.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.322 1.23 . . . . 74.22 114.322 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 pt -80.95 -5.0 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.043 1.127 . . . . 75.3 114.043 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.99 19.33 26.81 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.229 -1.317 . . . . 54.2 114.646 161.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.25 142.63 97.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 119.54 1.67 . . . . 72.53 110.319 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.54 141.18 59.92 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.143 1.895 . . . . 74.4 111.65 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.31 27.3 tt0 -65.93 -14.3 61.3 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.668 1.729 . . . . 71.15 115.668 -173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.04 -53.17 61.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.616 1.167 . . . . 75.2 112.556 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.47 -26.01 66.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.563 1.545 . . . . 72.51 112.86 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.7 mt -78.85 -47.43 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 117.55 -1.214 . . . . 72.31 111.161 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -65.36 -39.48 92.38 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 113.731 1.011 . . . . 73.04 113.731 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -16.67 57.78 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.256 -0.878 . . . . 72.32 112.472 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.18 -37.74 10.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.974 -0.903 . . . . 51.5 111.35 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -26.27 34.73 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.465 1.106 . . . . 73.53 113.584 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -84.95 -62.82 1.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 124.163 0.914 . . . . 73.22 110.304 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.56 120.15 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.866 0.866 . . . . 60.01 108.914 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -66.33 127.58 32.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.051 0.94 . . . . 71.21 111.334 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.3 -172.57 48.87 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 124.712 1.258 . . . . 64.02 110.554 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.0 t -137.59 152.97 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.6 1.56 . . . . 75.42 107.389 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -135.77 155.61 50.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.257 1.023 . . . . 71.4 109.112 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -137.72 140.4 40.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.178 -0.675 . . . . 73.42 109.178 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.6 mt -123.61 129.61 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.863 1.352 . . . . 73.42 107.477 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.92 90.53 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -74.29 136.46 42.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.698 0.799 . . . . 74.35 110.223 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.07 86.22 1.43 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.233 1.013 . . . . 73.01 109.845 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.64 -114.29 4.06 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 109.526 -1.429 . . . . 75.11 109.526 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -91.58 -15.81 28.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.998 1.319 . . . . 74.42 111.874 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -86.15 147.65 26.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.322 1.449 . . . . 74.42 112.49 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -133.33 118.99 19.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.793 1.637 . . . . 75.01 107.828 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -87.6 131.93 34.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.046 1.338 . . . . 72.52 108.567 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.24 109.36 12.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.162 -1.792 . . . . 73.22 106.162 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -106.15 141.88 36.78 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.158 1.383 . . . . 72.25 109.536 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.91 107.41 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.145 1.378 . . . . 75.43 108.016 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.5 m -87.64 132.04 34.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.566 1.546 . . . . 73.34 109.068 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.88 4.64 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.653 . . . . 75.44 110.225 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.83 -86.93 0.86 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 109.674 -1.37 . . . . 72.42 109.674 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 t -150.25 21.56 0.85 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.996 1.318 . . . . 72.4 111.781 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HZ2' ' CD1' ' A' ' 59' ' ' ILE . 5.2 ptmm? -129.25 149.39 51.06 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.475 1.51 . . . . 74.54 109.818 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.91 111.68 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 124.198 0.936 . . . . 72.31 109.567 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.428 ' CD1' ' HZ2' ' A' ' 57' ' ' LYS . 38.2 mt -84.19 144.61 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.77 1.228 . . . . 72.03 107.988 166.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.29 141.68 23.34 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 123.955 0.784 . . . . 71.21 110.762 165.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.79 158.52 41.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.455 1.902 . . . . 74.13 107.817 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.37 145.83 39.47 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 124.081 0.863 . . . . 64.34 109.909 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -139.62 149.91 44.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.829 1.331 . . . . 74.31 110.175 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -94.03 126.1 39.05 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.915 1.384 . . . . 75.33 108.094 168.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.23 130.45 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.862 0.865 . . . . 73.42 111.675 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.74 -5.47 81.84 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.21 -1.328 . . . . 55.35 113.672 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.49 157.03 21.6 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.122 1.461 . . . . 75.42 109.71 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.62 143.75 46.21 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.057 0.848 . . . . 64.11 111.794 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.11 -173.01 3.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.633 2.373 . . . . 72.2 107.576 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.69 129.47 38.8 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.146 -0.687 . . . . 62.11 109.146 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mp -104.71 161.42 14.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.877 1.671 . . . . 74.32 109.448 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.22 142.58 39.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.233 1.413 . . . . 74.0 109.013 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 m -109.03 142.89 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.562 1.145 . . . . 73.14 108.035 168.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.1 mtt -44.53 -32.07 1.31 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 118.769 2.877 . . . . 74.13 118.769 -163.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -71.05 -22.43 62.13 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.12 1.368 . . . . 73.52 114.262 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.27 5.57 10.38 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.209 -1.328 . . . . 72.12 112.298 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.18 147.03 52.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.448 1.624 . . . . 72.11 111.923 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 124.39 44.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.442 1.497 . . . . 62.42 107.732 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.33 128.62 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.196 0.998 . . . . 74.43 111.928 -169.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 148.4 48.9 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.89 1.276 . . . . 75.41 111.791 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -169.46 162.87 10.34 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.548 1.155 . . . . 74.23 111.039 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.06 150.62 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 126.047 1.739 . . . . 75.14 107.465 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.03 139.65 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.847 -0.798 . . . . 72.03 108.847 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -125.35 152.03 45.29 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.73 1.612 . . . . 70.34 110.86 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.75 118.11 35.26 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 72.31 106.513 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.05 11.65 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.22 1.563 . . . . 74.41 115.22 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.76 11.16 85.7 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.04 1.305 . . . . 74.32 112.596 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -134.04 35.78 3.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.391 1.476 . . . . 73.41 109.702 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.318 0.5 OUTLIER 53.51 27.08 6.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.469 1.908 . . . . 73.4 114.785 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -124.93 126.35 45.37 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.834 1.654 . . . . 74.12 108.832 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 45.6 mt -94.05 127.51 39.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.157 0.983 . . . . 73.5 109.639 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.69 134.89 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 74.34 108.684 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 t -160.9 151.26 17.92 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.222 1.009 . . . . 75.43 111.362 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -161.23 141.24 10.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.74 1.216 . . . . 73.32 110.861 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -83.65 -61.32 1.86 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.227 0.954 . . . . 64.5 109.18 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -129.72 -52.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.75 1.62 . . . . 75.14 110.241 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -147.56 -5.98 0.47 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.089 -0.958 . . . . 75.11 113.341 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -78.43 85.65 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.787 1.235 . . . . 64.22 109.761 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.06 93.91 1.45 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.745 1.618 . . . . 75.22 111.725 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 t -85.28 128.41 34.68 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.496 1.123 . . . . 74.44 108.952 169.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.56 96.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.877 -1.527 . . . . 73.31 106.877 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -77.53 150.34 34.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.471 1.108 . . . . 75.43 109.665 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -132.6 128.85 38.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.733 2.013 . . . . 74.33 107.643 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.37 123.18 43.43 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.459 -1.312 . . . . 75.11 107.459 165.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.58 69.31 1.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.148 -1.797 . . . . 74.43 106.148 170.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.51 8.8 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.852 -1.299 . . . . 71.31 109.852 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.06 7.36 5.04 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.223 1.564 . . . . 74.01 115.223 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.44 138.05 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.141 0.976 . . . . 75.34 108.983 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 mm -123.62 98.52 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.05 1.34 . . . . 71.12 108.024 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -88.36 154.67 20.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.137 -0.69 . . . . 75.51 109.137 167.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -154.21 143.27 21.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.788 1.235 . . . . 72.52 108.343 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.8 m -130.56 126.76 37.58 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.832 1.332 . . . . 71.42 108.672 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mmm -119.08 105.55 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.266 2.227 . . . . 65.42 108.929 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.0 m -101.3 115.76 31.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.667 0.787 . . . . 63.04 110.275 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 110.16 12.7 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.422 1.889 . . . . 75.53 107.203 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.33 -135.74 47.95 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 109.893 -1.283 . . . . 65.23 109.893 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.73 3.38 37.66 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.845 1.258 . . . . 74.43 113.733 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.4 mt -93.63 132.75 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.402 -0.962 . . . . 72.41 108.402 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.88 95.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.439 -0.948 . . . . 72.05 108.439 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -78.48 136.15 37.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.472 1.909 . . . . 65.45 111.279 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.8 146.1 46.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.566 1.146 . . . . 74.32 109.698 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -130.9 140.79 50.24 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.881 1.672 . . . . 74.15 108.213 168.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.74 131.12 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.076 -1.824 . . . . 74.43 106.076 169.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m -136.71 159.05 42.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.79 1.636 . . . . 71.2 108.745 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -140.39 140.42 35.51 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.933 0.893 . . . . 73.22 110.381 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.73 136.51 57.02 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.308 2.243 . . . . 75.52 111.463 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.339 -2.467 . . . . 74.44 104.339 -175.124 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 104.269 -2.493 . . . . 52.31 104.269 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 58.63 61.86 2.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.198 2.199 . . . . 75.54 111.594 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.85 173.5 16.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.834 1.654 . . . . 64.31 109.739 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 66.94 76.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.435 1.894 . . . . 73.03 111.766 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -78.74 72.79 5.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.652 1.581 . . . . 74.24 110.703 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 46.8 m170 65.46 18.24 11.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.466 2.306 . . . . 62.12 114.376 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.94 123.19 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.982 1.313 . . . . 71.32 109.936 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -141.16 168.62 19.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.76 1.624 . . . . 75.33 110.101 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' HE3' ' H ' ' A' ' 106' ' ' GLY . 41.9 mmm 70.44 145.5 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.805 2.442 . . . . 75.42 112.286 -172.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p -150.87 115.35 5.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.804 -0.634 . . . . 70.03 110.689 -170.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -66.6 -14.42 62.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.591 1.556 . . . . 74.34 114.568 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 115.7 6.7 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.992 1.317 . . . . 73.1 112.359 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.18 173.4 35.38 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 110.283 -1.127 . . . . 70.14 110.283 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -117.62 145.45 44.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.044 0.937 . . . . 73.53 109.046 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -135.82 172.77 12.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.144 2.178 . . . . 74.21 110.579 -169.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -151.69 119.66 6.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.582 1.153 . . . . 74.2 108.04 -164.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 37' ' ' GLY . 46.7 tp -57.57 122.98 14.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.975 1.31 . . . . 64.31 112.177 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -100.22 -49.69 4.19 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 124.921 1.388 . . . . 75.31 110.436 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -161.41 159.77 28.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.57 1.148 . . . . 61.25 110.6 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -160.56 142.37 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.34 1.056 . . . . 74.33 110.661 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -127.65 148.59 50.38 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.233 1.813 . . . . 74.05 108.799 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.17 16.13 6.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.886 1.675 . . . . 73.45 113.509 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.54 -56.68 18.27 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.188 1.395 . . . . 74.31 112.909 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -60.99 -48.23 82.8 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.397 1.061 . . . . 62.3 112.767 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.85 -42.64 76.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.727 1.211 . . . . 74.32 113.794 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -68.6 -46.86 68.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.256 1.422 . . . . 72.24 113.241 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mmt -66.13 -41.23 90.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.646 1.178 . . . . 72.2 113.144 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -60.89 -40.78 94.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.39 1.076 . . . . 74.34 112.226 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.59 66.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.885 1.439 . . . . 74.22 114.885 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 pt -86.84 0.96 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 113.214 0.82 . . . . 75.3 113.214 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.91 22.57 38.43 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.381 -1.233 . . . . 54.2 113.774 166.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.16 145.93 70.07 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 119.278 1.539 . . . . 72.53 110.859 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 149.65 58.45 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.25 . . . . 74.4 111.998 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -55.52 -29.18 58.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.366 1.466 . . . . 71.15 114.693 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.31 -54.08 51.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.475 1.51 . . . . 75.2 113.257 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.69 -22.75 66.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.892 1.277 . . . . 72.51 113.698 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.2 mt -78.25 -49.56 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.444 1.098 . . . . 72.31 111.366 176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -65.74 -36.56 83.92 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.247 1.203 . . . . 73.04 114.247 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -27.67 55.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 118.524 -0.75 . . . . 72.32 112.28 171.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.3 -29.38 56.32 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.754 -1.026 . . . . 51.5 112.361 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.19 -30.12 18.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.436 1.095 . . . . 73.53 112.797 175.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.34 -59.86 2.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.738 0.815 . . . . 73.22 110.436 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.64 109.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.451 1.094 . . . . 60.01 108.822 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.14 115.77 8.82 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 124.12 0.887 . . . . 71.21 110.191 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.422 ' H ' HD23 ' A' ' 9' ' ' LEU . . . -77.43 179.66 50.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.974 1.421 . . . . 64.02 111.674 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 t -116.93 160.01 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.613 1.565 . . . . 75.42 106.81 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 t -148.15 149.83 32.7 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 108.713 -0.847 . . . . 71.4 108.713 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -147.07 139.56 24.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.628 -0.878 . . . . 73.42 108.628 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.5 mt -136.29 140.41 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.306 -1.368 . . . . 73.42 107.306 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.25 107.56 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.192 -1.04 . . . . 70.04 108.192 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -76.89 131.6 38.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.309 -0.997 . . . . 74.35 108.309 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -130.41 51.21 2.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.988 1.315 . . . . 73.01 108.79 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.25 -115.56 5.17 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.667 -1.773 . . . . 75.11 108.667 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 74.42 112.908 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.33 155.29 39.57 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.972 1.309 . . . . 74.42 112.134 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -147.36 128.27 14.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.621 1.569 . . . . 75.01 107.78 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -106.26 136.0 46.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.657 1.583 . . . . 72.52 108.707 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.74 134.48 55.22 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.083 -1.451 . . . . 73.22 107.083 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.89 122.94 15.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.059 1.343 . . . . 72.25 107.991 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.22 113.7 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.873 -1.158 . . . . 75.43 107.873 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -90.94 104.77 17.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.552 1.141 . . . . 73.34 109.695 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.61 174.99 11.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.644 1.178 . . . . 75.44 110.658 166.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.79 21.15 0.98 Allowed Glycine 0 CA--C 1.544 1.859 0 C-N-CA 125.714 1.626 . . . . 72.42 115.174 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.8 p -158.22 -30.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.578 1.689 . . . . 72.4 113.459 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -151.23 165.07 35.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.195 0.998 . . . . 74.54 110.742 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -108.73 139.72 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 124.462 1.101 . . . . 72.31 108.723 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 117.33 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 106.666 -1.605 . . . . 72.03 106.666 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.66 140.91 39.97 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.348 1.03 . . . . 71.21 109.016 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -144.42 158.97 43.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.954 1.702 . . . . 74.13 109.043 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -145.35 146.82 31.74 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.273 0.983 . . . . 64.34 109.563 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -148.4 171.27 16.3 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.436 1.494 . . . . 74.31 109.474 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.2 m -118.07 132.7 56.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.46 -1.311 . . . . 75.33 107.46 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.91 129.87 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 73.42 110.876 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.21 -7.96 49.16 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 118.179 -1.345 . . . . 55.35 113.821 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -101.62 152.37 20.89 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.202 1.501 . . . . 75.42 109.032 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.63 104.41 16.34 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.098 0.959 . . . . 64.11 110.879 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.7 m -125.18 -162.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.483 1.913 . . . . 72.2 109.067 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.06 155.74 49.76 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.707 1.203 . . . . 62.11 111.522 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.9 mt -132.03 139.04 48.44 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.792 1.637 . . . . 74.32 108.647 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.03 132.86 44.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.069 1.347 . . . . 74.0 109.892 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 m -83.72 162.41 20.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.432 1.493 . . . . 73.14 110.439 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.8 mtt -56.75 -30.1 63.22 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.94 1.459 . . . . 74.13 114.94 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.9 t -71.84 -11.33 60.75 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.427 1.491 . . . . 73.52 114.211 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.49 1.97 70.87 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.88 1.229 . . . . 72.12 112.028 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.89 132.52 47.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.303 1.441 . . . . 72.11 110.881 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -101.29 128.64 47.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.431 1.492 . . . . 62.42 108.375 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.97 126.15 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 124.038 0.836 . . . . 74.43 111.228 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.24 144.52 40.33 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.827 1.651 . . . . 75.41 111.729 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -171.88 179.59 2.69 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.113 1.365 . . . . 74.23 111.069 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.49 145.8 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 126.52 1.928 . . . . 75.14 107.557 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.21 143.33 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.111 0.964 . . . . 72.03 109.474 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -125.06 166.44 16.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.305 1.842 . . . . 70.34 111.216 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.11 135.77 41.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.659 1.584 . . . . 72.31 107.112 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.71 18.99 7.97 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.642 1.177 . . . . 74.41 113.74 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.48 9.18 64.27 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.991 1.758 . . . . 74.32 113.893 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -132.05 46.09 2.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.88 1.272 . . . . 73.41 109.574 -166.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.288 0.9 OUTLIER 49.65 32.06 4.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.071 2.148 . . . . 73.4 114.884 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -137.48 119.82 15.79 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.044 1.738 . . . . 74.12 108.572 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.22 146.42 23.73 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.204 0.94 . . . . 73.5 109.496 171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.72 138.0 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.914 1.286 . . . . 74.34 108.501 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 t -153.43 146.38 24.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.964 0.906 . . . . 75.43 109.51 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.9 p -120.14 174.29 6.58 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.758 1.223 . . . . 73.32 109.007 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.85 -85.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.412 -0.958 . . . . 64.5 108.412 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -51.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.809 1.244 . . . . 75.14 109.11 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.6 12.87 1.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.128 1.771 . . . . 75.11 111.601 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.7 mt -112.21 118.98 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.451 1.9 . . . . 64.22 106.683 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -111.08 102.08 10.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.611 1.164 . . . . 75.22 108.736 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.7 m -99.48 129.18 45.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.293 1.437 . . . . 74.44 110.344 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -133.06 108.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.589 1.156 . . . . 73.31 108.608 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.7 m -85.92 148.49 25.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.456 1.102 . . . . 75.43 109.221 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.85 118.01 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.999 1.32 . . . . 74.33 109.262 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.92 127.28 41.8 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.522 -0.918 . . . . 75.11 108.522 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.14 81.52 2.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.279 1.832 . . . . 74.43 107.729 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.451 ' H ' ' HE3' ' A' ' 1' ' ' MET . . . 66.95 -110.38 3.45 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.927 1.251 . . . . 71.31 110.922 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.81 21.24 9.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.562 1.545 . . . . 74.01 111.99 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -129.4 141.38 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.747 1.219 . . . . 75.34 108.646 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.07 107.97 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.941 1.296 . . . . 71.12 107.89 172.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 m -85.9 144.2 27.79 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.835 1.254 . . . . 75.51 108.283 165.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -149.3 122.43 8.89 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.209 -1.404 . . . . 72.52 107.209 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.93 120.33 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.513 1.133 . . . . 71.42 108.87 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.4 mtp -118.43 142.59 47.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.894 1.678 . . . . 65.42 109.216 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -133.71 95.74 3.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 63.04 109.905 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -96.08 106.37 18.54 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 125.038 1.335 . . . . 75.53 108.287 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.47 -109.84 3.08 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 110.218 -1.153 . . . . 65.23 110.218 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.78 -9.06 20.3 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.527 1.531 . . . . 74.43 112.014 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.24 130.87 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.05 1.34 . . . . 72.41 108.956 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.49 82.24 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 124.168 0.918 . . . . 72.05 109.621 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.96 131.91 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.434 1.093 . . . . 65.45 112.534 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -127.97 152.24 48.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.038 1.335 . . . . 74.32 109.577 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -155.79 130.22 8.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.605 1.162 . . . . 74.15 109.401 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.43 131.69 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.096 1.358 . . . . 74.43 107.497 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m -131.02 159.29 37.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.412 1.485 . . . . 71.2 108.924 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -129.2 131.57 47.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.558 1.143 . . . . 73.22 110.016 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -69.33 119.96 14.4 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.852 2.061 . . . . 75.52 110.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 124.098 1.904 . . . . 74.44 108.425 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 . . . . . 0 N--CA 1.504 2.251 0 N-CA-C 104.777 -2.305 . . . . 52.31 104.777 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -149.4 123.39 9.4 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 118.97 0.804 . . . . 75.54 109.296 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -170.64 -56.62 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.102 1.761 . . . . 64.31 108.479 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 45.06 32.47 0.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.641 2.776 . . . . 73.03 115.658 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -28.15 67.92 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 116.355 1.983 . . . . 74.24 116.355 -165.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 58.81 42.59 19.68 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.144 1.778 . . . . 62.12 113.294 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.81 -25.57 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 71.32 113.495 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -171.17 149.44 2.85 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.249 1.419 . . . . 75.33 109.649 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt -96.8 143.11 28.02 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 124.472 1.107 . . . . 75.42 109.507 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -151.66 116.85 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 124.3 1.0 . . . . 70.03 109.957 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.65 -6.88 40.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.993 1.717 . . . . 74.34 114.447 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -57.01 120.78 8.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.329 2.252 . . . . 73.1 112.837 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.62 169.8 21.02 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 109.944 -1.262 . . . . 70.14 109.944 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 ttmt -121.22 133.03 55.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.974 1.309 . . . . 73.53 108.88 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -134.04 122.92 23.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.198 1.399 . . . . 74.21 110.217 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.68 153.31 37.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.264 1.025 . . . . 74.2 110.061 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.65 137.02 49.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.195 0.309 . . . . 64.31 110.726 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -109.17 -48.57 3.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.744 1.277 . . . . 75.31 110.095 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.55 160.24 25.74 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 124.255 0.972 . . . . 61.25 111.786 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.27 153.45 50.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.826 1.65 . . . . 74.33 107.628 172.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -129.87 142.03 50.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.968 0.907 . . . . 74.05 109.613 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 58.86 25.37 13.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.346 1.858 . . . . 73.45 113.495 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -53.83 -55.15 29.19 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.159 1.384 . . . . 74.31 112.794 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.37 -45.24 76.87 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 124.791 1.307 . . . . 62.3 112.946 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.75 86.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.359 1.064 . . . . 74.32 113.577 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.98 -45.4 67.43 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.698 1.199 . . . . 72.24 112.815 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 16.3 mmt -65.82 -40.44 91.83 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.514 1.134 . . . . 72.2 112.945 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -59.34 -39.48 83.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.436 1.094 . . . . 74.34 113.014 168.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.68 72.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.614 1.339 . . . . 74.22 114.614 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -77.16 -1.54 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 113.682 0.993 . . . . 75.3 113.682 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.56 38.07 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.83 -0.983 . . . . 54.2 113.146 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.57 142.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 118.581 1.19 . . . . 72.53 109.276 175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.02 149.49 77.18 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.58 2.187 . . . . 74.4 111.565 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -59.74 -24.85 64.37 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.1 1.519 . . . . 71.15 115.1 -174.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.97 -46.39 78.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.575 0.954 . . . . 75.2 113.575 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -67.97 -25.7 65.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.352 -0.832 . . . . 72.51 113.001 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -72.73 -53.16 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 117.86 -1.067 . . . . 72.31 111.009 172.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -62.96 -43.13 99.64 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.025 1.12 . . . . 73.04 114.025 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -23.22 63.3 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.735 0.647 . . . . 72.32 111.926 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.57 -28.36 47.8 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.127 -1.374 . . . . 51.5 112.469 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.37 -28.34 16.96 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 116.756 -1.592 . . . . 73.53 113.79 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -80.35 -34.95 36.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.865 1.212 . . . . 73.22 110.942 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.3 mt -93.47 122.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.361 1.065 . . . . 60.01 108.883 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.71 144.91 29.05 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.983 0.802 . . . . 71.21 110.668 165.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.3 -162.75 26.42 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 124.603 1.19 . . . . 64.02 110.725 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -143.86 152.64 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.607 1.963 . . . . 75.42 107.5 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -132.88 149.21 52.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.841 0.856 . . . . 71.4 109.598 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.14 136.91 54.98 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.023 -1.103 . . . . 73.42 108.023 166.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.63 128.42 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.509 -2.034 . . . . 73.42 105.509 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.92 99.11 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 124.162 0.914 . . . . 70.04 108.738 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -78.51 120.31 23.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.574 1.15 . . . . 74.35 109.685 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -117.45 54.83 0.87 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.381 1.472 . . . . 73.01 109.831 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -118.1 6.47 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.526 -1.83 . . . . 75.11 108.526 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -31.58 60.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.262 1.025 . . . . 74.42 112.829 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 161.92 29.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.339 1.056 . . . . 74.42 111.078 169.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -155.55 138.31 15.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.584 -1.265 . . . . 75.01 107.584 -175.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.98 144.7 48.37 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 125.53 1.532 . . . . 72.52 109.894 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.59 123.41 27.85 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.864 -1.902 . . . . 73.22 105.864 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -116.6 135.52 53.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.313 1.845 . . . . 72.25 108.525 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.52 105.26 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.325 -0.991 . . . . 75.43 108.325 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -97.02 114.84 26.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.824 1.649 . . . . 73.34 109.125 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.86 147.97 17.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.584 0.754 . . . . 75.44 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.63 -105.58 1.96 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 107.608 -2.197 . . . . 72.42 107.608 -173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -147.79 34.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.017 1.327 . . . . 72.4 110.912 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.03 164.4 30.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.0 1.72 . . . . 74.54 109.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.31 129.91 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.977 0.798 . . . . 72.31 109.0 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.27 133.8 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.396 -1.335 . . . . 72.03 107.396 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.82 124.38 43.17 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.245 -1.391 . . . . 71.21 107.245 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.501 HD22 ' HB3' ' A' ' 72' ' ' GLU . 25.3 m120 -123.33 150.71 43.27 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 124.645 1.216 . . . . 74.13 109.014 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.66 142.27 41.15 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 125.205 1.566 . . . . 64.34 108.99 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.81 162.3 40.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.063 1.345 . . . . 74.31 109.756 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.5 m -109.51 135.46 50.48 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.309 -1.367 . . . . 75.33 107.309 166.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.5 130.46 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.953 0.901 . . . . 73.42 111.032 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.88 -7.97 64.48 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 117.941 -1.477 . . . . 55.35 114.092 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -98.75 136.09 39.29 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.538 1.669 . . . . 75.42 110.08 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.66 136.12 45.58 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.364 1.04 . . . . 64.11 111.068 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -167.63 159.17 11.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.853 1.261 . . . . 72.2 109.403 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -100.94 124.23 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.236 0.96 . . . . 62.11 110.915 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -105.67 168.66 8.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.941 2.096 . . . . 74.32 109.787 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.501 ' HB3' HD22 ' A' ' 61' ' ' ASN . 35.0 tt0 -129.79 157.96 40.74 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.954 1.301 . . . . 74.0 110.545 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.6 p -124.11 173.09 8.52 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.093 1.757 . . . . 73.14 109.703 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -59.82 -20.39 56.61 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.509 1.67 . . . . 74.13 115.509 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.3 p -78.57 -14.88 59.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.159 1.783 . . . . 73.52 113.842 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.15 -2.08 83.35 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.996 1.284 . . . . 72.12 112.653 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -65.2 135.74 55.8 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 119.121 1.46 . . . . 72.11 112.559 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -103.93 143.14 33.26 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 125.126 1.516 . . . . 62.42 110.93 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.48 123.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.747 1.219 . . . . 74.43 111.272 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -71.43 137.92 48.66 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.738 1.215 . . . . 75.41 111.582 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -167.41 169.67 12.07 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.677 1.236 . . . . 74.23 110.315 -172.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.71 132.2 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.866 1.266 . . . . 75.14 107.998 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.41 140.88 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 124.11 0.881 . . . . 72.03 109.524 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -131.59 168.58 17.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 70.34 111.373 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -122.44 127.2 49.35 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.006 -1.479 . . . . 72.31 107.006 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -84.9 18.55 2.4 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.596 1.332 . . . . 74.41 114.596 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 18.16 78.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.98 1.276 . . . . 74.32 113.719 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -143.43 48.14 1.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.605 1.162 . . . . 73.41 109.47 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.29 0.7 OUTLIER 47.21 37.58 5.79 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.695 1.998 . . . . 73.4 114.178 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -137.47 121.34 17.61 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.862 1.665 . . . . 74.12 109.072 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.58 140.77 29.44 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.556 1.16 . . . . 73.5 109.725 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.22 138.68 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.326 1.45 . . . . 74.34 108.476 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -160.11 143.62 13.99 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.959 0.787 . . . . 75.43 110.85 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.4 p -129.17 117.35 20.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.243 1.417 . . . . 73.32 107.343 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -69.33 -52.3 28.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.268 1.027 . . . . 64.5 110.604 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -149.26 -101.71 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.828 -2.286 . . . . 75.14 104.828 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -76.72 -20.23 56.79 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.481 2.312 . . . . 75.11 113.674 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.69 102.31 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.312 1.045 . . . . 64.22 108.636 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.84 146.89 24.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.105 1.362 . . . . 75.22 109.838 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 m -138.71 126.89 22.73 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.462 1.505 . . . . 74.44 107.43 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.59 97.71 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.173 -1.418 . . . . 73.31 107.173 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 m -94.54 152.91 18.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.157 1.383 . . . . 75.43 110.156 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -141.32 139.48 33.62 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.7 2.0 . . . . 74.33 108.545 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.11 137.38 47.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 75.11 107.556 162.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -142.11 77.22 1.57 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.927 1.691 . . . . 74.43 106.8 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.88 -98.31 0.48 Allowed Glycine 0 C--N 1.346 1.115 0 C-N-CA 125.435 1.493 . . . . 71.31 110.752 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -87.76 -13.69 41.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.335 1.454 . . . . 74.01 113.133 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.89 140.23 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 119.798 1.181 . . . . 75.34 110.754 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.7 mm -119.5 107.66 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.088 1.355 . . . . 71.12 107.855 168.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -96.04 138.23 33.97 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.154 -1.054 . . . . 75.51 108.154 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -147.0 91.45 2.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.389 0.676 . . . . 72.52 109.252 -170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -82.97 144.24 30.12 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.7 1.25 . . . . 71.42 110.616 173.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 92.9 mtp -130.64 153.09 49.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.519 1.527 . . . . 65.42 108.491 168.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 m -141.03 114.03 8.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.842 0.857 . . . . 63.04 108.737 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.3 tp -123.95 125.08 43.97 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.568 1.547 . . . . 75.53 107.915 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.22 -101.44 0.38 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 124.983 1.427 . . . . 65.23 110.674 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.2 0.18 12.23 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.586 1.955 . . . . 74.43 112.951 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.76 137.79 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.878 1.271 . . . . 72.41 109.817 -172.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.16 102.24 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.544 1.138 . . . . 72.05 109.324 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -84.85 150.99 24.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.539 1.536 . . . . 65.45 111.515 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -136.52 157.24 47.25 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.946 0.898 . . . . 74.32 110.199 167.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -137.46 143.64 41.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.531 1.533 . . . . 74.15 108.645 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.72 123.25 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.428 -1.693 . . . . 74.43 106.428 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -130.32 152.56 49.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.365 1.466 . . . . 71.2 108.988 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -133.29 138.28 46.35 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.85 0.86 . . . . 73.22 110.665 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -64.27 135.99 56.76 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.856 2.062 . . . . 75.52 112.526 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--N 1.343 0.319 0 N-CA-C 103.369 -2.826 . . . . 74.44 103.369 -177.414 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.9 m170 . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 104.116 -2.549 . . . . 52.31 104.116 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -170.56 -43.26 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.353 2.661 . . . . 75.54 107.956 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -65.74 162.69 18.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.821 1.648 . . . . 64.31 112.324 168.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -163.08 156.0 19.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.305 1.442 . . . . 73.03 108.948 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -155.51 149.27 25.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.195 0.998 . . . . 74.24 109.968 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -170.06 -12.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.238 1.415 . . . . 62.12 112.495 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.0 m -75.19 78.47 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.059 1.744 . . . . 71.32 112.05 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -148.86 166.63 27.94 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.308 1.843 . . . . 75.33 109.624 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm 64.12 -175.62 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.446 1.899 . . . . 75.42 113.501 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -173.23 136.35 0.62 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.443 1.897 . . . . 70.03 107.444 170.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -88.91 64.37 7.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 74.34 109.581 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.3 p -128.56 124.86 37.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.763 1.225 . . . . 73.1 109.05 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.42 174.21 27.82 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 109.63 -1.388 . . . . 70.14 109.63 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.25 134.01 46.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 73.53 108.98 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.27 130.7 33.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.509 1.524 . . . . 74.21 110.04 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.73 152.47 21.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.273 1.029 . . . . 74.2 110.009 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.62 149.3 50.31 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.838 1.255 . . . . 64.31 112.011 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -125.99 -46.11 1.69 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.697 1.199 . . . . 75.31 111.126 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -162.43 155.71 20.27 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.303 1.041 . . . . 61.25 111.405 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -137.48 140.38 41.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.239 1.415 . . . . 74.33 108.522 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -116.33 149.33 39.48 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.084 0.954 . . . . 74.05 109.208 167.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.93 26.22 14.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.321 1.848 . . . . 73.45 113.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.34 -61.4 2.6 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 124.583 1.153 . . . . 74.31 113.373 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.43 -32.99 74.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.151 -0.928 . . . . 62.3 113.284 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.78 95.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.101 0.961 . . . . 74.32 113.112 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -68.56 -51.01 47.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.419 1.488 . . . . 72.24 113.42 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 mmt -63.37 -42.74 98.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.006 1.322 . . . . 72.2 112.966 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -74.91 -26.54 59.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.036 -0.983 . . . . 74.34 113.071 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.28 66.47 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 118.21 -0.9 . . . . 74.22 113.327 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.24 -13.31 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.968 0.792 . . . . 75.3 112.77 170.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.34 17.88 27.91 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 117.998 -1.446 . . . . 54.2 113.849 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.3 mt -61.56 142.22 94.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 119.694 1.747 . . . . 72.53 112.112 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.15 143.51 90.26 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.502 2.135 . . . . 74.4 111.742 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.73 -24.43 64.01 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.839 1.422 . . . . 71.15 114.839 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.09 -47.39 83.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.418 1.487 . . . . 75.2 113.397 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.6 -27.43 66.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.83 1.252 . . . . 72.51 112.642 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.15 -54.72 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 117.764 -1.112 . . . . 72.31 111.085 168.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -60.96 -42.92 99.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.6 1.333 . . . . 73.04 114.6 -175.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -13.23 59.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.36 -0.829 . . . . 72.32 112.986 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.09 -35.67 9.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.847 -0.974 . . . . 51.5 111.443 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -33.39 23.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.451 1.125 . . . . 73.53 112.874 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -71.96 -60.1 2.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.833 0.853 . . . . 73.22 110.542 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.48 114.99 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 124.339 1.024 . . . . 60.01 109.371 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.97 110.82 3.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.68 1.592 . . . . 71.21 109.415 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.29 -178.68 45.54 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.756 1.169 . . . . 64.02 111.893 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.97 158.3 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.241 1.416 . . . . 75.42 108.846 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -144.32 146.39 32.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.107 1.363 . . . . 71.4 109.76 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -128.38 138.22 52.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.75 1.22 . . . . 73.42 108.318 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -126.46 130.9 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.671 -1.603 . . . . 73.42 106.671 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.31 90.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.844 0.715 . . . . 70.04 109.729 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -76.36 136.32 39.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.325 0.65 . . . . 74.35 110.241 167.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.98 79.07 1.68 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.617 1.567 . . . . 73.01 107.477 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 -126.05 12.53 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.28 -1.528 . . . . 75.11 109.28 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -68.4 -29.35 68.02 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.558 1.318 . . . . 74.42 114.558 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 151.5 39.11 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.913 0.758 . . . . 74.42 111.493 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.06 137.35 23.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.164 1.786 . . . . 75.01 107.382 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -121.75 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.547 1.154 . . . . 72.52 108.85 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.61 103.4 5.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.75 -1.945 . . . . 73.22 105.75 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -92.93 138.7 31.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.698 1.199 . . . . 72.25 108.466 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.78 111.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.786 1.234 . . . . 75.43 107.774 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -86.64 107.3 18.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.873 1.269 . . . . 73.34 108.59 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 -173.63 1.68 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.825 1.65 . . . . 75.44 111.872 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.66 -31.54 63.98 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.783 1.182 . . . . 72.42 114.621 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -162.11 46.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.99 1.316 . . . . 72.4 109.324 167.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.34 160.85 43.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.495 1.518 . . . . 74.54 108.53 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.48 128.79 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.311 -0.996 . . . . 72.31 108.311 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -127.71 141.89 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.748 -1.575 . . . . 72.03 106.748 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.32 137.52 37.47 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.898 0.749 . . . . 71.21 110.766 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -124.17 158.13 33.09 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 125.475 1.734 . . . . 74.13 108.872 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.62 141.71 28.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 124.759 1.287 . . . . 64.34 108.972 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.69 160.67 42.44 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.48 1.112 . . . . 74.31 110.635 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 m -109.48 130.61 55.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.869 -1.16 . . . . 75.33 107.869 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.4 117.21 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.893 0.877 . . . . 73.42 110.242 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.68 56.58 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.74 -1.589 . . . . 55.35 112.759 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -119.16 150.77 39.48 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.502 1.651 . . . . 75.42 110.063 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.8 122.09 24.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.766 1.226 . . . . 64.11 110.732 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.7 m -144.97 151.9 39.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.966 1.306 . . . . 72.2 109.712 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -100.09 134.4 43.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.665 1.186 . . . . 62.11 110.857 -165.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.48 106.65 9.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.013 1.325 . . . . 74.32 109.67 -165.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.78 125.75 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.494 1.518 . . . . 74.0 111.664 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.7 m -82.3 166.38 19.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.728 1.611 . . . . 73.14 111.179 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.12 -27.42 14.14 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.579 1.952 . . . . 74.13 115.488 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -86.44 -17.19 34.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.266 1.826 . . . . 73.52 114.255 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.34 -16.08 45.69 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.785 1.183 . . . . 72.12 112.123 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -62.19 136.7 58.05 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.501 1.52 . . . . 72.11 110.4 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -133.65 153.76 51.43 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 124.382 1.051 . . . . 62.42 111.25 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -150.58 140.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.565 1.946 . . . . 74.43 108.517 -168.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -109.17 134.57 51.56 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.485 1.116 . . . . 75.41 109.867 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 t -168.21 161.05 12.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.327 1.051 . . . . 74.23 111.124 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.78 117.94 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.867 1.267 . . . . 75.14 109.302 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.52 138.15 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.906 0.883 . . . . 72.03 108.818 171.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -129.92 153.93 47.84 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.979 1.312 . . . . 70.34 111.821 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.9 tt -97.74 132.41 43.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.929 1.292 . . . . 72.31 109.565 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -93.54 27.28 2.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.757 1.623 . . . . 74.41 113.607 -170.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.9 6.13 54.96 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.88 1.705 . . . . 74.32 115.304 171.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.26 57.36 0.89 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.329 1.565 . . . . 73.41 109.012 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.341 0.0 OUTLIER 49.4 32.6 4.72 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.337 1.855 . . . . 73.4 114.92 178.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -124.43 138.62 54.34 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 126.532 1.933 . . . . 74.12 108.641 -174.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.5 mt -114.34 125.15 53.54 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 124.342 1.026 . . . . 73.5 108.896 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.0 141.7 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.425 1.49 . . . . 74.34 108.718 173.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.8 t -150.78 140.53 21.76 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.212 0.945 . . . . 75.43 110.141 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 76.6 p -135.74 160.09 39.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.347 1.859 . . . . 73.32 108.743 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -127.71 -56.81 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.005 -0.739 . . . . 64.5 109.005 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -140.62 -63.1 0.48 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.697 1.599 . . . . 75.14 109.414 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -127.13 -26.36 3.13 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.633 1.208 . . . . 75.11 112.068 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.1 mt -74.07 100.58 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 124.032 0.933 . . . . 64.22 109.58 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -74.57 148.97 40.35 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.595 1.184 . . . . 75.22 109.01 165.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -149.75 125.11 10.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.812 -1.551 . . . . 74.44 106.812 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.2 t -127.06 100.43 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.82 -1.548 . . . . 73.31 106.82 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 96.1 m -77.99 147.75 34.73 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.463 1.102 . . . . 75.43 108.578 165.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -149.33 114.61 5.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.555 1.142 . . . . 74.33 109.498 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.7 124.25 38.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.439 1.496 . . . . 75.11 109.145 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -129.78 67.65 1.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.235 -1.765 . . . . 74.43 106.235 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.78 -106.4 1.55 Allowed Glycine 0 C--N 1.348 1.202 0 C-N-CA 125.394 1.474 . . . . 71.31 110.278 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.72 -10.82 59.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.459 1.281 . . . . 74.01 114.459 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.58 137.0 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.199 1.0 . . . . 75.34 109.847 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.9 mm -124.77 104.82 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.023 1.329 . . . . 71.12 107.861 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.5 m -94.74 135.31 36.37 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.564 -1.273 . . . . 75.51 107.564 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.73 95.74 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.81 -0.811 . . . . 72.52 108.81 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.1 m -88.96 138.89 31.0 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.618 1.199 . . . . 71.42 109.653 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.7 mtp -130.67 154.37 47.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.425 1.49 . . . . 65.42 109.195 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.1 m -147.64 88.17 1.68 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.819 0.447 . . . . 63.04 111.474 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.09 107.48 16.46 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.502 1.121 . . . . 75.53 108.373 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.23 -99.14 0.22 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.782 1.182 . . . . 65.23 111.685 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.33 -3.81 15.98 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.22 1.808 . . . . 74.43 111.95 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.71 102.29 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.159 1.383 . . . . 72.41 109.075 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.69 84.34 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.498 1.119 . . . . 72.05 109.681 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -70.8 148.55 47.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.633 1.173 . . . . 65.45 112.261 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.28 156.02 49.17 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.722 0.809 . . . . 74.32 110.323 167.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -141.26 136.46 31.68 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.045 1.738 . . . . 74.15 107.339 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.38 132.77 70.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.129 -1.804 . . . . 74.43 106.129 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -139.64 155.26 47.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.616 1.567 . . . . 71.2 109.284 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -142.15 145.57 34.36 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.069 0.948 . . . . 73.22 110.883 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpt85 -51.4 141.09 16.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.023 2.929 . . . . 75.52 113.993 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.1 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 104.103 -2.555 . . . . 74.44 104.103 176.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 102.696 -3.076 . . . . 52.31 102.696 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.8 119.12 8.96 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.231 1.412 . . . . 75.54 109.112 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -69.84 158.17 36.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.5 1.52 . . . . 64.31 111.975 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.4 125.56 52.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.292 1.037 . . . . 73.03 108.517 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -129.43 146.04 51.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.673 1.189 . . . . 74.24 110.151 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -158.52 -32.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.245 1.818 . . . . 62.12 111.042 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 16.9 t 61.43 53.1 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.966 2.106 . . . . 71.32 109.935 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -168.4 151.32 5.44 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.758 1.623 . . . . 75.33 109.54 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.29 138.16 41.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.225 0.953 . . . . 75.42 111.216 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -164.29 142.71 7.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.49 1.516 . . . . 70.03 108.72 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -75.72 -2.75 31.09 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.504 1.668 . . . . 74.34 115.504 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -59.01 127.2 31.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.929 1.692 . . . . 73.1 113.725 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.11 174.58 27.0 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.9 -0.88 . . . . 70.14 110.9 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.8 ttmm -125.23 137.01 54.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.863 1.665 . . . . 73.53 108.094 173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.47 127.88 26.5 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.397 1.479 . . . . 74.21 110.527 -166.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.96 152.0 28.23 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.734 0.814 . . . . 74.2 110.046 168.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.39 146.94 50.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.194 0.598 . . . . 64.31 110.409 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -120.39 -60.63 1.66 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.442 1.097 . . . . 75.31 109.779 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 m -143.17 157.28 44.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.69 1.196 . . . . 61.25 110.982 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -142.86 149.97 39.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.289 1.435 . . . . 74.33 109.36 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -125.7 148.96 48.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.059 0.944 . . . . 74.05 109.38 165.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 54.33 33.1 17.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.819 2.048 . . . . 73.45 112.402 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -61.51 -64.61 0.89 Allowed 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.572 1.149 . . . . 74.31 111.318 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.85 -38.99 90.31 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 124.446 1.091 . . . . 62.3 113.062 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.45 78.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.546 1.139 . . . . 74.32 113.476 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -74.39 -40.79 61.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.541 1.136 . . . . 72.24 113.322 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.1 mmt -68.08 -36.64 80.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.492 1.117 . . . . 72.2 113.395 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -65.0 -40.66 95.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.846 0.858 . . . . 74.34 112.313 167.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.85 -33.18 70.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.081 1.511 . . . . 74.22 115.081 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -75.87 -14.12 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 113.371 0.878 . . . . 75.3 113.371 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.7 20.69 39.43 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.593 -1.115 . . . . 54.2 112.719 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.7 135.55 96.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 118.909 1.354 . . . . 72.53 109.296 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.77 153.25 78.73 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.338 2.025 . . . . 74.4 112.268 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -56.97 -27.66 61.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.131 1.53 . . . . 71.15 115.131 -174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.78 -52.99 61.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.087 -0.958 . . . . 75.2 112.546 169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.62 -22.9 67.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.643 1.177 . . . . 72.51 114.059 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -75.04 -56.65 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 72.31 110.197 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -66.08 -36.38 83.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.702 1.371 . . . . 73.04 114.702 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -13.78 49.44 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.722 0.638 . . . . 72.32 112.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.74 -21.5 76.65 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 118.698 -1.056 . . . . 51.5 111.424 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -103.35 -22.33 13.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 116.365 -1.778 . . . . 73.53 113.86 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.25 20.0 p-10 -70.46 -51.68 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.127 1.33 . . . . 73.22 110.778 -173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.4 mm -97.96 122.98 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.606 1.562 . . . . 60.01 107.418 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.1 126.46 29.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.392 1.057 . . . . 71.21 109.553 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.79 -168.76 10.31 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 124.598 1.186 . . . . 64.02 112.172 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.2 153.86 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 107.801 -1.185 . . . . 75.42 107.801 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -135.98 148.99 48.68 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.11 1.364 . . . . 71.4 108.79 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -138.47 135.78 35.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.9 0.88 . . . . 73.42 108.727 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.96 130.84 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.358 -1.349 . . . . 73.42 107.358 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -136.23 97.81 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.329 -0.989 . . . . 70.04 108.329 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -76.28 143.12 41.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.873 0.869 . . . . 74.35 109.808 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -145.24 83.07 1.67 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.87 -1.159 . . . . 73.01 107.87 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.72 -120.3 10.92 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.292 -1.523 . . . . 75.11 109.292 -175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -77.67 -24.79 49.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 74.42 114.243 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.69 154.13 36.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.305 1.042 . . . . 74.42 111.678 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.78 119.8 6.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.775 1.23 . . . . 75.01 108.39 -173.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -99.69 137.48 38.1 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.413 1.071 . . . . 72.52 108.901 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.71 140.86 51.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.336 -1.727 . . . . 73.22 106.336 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 m -140.09 136.95 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.966 1.706 . . . . 72.25 107.929 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.26 114.15 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.635 1.574 . . . . 75.43 106.806 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.3 m -96.8 130.63 44.03 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.296 1.439 . . . . 73.34 109.608 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.39 172.55 8.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.615 1.566 . . . . 75.44 109.365 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.23 7.5 8.02 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 118.249 -1.306 . . . . 72.42 114.638 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -36.9 1.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.23 1.515 . . . . 72.4 112.062 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.5 168.92 22.77 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.967 1.307 . . . . 74.54 110.401 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.73 138.31 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 124.56 1.163 . . . . 72.31 108.242 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.58 127.41 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.197 1.799 . . . . 72.03 106.778 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.18 144.3 30.79 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.737 0.648 . . . . 71.21 111.41 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -146.45 161.18 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.597 1.959 . . . . 74.13 108.857 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -133.81 144.46 49.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.033 0.933 . . . . 64.34 109.88 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.08 171.41 18.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.24 1.416 . . . . 74.31 110.122 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.8 m -112.83 132.09 55.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.59 1.156 . . . . 75.33 108.204 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.39 133.28 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.163 0.985 . . . . 73.42 110.307 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.15 -26.84 13.11 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.59 -1.117 . . . . 55.35 111.593 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.37 153.12 21.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.972 1.309 . . . . 75.42 110.172 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.26 158.0 24.96 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.408 1.067 . . . . 64.11 110.721 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.33 165.01 27.13 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.755 1.222 . . . . 72.2 110.145 -165.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.99 117.23 30.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.736 1.214 . . . . 62.11 109.187 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.06 166.36 11.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 74.32 110.645 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -115.38 148.13 39.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.5 1.92 . . . . 74.0 109.481 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p -111.79 173.88 6.14 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.715 1.606 . . . . 73.14 110.361 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -55.3 -28.73 55.53 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 116.52 2.044 . . . . 74.13 116.52 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.7 p -85.75 -15.87 40.73 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.371 1.068 . . . . 73.52 113.411 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.16 65.35 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 118.339 -1.256 . . . . 72.12 111.542 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.18 129.69 41.94 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 119.261 1.531 . . . . 72.11 109.868 164.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -108.43 150.4 27.46 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 124.792 1.308 . . . . 62.42 110.5 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.31 127.11 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.088 -1.415 . . . . 74.43 109.317 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -74.87 143.14 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.084 0.865 . . . . 75.41 110.663 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 t -160.74 161.0 32.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.12 1.368 . . . . 74.23 109.588 -166.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.36 144.61 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.918 -1.141 . . . . 75.14 107.918 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.18 132.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.098 0.959 . . . . 72.03 109.472 -174.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -134.53 150.73 50.79 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.232 1.413 . . . . 70.34 110.751 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 12.9 tp -80.05 137.85 36.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.275 1.03 . . . . 72.31 110.267 171.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -85.59 6.49 27.07 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.769 1.228 . . . . 74.41 112.441 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.436 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 73.6 5.07 67.29 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.695 1.617 . . . . 74.32 113.42 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -127.41 42.31 3.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.356 1.862 . . . . 73.41 108.922 -169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.337 0.2 OUTLIER 47.15 38.52 6.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.456 1.902 . . . . 73.4 113.904 -172.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -134.14 138.94 45.55 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.677 1.991 . . . . 74.12 108.993 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.8 mt -101.28 143.42 31.37 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 124.632 1.207 . . . . 73.5 108.618 164.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -121.84 134.38 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.098 -1.445 . . . . 74.34 107.098 170.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -151.09 150.17 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 75.43 110.898 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.1 p -140.87 126.28 18.75 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.241 1.416 . . . . 73.32 108.216 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.54 -87.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.885 1.366 . . . . 64.5 109.493 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.19 -43.44 1.79 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.245 1.418 . . . . 75.14 111.181 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -157.22 26.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.588 1.155 . . . . 75.11 111.533 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.6 mt -130.41 102.74 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.489 -1.3 . . . . 64.22 107.489 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -65.55 132.85 49.89 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.819 0.7 . . . . 75.22 109.518 167.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -142.27 108.81 5.33 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 124.683 1.239 . . . . 74.44 108.129 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -116.98 131.53 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.669 1.188 . . . . 73.31 108.67 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.6 m -113.53 151.83 31.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.251 1.821 . . . . 75.43 108.713 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.87 144.34 37.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.853 1.661 . . . . 74.33 108.534 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.9 tp -117.92 124.29 47.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.789 2.035 . . . . 75.11 106.725 167.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.17 85.44 2.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.28 1.832 . . . . 74.43 106.844 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.28 -106.69 2.09 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.767 -1.333 . . . . 71.31 109.767 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.46 -20.68 19.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.92 1.288 . . . . 74.01 112.452 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.18 135.02 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.231 1.013 . . . . 75.34 110.52 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mm -119.54 95.1 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.01 1.324 . . . . 71.12 107.707 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.5 m -86.26 127.36 34.75 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.182 0.926 . . . . 75.51 108.858 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.11 141.26 51.81 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.732 -0.84 . . . . 72.52 108.732 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 m -140.93 120.6 13.36 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.715 1.206 . . . . 71.42 108.723 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 83.3 mtp -116.53 156.27 27.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 65.42 109.289 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.4 m -143.76 114.26 7.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.319 1.048 . . . . 63.04 109.557 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.67 105.03 11.17 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.506 1.922 . . . . 75.53 107.162 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.01 -128.91 43.13 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 110.483 -1.047 . . . . 65.23 110.483 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -73.75 -13.83 61.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.83 1.652 . . . . 74.43 114.139 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.4 mt -97.69 132.71 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.854 1.262 . . . . 72.41 109.469 -171.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.63 85.63 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 124.383 1.052 . . . . 72.05 109.458 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -68.47 139.6 55.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.078 1.351 . . . . 65.45 113.052 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 152.45 50.27 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.62 1.168 . . . . 74.32 111.104 173.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -130.45 151.18 51.22 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.663 1.585 . . . . 74.15 108.659 161.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 124.44 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.246 -2.131 . . . . 74.43 105.246 160.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -122.86 157.45 32.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 71.2 108.332 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -134.49 142.08 46.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.862 0.865 . . . . 73.22 110.45 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.7 ttp85 -61.73 138.21 58.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.692 1.997 . . . . 75.52 112.627 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 125.04 2.352 . . . . 74.44 107.996 -178.1 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 104.063 -2.569 . . . . 52.31 104.063 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 48.49 56.5 7.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.648 2.379 . . . . 75.54 114.075 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -66.86 144.74 56.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.388 1.075 . . . . 64.31 111.224 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -67.52 149.01 50.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.306 1.004 . . . . 73.03 112.54 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.95 159.13 26.2 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.703 2.001 . . . . 74.24 108.313 -171.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -82.59 36.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.451 1.1 . . . . 62.12 113.324 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.39 120.3 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.142 1.777 . . . . 71.32 108.032 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -82.27 167.02 19.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.107 1.363 . . . . 75.33 111.426 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt 64.92 -169.53 0.2 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 75.42 113.404 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -144.24 117.0 8.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.777 1.631 . . . . 70.03 107.603 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -78.38 46.24 0.61 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.529 1.532 . . . . 74.34 112.175 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -132.77 114.1 13.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.172 1.789 . . . . 73.1 109.183 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 165.97 18.6 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 109.187 -1.565 . . . . 70.14 109.187 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tmmt? -120.29 138.46 53.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 73.53 109.744 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -133.64 151.35 51.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.337 1.855 . . . . 74.21 110.59 -164.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.38 149.98 30.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.936 1.294 . . . . 74.2 109.086 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.26 49.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.883 0.873 . . . . 64.31 110.398 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -102.48 -67.86 0.86 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.849 1.26 . . . . 75.31 109.117 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -141.56 167.88 21.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.649 1.18 . . . . 61.25 111.397 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.805 1.242 . . . . 74.33 110.133 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.85 146.46 50.27 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.681 1.592 . . . . 74.05 108.694 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 59.3 20.56 8.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.909 1.684 . . . . 73.45 113.679 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -57.96 -62.07 2.08 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.735 1.214 . . . . 74.31 112.793 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.89 -36.33 82.97 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.332 1.02 . . . . 62.3 112.987 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.16 78.71 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.368 1.067 . . . . 74.32 113.057 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -66.79 -47.06 73.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.266 1.426 . . . . 72.24 113.618 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.6 mmt -66.19 -36.58 83.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.874 1.269 . . . . 72.2 113.346 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -75.7 -28.99 58.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.383 1.073 . . . . 74.34 112.746 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.22 -38.96 71.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.134 0.973 . . . . 74.22 113.135 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.16 -9.73 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 113.174 0.805 . . . . 75.3 113.174 172.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 30.34 22.36 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.48 -1.178 . . . . 54.2 113.968 164.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.46 152.73 95.93 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 119.135 1.467 . . . . 72.53 111.367 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.11 145.74 68.0 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.516 2.144 . . . . 74.4 112.221 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -33.14 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.333 1.853 . . . . 71.15 114.801 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -53.54 -55.46 25.33 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.979 1.712 . . . . 75.2 113.18 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.64 -28.48 68.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.827 1.251 . . . . 72.51 113.87 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.56 -52.06 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 118.085 -0.96 . . . . 72.31 111.526 170.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -67.02 -36.41 82.08 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.696 1.369 . . . . 73.04 114.696 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -23.93 49.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.183 -0.913 . . . . 72.32 111.809 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.03 -32.43 32.24 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.765 -1.02 . . . . 51.5 111.972 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -29.11 30.87 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 118.442 1.121 . . . . 73.53 112.96 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -85.12 -60.36 2.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.062 0.945 . . . . 73.22 109.98 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.4 mm -85.21 128.24 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.141 0.976 . . . . 60.01 109.31 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -81.79 138.57 35.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.339 1.056 . . . . 71.21 110.737 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.32 -171.09 47.58 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 124.586 1.179 . . . . 64.02 111.065 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.1 t -136.78 152.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.852 1.661 . . . . 75.42 107.123 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -144.23 147.63 33.85 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.515 0.726 . . . . 71.4 109.794 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.57 146.15 50.92 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 108.348 -0.982 . . . . 73.42 108.348 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 mt -123.2 138.01 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 105.667 -1.975 . . . . 73.42 105.667 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.84 137.97 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.099 -1.074 . . . . 70.04 108.099 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -129.04 128.9 44.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.988 1.315 . . . . 74.35 108.601 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -137.57 78.63 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.816 1.322 . . . . 73.01 107.759 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.05 -126.64 13.76 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 109.212 -1.555 . . . . 75.11 109.212 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -66.8 -24.73 66.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.512 1.525 . . . . 74.42 114.535 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 146.4 37.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.349 1.06 . . . . 74.42 112.036 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.11 136.69 36.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.65 1.98 . . . . 75.01 107.801 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -125.42 149.22 48.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.67 1.988 . . . . 72.52 108.298 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.92 101.11 3.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.391 0.676 . . . . 73.22 109.544 -174.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -83.44 135.53 34.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.209 1.404 . . . . 72.25 109.878 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.7 mt -137.73 99.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.615 -1.254 . . . . 75.43 107.615 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -92.97 138.15 31.74 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.861 2.064 . . . . 73.34 110.373 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.13 -145.96 0.4 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 75.44 109.401 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.2 85.79 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.2 -0.778 . . . . 72.42 112.52 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -140.9 -62.03 0.48 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.055 1.342 . . . . 72.4 109.477 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -61.68 143.74 55.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.516 1.526 . . . . 74.54 114.157 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.89 144.15 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.767 1.292 . . . . 72.31 108.886 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.5 mt -122.57 127.07 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.868 -1.53 . . . . 72.03 106.868 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 91.36 3.27 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.903 0.881 . . . . 71.21 110.433 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -84.48 155.01 22.38 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.126 1.37 . . . . 74.13 111.42 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.99 138.91 28.76 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 124.851 1.345 . . . . 64.34 110.09 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.91 167.98 27.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.624 1.17 . . . . 74.31 111.032 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.7 m -118.89 128.36 54.36 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 124.704 1.253 . . . . 75.33 107.797 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.92 128.93 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.135 0.974 . . . . 73.42 111.801 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -3.38 86.19 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-O 117.979 -1.456 . . . . 55.35 113.303 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -117.42 147.05 43.04 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.304 1.552 . . . . 75.42 110.936 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.37 119.5 14.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.317 1.847 . . . . 64.11 111.901 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -140.13 169.57 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.047 1.739 . . . . 72.2 109.254 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.6 127.71 55.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.146 0.978 . . . . 62.11 110.33 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.39 141.86 47.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.695 1.598 . . . . 74.32 110.002 -170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -122.27 142.09 50.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.466 1.907 . . . . 74.0 110.383 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -116.7 -178.96 3.55 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.638 1.575 . . . . 73.14 111.132 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -65.94 -24.23 66.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.423 1.489 . . . . 74.13 114.983 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.3 p -81.47 -11.58 59.17 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.261 1.424 . . . . 73.52 112.045 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.85 88.09 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.114 1.34 . . . . 72.12 112.615 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.89 120.18 10.24 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 125.401 1.481 . . . . 72.11 111.364 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -97.8 126.94 43.43 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 124.953 1.408 . . . . 62.42 110.37 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.53 123.57 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.924 1.69 . . . . 74.43 108.801 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -76.01 137.11 40.03 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 124.206 0.941 . . . . 75.41 111.495 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.7 t -165.24 -175.94 3.85 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 124.993 1.433 . . . . 74.23 109.834 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.18 144.61 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.716 1.606 . . . . 75.14 107.765 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.02 133.09 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.861 0.864 . . . . 72.03 108.707 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -115.34 174.96 5.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.193 1.797 . . . . 70.34 111.509 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 13.2 tp -124.96 136.04 53.37 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 72.31 107.178 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -89.0 9.23 25.92 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.231 1.197 . . . . 74.41 114.231 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 84.79 3.3 88.17 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-O 118.147 -1.363 . . . . 74.32 113.86 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -124.64 50.28 1.73 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.08 1.44 . . . . 73.41 108.817 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.333 0.1 OUTLIER 51.19 27.3 3.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.648 1.979 . . . . 73.4 115.297 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -121.73 111.97 17.82 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.329 1.852 . . . . 74.12 109.446 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.53 143.61 46.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.743 1.277 . . . . 73.5 110.336 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.4 135.01 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.515 1.126 . . . . 74.34 108.73 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -158.36 161.57 37.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.935 0.894 . . . . 75.43 110.716 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.8 p -135.37 -178.87 5.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.178 1.791 . . . . 73.32 108.297 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -139.3 -76.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 64.5 109.284 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -133.4 -50.2 0.86 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.72 1.608 . . . . 75.14 109.406 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -148.29 1.86 0.64 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 75.11 111.923 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 58.5 mt -105.76 120.46 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.841 1.656 . . . . 64.22 107.155 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -108.27 113.46 26.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.818 1.247 . . . . 75.22 108.661 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -113.26 129.41 56.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.842 1.339 . . . . 74.44 109.835 -174.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.97 120.2 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.98 -1.119 . . . . 73.31 107.98 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.9 m -102.74 156.15 17.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.794 1.238 . . . . 75.43 109.205 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.82 142.25 38.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.7 2.0 . . . . 74.33 108.812 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 tt -120.48 119.8 34.03 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.451 -1.685 . . . . 75.11 106.451 171.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -129.45 83.56 2.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.535 1.534 . . . . 74.43 107.156 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.85 -111.88 3.95 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.913 1.244 . . . . 71.31 110.538 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -79.59 -24.2 42.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.18 1.392 . . . . 74.01 112.974 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -87.62 136.75 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.126 0.97 . . . . 75.34 110.709 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.23 107.62 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.895 1.278 . . . . 71.12 107.83 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -99.02 151.74 20.6 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 124.214 0.946 . . . . 75.51 109.328 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -146.7 141.46 26.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.926 1.29 . . . . 72.52 108.288 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 93.1 m -132.5 132.23 42.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.012 1.725 . . . . 71.42 108.239 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.2 mtp -131.12 119.07 21.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.444 1.497 . . . . 65.42 108.911 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -104.26 110.41 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.257 0.973 . . . . 63.04 109.116 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.8 tp -116.16 98.55 6.67 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 106.816 -1.55 . . . . 75.53 106.816 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.49 -130.59 40.69 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 109.768 -1.333 . . . . 65.23 109.768 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.45 8.74 20.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 74.43 114.013 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 74.3 mt -108.88 123.0 64.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 108.511 -0.922 . . . . 72.41 108.511 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.57 85.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.524 1.14 . . . . 72.05 108.366 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.32 137.81 58.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.821 1.248 . . . . 65.45 111.753 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -134.03 148.5 51.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.012 1.325 . . . . 74.32 109.715 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -143.78 141.54 30.46 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.633 1.173 . . . . 74.15 108.83 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.91 134.1 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.665 -1.235 . . . . 74.43 107.665 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.5 m -133.1 161.02 35.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.782 1.633 . . . . 71.2 109.516 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.73 142.73 33.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.467 1.107 . . . . 73.22 110.741 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -63.44 138.39 58.5 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.222 1.809 . . . . 75.52 113.681 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 104.595 -2.372 . . . . 74.44 104.595 -179.086 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 101.822 -3.399 . . . . 52.31 101.822 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -174.71 19.63 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.762 2.025 . . . . 75.54 111.311 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -153.76 175.62 13.08 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.364 1.466 . . . . 64.31 109.799 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -135.05 -87.71 0.37 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.441 -1.318 . . . . 73.03 107.441 170.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -148.68 115.51 6.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.307 -1.368 . . . . 74.24 107.307 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -157.75 119.77 3.72 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.834 -1.173 . . . . 62.12 107.834 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 86.8 t -123.48 86.19 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 124.696 1.247 . . . . 71.32 107.885 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -162.8 152.71 15.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.133 1.773 . . . . 75.33 108.561 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.28 148.81 45.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.954 1.302 . . . . 75.42 110.124 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.8 m -139.25 118.61 12.83 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.728 1.267 . . . . 70.03 109.701 -171.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -68.06 -29.14 68.04 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.041 0.838 . . . . 74.34 112.913 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -60.44 112.78 2.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.296 1.839 . . . . 73.1 112.69 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.96 173.44 32.63 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.092 -1.603 . . . . 70.14 109.092 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -127.03 138.96 53.32 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.875 0.87 . . . . 73.53 109.322 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -134.55 139.94 45.76 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.463 1.505 . . . . 74.21 109.634 -168.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.99 152.8 18.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.46 1.104 . . . . 74.2 109.36 171.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.34 140.82 57.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.839 0.856 . . . . 64.31 110.031 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -118.18 -48.1 2.54 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.95 1.3 . . . . 75.31 110.887 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -152.15 152.23 32.03 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.761 1.224 . . . . 61.25 109.868 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -149.6 136.58 19.62 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.356 1.062 . . . . 74.33 110.142 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -128.64 147.07 50.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.965 1.706 . . . . 74.05 110.046 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 55.94 24.91 8.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.305 1.842 . . . . 73.45 112.712 -167.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.61 -62.66 1.63 Allowed 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.556 1.142 . . . . 74.31 112.136 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.87 -43.1 99.52 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.298 0.998 . . . . 62.3 113.173 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.31 75.82 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.685 1.194 . . . . 74.32 113.602 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.06 -46.93 76.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.456 1.502 . . . . 72.24 113.271 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.92 -40.05 79.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.563 1.145 . . . . 72.2 113.183 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.65 -37.67 88.38 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 74.34 112.419 169.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.6 74.03 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.235 1.198 . . . . 74.22 114.235 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.9 pt -79.72 -5.19 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.262 0.838 . . . . 75.3 113.262 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.34 22.52 26.75 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.239 -1.312 . . . . 54.2 113.79 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -69.96 146.11 94.85 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.478 1.639 . . . . 72.53 111.38 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 146.96 77.12 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.474 2.116 . . . . 74.4 111.864 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -30.23 64.04 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.829 1.418 . . . . 71.15 114.829 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.2 -51.52 69.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.387 1.075 . . . . 75.2 112.995 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.8 -24.42 67.75 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.616 1.167 . . . . 72.51 113.207 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.99 -45.55 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 118.005 -0.998 . . . . 72.31 111.073 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -67.28 -33.19 74.78 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.498 1.295 . . . . 73.04 114.498 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HZ1' ' HA3' ' A' ' 55' ' ' GLY . 0.6 OUTLIER -83.8 -11.15 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.123 0.969 . . . . 72.32 112.56 173.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 -28.0 8.82 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.75 -1.028 . . . . 51.5 111.549 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -32.68 37.53 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.49 1.145 . . . . 73.53 113.366 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -83.61 -51.9 6.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.783 0.833 . . . . 73.22 111.301 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.26 113.04 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.411 1.084 . . . . 60.01 108.854 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -67.55 130.35 42.77 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.584 1.178 . . . . 71.21 110.561 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.63 31.25 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 124.834 1.334 . . . . 64.02 111.403 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 t -141.02 154.09 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.398 -1.334 . . . . 75.42 107.398 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -142.72 120.19 11.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.351 1.061 . . . . 71.4 109.922 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -99.8 131.27 45.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 124.302 1.001 . . . . 73.42 108.704 167.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.1 133.58 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.669 -1.604 . . . . 73.42 106.669 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.4 128.56 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 123.485 0.49 . . . . 70.04 109.823 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -88.94 128.6 35.69 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.725 -1.213 . . . . 74.35 107.725 165.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.83 53.11 1.4 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.896 1.278 . . . . 73.01 109.942 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.26 -119.82 5.27 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.035 -2.026 . . . . 75.11 108.035 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -77.2 -29.82 54.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.441 0.696 . . . . 74.42 111.923 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -69.37 164.25 23.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.417 1.087 . . . . 74.42 112.266 169.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -156.32 140.96 16.93 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.133 -1.803 . . . . 75.01 106.133 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -118.07 134.05 55.35 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.75 1.22 . . . . 72.52 109.957 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.59 112.93 18.59 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 125.115 1.509 . . . . 73.22 107.485 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -114.15 124.78 52.92 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.145 -1.428 . . . . 72.25 107.145 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.46 143.52 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.517 1.127 . . . . 75.43 108.601 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -133.74 153.86 51.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 73.34 110.821 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.94 139.66 19.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.096 1.758 . . . . 75.44 108.807 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' HZ1' ' A' ' 31' ' ' LYS . . . 70.44 -98.66 0.68 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.057 -1.617 . . . . 72.42 109.057 -174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -149.66 39.05 0.78 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.897 1.279 . . . . 72.4 111.314 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -142.2 135.47 28.95 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.121 0.968 . . . . 74.54 110.921 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.61 144.63 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.269 1.428 . . . . 72.31 109.938 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.51 139.32 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.683 1.593 . . . . 72.03 108.095 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.55 132.36 55.13 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.805 1.242 . . . . 71.21 108.075 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.37 158.45 42.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.887 1.275 . . . . 74.13 109.952 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -137.9 148.56 45.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 125.181 1.551 . . . . 64.34 108.853 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.46 157.52 41.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.329 1.452 . . . . 74.31 109.867 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.11 53.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.637 1.175 . . . . 75.33 108.084 171.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.76 113.06 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.648 1.179 . . . . 73.42 110.494 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.02 -11.45 60.52 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.118 -1.379 . . . . 55.35 112.994 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -97.62 144.02 27.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.248 1.524 . . . . 75.42 110.08 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -73.67 134.59 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.572 1.149 . . . . 64.11 110.74 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.568 ' HG ' HD23 ' A' ' 71' ' ' LEU . 27.0 p -164.62 160.0 19.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.979 1.312 . . . . 72.2 109.619 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.44 114.97 28.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.376 1.07 . . . . 62.11 109.972 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.568 HD23 ' HG ' ' A' ' 69' ' ' CYS . 3.7 mm? -103.65 136.22 43.76 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.797 1.639 . . . . 74.32 110.339 -171.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.56 154.88 26.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.869 1.268 . . . . 74.0 111.267 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -117.17 169.34 9.52 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.647 1.979 . . . . 73.14 109.286 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -54.13 -32.75 56.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.145 1.535 . . . . 74.13 115.145 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 p -77.6 -11.15 59.83 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.293 2.237 . . . . 73.52 113.976 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.36 81.2 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.431 -1.205 . . . . 72.12 112.361 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.81 126.23 27.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.276 1.83 . . . . 72.11 110.668 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -112.89 119.33 37.58 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.165 0.916 . . . . 62.42 108.931 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.78 130.09 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.118 1.367 . . . . 74.43 111.928 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -73.93 142.19 45.95 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.194 1.397 . . . . 75.41 113.536 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -174.35 177.11 2.29 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 125.394 1.684 . . . . 74.23 110.615 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.95 148.72 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.773 2.029 . . . . 75.14 107.866 166.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.2 t -112.66 139.43 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.707 -0.849 . . . . 72.03 108.707 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -128.31 155.76 44.11 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.452 1.501 . . . . 70.34 111.102 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -114.18 117.48 31.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 72.31 107.148 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.67 14.15 4.96 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.058 1.503 . . . . 74.41 115.058 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.11 -7.0 64.86 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.423 1.487 . . . . 74.32 113.816 174.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -110.78 38.1 2.59 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.004 1.721 . . . . 73.41 111.568 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.312 0.2 OUTLIER 52.75 40.65 30.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.275 1.83 . . . . 73.4 112.96 -177.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -137.95 127.07 24.33 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.438 1.495 . . . . 74.12 109.553 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.1 mt -91.64 144.4 25.57 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.71 1.256 . . . . 73.5 109.11 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -130.97 138.39 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.204 1.402 . . . . 74.34 108.61 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -160.01 159.57 32.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.479 1.111 . . . . 75.43 109.971 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 73.9 p -130.85 -179.25 5.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 73.32 108.443 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -143.53 -55.02 0.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.645 0.657 . . . . 64.5 111.621 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -157.02 -54.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.524 1.13 . . . . 75.14 109.003 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -146.68 2.58 0.83 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.687 1.595 . . . . 75.11 111.699 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.31 102.08 13.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 C-N-CA 125.591 1.557 . . . . 64.22 107.582 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -76.01 144.69 40.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.525 -0.916 . . . . 75.22 108.525 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -143.31 106.61 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.312 1.045 . . . . 74.44 108.466 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -115.12 110.0 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 124.866 1.354 . . . . 73.31 108.018 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -97.67 152.48 19.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.845 1.258 . . . . 75.43 109.539 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.14 146.89 39.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.997 1.719 . . . . 74.33 109.697 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -119.78 137.8 53.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.093 2.157 . . . . 75.11 107.788 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -138.35 64.46 1.5 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.122 2.169 . . . . 74.43 106.561 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.47 -105.0 1.32 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.795 1.188 . . . . 71.31 111.014 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.01 -7.95 59.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.784 1.234 . . . . 74.01 113.095 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.39 146.46 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.579 1.152 . . . . 75.34 109.146 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.4 mm -130.39 143.61 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.478 1.511 . . . . 71.12 108.39 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -127.94 148.76 50.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.398 1.061 . . . . 75.51 108.315 168.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -140.17 117.27 11.18 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.347 -1.723 . . . . 72.52 106.347 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.2 m -120.95 102.01 8.07 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.858 1.349 . . . . 71.42 107.845 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 mtm -93.76 155.39 17.25 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.25 0.969 . . . . 65.42 110.45 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -134.6 97.2 3.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.507 1.123 . . . . 63.04 108.846 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt -85.99 95.06 9.38 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.526 1.13 . . . . 75.53 108.047 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.55 -108.57 1.73 Allowed Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.678 1.132 . . . . 65.23 111.523 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.53 -2.72 57.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.871 2.068 . . . . 74.43 115.5 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.34 137.46 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.079 -1.082 . . . . 72.41 108.079 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.65 88.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 123.944 0.778 . . . . 72.05 109.298 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -67.4 139.58 57.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.217 1.007 . . . . 65.45 112.073 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -133.61 148.83 51.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.564 1.545 . . . . 74.32 109.955 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -157.32 108.88 2.35 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.811 1.244 . . . . 74.15 108.715 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -100.98 135.09 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.304 1.442 . . . . 74.43 107.773 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.7 m -136.11 159.01 43.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 71.2 109.971 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -143.66 144.12 31.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.982 0.913 . . . . 73.22 110.697 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -65.48 136.92 57.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.704 2.002 . . . . 75.52 113.933 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 124.915 2.293 . . . . 74.44 107.798 178.367 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 108.346 -0.983 . . . . 52.31 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -73.61 146.6 44.52 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 124.392 1.077 . . . . 75.54 111.562 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -158.59 -55.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.694 1.246 . . . . 64.31 109.837 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 68.32 -15.68 0.22 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.924 2.489 . . . . 73.03 115.095 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -164.64 158.91 18.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.831 2.852 . . . . 74.24 107.563 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -77.88 145.42 36.24 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.586 0.554 . . . . 62.12 110.545 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.64 14.1 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.114 1.366 . . . . 71.32 111.744 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 67.79 177.26 0.25 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.724 2.409 . . . . 75.33 112.179 -168.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtm -76.12 151.34 37.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 111.888 0.329 . . . . 75.42 111.888 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.5 m -89.59 107.23 18.96 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.591 1.557 . . . . 70.03 110.483 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -65.7 -25.21 67.21 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 117.101 2.26 . . . . 74.34 117.101 -174.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -63.18 147.42 50.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.114 1.524 . . . . 73.1 115.114 -170.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.66 168.0 12.14 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.467 1.508 . . . . 70.14 110.646 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -89.71 152.86 21.12 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.902 1.281 . . . . 73.53 112.369 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -143.78 134.71 25.37 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.963 1.705 . . . . 74.21 107.782 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.25 154.02 22.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.919 0.781 . . . . 74.2 109.458 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.24 130.17 40.16 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.615 0.572 . . . . 64.31 109.649 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -103.57 -61.38 1.43 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.292 1.037 . . . . 75.31 110.797 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 m -143.62 155.08 44.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.384 1.073 . . . . 61.25 110.902 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.57 147.66 48.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 74.33 109.062 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -129.85 136.98 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.829 1.652 . . . . 74.05 108.333 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 56.44 28.18 13.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.861 1.665 . . . . 73.45 112.54 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.78 -63.33 1.28 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.514 1.126 . . . . 74.31 112.608 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -64.02 -37.49 87.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.543 1.152 . . . . 62.3 113.128 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.21 -44.31 88.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.414 1.086 . . . . 74.32 113.171 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.12 -43.46 67.59 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.241 1.416 . . . . 72.24 114.032 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.4 mmt -67.83 -38.27 82.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.177 0.991 . . . . 72.2 112.683 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -64.79 -40.38 95.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.867 0.867 . . . . 74.34 112.721 167.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.28 -27.92 64.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.963 1.468 . . . . 74.22 114.963 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -84.97 -8.3 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.104 0.779 . . . . 75.3 113.104 171.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.7 24.73 22.62 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.07 -1.406 . . . . 54.2 113.54 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.98 149.75 97.77 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.675 1.737 . . . . 72.53 111.29 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.96 152.22 62.91 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.329 2.019 . . . . 74.4 111.847 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -52.66 -34.45 51.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.025 1.33 . . . . 71.15 114.31 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -49.55 -54.83 15.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.73 2.012 . . . . 75.2 113.258 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.11 -26.13 62.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.506 1.523 . . . . 72.51 112.857 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 62.2 mt -75.13 -45.94 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.125 0.97 . . . . 72.31 111.849 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.24 -37.41 74.97 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.307 1.225 . . . . 73.04 114.307 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -18.25 49.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.648 -0.692 . . . . 72.32 112.506 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -38.0 11.07 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.732 -1.038 . . . . 51.5 111.517 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -36.02 61.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.592 1.196 . . . . 73.53 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.81 -65.74 0.79 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.104 1.361 . . . . 73.22 110.661 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -76.83 121.36 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.563 1.165 . . . . 60.01 109.234 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -78.42 127.91 32.86 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.231 0.957 . . . . 71.21 109.716 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.06 -156.86 28.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.791 1.307 . . . . 64.02 111.127 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.89 164.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.865 1.266 . . . . 75.42 108.745 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.12 155.75 47.65 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.017 1.727 . . . . 71.4 107.819 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.13 145.53 31.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.905 -1.517 . . . . 73.42 106.905 167.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 98.8 mt -126.78 135.74 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.505 -1.665 . . . . 73.42 106.505 166.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.2 87.06 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.965 -1.124 . . . . 70.04 107.965 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -71.5 131.23 43.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.511 -0.768 . . . . 74.35 109.205 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.65 74.16 1.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.36 -1.348 . . . . 73.01 107.36 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.54 -125.27 9.22 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 108.993 -1.643 . . . . 75.11 108.993 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -72.22 -29.14 63.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.216 1.406 . . . . 74.42 114.266 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.95 152.63 42.37 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.117 0.885 . . . . 74.42 110.975 169.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -152.94 133.87 14.0 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.354 -1.35 . . . . 75.01 107.354 -171.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -119.29 148.06 43.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.106 1.362 . . . . 72.52 108.245 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.7 102.8 3.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.94 -1.504 . . . . 73.22 106.94 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.2 m -109.48 92.26 3.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.762 0.825 . . . . 72.25 109.397 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.6 mt -102.85 129.61 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.07 0.948 . . . . 75.43 109.093 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -126.29 150.07 48.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.501 1.12 . . . . 73.34 110.745 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.64 -152.32 0.4 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.374 1.87 . . . . 75.44 109.812 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.12 -0.92 82.53 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.98 -1.456 . . . . 72.42 113.191 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -157.93 9.3 0.16 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.681 1.74 . . . . 72.4 114.094 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -167.41 155.27 9.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.943 0.897 . . . . 74.54 111.928 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.75 144.78 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.598 1.559 . . . . 72.31 109.512 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -119.2 140.44 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.371 1.868 . . . . 72.03 106.48 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.2 123.85 39.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.742 0.817 . . . . 71.21 109.323 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -120.98 150.43 41.12 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.144 1.378 . . . . 74.13 108.983 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -147.56 143.14 27.56 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.707 1.255 . . . . 64.34 108.713 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.65 167.56 29.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.021 1.328 . . . . 74.31 110.55 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -119.25 128.34 54.09 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.419 -1.326 . . . . 75.33 107.419 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.36 103.78 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.436 1.094 . . . . 73.42 110.281 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.0 -7.07 11.97 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 117.85 -1.528 . . . . 55.35 112.621 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -123.95 156.66 35.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.374 1.587 . . . . 75.42 111.518 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -74.36 123.09 23.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.614 1.565 . . . . 64.11 110.717 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.9 m -142.02 156.34 45.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.333 1.453 . . . . 72.2 108.4 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.95 124.24 42.31 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.004 0.921 . . . . 62.11 110.14 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.26 125.42 51.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.985 1.714 . . . . 74.32 108.981 -172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -78.89 128.32 33.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.586 1.154 . . . . 74.0 110.876 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -90.45 166.18 13.4 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.253 1.821 . . . . 73.14 110.329 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 mtt -49.47 -38.16 28.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.954 1.835 . . . . 74.13 115.954 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 p -80.71 -7.37 59.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.965 1.706 . . . . 73.52 113.978 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.05 86.85 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 118.552 -1.138 . . . . 72.12 111.549 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.94 148.25 50.0 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.033 1.333 . . . . 72.11 110.043 163.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -135.57 142.96 45.42 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.768 0.668 . . . . 62.42 109.487 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.96 131.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.576 1.151 . . . . 74.43 110.826 -173.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -81.91 142.84 32.11 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.383 1.073 . . . . 75.41 112.004 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.5 t -169.86 160.74 8.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.634 1.574 . . . . 74.23 109.044 -176.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.6 t -104.4 125.21 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.709 -1.219 . . . . 75.14 107.709 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.03 138.64 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.118 0.886 . . . . 72.03 108.792 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -125.74 173.85 8.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.023 1.729 . . . . 70.34 111.204 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.45 127.34 19.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.414 1.485 . . . . 72.31 107.414 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.02 26.19 2.56 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.618 1.34 . . . . 74.41 114.618 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.8 -0.29 78.23 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.258 1.409 . . . . 74.32 114.586 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.05 61.38 1.65 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.35 1.575 . . . . 73.41 108.519 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.99 34.99 3.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.196 2.198 . . . . 73.4 115.331 171.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -128.26 109.76 11.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.875 1.67 . . . . 74.12 108.598 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -83.2 131.4 35.11 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.767 1.292 . . . . 73.5 109.587 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -124.34 137.47 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.761 1.224 . . . . 74.34 109.143 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -157.3 146.41 19.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.611 0.764 . . . . 75.43 110.644 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -138.14 110.09 7.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.398 1.479 . . . . 73.32 107.84 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -72.42 -59.6 2.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.312 1.045 . . . . 64.5 111.79 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -145.97 -61.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.974 1.31 . . . . 75.14 109.314 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -141.27 7.98 2.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.213 1.805 . . . . 75.11 111.64 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.5 mt -115.73 113.79 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.021 1.728 . . . . 64.22 106.795 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.241 0.963 . . . . 75.22 108.853 168.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -143.31 119.66 10.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.384 -1.339 . . . . 74.44 107.384 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -127.59 97.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 124.983 1.427 . . . . 73.31 107.376 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.3 m -78.17 146.35 35.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.614 1.166 . . . . 75.43 109.257 168.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -138.82 112.14 8.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.915 1.686 . . . . 74.33 108.193 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 tp -83.44 124.17 30.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.624 1.17 . . . . 75.11 108.521 165.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.45 83.14 2.05 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.301 1.84 . . . . 74.43 106.135 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.4 -109.73 3.07 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 109.999 -1.241 . . . . 71.31 109.999 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.3 2.85 56.42 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 74.01 113.846 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -113.96 136.08 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.03 0.932 . . . . 75.34 109.326 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mm -118.17 105.09 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.974 1.31 . . . . 71.12 108.267 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 m -86.17 144.64 27.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.05 -1.093 . . . . 75.51 108.05 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -144.45 95.6 2.74 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 107.83 -1.174 . . . . 72.52 107.83 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.1 m -82.17 137.91 34.83 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 125.205 1.566 . . . . 71.42 109.509 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 mtm -127.56 155.83 43.19 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.275 1.03 . . . . 65.42 109.562 168.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.1 m -140.34 101.85 4.22 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.097 0.873 . . . . 63.04 110.03 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.98 110.31 22.63 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.731 1.212 . . . . 75.53 107.888 171.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.33 -89.68 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.183 1.373 . . . . 65.23 112.943 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -132.2 36.97 3.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.444 1.898 . . . . 74.43 109.847 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.4 mm -133.92 137.98 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.947 1.699 . . . . 72.41 106.972 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.8 90.25 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 124.06 0.85 . . . . 72.05 108.932 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -78.76 143.79 35.81 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.052 1.341 . . . . 65.45 111.406 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.79 152.73 51.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.183 0.993 . . . . 74.32 109.587 164.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -146.08 126.33 13.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.236 1.414 . . . . 74.15 107.988 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -116.17 128.3 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 125.025 1.453 . . . . 74.43 107.397 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 56.3 m -127.82 157.68 39.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.755 . . . . 71.2 108.83 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -141.91 143.23 33.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.277 1.031 . . . . 73.22 110.875 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -51.32 140.96 16.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.42 2.288 . . . . 75.52 113.558 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 125.181 2.42 . . . . 74.44 108.334 -179.446 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 78.7 t60 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 103.464 -2.791 . . . . 52.31 103.464 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -117.36 148.39 41.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.61 1.564 . . . . 75.54 109.159 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -159.2 79.75 0.75 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.838 0.855 . . . . 64.31 109.583 -167.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -148.49 157.49 43.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.308 1.043 . . . . 73.03 111.26 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . 0.49 ' CG ' ' H ' ' A' ' -2' ' ' HIS . 7.2 p80 -105.23 -66.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.561 1.945 . . . . 74.24 109.879 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . 0.49 ' H ' ' CG ' ' A' ' -3' ' ' HIS . 48.1 t-80 -152.07 84.49 1.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.703 2.001 . . . . 62.12 106.221 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 2.5 m -155.95 -52.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.208 1.403 . . . . 71.32 109.825 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 61.32 165.53 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.839 2.056 . . . . 75.33 112.224 -160.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.43 177.36 0.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.311 1.444 . . . . 75.42 114.356 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t -169.99 141.37 2.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.454 1.901 . . . . 70.03 107.67 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -86.24 3.01 44.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.919 1.288 . . . . 74.34 113.914 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.0 p -60.7 110.16 1.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.371 1.868 . . . . 73.1 114.454 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.81 169.26 34.41 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 110.08 -1.208 . . . . 70.14 110.08 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -119.0 141.93 48.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.405 1.482 . . . . 73.53 108.542 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -137.18 159.1 42.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.228 1.811 . . . . 74.21 110.559 -168.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -121.27 143.41 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.287 1.435 . . . . 74.2 108.257 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 37' ' ' GLY . 37.5 tp -61.1 139.57 58.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.845 1.258 . . . . 64.31 111.608 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -122.79 -43.97 2.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.65 1.18 . . . . 75.31 111.334 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -155.49 156.14 34.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.295 1.038 . . . . 61.25 111.336 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -135.33 155.25 50.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.103 1.361 . . . . 74.33 109.332 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -131.31 144.42 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.707 1.203 . . . . 74.05 108.34 171.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 57.23 22.51 7.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.165 1.786 . . . . 73.45 114.227 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -56.32 -59.22 5.26 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.518 1.127 . . . . 74.31 113.478 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.61 -39.28 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.228 0.955 . . . . 62.3 112.909 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.84 76.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.561 1.144 . . . . 74.32 112.81 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.65 -49.24 74.0 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.321 1.448 . . . . 72.24 113.489 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.17 -37.19 85.03 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 124.512 1.132 . . . . 72.2 113.768 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -73.37 -27.46 61.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.272 -0.87 . . . . 74.34 112.768 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.67 63.75 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.454 1.102 . . . . 74.22 113.839 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.4 pt -80.67 -6.57 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 113.457 0.91 . . . . 75.3 113.457 170.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.75 28.95 27.78 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 118.759 -1.023 . . . . 54.2 113.379 167.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.84 147.26 88.72 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 118.774 1.287 . . . . 72.53 110.541 175.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.29 149.55 63.65 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.742 2.295 . . . . 74.4 112.588 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.74 -35.54 22.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.242 1.817 . . . . 71.15 114.988 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -51.07 -60.71 2.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.872 1.669 . . . . 75.2 112.614 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.5 -26.13 67.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.71 1.604 . . . . 72.51 113.917 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.6 -58.51 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 CA-C-O 118.233 -0.889 . . . . 72.31 110.691 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -63.98 -34.14 77.31 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.078 1.51 . . . . 73.04 115.078 -173.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -20.23 35.17 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.175 -0.917 . . . . 72.32 112.513 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -34.67 21.05 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.104 -0.831 . . . . 51.5 111.603 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -26.18 42.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.593 1.157 . . . . 73.53 112.769 170.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.67 -67.53 0.63 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.28 1.032 . . . . 73.22 110.52 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.79 108.74 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.572 1.17 . . . . 60.01 109.794 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -63.84 116.2 5.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.425 1.89 . . . . 71.21 109.908 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' H ' HD22 ' A' ' 9' ' ' LEU . . . -75.68 171.98 54.11 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 124.557 1.161 . . . . 64.02 111.834 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.96 149.24 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.189 -1.412 . . . . 75.42 107.189 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.2 t -142.66 149.65 39.17 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.566 0.746 . . . . 71.4 109.71 -172.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.56 140.54 26.19 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.215 1.006 . . . . 73.42 108.298 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -140.4 140.28 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.583 -1.636 . . . . 73.42 106.583 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.4 t -141.69 120.94 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.661 -0.866 . . . . 70.04 108.661 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -95.46 136.35 35.95 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.069 0.856 . . . . 74.35 108.987 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.72 49.57 2.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.155 1.382 . . . . 73.01 110.251 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -70.99 3.0 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.835 1.207 . . . . 75.11 110.858 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -120.74 -34.39 3.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.861 1.664 . . . . 74.42 110.794 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.99 165.45 24.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.316 1.046 . . . . 74.42 111.28 169.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -158.98 136.58 10.13 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.095 -1.446 . . . . 75.01 107.095 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -118.49 152.2 36.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.035 1.334 . . . . 72.52 110.795 168.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.24 137.69 39.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.394 -2.076 . . . . 73.22 105.394 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -143.35 127.13 17.15 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.667 1.187 . . . . 72.25 107.916 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.6 122.43 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.641 -0.874 . . . . 75.43 108.641 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -95.66 114.35 26.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.449 1.5 . . . . 73.34 109.67 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.83 -179.73 6.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.455 1.502 . . . . 75.44 110.487 167.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 17.6 1.59 Allowed Glycine 0 CA--C 1.545 1.939 0 C-N-CA 125.27 1.414 . . . . 72.42 114.99 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -150.03 -40.13 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 72.4 112.261 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 170.56 17.5 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.838 1.255 . . . . 74.54 110.749 -161.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.8 130.43 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.516 1.135 . . . . 72.31 108.825 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.67 144.01 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.525 1.13 . . . . 72.03 108.257 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.42 149.41 45.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 71.21 110.618 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -135.67 163.14 30.82 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.335 1.454 . . . . 74.13 109.44 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -145.39 139.09 26.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.263 -1.335 . . . . 64.34 108.539 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.73 167.18 31.23 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 124.229 0.956 . . . . 74.31 111.343 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.2 126.66 54.84 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.706 1.254 . . . . 75.33 108.271 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.44 123.8 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.093 0.957 . . . . 73.42 111.02 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.5 73.18 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.163 -1.354 . . . . 55.35 113.243 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -125.93 153.17 44.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.01 1.405 . . . . 75.42 109.825 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -72.76 136.92 45.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.096 0.959 . . . . 64.11 112.561 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 m -152.8 153.18 32.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.115 1.766 . . . . 72.2 108.343 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.66 113.55 25.64 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.244 0.965 . . . . 62.11 110.641 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.27 146.72 23.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.573 1.549 . . . . 74.32 109.267 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -112.44 130.58 55.93 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.262 1.025 . . . . 74.0 110.463 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.9 m -78.09 158.91 28.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.47 1.908 . . . . 73.14 110.747 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.38 -18.29 58.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.785 1.772 . . . . 74.13 115.785 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.9 p -76.23 -40.4 52.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.489 1.515 . . . . 73.52 112.38 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.38 2.26 13.49 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.535 -1.703 . . . . 72.12 112.052 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.36 125.72 26.52 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.291 2.046 . . . . 72.11 110.119 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -107.95 120.24 41.73 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.617 1.198 . . . . 62.42 108.617 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.49 127.95 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.337 1.455 . . . . 74.43 111.278 -167.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -80.1 141.42 35.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.091 1.357 . . . . 75.41 112.656 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -167.89 170.94 10.25 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.28 1.432 . . . . 74.23 110.034 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -108.84 137.78 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.454 1.502 . . . . 75.14 108.459 170.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.72 142.15 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 124.082 0.864 . . . . 72.03 108.912 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -126.98 173.04 9.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.811 2.044 . . . . 70.34 111.213 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.39 132.2 35.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 72.31 107.275 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.07 16.73 6.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.706 1.203 . . . . 74.41 113.889 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.29 5.73 77.87 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.042 1.782 . . . . 74.32 114.019 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -131.32 50.53 2.22 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.843 1.322 . . . . 73.41 109.625 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.32 0.4 OUTLIER 41.43 35.95 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 73.4 115.694 -174.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -137.92 122.84 18.95 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 126.021 1.728 . . . . 74.12 107.859 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.86 152.04 22.39 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.35 1.031 . . . . 73.5 109.586 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.53 139.28 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.928 1.291 . . . . 74.34 107.834 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -154.7 165.37 36.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.515 0.726 . . . . 75.43 109.703 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.472 HG21 ' H ' ' A' ' 95' ' ' PHE . 2.5 m -139.06 -176.57 4.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.956 1.302 . . . . 73.32 108.476 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' H ' HG21 ' A' ' 94' ' ' THR . 93.7 m-85 -135.62 -106.47 0.21 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.128 -1.804 . . . . 64.5 106.128 165.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.84 -40.16 6.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.775 1.23 . . . . 75.14 111.259 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -149.11 5.4 0.65 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.144 1.378 . . . . 75.11 112.78 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -124.16 107.79 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.59 -1.263 . . . . 64.22 107.59 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -80.09 165.07 22.86 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 123.975 0.797 . . . . 75.22 110.209 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.4 t -152.74 133.17 13.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.225 1.81 . . . . 74.44 108.483 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -139.03 105.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.941 1.697 . . . . 73.31 106.791 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.8 m -88.52 154.8 20.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.008 1.323 . . . . 75.43 109.746 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -137.19 143.32 42.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.863 1.265 . . . . 74.33 108.786 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.6 tp -120.39 117.46 27.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.33 1.852 . . . . 75.11 106.375 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 86.93 2.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.715 -1.587 . . . . 74.43 106.715 173.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.99 -106.43 2.02 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.385 -1.486 . . . . 71.31 109.385 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -96.7 -19.68 18.8 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 74.01 112.605 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -80.76 133.16 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.475 1.11 . . . . 75.34 109.776 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.6 ' HB ' ' HG ' ' A' ' 124' ' ' SER . 38.8 mm -121.29 103.49 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.03 -1.1 . . . . 71.12 108.03 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.5 m -104.53 97.37 7.29 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.169 0.918 . . . . 75.51 109.845 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.21 143.96 25.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.852 1.261 . . . . 72.52 110.226 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.1 m -145.67 122.8 11.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.655 1.182 . . . . 71.42 109.493 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.04 162.56 16.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.366 1.466 . . . . 65.42 110.091 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 m -144.85 92.2 2.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.566 0.746 . . . . 63.04 110.812 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.6 tp -88.36 114.17 24.71 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 124.28 1.032 . . . . 75.53 109.135 168.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.59 -103.06 0.23 Allowed Glycine 0 CA--C 1.535 1.29 0 O-C-N 125.158 1.536 . . . . 65.23 111.904 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.95 -13.24 25.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.901 2.08 . . . . 74.43 113.835 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.0 mt -119.07 121.98 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.068 0.849 . . . . 72.41 110.863 -166.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.6 96.48 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 O-C-N 124.727 1.267 . . . . 72.05 109.089 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.61 145.63 43.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.444 1.098 . . . . 65.45 111.853 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 154.33 51.27 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 123.411 0.684 . . . . 74.32 110.925 168.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -139.87 125.47 19.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.336 1.454 . . . . 74.15 108.384 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.72 133.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.924 1.289 . . . . 74.43 107.96 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.6 ' HG ' ' HB ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -140.41 162.5 35.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.979 1.312 . . . . 71.2 110.2 -175.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -138.87 146.93 41.77 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.308 1.443 . . . . 73.22 109.449 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -60.25 145.02 48.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.473 1.509 . . . . 75.52 114.239 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 105.818 -1.919 . . . . 74.44 105.818 174.743 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 103.454 -2.795 . . . . 52.31 103.454 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -144.99 143.94 30.78 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.027 1.731 . . . . 75.54 108.688 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 67.99 169.85 0.27 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.796 2.038 . . . . 64.31 112.624 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -168.55 157.44 8.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.173 0.989 . . . . 73.03 110.661 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -146.69 119.22 8.48 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.119 1.368 . . . . 74.24 107.874 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -167.67 150.05 5.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.484 1.113 . . . . 62.12 110.031 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.84 76.7 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 106.83 -1.544 . . . . 71.32 106.83 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -170.84 176.76 4.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.608 1.963 . . . . 75.33 109.49 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -117.58 165.32 13.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.953 1.301 . . . . 75.42 110.194 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t -165.58 142.84 5.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.065 1.346 . . . . 70.03 108.634 165.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.823 1.416 . . . . 74.34 114.823 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 m -65.53 120.69 13.34 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.846 1.259 . . . . 73.1 113.352 -174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.94 175.98 28.49 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.398 0.999 . . . . 70.14 110.701 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -115.7 144.72 43.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.958 1.303 . . . . 73.53 109.951 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -139.84 141.17 36.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.158 1.783 . . . . 74.21 110.207 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -97.72 152.58 18.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.037 1.335 . . . . 74.2 109.66 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mt -64.85 143.5 57.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.248 0.619 . . . . 64.31 111.782 170.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -119.21 -61.45 1.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.383 1.473 . . . . 75.31 108.767 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 m -135.5 158.69 43.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.669 1.188 . . . . 61.25 110.521 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -144.12 162.42 36.32 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.779 1.632 . . . . 74.33 108.589 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.75 138.48 14.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.422 -0.585 . . . . 74.05 109.422 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.93 30.05 19.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.475 1.91 . . . . 73.45 112.559 -165.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.97 -57.17 13.76 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.106 0.962 . . . . 74.31 112.433 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.77 -43.68 95.64 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.606 1.191 . . . . 62.3 112.253 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.73 -47.67 76.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.827 1.251 . . . . 74.32 113.491 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.72 -47.0 73.7 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.005 1.322 . . . . 72.24 113.348 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.0 mmt -67.91 -35.56 78.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.909 1.077 . . . . 72.2 113.909 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -71.03 -30.67 66.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.282 -0.866 . . . . 74.34 112.115 171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.71 -37.77 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.515 1.126 . . . . 74.22 113.605 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.4 pt -83.86 -1.25 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 113.623 0.972 . . . . 75.3 113.623 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 27.96 50.46 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.738 -1.034 . . . . 54.2 114.088 164.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 147.32 99.0 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.683 1.242 . . . . 72.53 111.055 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.26 141.3 81.57 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 74.4 111.556 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -55.21 -30.41 59.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.909 1.284 . . . . 71.15 114.194 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -51.72 -54.04 32.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 75.2 113.568 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.31 -25.84 66.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.422 1.489 . . . . 72.51 113.004 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.9 mt -75.18 -49.73 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.02 0.928 . . . . 72.31 111.168 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -62.61 -42.78 99.78 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.972 0.909 . . . . 73.04 113.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.18 -13.49 58.55 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.37 1.044 . . . . 72.32 113.057 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.99 -18.83 45.36 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-O 118.263 -1.298 . . . . 51.5 112.183 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -35.01 11.2 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 116.913 -1.518 . . . . 73.53 113.549 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -78.15 -56.04 4.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.72 1.145 . . . . 73.22 111.085 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.4 124.99 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.436 1.494 . . . . 60.01 107.725 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.52 131.22 34.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 124.461 1.101 . . . . 71.21 109.375 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.06 -176.35 34.4 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 124.697 1.248 . . . . 64.02 111.574 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.96 156.38 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.816 1.646 . . . . 75.42 107.283 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -148.56 141.39 24.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.054 0.941 . . . . 71.4 109.162 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -124.24 144.0 50.21 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.242 -1.021 . . . . 73.42 108.242 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -129.54 139.01 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 106.442 -1.688 . . . . 73.42 106.442 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.07 112.32 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 107.321 -1.363 . . . . 70.04 107.321 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.32 121.47 40.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.153 1.381 . . . . 74.35 109.116 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -122.56 44.01 2.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 73.01 110.36 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -117.52 5.37 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.963 -2.055 . . . . 75.11 107.963 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -73.84 -29.52 62.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.555 1.317 . . . . 74.42 114.555 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 154.51 35.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.524 0.602 . . . . 74.42 110.526 169.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -151.94 137.76 18.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.575 -1.268 . . . . 75.01 107.575 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -125.01 150.4 46.77 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 124.587 1.18 . . . . 72.52 110.128 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 128.24 20.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.491 -1.67 . . . . 73.22 106.491 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 m -111.05 129.91 55.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.291 -1.374 . . . . 72.25 107.291 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.61 109.38 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.974 -1.861 . . . . 75.43 105.974 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 47.4 m -113.87 105.45 13.28 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.375 1.047 . . . . 73.34 109.414 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.04 -173.21 0.99 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 75.44 111.931 169.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.6 46.38 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.277 1.417 . . . . 72.42 114.915 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.1 p -159.04 20.2 0.19 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.201 1.4 . . . . 72.4 113.101 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 153.67 41.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.204 1.402 . . . . 74.54 109.562 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.54 129.81 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.331 1.052 . . . . 72.31 108.302 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -124.23 131.15 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.928 1.691 . . . . 72.03 107.404 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.06 130.54 50.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.252 1.021 . . . . 71.21 109.312 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.79 145.07 39.7 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.183 1.393 . . . . 74.13 109.46 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 146.35 51.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.763 1.625 . . . . 64.34 109.041 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -160.21 162.08 33.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.312 1.045 . . . . 74.31 111.663 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.2 m -96.84 128.28 43.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.564 1.165 . . . . 75.33 108.448 168.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.4 t -66.08 134.02 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.725 1.61 . . . . 73.42 110.737 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.13 -13.14 60.39 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.04 1.305 . . . . 55.35 113.049 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -105.67 145.93 30.4 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.461 1.504 . . . . 75.42 109.639 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.55 139.38 58.26 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.727 1.211 . . . . 64.11 112.244 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.08 161.53 42.38 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 124.792 1.307 . . . . 72.2 109.728 -170.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.84 118.05 30.98 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 124.358 1.036 . . . . 62.11 108.628 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.04 148.64 29.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.66 1.584 . . . . 74.32 109.097 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.67 125.25 43.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.588 1.155 . . . . 74.0 110.257 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -74.83 162.82 28.31 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.817 1.647 . . . . 73.14 110.626 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.05 -26.83 62.99 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.253 1.575 . . . . 74.13 115.253 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 -13.46 61.11 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.224 1.81 . . . . 73.52 113.901 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.98 -3.15 82.6 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.122 -1.377 . . . . 72.12 111.773 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.24 116.07 8.42 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 119.541 1.67 . . . . 72.11 111.087 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -87.12 123.77 32.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 124.809 1.318 . . . . 62.42 110.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.59 129.37 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.071 1.748 . . . . 74.43 109.966 -168.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -74.4 141.61 45.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.355 1.062 . . . . 75.41 111.741 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 t -166.07 166.65 17.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.185 1.394 . . . . 74.23 110.015 -168.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.07 146.54 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 75.14 107.643 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.75 145.41 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.23 1.012 . . . . 72.03 108.92 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.82 149.85 51.4 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.414 1.485 . . . . 70.34 109.837 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -106.21 124.63 49.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.24 1.416 . . . . 72.31 107.524 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -86.55 12.44 10.44 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.945 1.298 . . . . 74.41 114.428 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.5 -10.49 55.25 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.224 1.869 . . . . 74.32 113.872 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.9 49.77 1.14 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.517 1.527 . . . . 73.41 110.973 -169.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.291 0.6 OUTLIER 46.9 43.12 13.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.003 2.121 . . . . 73.4 114.054 -177.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -143.39 141.17 30.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.324 1.85 . . . . 74.12 108.642 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -115.94 148.07 40.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.539 1.535 . . . . 73.5 108.14 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -130.03 133.56 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.867 -1.16 . . . . 74.34 107.867 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -148.77 143.95 26.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.36 1.064 . . . . 75.43 111.219 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 p -139.51 127.91 22.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.363 1.465 . . . . 73.32 108.834 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.5 -98.88 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.495 1.918 . . . . 64.5 108.588 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -106.01 -53.13 2.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.827 1.251 . . . . 75.14 110.51 167.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -143.06 13.94 1.86 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.878 1.271 . . . . 75.11 112.7 -170.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.0 mt -113.65 99.15 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.074 -1.454 . . . . 64.22 107.074 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -87.83 105.58 17.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.071 0.948 . . . . 75.22 109.236 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 t -112.79 117.72 32.96 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.172 1.389 . . . . 74.44 110.631 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.34 128.31 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.227 -1.397 . . . . 73.31 107.227 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 m -109.11 146.19 34.45 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -142.24 148.41 38.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.808 0.843 . . . . 74.33 110.743 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.89 122.47 38.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.992 2.117 . . . . 75.11 107.486 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.14 79.74 1.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 74.43 107.376 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.67 -116.85 6.27 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 109.402 -1.479 . . . . 71.31 109.402 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.1 -10.09 51.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.319 1.448 . . . . 74.01 114.187 172.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.25 139.86 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.698 0.799 . . . . 75.34 109.052 175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.31 144.72 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.283 1.433 . . . . 71.12 108.599 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -127.21 148.79 50.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.442 1.897 . . . . 75.51 108.23 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.94 145.79 33.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.922 0.889 . . . . 72.52 109.121 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.7 m -144.77 86.73 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.674 1.59 . . . . 71.42 107.927 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mtm -84.66 139.34 32.11 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.016 0.927 . . . . 65.42 109.747 170.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.1 m -130.82 103.08 6.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.662 1.185 . . . . 63.04 108.277 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.5 tp -118.36 119.56 34.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.334 1.454 . . . . 75.53 108.775 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.79 -105.49 1.34 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.138 -1.585 . . . . 65.23 109.138 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.4 0.05 10.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.681 1.993 . . . . 74.43 112.292 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.6 mt -99.3 142.59 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.96 1.704 . . . . 72.41 109.291 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -121.67 92.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.791 0.837 . . . . 72.05 109.574 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.87 112.09 7.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 65.45 112.307 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -94.5 146.6 23.98 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.289 1.435 . . . . 74.32 110.62 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -134.85 148.93 50.26 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.816 1.322 . . . . 74.15 108.019 161.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.82 131.06 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 105.954 -1.869 . . . . 74.43 105.954 169.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.2 m -131.93 165.3 24.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.16 1.384 . . . . 71.2 109.682 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -147.64 143.11 27.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.823 0.849 . . . . 73.22 110.799 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -54.5 140.09 35.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.629 2.372 . . . . 75.52 113.133 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 124.605 2.145 . . . . 74.44 107.263 178.642 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 58.8 m170 . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 105.215 -2.142 . . . . 52.31 105.215 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -125.45 83.88 2.21 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 125.096 1.358 . . . . 75.54 107.864 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 51.4 m80 65.51 -82.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.856 2.462 . . . . 64.31 113.521 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -151.89 158.94 43.89 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.13 0.972 . . . . 73.03 110.789 -172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -156.08 77.13 0.94 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.701 1.2 . . . . 74.24 108.57 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 179.03 7.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.725 1.21 . . . . 62.12 111.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.28 18.58 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 125.588 1.555 . . . . 71.32 112.926 -175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -67.67 139.81 56.79 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.664 1.186 . . . . 75.33 111.844 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mmt -97.85 97.78 9.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.33 1.052 . . . . 75.42 109.072 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.7 m -118.87 118.81 32.55 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 125.201 1.563 . . . . 70.03 109.167 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.083 1.512 . . . . 74.34 115.083 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -59.83 116.25 3.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.165 1.786 . . . . 73.1 113.715 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.82 170.86 29.32 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.627 -0.989 . . . . 70.14 110.627 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -112.92 140.46 47.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.981 1.312 . . . . 73.53 107.993 173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.41 125.52 26.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.165 1.386 . . . . 74.21 110.34 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.58 152.36 30.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.973 0.909 . . . . 74.2 110.318 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.67 126.64 30.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.712 0.805 . . . . 64.31 109.033 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -95.79 -56.52 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.37 1.068 . . . . 75.31 110.917 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -156.89 163.36 39.26 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.079 1.352 . . . . 61.25 110.39 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -160.09 151.12 19.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.518 1.127 . . . . 74.33 109.59 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.59 143.95 43.86 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.204 1.401 . . . . 74.05 109.18 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.11 16.84 10.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.555 1.942 . . . . 73.45 114.783 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.79 -50.65 69.91 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.669 1.588 . . . . 74.31 113.189 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.17 -59.51 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.296 1.838 . . . . 62.3 112.782 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.5 83.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.213 1.405 . . . . 74.32 113.787 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.69 -52.71 49.26 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.987 1.315 . . . . 72.24 112.835 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 mmt -68.08 -35.35 78.05 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.373 1.046 . . . . 72.2 113.702 -176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -44.42 97.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.644 0.777 . . . . 74.34 112.314 168.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.45 79.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.322 1.23 . . . . 74.22 114.322 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 pt -80.95 -5.0 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.043 1.127 . . . . 75.3 114.043 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.99 19.33 26.81 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.229 -1.317 . . . . 54.2 114.646 161.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.25 142.63 97.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 119.54 1.67 . . . . 72.53 110.319 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.54 141.18 59.92 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.143 1.895 . . . . 74.4 111.65 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . 0.31 27.3 tt0 -65.93 -14.3 61.3 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.668 1.729 . . . . 71.15 115.668 -173.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.04 -53.17 61.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.616 1.167 . . . . 75.2 112.556 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.47 -26.01 66.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.563 1.545 . . . . 72.51 112.86 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.7 mt -78.85 -47.43 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 117.55 -1.214 . . . . 72.31 111.161 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -65.36 -39.48 92.38 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 113.731 1.011 . . . . 73.04 113.731 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -16.67 57.78 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.256 -0.878 . . . . 72.32 112.472 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.18 -37.74 10.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.974 -0.903 . . . . 51.5 111.35 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -26.27 34.73 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.465 1.106 . . . . 73.53 113.584 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -84.95 -62.82 1.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 124.163 0.914 . . . . 73.22 110.304 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.56 120.15 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.866 0.866 . . . . 60.01 108.914 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -66.33 127.58 32.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.051 0.94 . . . . 71.21 111.334 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.3 -172.57 48.87 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 124.712 1.258 . . . . 64.02 110.554 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.0 t -137.59 152.97 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.6 1.56 . . . . 75.42 107.389 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -135.77 155.61 50.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.257 1.023 . . . . 71.4 109.112 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -137.72 140.4 40.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.178 -0.675 . . . . 73.42 109.178 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 84.6 mt -123.61 129.61 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.863 1.352 . . . . 73.42 107.477 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.92 90.53 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -74.29 136.46 42.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.698 0.799 . . . . 74.35 110.223 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.07 86.22 1.43 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.233 1.013 . . . . 73.01 109.845 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.64 -114.29 4.06 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 109.526 -1.429 . . . . 75.11 109.526 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -91.58 -15.81 28.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.998 1.319 . . . . 74.42 111.874 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -86.15 147.65 26.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.322 1.449 . . . . 74.42 112.49 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -133.33 118.99 19.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.793 1.637 . . . . 75.01 107.828 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -87.6 131.93 34.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.046 1.338 . . . . 72.52 108.567 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.24 109.36 12.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.162 -1.792 . . . . 73.22 106.162 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -106.15 141.88 36.78 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.158 1.383 . . . . 72.25 109.536 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.91 107.41 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.145 1.378 . . . . 75.43 108.016 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.5 m -87.64 132.04 34.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.566 1.546 . . . . 73.34 109.068 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.88 4.64 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.653 . . . . 75.44 110.225 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.83 -86.93 0.86 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 109.674 -1.37 . . . . 72.42 109.674 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 t -150.25 21.56 0.85 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.996 1.318 . . . . 72.4 111.781 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.428 ' HZ2' ' CD1' ' A' ' 59' ' ' ILE . 5.2 ptmm? -129.25 149.39 51.06 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.475 1.51 . . . . 74.54 109.818 175.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.91 111.68 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 124.198 0.936 . . . . 72.31 109.567 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.428 ' CD1' ' HZ2' ' A' ' 57' ' ' LYS . 38.2 mt -84.19 144.61 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.77 1.228 . . . . 72.03 107.988 166.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.29 141.68 23.34 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 123.955 0.784 . . . . 71.21 110.762 165.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.79 158.52 41.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.455 1.902 . . . . 74.13 107.817 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.37 145.83 39.47 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 124.081 0.863 . . . . 64.34 109.909 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -139.62 149.91 44.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.829 1.331 . . . . 74.31 110.175 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -94.03 126.1 39.05 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.915 1.384 . . . . 75.33 108.094 168.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.23 130.45 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.862 0.865 . . . . 73.42 111.675 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.74 -5.47 81.84 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.21 -1.328 . . . . 55.35 113.672 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.49 157.03 21.6 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.122 1.461 . . . . 75.42 109.71 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.62 143.75 46.21 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.057 0.848 . . . . 64.11 111.794 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.11 -173.01 3.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.633 2.373 . . . . 72.2 107.576 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.69 129.47 38.8 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.146 -0.687 . . . . 62.11 109.146 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mp -104.71 161.42 14.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.877 1.671 . . . . 74.32 109.448 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.22 142.58 39.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.233 1.413 . . . . 74.0 109.013 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 m -109.03 142.89 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.562 1.145 . . . . 73.14 108.035 168.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.1 mtt -44.53 -32.07 1.31 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 118.769 2.877 . . . . 74.13 118.769 -163.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -71.05 -22.43 62.13 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.12 1.368 . . . . 73.52 114.262 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.27 5.57 10.38 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.209 -1.328 . . . . 72.12 112.298 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.18 147.03 52.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.448 1.624 . . . . 72.11 111.923 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 124.39 44.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.442 1.497 . . . . 62.42 107.732 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.33 128.62 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.196 0.998 . . . . 74.43 111.928 -169.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 148.4 48.9 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.89 1.276 . . . . 75.41 111.791 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -169.46 162.87 10.34 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.548 1.155 . . . . 74.23 111.039 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.06 150.62 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 126.047 1.739 . . . . 75.14 107.465 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.03 139.65 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.847 -0.798 . . . . 72.03 108.847 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -125.35 152.03 45.29 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.73 1.612 . . . . 70.34 110.86 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.75 118.11 35.26 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 72.31 106.513 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.05 11.65 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.22 1.563 . . . . 74.41 115.22 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.76 11.16 85.7 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.04 1.305 . . . . 74.32 112.596 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -134.04 35.78 3.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.391 1.476 . . . . 73.41 109.702 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.318 0.5 OUTLIER 53.51 27.08 6.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.469 1.908 . . . . 73.4 114.785 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -124.93 126.35 45.37 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.834 1.654 . . . . 74.12 108.832 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 45.6 mt -94.05 127.51 39.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.157 0.983 . . . . 73.5 109.639 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.69 134.89 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 74.34 108.684 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 t -160.9 151.26 17.92 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.222 1.009 . . . . 75.43 111.362 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -161.23 141.24 10.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.74 1.216 . . . . 73.32 110.861 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -83.65 -61.32 1.86 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.227 0.954 . . . . 64.5 109.18 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -129.72 -52.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.75 1.62 . . . . 75.14 110.241 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -147.56 -5.98 0.47 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.089 -0.958 . . . . 75.11 113.341 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 56.2 mt -78.43 85.65 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.787 1.235 . . . . 64.22 109.761 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.06 93.91 1.45 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.745 1.618 . . . . 75.22 111.725 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 t -85.28 128.41 34.68 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.496 1.123 . . . . 74.44 108.952 169.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.56 96.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.877 -1.527 . . . . 73.31 106.877 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -77.53 150.34 34.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.471 1.108 . . . . 75.43 109.665 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -132.6 128.85 38.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.733 2.013 . . . . 74.33 107.643 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.37 123.18 43.43 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.459 -1.312 . . . . 75.11 107.459 165.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.58 69.31 1.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.148 -1.797 . . . . 74.43 106.148 170.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.51 8.8 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.852 -1.299 . . . . 71.31 109.852 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.06 7.36 5.04 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.223 1.564 . . . . 74.01 115.223 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.44 138.05 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.141 0.976 . . . . 75.34 108.983 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 mm -123.62 98.52 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.05 1.34 . . . . 71.12 108.024 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -88.36 154.67 20.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.137 -0.69 . . . . 75.51 109.137 167.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -154.21 143.27 21.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.788 1.235 . . . . 72.52 108.343 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.8 m -130.56 126.76 37.58 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.832 1.332 . . . . 71.42 108.672 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mmm -119.08 105.55 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.266 2.227 . . . . 65.42 108.929 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.0 m -101.3 115.76 31.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.667 0.787 . . . . 63.04 110.275 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.96 110.16 12.7 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.422 1.889 . . . . 75.53 107.203 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.33 -135.74 47.95 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 109.893 -1.283 . . . . 65.23 109.893 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.73 3.38 37.66 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.845 1.258 . . . . 74.43 113.733 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.4 mt -93.63 132.75 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.402 -0.962 . . . . 72.41 108.402 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.88 95.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.439 -0.948 . . . . 72.05 108.439 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -78.48 136.15 37.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.472 1.909 . . . . 65.45 111.279 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.8 146.1 46.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.566 1.146 . . . . 74.32 109.698 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -130.9 140.79 50.24 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.881 1.672 . . . . 74.15 108.213 168.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.74 131.12 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.076 -1.824 . . . . 74.43 106.076 169.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m -136.71 159.05 42.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.79 1.636 . . . . 71.2 108.745 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -140.39 140.42 35.51 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.933 0.893 . . . . 73.22 110.381 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.73 136.51 57.02 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.308 2.243 . . . . 75.52 111.463 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.339 -2.467 . . . . 74.44 104.339 -175.124 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.568 1.321 . . . . 61.34 114.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 115.7 6.7 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.992 1.317 . . . . 73.1 112.359 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.18 173.4 35.38 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 110.283 -1.127 . . . . 70.14 110.283 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -117.62 145.45 44.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.044 0.937 . . . . 73.45 109.046 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -135.82 172.77 12.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.144 2.178 . . . . 71.04 110.579 -169.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -151.69 119.66 6.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.582 1.153 . . . . 74.2 108.04 -164.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' HE ' ' A' ' 122' ' ' ARG . 46.7 tp -57.57 122.98 14.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.975 1.31 . . . . 53.02 112.177 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -100.22 -49.69 4.19 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 124.921 1.388 . . . . 73.23 110.436 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -161.41 159.77 28.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.57 1.148 . . . . 60.01 110.6 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -160.56 142.37 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.34 1.056 . . . . 74.33 110.661 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -127.65 148.59 50.38 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.233 1.813 . . . . 74.05 108.799 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.17 16.13 6.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.886 1.675 . . . . 73.45 113.509 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.54 -56.68 18.27 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.188 1.395 . . . . 74.31 112.909 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -60.99 -48.23 82.8 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.397 1.061 . . . . 62.3 112.767 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.85 -42.64 76.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.727 1.211 . . . . 64.44 113.794 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -68.6 -46.86 68.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.256 1.422 . . . . 72.24 113.241 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mmt -66.13 -41.23 90.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.646 1.178 . . . . 55.3 113.144 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.5 mptm? -60.89 -40.78 94.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.39 1.076 . . . . 73.32 112.226 169.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.59 66.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.885 1.439 . . . . 70.25 114.885 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 pt -86.84 0.96 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 113.214 0.82 . . . . 74.23 113.214 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.91 22.57 38.43 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.381 -1.233 . . . . 54.2 113.774 166.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.16 145.93 70.07 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 119.278 1.539 . . . . 71.32 110.859 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 149.65 58.45 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.25 . . . . 64.41 111.998 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 29' ' ' ILE . 51.8 tt0 -55.52 -29.18 58.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.366 1.466 . . . . 71.15 114.693 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.31 -54.08 51.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.475 1.51 . . . . 75.2 113.257 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.69 -22.75 66.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.892 1.277 . . . . 71.15 113.698 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.571 HD13 ' HD2' ' A' ' 20' ' ' LYS . 66.2 mt -78.25 -49.56 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.444 1.098 . . . . 63.41 111.366 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -65.74 -36.56 83.92 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.247 1.203 . . . . 73.04 114.247 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -27.67 55.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 118.524 -0.75 . . . . 61.25 112.28 171.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.3 -29.38 56.32 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.754 -1.026 . . . . 51.5 112.361 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.19 -30.12 18.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.436 1.095 . . . . 73.42 112.797 175.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.34 -59.86 2.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.738 0.815 . . . . 73.22 110.436 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.64 109.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.451 1.094 . . . . 53.41 108.822 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.14 115.77 8.82 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 124.12 0.887 . . . . 71.21 110.191 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.43 179.66 50.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.974 1.421 . . . . 34.23 111.674 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 t -116.93 160.01 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.613 1.565 . . . . 73.42 106.81 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 t -148.15 149.83 32.7 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 108.713 -0.847 . . . . 61.43 108.713 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -147.07 139.56 24.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.628 -0.878 . . . . 53.23 108.628 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.5 mt -136.29 140.41 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.306 -1.368 . . . . 73.42 107.306 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.25 107.56 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.192 -1.04 . . . . 70.04 108.192 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -76.89 131.6 38.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.309 -0.997 . . . . 74.35 108.309 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -130.41 51.21 2.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.988 1.315 . . . . 73.01 108.79 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.25 -115.56 5.17 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.667 -1.773 . . . . 72.23 108.667 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 74.42 112.908 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.33 155.29 39.57 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.972 1.309 . . . . 74.35 112.134 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -147.36 128.27 14.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.621 1.569 . . . . 75.01 107.78 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -106.26 136.0 46.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.657 1.583 . . . . 72.32 108.707 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.74 134.48 55.22 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.083 -1.451 . . . . 73.22 107.083 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.89 122.94 15.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.059 1.343 . . . . 72.25 107.991 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.22 113.7 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.873 -1.158 . . . . 74.01 107.873 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -90.94 104.77 17.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.552 1.141 . . . . 63.33 109.695 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.61 174.99 11.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.644 1.178 . . . . 75.44 110.658 166.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.79 21.15 0.98 Allowed Glycine 0 CA--C 1.544 1.859 0 C-N-CA 125.714 1.626 . . . . 72.42 115.174 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.8 p -158.22 -30.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.578 1.689 . . . . 51.21 113.459 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -151.23 165.07 35.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.195 0.998 . . . . 74.54 110.742 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -108.73 139.72 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 124.462 1.101 . . . . 72.31 108.723 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 117.33 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 106.666 -1.605 . . . . 63.31 106.666 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.66 140.91 39.97 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.348 1.03 . . . . 71.21 109.016 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -144.42 158.97 43.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.954 1.702 . . . . 74.13 109.043 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -145.35 146.82 31.74 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.273 0.983 . . . . 64.34 109.563 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -148.4 171.27 16.3 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.436 1.494 . . . . 72.14 109.474 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.2 m -118.07 132.7 56.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.46 -1.311 . . . . 74.12 107.46 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.91 129.87 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 72.44 110.876 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.21 -7.96 49.16 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 118.179 -1.345 . . . . 55.35 113.821 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -101.62 152.37 20.89 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.202 1.501 . . . . 70.23 109.032 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.63 104.41 16.34 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.098 0.959 . . . . 64.11 110.879 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.7 m -125.18 -162.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.483 1.913 . . . . 70.35 109.067 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.06 155.74 49.76 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.707 1.203 . . . . 62.11 111.522 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.9 mt -132.03 139.04 48.44 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.792 1.637 . . . . 63.25 108.647 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.03 132.86 44.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.069 1.347 . . . . 41.41 109.892 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 m -83.72 162.41 20.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.432 1.493 . . . . 73.14 110.439 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.8 mtt -56.75 -30.1 63.22 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.94 1.459 . . . . 71.13 114.94 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.9 t -71.84 -11.33 60.75 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.427 1.491 . . . . 73.34 114.211 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.49 1.97 70.87 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.88 1.229 . . . . 72.12 112.028 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.89 132.52 47.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.303 1.441 . . . . 62.44 110.881 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -101.29 128.64 47.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.431 1.492 . . . . 62.24 108.375 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.97 126.15 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 124.038 0.836 . . . . 74.43 111.228 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.24 144.52 40.33 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.827 1.651 . . . . 75.41 111.729 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -171.88 179.59 2.69 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.113 1.365 . . . . 71.1 111.069 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.49 145.8 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 126.52 1.928 . . . . 75.14 107.557 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.21 143.33 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.111 0.964 . . . . 72.03 109.474 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -125.06 166.44 16.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.305 1.842 . . . . 70.34 111.216 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.11 135.77 41.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.659 1.584 . . . . 65.52 107.112 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.71 18.99 7.97 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.642 1.177 . . . . 63.23 113.74 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.48 9.18 64.27 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.991 1.758 . . . . 62.21 113.893 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -132.05 46.09 2.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.88 1.272 . . . . 73.41 109.574 -166.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.288 0.9 OUTLIER 49.65 32.06 4.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.071 2.148 . . . . 72.33 114.884 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -137.48 119.82 15.79 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.044 1.738 . . . . 70.41 108.572 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.22 146.42 23.73 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.204 0.94 . . . . 73.5 109.496 171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.72 138.0 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.914 1.286 . . . . 73.14 108.501 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 t -153.43 146.38 24.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.964 0.906 . . . . 65.32 109.51 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.9 p -120.14 174.29 6.58 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.758 1.223 . . . . 73.32 109.007 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.85 -85.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.412 -0.958 . . . . 64.5 108.412 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -51.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.809 1.244 . . . . 75.14 109.11 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.6 12.87 1.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.128 1.771 . . . . 75.11 111.601 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.7 mt -112.21 118.98 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.451 1.9 . . . . 63.21 106.683 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -111.08 102.08 10.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.611 1.164 . . . . 53.13 108.736 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.7 m -99.48 129.18 45.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.293 1.437 . . . . 70.42 110.344 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -133.06 108.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.589 1.156 . . . . 63.2 108.608 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.7 m -85.92 148.49 25.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.456 1.102 . . . . 75.43 109.221 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.85 118.01 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.999 1.32 . . . . 73.42 109.262 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.92 127.28 41.8 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.522 -0.918 . . . . 75.11 108.522 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.14 81.52 2.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.279 1.832 . . . . 74.43 107.729 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.95 -110.38 3.45 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.927 1.251 . . . . 71.31 110.922 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.81 21.24 9.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.562 1.545 . . . . 74.01 111.99 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -129.4 141.38 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.747 1.219 . . . . 64.11 108.646 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.07 107.97 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.941 1.296 . . . . 71.12 107.89 172.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 m -85.9 144.2 27.79 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.835 1.254 . . . . 75.51 108.283 165.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.3 122.43 8.89 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.209 -1.404 . . . . 72.52 107.209 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.93 120.33 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.513 1.133 . . . . 71.42 108.87 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.4 mtp -118.43 142.59 47.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.894 1.678 . . . . 63.21 109.216 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -133.71 95.74 3.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 43.55 109.905 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -96.08 106.37 18.54 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 125.038 1.335 . . . . 64.31 108.287 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.47 -109.84 3.08 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 110.218 -1.153 . . . . 61.13 110.218 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.78 -9.06 20.3 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.527 1.531 . . . . 74.43 112.014 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.24 130.87 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.05 1.34 . . . . 44.24 108.956 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.49 82.24 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 124.168 0.918 . . . . 72.05 109.621 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.96 131.91 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.434 1.093 . . . . 63.23 112.534 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -127.97 152.24 48.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.038 1.335 . . . . 61.44 109.577 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HE ' HD13 ' A' ' 9' ' ' LEU . 50.6 ttt-85 -155.79 130.22 8.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.605 1.162 . . . . 72.2 109.401 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.43 131.69 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.096 1.358 . . . . 74.43 107.497 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m -131.02 159.29 37.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.412 1.485 . . . . 71.2 108.924 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -129.2 131.57 47.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.558 1.143 . . . . 73.22 110.016 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -69.33 119.96 14.4 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.852 2.061 . . . . 75.52 110.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 124.098 1.904 . . . . 74.44 108.425 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 114.447 1.277 . . . . 61.34 114.447 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -57.01 120.78 8.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.329 2.252 . . . . 73.1 112.837 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.62 169.8 21.02 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 109.944 -1.262 . . . . 70.14 109.944 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.3 ttmt -121.22 133.03 55.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.974 1.309 . . . . 73.45 108.88 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -134.04 122.92 23.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.198 1.399 . . . . 71.04 110.217 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.68 153.31 37.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.264 1.025 . . . . 74.2 110.061 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' A' ' 122' ' ' ARG . 1.3 mt -70.65 137.02 49.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.195 0.309 . . . . 53.02 110.726 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -109.17 -48.57 3.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.744 1.277 . . . . 73.23 110.095 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.55 160.24 25.74 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 124.255 0.972 . . . . 60.01 111.786 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.27 153.45 50.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.826 1.65 . . . . 74.33 107.628 172.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -129.87 142.03 50.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.968 0.907 . . . . 74.05 109.613 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 58.86 25.37 13.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.346 1.858 . . . . 73.45 113.495 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -53.83 -55.15 29.19 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.159 1.384 . . . . 74.31 112.794 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.37 -45.24 76.87 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 124.791 1.307 . . . . 62.3 112.946 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.75 86.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.359 1.064 . . . . 64.44 113.577 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.98 -45.4 67.43 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.698 1.199 . . . . 72.24 112.815 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 16.3 mmt -65.82 -40.44 91.83 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.514 1.134 . . . . 55.3 112.945 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.4 mptt -59.34 -39.48 83.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.436 1.094 . . . . 73.32 113.014 168.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.68 72.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.614 1.339 . . . . 70.25 114.614 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.571 HG13 HD23 ' A' ' 24' ' ' LEU . 45.9 pt -77.16 -1.54 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 113.682 0.993 . . . . 74.23 113.682 171.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.56 38.07 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.83 -0.983 . . . . 54.2 113.146 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.571 HD23 HG13 ' A' ' 22' ' ' ILE . 1.1 mm? -74.57 142.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 118.581 1.19 . . . . 71.32 109.276 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.02 149.49 77.18 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.58 2.187 . . . . 64.41 111.565 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 29' ' ' ILE . 59.2 tt0 -59.74 -24.85 64.37 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.1 1.519 . . . . 71.15 115.1 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.97 -46.39 78.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.575 0.954 . . . . 75.2 113.575 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -67.97 -25.7 65.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.352 -0.832 . . . . 71.15 113.001 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 26' ' ' GLU . 56.2 mt -72.73 -53.16 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 117.86 -1.067 . . . . 63.41 111.009 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -62.96 -43.13 99.64 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.025 1.12 . . . . 73.04 114.025 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -23.22 63.3 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.735 0.647 . . . . 61.25 111.926 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.57 -28.36 47.8 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.127 -1.374 . . . . 51.5 112.469 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.37 -28.34 16.96 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 116.756 -1.592 . . . . 73.42 113.79 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -80.35 -34.95 36.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.865 1.212 . . . . 73.22 110.942 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.3 mt -93.47 122.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.361 1.065 . . . . 53.41 108.883 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.71 144.91 29.05 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.983 0.802 . . . . 71.21 110.668 165.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.3 -162.75 26.42 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 124.603 1.19 . . . . 34.23 110.725 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -143.86 152.64 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.607 1.963 . . . . 73.42 107.5 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -132.88 149.21 52.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.841 0.856 . . . . 61.43 109.598 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.14 136.91 54.98 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.023 -1.103 . . . . 53.23 108.023 166.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.63 128.42 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.509 -2.034 . . . . 73.42 105.509 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.92 99.11 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 124.162 0.914 . . . . 70.04 108.738 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -78.51 120.31 23.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.574 1.15 . . . . 74.35 109.685 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -117.45 54.83 0.87 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.381 1.472 . . . . 73.01 109.831 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -118.1 6.47 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.526 -1.83 . . . . 72.23 108.526 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -31.58 60.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.262 1.025 . . . . 74.42 112.829 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 161.92 29.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.339 1.056 . . . . 74.35 111.078 169.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -155.55 138.31 15.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.584 -1.265 . . . . 75.01 107.584 -175.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.98 144.7 48.37 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 125.53 1.532 . . . . 72.32 109.894 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.59 123.41 27.85 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.864 -1.902 . . . . 73.22 105.864 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -116.6 135.52 53.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.313 1.845 . . . . 72.25 108.525 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.52 105.26 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.325 -0.991 . . . . 74.01 108.325 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -97.02 114.84 26.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.824 1.649 . . . . 63.33 109.125 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.86 147.97 17.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.584 0.754 . . . . 75.44 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.63 -105.58 1.96 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 107.608 -2.197 . . . . 72.42 107.608 -173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -147.79 34.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.017 1.327 . . . . 51.21 110.912 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.03 164.4 30.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.0 1.72 . . . . 74.54 109.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.31 129.91 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.977 0.798 . . . . 72.31 109.0 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.27 133.8 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.396 -1.335 . . . . 63.31 107.396 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -122.82 124.38 43.17 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.245 -1.391 . . . . 71.21 107.245 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -123.33 150.71 43.27 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 124.645 1.216 . . . . 74.13 109.014 172.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.66 142.27 41.15 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 125.205 1.566 . . . . 64.34 108.99 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.81 162.3 40.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.063 1.345 . . . . 72.14 109.756 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.5 m -109.51 135.46 50.48 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.309 -1.367 . . . . 74.12 107.309 166.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.5 130.46 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.953 0.901 . . . . 72.44 111.032 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.88 -7.97 64.48 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 117.941 -1.477 . . . . 55.35 114.092 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -98.75 136.09 39.29 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.538 1.669 . . . . 70.23 110.08 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.66 136.12 45.58 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.364 1.04 . . . . 64.11 111.068 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -167.63 159.17 11.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.853 1.261 . . . . 70.35 109.403 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -100.94 124.23 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.236 0.96 . . . . 62.11 110.915 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 81' ' ' THR . 4.5 mm? -105.67 168.66 8.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.941 2.096 . . . . 63.25 109.787 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -129.79 157.96 40.74 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.954 1.301 . . . . 41.41 110.545 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.6 p -124.11 173.09 8.52 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.093 1.757 . . . . 73.14 109.703 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -59.82 -20.39 56.61 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.509 1.67 . . . . 71.13 115.509 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 24' ' ' LEU . 54.3 p -78.57 -14.88 59.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.159 1.783 . . . . 73.34 113.842 172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.15 -2.08 83.35 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.996 1.284 . . . . 72.12 112.653 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -65.2 135.74 55.8 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 119.121 1.46 . . . . 62.44 112.559 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -103.93 143.14 33.26 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 125.126 1.516 . . . . 62.24 110.93 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.48 123.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.747 1.219 . . . . 74.43 111.272 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -71.43 137.92 48.66 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.738 1.215 . . . . 75.41 111.582 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 71' ' ' LEU . 13.8 t -167.41 169.67 12.07 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.677 1.236 . . . . 71.1 110.315 -172.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.71 132.2 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.866 1.266 . . . . 75.14 107.998 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.41 140.88 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 124.11 0.881 . . . . 72.03 109.524 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -131.59 168.58 17.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 70.34 111.373 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -122.44 127.2 49.35 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.006 -1.479 . . . . 65.52 107.006 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -84.9 18.55 2.4 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.596 1.332 . . . . 63.23 114.596 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 18.16 78.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.98 1.276 . . . . 62.21 113.719 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -143.43 48.14 1.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.605 1.162 . . . . 73.41 109.47 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.29 0.7 OUTLIER 47.21 37.58 5.79 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.695 1.998 . . . . 72.33 114.178 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -137.47 121.34 17.61 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.862 1.665 . . . . 70.41 109.072 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.58 140.77 29.44 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.556 1.16 . . . . 73.5 109.725 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.22 138.68 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.326 1.45 . . . . 73.14 108.476 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -160.11 143.62 13.99 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.959 0.787 . . . . 65.32 110.85 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.4 p -129.17 117.35 20.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.243 1.417 . . . . 73.32 107.343 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -69.33 -52.3 28.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.268 1.027 . . . . 64.5 110.604 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -149.26 -101.71 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.828 -2.286 . . . . 75.14 104.828 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -76.72 -20.23 56.79 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.481 2.312 . . . . 75.11 113.674 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 HD13 ' A' ' 115' ' ' LEU . 68.5 mt -81.69 102.31 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.312 1.045 . . . . 63.21 108.636 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.84 146.89 24.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.105 1.362 . . . . 53.13 109.838 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 m -138.71 126.89 22.73 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.462 1.505 . . . . 70.42 107.43 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.59 97.71 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.173 -1.418 . . . . 63.2 107.173 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 m -94.54 152.91 18.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.157 1.383 . . . . 75.43 110.156 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -141.32 139.48 33.62 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.7 2.0 . . . . 73.42 108.545 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.11 137.38 47.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 75.11 107.556 162.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -142.11 77.22 1.57 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.927 1.691 . . . . 74.43 106.8 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.88 -98.31 0.48 Allowed Glycine 0 C--N 1.346 1.115 0 C-N-CA 125.435 1.493 . . . . 71.31 110.752 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -87.76 -13.69 41.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.335 1.454 . . . . 74.01 113.133 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.89 140.23 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 119.798 1.181 . . . . 64.11 110.754 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.7 mm -119.5 107.66 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.088 1.355 . . . . 71.12 107.855 168.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -96.04 138.23 33.97 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.154 -1.054 . . . . 75.51 108.154 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -147.0 91.45 2.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.389 0.676 . . . . 72.52 109.252 -170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -82.97 144.24 30.12 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.7 1.25 . . . . 71.42 110.616 173.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 92.9 mtp -130.64 153.09 49.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.519 1.527 . . . . 63.21 108.491 168.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 m -141.03 114.03 8.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.842 0.857 . . . . 43.55 108.737 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.564 HD13 HG12 ' A' ' 98' ' ' ILE . 9.3 tp -123.95 125.08 43.97 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.568 1.547 . . . . 64.31 107.915 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.22 -101.44 0.38 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 124.983 1.427 . . . . 61.13 110.674 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.2 0.18 12.23 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.586 1.955 . . . . 74.43 112.951 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.76 137.79 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.878 1.271 . . . . 44.24 109.817 -172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.16 102.24 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.544 1.138 . . . . 72.05 109.324 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -84.85 150.99 24.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.539 1.536 . . . . 63.23 111.515 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -136.52 157.24 47.25 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.946 0.898 . . . . 61.44 110.199 167.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.521 ' HG2' HD21 ' A' ' 9' ' ' LEU . 5.3 ttp180 -137.46 143.64 41.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.531 1.533 . . . . 72.2 108.645 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.72 123.25 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.428 -1.693 . . . . 74.43 106.428 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -130.32 152.56 49.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.365 1.466 . . . . 71.2 108.988 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -133.29 138.28 46.35 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.85 0.86 . . . . 73.22 110.665 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -64.27 135.99 56.76 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.856 2.062 . . . . 75.52 112.526 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.59 HD12 ' HD2' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 C--N 1.343 0.319 0 N-CA-C 103.369 -2.826 . . . . 74.44 103.369 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 109.581 -0.526 . . . . 61.34 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.3 p -128.56 124.86 37.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.763 1.225 . . . . 73.1 109.05 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.42 174.21 27.82 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 109.63 -1.388 . . . . 70.14 109.63 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.2 ttmt -130.25 134.01 46.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 73.45 108.98 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.27 130.7 33.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.509 1.524 . . . . 71.04 110.04 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.73 152.47 21.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.273 1.029 . . . . 74.2 110.009 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.62 149.3 50.31 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.838 1.255 . . . . 53.02 112.011 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -125.99 -46.11 1.69 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.697 1.199 . . . . 73.23 111.126 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -162.43 155.71 20.27 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.303 1.041 . . . . 60.01 111.405 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -137.48 140.38 41.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.239 1.415 . . . . 74.33 108.522 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -116.33 149.33 39.48 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.084 0.954 . . . . 74.05 109.208 167.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.93 26.22 14.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.321 1.848 . . . . 73.45 113.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.34 -61.4 2.6 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 124.583 1.153 . . . . 74.31 113.373 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.43 -32.99 74.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.151 -0.928 . . . . 62.3 113.284 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.78 95.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.101 0.961 . . . . 64.44 113.112 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -68.56 -51.01 47.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.419 1.488 . . . . 72.24 113.42 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 mmt -63.37 -42.74 98.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.006 1.322 . . . . 55.3 112.966 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -74.91 -26.54 59.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.036 -0.983 . . . . 73.32 113.071 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.28 66.47 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 118.21 -0.9 . . . . 70.25 113.327 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.24 -13.31 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.968 0.792 . . . . 74.23 112.77 170.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.34 17.88 27.91 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 117.998 -1.446 . . . . 54.2 113.849 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.3 mt -61.56 142.22 94.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 119.694 1.747 . . . . 71.32 112.112 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.15 143.51 90.26 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.502 2.135 . . . . 64.41 111.742 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.73 -24.43 64.01 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.839 1.422 . . . . 71.15 114.839 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.09 -47.39 83.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.418 1.487 . . . . 75.2 113.397 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.6 -27.43 66.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.83 1.252 . . . . 71.15 112.642 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.15 -54.72 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 117.764 -1.112 . . . . 63.41 111.085 168.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -60.96 -42.92 99.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.6 1.333 . . . . 73.04 114.6 -175.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -13.23 59.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.36 -0.829 . . . . 61.25 112.986 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.09 -35.67 9.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.847 -0.974 . . . . 51.5 111.443 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -33.39 23.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.451 1.125 . . . . 73.42 112.874 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -71.96 -60.1 2.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.833 0.853 . . . . 73.22 110.542 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.48 114.99 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 124.339 1.024 . . . . 53.41 109.371 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.97 110.82 3.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.68 1.592 . . . . 71.21 109.415 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.29 -178.68 45.54 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.756 1.169 . . . . 34.23 111.893 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.97 158.3 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.241 1.416 . . . . 73.42 108.846 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -144.32 146.39 32.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.107 1.363 . . . . 61.43 109.76 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -128.38 138.22 52.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.75 1.22 . . . . 53.23 108.318 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -126.46 130.9 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.671 -1.603 . . . . 73.42 106.671 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.31 90.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.844 0.715 . . . . 70.04 109.729 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -76.36 136.32 39.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.325 0.65 . . . . 74.35 110.241 167.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.98 79.07 1.68 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.617 1.567 . . . . 73.01 107.477 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 -126.05 12.53 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.28 -1.528 . . . . 72.23 109.28 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -68.4 -29.35 68.02 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.558 1.318 . . . . 74.42 114.558 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 151.5 39.11 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.913 0.758 . . . . 74.35 111.493 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.06 137.35 23.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.164 1.786 . . . . 75.01 107.382 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -121.75 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.547 1.154 . . . . 72.32 108.85 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.61 103.4 5.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.75 -1.945 . . . . 73.22 105.75 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -92.93 138.7 31.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.698 1.199 . . . . 72.25 108.466 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.78 111.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.786 1.234 . . . . 74.01 107.774 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -86.64 107.3 18.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.873 1.269 . . . . 63.33 108.59 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 -173.63 1.68 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.825 1.65 . . . . 75.44 111.872 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.66 -31.54 63.98 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.783 1.182 . . . . 72.42 114.621 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -162.11 46.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.99 1.316 . . . . 51.21 109.324 167.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.34 160.85 43.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.495 1.518 . . . . 74.54 108.53 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.48 128.79 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.311 -0.996 . . . . 72.31 108.311 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -127.71 141.89 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.748 -1.575 . . . . 63.31 106.748 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.32 137.52 37.47 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.898 0.749 . . . . 71.21 110.766 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -124.17 158.13 33.09 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 125.475 1.734 . . . . 74.13 108.872 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.62 141.71 28.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 124.759 1.287 . . . . 64.34 108.972 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.69 160.67 42.44 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.48 1.112 . . . . 72.14 110.635 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 m -109.48 130.61 55.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.869 -1.16 . . . . 74.12 107.869 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.4 117.21 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.893 0.877 . . . . 72.44 110.242 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.68 56.58 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.74 -1.589 . . . . 55.35 112.759 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -119.16 150.77 39.48 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.502 1.651 . . . . 70.23 110.063 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.8 122.09 24.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.766 1.226 . . . . 64.11 110.732 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.7 m -144.97 151.9 39.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.966 1.306 . . . . 70.35 109.712 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -100.09 134.4 43.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.665 1.186 . . . . 62.11 110.857 -165.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.48 106.65 9.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.013 1.325 . . . . 63.25 109.67 -165.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.78 125.75 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.494 1.518 . . . . 41.41 111.664 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.7 m -82.3 166.38 19.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.728 1.611 . . . . 73.14 111.179 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.12 -27.42 14.14 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.579 1.952 . . . . 71.13 115.488 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -86.44 -17.19 34.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.266 1.826 . . . . 73.34 114.255 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.34 -16.08 45.69 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.785 1.183 . . . . 72.12 112.123 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -62.19 136.7 58.05 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.501 1.52 . . . . 62.44 110.4 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -133.65 153.76 51.43 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 124.382 1.051 . . . . 62.24 111.25 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -150.58 140.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.565 1.946 . . . . 74.43 108.517 -168.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -109.17 134.57 51.56 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.485 1.116 . . . . 75.41 109.867 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 t -168.21 161.05 12.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.327 1.051 . . . . 71.1 111.124 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.78 117.94 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.867 1.267 . . . . 75.14 109.302 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.52 138.15 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.906 0.883 . . . . 72.03 108.818 171.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -129.92 153.93 47.84 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.979 1.312 . . . . 70.34 111.821 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.9 tt -97.74 132.41 43.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.929 1.292 . . . . 65.52 109.565 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -93.54 27.28 2.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.757 1.623 . . . . 63.23 113.607 -170.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 69.9 6.13 54.96 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.88 1.705 . . . . 62.21 115.304 171.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.26 57.36 0.89 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.329 1.565 . . . . 73.41 109.012 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.341 0.0 OUTLIER 49.4 32.6 4.72 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.337 1.855 . . . . 72.33 114.92 178.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -124.43 138.62 54.34 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 126.532 1.933 . . . . 70.41 108.641 -174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.5 mt -114.34 125.15 53.54 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 124.342 1.026 . . . . 73.5 108.896 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.0 141.7 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.425 1.49 . . . . 73.14 108.718 173.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.8 t -150.78 140.53 21.76 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.212 0.945 . . . . 65.32 110.141 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 76.6 p -135.74 160.09 39.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.347 1.859 . . . . 73.32 108.743 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -127.71 -56.81 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.005 -0.739 . . . . 64.5 109.005 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -140.62 -63.1 0.48 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.697 1.599 . . . . 75.14 109.414 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -127.13 -26.36 3.13 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.633 1.208 . . . . 75.11 112.068 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.1 mt -74.07 100.58 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 124.032 0.933 . . . . 63.21 109.58 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -74.57 148.97 40.35 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.595 1.184 . . . . 53.13 109.01 165.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -149.75 125.11 10.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.812 -1.551 . . . . 70.42 106.812 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.2 t -127.06 100.43 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.82 -1.548 . . . . 63.2 106.82 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 96.1 m -77.99 147.75 34.73 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.463 1.102 . . . . 75.43 108.578 165.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -149.33 114.61 5.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.555 1.142 . . . . 73.42 109.498 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.7 124.25 38.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.439 1.496 . . . . 75.11 109.145 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -129.78 67.65 1.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.235 -1.765 . . . . 74.43 106.235 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.78 -106.4 1.55 Allowed Glycine 0 C--N 1.348 1.202 0 C-N-CA 125.394 1.474 . . . . 71.31 110.278 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.72 -10.82 59.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.459 1.281 . . . . 74.01 114.459 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.58 137.0 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.199 1.0 . . . . 64.11 109.847 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.9 mm -124.77 104.82 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.023 1.329 . . . . 71.12 107.861 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.5 m -94.74 135.31 36.37 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.564 -1.273 . . . . 75.51 107.564 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.73 95.74 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.81 -0.811 . . . . 72.52 108.81 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.1 m -88.96 138.89 31.0 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.618 1.199 . . . . 71.42 109.653 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.7 mtp -130.67 154.37 47.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.425 1.49 . . . . 63.21 109.195 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.1 m -147.64 88.17 1.68 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.819 0.447 . . . . 43.55 111.474 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.09 107.48 16.46 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.502 1.121 . . . . 64.31 108.373 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.23 -99.14 0.22 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.782 1.182 . . . . 61.13 111.685 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.33 -3.81 15.98 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.22 1.808 . . . . 74.43 111.95 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.71 102.29 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.159 1.383 . . . . 44.24 109.075 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.69 84.34 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.498 1.119 . . . . 72.05 109.681 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -70.8 148.55 47.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.633 1.173 . . . . 63.23 112.261 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.28 156.02 49.17 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.722 0.809 . . . . 61.44 110.323 167.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -141.26 136.46 31.68 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.045 1.738 . . . . 72.2 107.339 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.38 132.77 70.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.129 -1.804 . . . . 74.43 106.129 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -139.64 155.26 47.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.616 1.567 . . . . 71.2 109.284 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -142.15 145.57 34.36 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.069 0.948 . . . . 73.22 110.883 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpt85 -51.4 141.09 16.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.023 2.929 . . . . 75.52 113.993 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.1 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 104.103 -2.555 . . . . 74.44 104.103 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' HA ' HD22 ' A' ' 104' ' ' LEU . 66.3 m-85 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 115.504 1.668 . . . . 61.34 115.504 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -59.01 127.2 31.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.929 1.692 . . . . 73.1 113.725 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.11 174.58 27.0 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.9 -0.88 . . . . 70.14 110.9 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.524 ' HD2' HD12 ' A' ' 127' ' ' ILE . 10.8 ttmm -125.23 137.01 54.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.863 1.665 . . . . 73.45 108.094 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.47 127.88 26.5 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.397 1.479 . . . . 71.04 110.527 -166.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.96 152.0 28.23 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.734 0.814 . . . . 74.2 110.046 168.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.39 146.94 50.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.194 0.598 . . . . 53.02 110.409 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -120.39 -60.63 1.66 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.442 1.097 . . . . 73.23 109.779 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 m -143.17 157.28 44.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.69 1.196 . . . . 60.01 110.982 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -142.86 149.97 39.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.289 1.435 . . . . 74.33 109.36 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -125.7 148.96 48.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.059 0.944 . . . . 74.05 109.38 165.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 54.33 33.1 17.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.819 2.048 . . . . 73.45 112.402 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -61.51 -64.61 0.89 Allowed 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.572 1.149 . . . . 74.31 111.318 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.85 -38.99 90.31 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 124.446 1.091 . . . . 62.3 113.062 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.45 78.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.546 1.139 . . . . 64.44 113.476 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -74.39 -40.79 61.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.541 1.136 . . . . 72.24 113.322 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.1 mmt -68.08 -36.64 80.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.492 1.117 . . . . 55.3 113.395 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -65.0 -40.66 95.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.846 0.858 . . . . 73.32 112.313 167.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.85 -33.18 70.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.081 1.511 . . . . 70.25 115.081 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -75.87 -14.12 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 113.371 0.878 . . . . 74.23 113.371 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.7 20.69 39.43 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.593 -1.115 . . . . 54.2 112.719 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.7 135.55 96.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 118.909 1.354 . . . . 71.32 109.296 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.77 153.25 78.73 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.338 2.025 . . . . 64.41 112.268 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 29' ' ' ILE . 45.1 tt0 -56.97 -27.66 61.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.131 1.53 . . . . 71.15 115.131 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.78 -52.99 61.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.087 -0.958 . . . . 75.2 112.546 169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.62 -22.9 67.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.643 1.177 . . . . 71.15 114.059 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' GLU . 49.2 mt -75.04 -56.65 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 63.41 110.197 171.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -66.08 -36.38 83.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.702 1.371 . . . . 73.04 114.702 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -13.78 49.44 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.722 0.638 . . . . 61.25 112.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.74 -21.5 76.65 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 118.698 -1.056 . . . . 51.5 111.424 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -103.35 -22.33 13.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 116.365 -1.778 . . . . 73.42 113.86 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.25 20.0 p-10 -70.46 -51.68 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.127 1.33 . . . . 73.22 110.778 -173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.4 mm -97.96 122.98 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.606 1.562 . . . . 53.41 107.418 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.1 126.46 29.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.392 1.057 . . . . 71.21 109.553 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.79 -168.76 10.31 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 124.598 1.186 . . . . 34.23 112.172 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.2 153.86 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 107.801 -1.185 . . . . 73.42 107.801 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -135.98 148.99 48.68 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.11 1.364 . . . . 61.43 108.79 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -138.47 135.78 35.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.9 0.88 . . . . 53.23 108.727 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.96 130.84 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.358 -1.349 . . . . 73.42 107.358 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -136.23 97.81 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.329 -0.989 . . . . 70.04 108.329 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -76.28 143.12 41.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.873 0.869 . . . . 74.35 109.808 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -145.24 83.07 1.67 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.87 -1.159 . . . . 73.01 107.87 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.72 -120.3 10.92 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.292 -1.523 . . . . 72.23 109.292 -175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -77.67 -24.79 49.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 74.42 114.243 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.69 154.13 36.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.305 1.042 . . . . 74.35 111.678 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.78 119.8 6.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.775 1.23 . . . . 75.01 108.39 -173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -99.69 137.48 38.1 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.413 1.071 . . . . 72.32 108.901 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.71 140.86 51.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.336 -1.727 . . . . 73.22 106.336 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 m -140.09 136.95 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.966 1.706 . . . . 72.25 107.929 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.26 114.15 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.635 1.574 . . . . 74.01 106.806 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.3 m -96.8 130.63 44.03 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.296 1.439 . . . . 63.33 109.608 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.39 172.55 8.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.615 1.566 . . . . 75.44 109.365 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.23 7.5 8.02 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 118.249 -1.306 . . . . 72.42 114.638 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -36.9 1.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.23 1.515 . . . . 51.21 112.062 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.5 168.92 22.77 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.967 1.307 . . . . 74.54 110.401 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.73 138.31 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 124.56 1.163 . . . . 72.31 108.242 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.58 127.41 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.197 1.799 . . . . 63.31 106.778 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.18 144.3 30.79 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.737 0.648 . . . . 71.21 111.41 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -146.45 161.18 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.597 1.959 . . . . 74.13 108.857 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -133.81 144.46 49.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.033 0.933 . . . . 64.34 109.88 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.08 171.41 18.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.24 1.416 . . . . 72.14 110.122 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.8 m -112.83 132.09 55.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.59 1.156 . . . . 74.12 108.204 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.39 133.28 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.163 0.985 . . . . 72.44 110.307 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.15 -26.84 13.11 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.59 -1.117 . . . . 55.35 111.593 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.37 153.12 21.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.972 1.309 . . . . 70.23 110.172 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.26 158.0 24.96 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.408 1.067 . . . . 64.11 110.721 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.33 165.01 27.13 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.755 1.222 . . . . 70.35 110.145 -165.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.99 117.23 30.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.736 1.214 . . . . 62.11 109.187 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.06 166.36 11.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 63.25 110.645 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -115.38 148.13 39.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.5 1.92 . . . . 41.41 109.481 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p -111.79 173.88 6.14 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.715 1.606 . . . . 73.14 110.361 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -55.3 -28.73 55.53 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 116.52 2.044 . . . . 71.13 116.52 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.7 p -85.75 -15.87 40.73 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.371 1.068 . . . . 73.34 113.411 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.16 65.35 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 118.339 -1.256 . . . . 72.12 111.542 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.18 129.69 41.94 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 119.261 1.531 . . . . 62.44 109.868 164.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -108.43 150.4 27.46 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 124.792 1.308 . . . . 62.24 110.5 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.31 127.11 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.088 -1.415 . . . . 74.43 109.317 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -74.87 143.14 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.084 0.865 . . . . 75.41 110.663 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 t -160.74 161.0 32.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.12 1.368 . . . . 71.1 109.588 -166.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.36 144.61 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.918 -1.141 . . . . 75.14 107.918 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 91' ' ' LEU . 40.2 t -130.18 132.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.098 0.959 . . . . 72.03 109.472 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -134.53 150.73 50.79 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.232 1.413 . . . . 70.34 110.751 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 12.9 tp -80.05 137.85 36.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.275 1.03 . . . . 65.52 110.267 171.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -85.59 6.49 27.07 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.769 1.228 . . . . 63.23 112.441 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.479 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 73.6 5.07 67.29 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.695 1.617 . . . . 62.21 113.42 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -127.41 42.31 3.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.356 1.862 . . . . 73.41 108.922 -169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.337 0.2 OUTLIER 47.15 38.52 6.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.456 1.902 . . . . 72.33 113.904 -172.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -134.14 138.94 45.55 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.677 1.991 . . . . 70.41 108.993 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.407 HD22 HG12 ' A' ' 83' ' ' VAL . 59.8 mt -101.28 143.42 31.37 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 124.632 1.207 . . . . 73.5 108.618 164.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -121.84 134.38 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.098 -1.445 . . . . 73.14 107.098 170.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -151.09 150.17 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 65.32 110.898 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.1 p -140.87 126.28 18.75 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.241 1.416 . . . . 73.32 108.216 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.54 -87.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.885 1.366 . . . . 64.5 109.493 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.19 -43.44 1.79 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.245 1.418 . . . . 75.14 111.181 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -157.22 26.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.588 1.155 . . . . 75.11 111.533 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.6 mt -130.41 102.74 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.489 -1.3 . . . . 63.21 107.489 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -65.55 132.85 49.89 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.819 0.7 . . . . 53.13 109.518 167.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -142.27 108.81 5.33 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 124.683 1.239 . . . . 70.42 108.129 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -116.98 131.53 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.669 1.188 . . . . 63.2 108.67 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.6 m -113.53 151.83 31.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.251 1.821 . . . . 75.43 108.713 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.87 144.34 37.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.853 1.661 . . . . 73.42 108.534 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.9 tp -117.92 124.29 47.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.789 2.035 . . . . 75.11 106.725 167.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.17 85.44 2.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.28 1.832 . . . . 74.43 106.844 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.28 -106.69 2.09 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.767 -1.333 . . . . 71.31 109.767 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.46 -20.68 19.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.92 1.288 . . . . 74.01 112.452 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.18 135.02 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.231 1.013 . . . . 64.11 110.52 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mm -119.54 95.1 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.01 1.324 . . . . 71.12 107.707 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.5 m -86.26 127.36 34.75 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.182 0.926 . . . . 75.51 108.858 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.11 141.26 51.81 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.732 -0.84 . . . . 72.52 108.732 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 m -140.93 120.6 13.36 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.715 1.206 . . . . 71.42 108.723 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 83.3 mtp -116.53 156.27 27.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 63.21 109.289 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.4 m -143.76 114.26 7.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.319 1.048 . . . . 43.55 109.557 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.67 105.03 11.17 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.506 1.922 . . . . 64.31 107.162 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.01 -128.91 43.13 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 110.483 -1.047 . . . . 61.13 110.483 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -73.75 -13.83 61.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.83 1.652 . . . . 74.43 114.139 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.4 mt -97.69 132.71 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.854 1.262 . . . . 44.24 109.469 -171.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.63 85.63 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 124.383 1.052 . . . . 72.05 109.458 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -68.47 139.6 55.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.078 1.351 . . . . 63.23 113.052 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 152.45 50.27 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.62 1.168 . . . . 61.44 111.104 173.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -130.45 151.18 51.22 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.663 1.585 . . . . 72.2 108.659 161.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 124.44 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.246 -2.131 . . . . 74.43 105.246 160.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -122.86 157.45 32.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 71.2 108.332 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -134.49 142.08 46.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.862 0.865 . . . . 73.22 110.45 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.7 ttp85 -61.73 138.21 58.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.692 1.997 . . . . 75.52 112.627 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 125.04 2.352 . . . . 74.44 107.996 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 104' ' ' LEU . 81.5 m-85 . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 112.175 0.435 . . . . 61.34 112.175 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -132.77 114.1 13.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.172 1.789 . . . . 73.1 109.183 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 165.97 18.6 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 109.187 -1.565 . . . . 70.14 109.187 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HD2' HD12 ' A' ' 127' ' ' ILE . 3.8 tmmt? -120.29 138.46 53.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 73.45 109.744 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -133.64 151.35 51.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.337 1.855 . . . . 71.04 110.59 -164.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.38 149.98 30.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.936 1.294 . . . . 74.2 109.086 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.26 49.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.883 0.873 . . . . 53.02 110.398 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -102.48 -67.86 0.86 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.849 1.26 . . . . 73.23 109.117 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -141.56 167.88 21.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.649 1.18 . . . . 60.01 111.397 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.805 1.242 . . . . 74.33 110.133 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.85 146.46 50.27 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.681 1.592 . . . . 74.05 108.694 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 59.3 20.56 8.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.909 1.684 . . . . 73.45 113.679 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -57.96 -62.07 2.08 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.735 1.214 . . . . 74.31 112.793 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.89 -36.33 82.97 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.332 1.02 . . . . 62.3 112.987 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.16 78.71 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.368 1.067 . . . . 64.44 113.057 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -66.79 -47.06 73.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.266 1.426 . . . . 72.24 113.618 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.6 mmt -66.19 -36.58 83.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.874 1.269 . . . . 55.3 113.346 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -75.7 -28.99 58.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.383 1.073 . . . . 73.32 112.746 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.22 -38.96 71.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.134 0.973 . . . . 70.25 113.135 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.16 -9.73 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 113.174 0.805 . . . . 74.23 113.174 172.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 30.34 22.36 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.48 -1.178 . . . . 54.2 113.968 164.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.46 152.73 95.93 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 119.135 1.467 . . . . 71.32 111.367 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.11 145.74 68.0 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.516 2.144 . . . . 64.41 112.221 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -33.14 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.333 1.853 . . . . 71.15 114.801 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -53.54 -55.46 25.33 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.979 1.712 . . . . 75.2 113.18 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.64 -28.48 68.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.827 1.251 . . . . 71.15 113.87 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.56 -52.06 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 118.085 -0.96 . . . . 63.41 111.526 170.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -67.02 -36.41 82.08 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.696 1.369 . . . . 73.04 114.696 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -23.93 49.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.183 -0.913 . . . . 61.25 111.809 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.03 -32.43 32.24 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.765 -1.02 . . . . 51.5 111.972 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -29.11 30.87 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 118.442 1.121 . . . . 73.42 112.96 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -85.12 -60.36 2.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.062 0.945 . . . . 73.22 109.98 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.4 mm -85.21 128.24 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.141 0.976 . . . . 53.41 109.31 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -81.79 138.57 35.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.339 1.056 . . . . 71.21 110.737 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.32 -171.09 47.58 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 124.586 1.179 . . . . 34.23 111.065 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.1 t -136.78 152.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.852 1.661 . . . . 73.42 107.123 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -144.23 147.63 33.85 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.515 0.726 . . . . 61.43 109.794 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.57 146.15 50.92 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 108.348 -0.982 . . . . 53.23 108.348 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 mt -123.2 138.01 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 105.667 -1.975 . . . . 73.42 105.667 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.84 137.97 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.099 -1.074 . . . . 70.04 108.099 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -129.04 128.9 44.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.988 1.315 . . . . 74.35 108.601 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -137.57 78.63 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.816 1.322 . . . . 73.01 107.759 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.05 -126.64 13.76 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 109.212 -1.555 . . . . 72.23 109.212 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -66.8 -24.73 66.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.512 1.525 . . . . 74.42 114.535 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 146.4 37.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.349 1.06 . . . . 74.35 112.036 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.11 136.69 36.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.65 1.98 . . . . 75.01 107.801 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -125.42 149.22 48.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.67 1.988 . . . . 72.32 108.298 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.92 101.11 3.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.391 0.676 . . . . 73.22 109.544 -174.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -83.44 135.53 34.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.209 1.404 . . . . 72.25 109.878 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.7 mt -137.73 99.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.615 -1.254 . . . . 74.01 107.615 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -92.97 138.15 31.74 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.861 2.064 . . . . 63.33 110.373 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.13 -145.96 0.4 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 75.44 109.401 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.2 85.79 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.2 -0.778 . . . . 72.42 112.52 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -140.9 -62.03 0.48 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.055 1.342 . . . . 51.21 109.477 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -61.68 143.74 55.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.516 1.526 . . . . 74.54 114.157 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.89 144.15 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.767 1.292 . . . . 72.31 108.886 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.5 mt -122.57 127.07 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.868 -1.53 . . . . 63.31 106.868 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 91.36 3.27 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.903 0.881 . . . . 71.21 110.433 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -84.48 155.01 22.38 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.126 1.37 . . . . 74.13 111.42 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.99 138.91 28.76 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 124.851 1.345 . . . . 64.34 110.09 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.91 167.98 27.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.624 1.17 . . . . 72.14 111.032 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.7 m -118.89 128.36 54.36 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 124.704 1.253 . . . . 74.12 107.797 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.92 128.93 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.135 0.974 . . . . 72.44 111.801 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -3.38 86.19 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-O 117.979 -1.456 . . . . 55.35 113.303 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -117.42 147.05 43.04 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.304 1.552 . . . . 70.23 110.936 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.37 119.5 14.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.317 1.847 . . . . 64.11 111.901 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -140.13 169.57 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.047 1.739 . . . . 70.35 109.254 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.6 127.71 55.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.146 0.978 . . . . 62.11 110.33 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 81' ' ' THR . 3.8 mm? -115.39 141.86 47.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.695 1.598 . . . . 63.25 110.002 -170.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -122.27 142.09 50.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.466 1.907 . . . . 41.41 110.383 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -116.7 -178.96 3.55 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.638 1.575 . . . . 73.14 111.132 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -65.94 -24.23 66.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.423 1.489 . . . . 71.13 114.983 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.3 p -81.47 -11.58 59.17 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.261 1.424 . . . . 73.34 112.045 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.85 88.09 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.114 1.34 . . . . 72.12 112.615 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.89 120.18 10.24 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 125.401 1.481 . . . . 62.44 111.364 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -97.8 126.94 43.43 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 124.953 1.408 . . . . 62.24 110.37 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.53 123.57 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.924 1.69 . . . . 74.43 108.801 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -76.01 137.11 40.03 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 124.206 0.941 . . . . 75.41 111.495 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.425 HG22 HD23 ' A' ' 71' ' ' LEU . 12.7 t -165.24 -175.94 3.85 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 124.993 1.433 . . . . 71.1 109.834 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.18 144.61 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.716 1.606 . . . . 75.14 107.765 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.02 133.09 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.861 0.864 . . . . 72.03 108.707 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.34 174.96 5.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.193 1.797 . . . . 70.34 111.509 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 13.2 tp -124.96 136.04 53.37 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 65.52 107.178 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -89.0 9.23 25.92 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.231 1.197 . . . . 63.23 114.231 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.474 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 84.79 3.3 88.17 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-O 118.147 -1.363 . . . . 62.21 113.86 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -124.64 50.28 1.73 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.08 1.44 . . . . 73.41 108.817 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.333 0.1 OUTLIER 51.19 27.3 3.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.648 1.979 . . . . 72.33 115.297 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -121.73 111.97 17.82 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.329 1.852 . . . . 70.41 109.446 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.53 143.61 46.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.743 1.277 . . . . 73.5 110.336 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.4 135.01 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.515 1.126 . . . . 73.14 108.73 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -158.36 161.57 37.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.935 0.894 . . . . 65.32 110.716 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.8 p -135.37 -178.87 5.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.178 1.791 . . . . 73.32 108.297 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -139.3 -76.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 64.5 109.284 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -133.4 -50.2 0.86 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.72 1.608 . . . . 75.14 109.406 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -148.29 1.86 0.64 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 75.11 111.923 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 115' ' ' LEU . 58.5 mt -105.76 120.46 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.841 1.656 . . . . 63.21 107.155 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -108.27 113.46 26.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.818 1.247 . . . . 53.13 108.661 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -113.26 129.41 56.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.842 1.339 . . . . 70.42 109.835 -174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.97 120.2 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.98 -1.119 . . . . 63.2 107.98 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.9 m -102.74 156.15 17.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.794 1.238 . . . . 75.43 109.205 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.82 142.25 38.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.7 2.0 . . . . 73.42 108.812 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 3' ' ' PHE . 4.0 tt -120.48 119.8 34.03 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.451 -1.685 . . . . 75.11 106.451 171.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -129.45 83.56 2.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.535 1.534 . . . . 74.43 107.156 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.85 -111.88 3.95 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.913 1.244 . . . . 71.31 110.538 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -79.59 -24.2 42.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.18 1.392 . . . . 74.01 112.974 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -87.62 136.75 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.126 0.97 . . . . 64.11 110.709 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.23 107.62 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.895 1.278 . . . . 71.12 107.83 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -99.02 151.74 20.6 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 124.214 0.946 . . . . 75.51 109.328 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -146.7 141.46 26.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.926 1.29 . . . . 72.52 108.288 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 93.1 m -132.5 132.23 42.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.012 1.725 . . . . 71.42 108.239 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.2 mtp -131.12 119.07 21.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.444 1.497 . . . . 63.21 108.911 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -104.26 110.41 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.257 0.973 . . . . 43.55 109.116 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 98' ' ' ILE . 19.8 tp -116.16 98.55 6.67 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 106.816 -1.55 . . . . 64.31 106.816 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.49 -130.59 40.69 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 109.768 -1.333 . . . . 61.13 109.768 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.45 8.74 20.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 74.43 114.013 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 74.3 mt -108.88 123.0 64.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 108.511 -0.922 . . . . 44.24 108.511 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.57 85.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.524 1.14 . . . . 72.05 108.366 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.32 137.81 58.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.821 1.248 . . . . 63.23 111.753 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -134.03 148.5 51.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.012 1.325 . . . . 61.44 109.715 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -143.78 141.54 30.46 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.633 1.173 . . . . 72.2 108.83 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.91 134.1 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.665 -1.235 . . . . 74.43 107.665 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.5 m -133.1 161.02 35.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.782 1.633 . . . . 71.2 109.516 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.73 142.73 33.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.467 1.107 . . . . 73.22 110.741 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -63.44 138.39 58.5 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.222 1.809 . . . . 75.52 113.681 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 104.595 -2.372 . . . . 74.44 104.595 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.913 0.708 . . . . 61.34 112.913 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -60.44 112.78 2.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.296 1.839 . . . . 73.1 112.69 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.96 173.44 32.63 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.092 -1.603 . . . . 70.14 109.092 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 127' ' ' ILE . 16.9 ttmt -127.03 138.96 53.32 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.875 0.87 . . . . 73.45 109.322 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -134.55 139.94 45.76 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.463 1.505 . . . . 71.04 109.634 -168.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.99 152.8 18.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.46 1.104 . . . . 74.2 109.36 171.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.34 140.82 57.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.839 0.856 . . . . 53.02 110.031 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -118.18 -48.1 2.54 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.95 1.3 . . . . 73.23 110.887 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -152.15 152.23 32.03 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.761 1.224 . . . . 60.01 109.868 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -149.6 136.58 19.62 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.356 1.062 . . . . 74.33 110.142 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -128.64 147.07 50.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.965 1.706 . . . . 74.05 110.046 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 55.94 24.91 8.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.305 1.842 . . . . 73.45 112.712 -167.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.61 -62.66 1.63 Allowed 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.556 1.142 . . . . 74.31 112.136 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.87 -43.1 99.52 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.298 0.998 . . . . 62.3 113.173 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.31 75.82 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.685 1.194 . . . . 64.44 113.602 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.06 -46.93 76.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.456 1.502 . . . . 72.24 113.271 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.92 -40.05 79.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.563 1.145 . . . . 55.3 113.183 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.65 -37.67 88.38 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 73.32 112.419 169.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.6 74.03 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.235 1.198 . . . . 70.25 114.235 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.9 pt -79.72 -5.19 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.262 0.838 . . . . 74.23 113.262 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.34 22.52 26.75 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.239 -1.312 . . . . 54.2 113.79 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -69.96 146.11 94.85 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.478 1.639 . . . . 71.32 111.38 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 146.96 77.12 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.474 2.116 . . . . 64.41 111.864 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -30.23 64.04 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.829 1.418 . . . . 71.15 114.829 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.2 -51.52 69.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.387 1.075 . . . . 75.2 112.995 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.8 -24.42 67.75 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.616 1.167 . . . . 71.15 113.207 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.99 -45.55 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 118.005 -0.998 . . . . 63.41 111.073 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -67.28 -33.19 74.78 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.498 1.295 . . . . 73.04 114.498 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.8 -11.15 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.123 0.969 . . . . 61.25 112.56 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 -28.0 8.82 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.75 -1.028 . . . . 51.5 111.549 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -32.68 37.53 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.49 1.145 . . . . 73.42 113.366 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -83.61 -51.9 6.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.783 0.833 . . . . 73.22 111.301 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.26 113.04 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.411 1.084 . . . . 53.41 108.854 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -67.55 130.35 42.77 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.584 1.178 . . . . 71.21 110.561 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.63 31.25 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 124.834 1.334 . . . . 34.23 111.403 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 t -141.02 154.09 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.398 -1.334 . . . . 73.42 107.398 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -142.72 120.19 11.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.351 1.061 . . . . 61.43 109.922 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -99.8 131.27 45.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 124.302 1.001 . . . . 53.23 108.704 167.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.1 133.58 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.669 -1.604 . . . . 73.42 106.669 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.4 128.56 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 123.485 0.49 . . . . 70.04 109.823 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -88.94 128.6 35.69 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.725 -1.213 . . . . 74.35 107.725 165.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.83 53.11 1.4 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.896 1.278 . . . . 73.01 109.942 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.26 -119.82 5.27 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.035 -2.026 . . . . 72.23 108.035 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -77.2 -29.82 54.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.441 0.696 . . . . 74.42 111.923 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -69.37 164.25 23.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.417 1.087 . . . . 74.35 112.266 169.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -156.32 140.96 16.93 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.133 -1.803 . . . . 75.01 106.133 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -118.07 134.05 55.35 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.75 1.22 . . . . 72.32 109.957 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.59 112.93 18.59 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 125.115 1.509 . . . . 73.22 107.485 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -114.15 124.78 52.92 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.145 -1.428 . . . . 72.25 107.145 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.46 143.52 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.517 1.127 . . . . 74.01 108.601 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -133.74 153.86 51.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 63.33 110.821 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.94 139.66 19.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.096 1.758 . . . . 75.44 108.807 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.44 -98.66 0.68 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.057 -1.617 . . . . 72.42 109.057 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -149.66 39.05 0.78 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.897 1.279 . . . . 51.21 111.314 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -142.2 135.47 28.95 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.121 0.968 . . . . 74.54 110.921 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.61 144.63 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.269 1.428 . . . . 72.31 109.938 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.51 139.32 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.683 1.593 . . . . 63.31 108.095 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.55 132.36 55.13 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.805 1.242 . . . . 71.21 108.075 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.37 158.45 42.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.887 1.275 . . . . 74.13 109.952 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -137.9 148.56 45.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 125.181 1.551 . . . . 64.34 108.853 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.46 157.52 41.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.329 1.452 . . . . 72.14 109.867 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.11 53.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.637 1.175 . . . . 74.12 108.084 171.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.76 113.06 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.648 1.179 . . . . 72.44 110.494 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.02 -11.45 60.52 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.118 -1.379 . . . . 55.35 112.994 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -97.62 144.02 27.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.248 1.524 . . . . 70.23 110.08 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -73.67 134.59 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.572 1.149 . . . . 64.11 110.74 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.0 p -164.62 160.0 19.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.979 1.312 . . . . 70.35 109.619 -171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.44 114.97 28.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.376 1.07 . . . . 62.11 109.972 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.65 136.22 43.76 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.797 1.639 . . . . 63.25 110.339 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.56 154.88 26.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.869 1.268 . . . . 41.41 111.267 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -117.17 169.34 9.52 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.647 1.979 . . . . 73.14 109.286 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -54.13 -32.75 56.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.145 1.535 . . . . 71.13 115.145 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 p -77.6 -11.15 59.83 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.293 2.237 . . . . 73.34 113.976 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.36 81.2 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.431 -1.205 . . . . 72.12 112.361 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.81 126.23 27.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.276 1.83 . . . . 62.44 110.668 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -112.89 119.33 37.58 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.165 0.916 . . . . 62.24 108.931 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.78 130.09 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.118 1.367 . . . . 74.43 111.928 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -73.93 142.19 45.95 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.194 1.397 . . . . 75.41 113.536 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -174.35 177.11 2.29 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 125.394 1.684 . . . . 71.1 110.615 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.95 148.72 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.773 2.029 . . . . 75.14 107.866 166.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.2 t -112.66 139.43 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.707 -0.849 . . . . 72.03 108.707 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -128.31 155.76 44.11 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.452 1.501 . . . . 70.34 111.102 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.666 HD13 ' H ' ' A' ' 87' ' ' GLY . 2.3 tm? -114.18 117.48 31.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 65.52 107.148 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.67 14.15 4.96 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.058 1.503 . . . . 63.23 115.058 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.666 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 82.11 -7.0 64.86 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.423 1.487 . . . . 62.21 113.816 174.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -110.78 38.1 2.59 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.004 1.721 . . . . 73.41 111.568 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.312 0.2 OUTLIER 52.75 40.65 30.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.275 1.83 . . . . 72.33 112.96 -177.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -137.95 127.07 24.33 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.438 1.495 . . . . 70.41 109.553 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.1 mt -91.64 144.4 25.57 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.71 1.256 . . . . 73.5 109.11 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -130.97 138.39 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.204 1.402 . . . . 73.14 108.61 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -160.01 159.57 32.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.479 1.111 . . . . 65.32 109.971 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 73.9 p -130.85 -179.25 5.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 73.32 108.443 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -143.53 -55.02 0.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.645 0.657 . . . . 64.5 111.621 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -157.02 -54.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.524 1.13 . . . . 75.14 109.003 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -146.68 2.58 0.83 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.687 1.595 . . . . 75.11 111.699 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.31 102.08 13.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 C-N-CA 125.591 1.557 . . . . 63.21 107.582 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -76.01 144.69 40.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.525 -0.916 . . . . 53.13 108.525 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -143.31 106.61 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.312 1.045 . . . . 70.42 108.466 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -115.12 110.0 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 124.866 1.354 . . . . 63.2 108.018 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -97.67 152.48 19.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.845 1.258 . . . . 75.43 109.539 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.14 146.89 39.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.997 1.719 . . . . 73.42 109.697 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -119.78 137.8 53.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.093 2.157 . . . . 75.11 107.788 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -138.35 64.46 1.5 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.122 2.169 . . . . 74.43 106.561 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.47 -105.0 1.32 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.795 1.188 . . . . 71.31 111.014 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.01 -7.95 59.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.784 1.234 . . . . 74.01 113.095 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.39 146.46 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.579 1.152 . . . . 64.11 109.146 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.4 mm -130.39 143.61 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.478 1.511 . . . . 71.12 108.39 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -127.94 148.76 50.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.398 1.061 . . . . 75.51 108.315 168.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -140.17 117.27 11.18 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.347 -1.723 . . . . 72.52 106.347 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.2 m -120.95 102.01 8.07 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.858 1.349 . . . . 71.42 107.845 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 mtm -93.76 155.39 17.25 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.25 0.969 . . . . 63.21 110.45 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -134.6 97.2 3.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.507 1.123 . . . . 43.55 108.846 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt -85.99 95.06 9.38 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.526 1.13 . . . . 64.31 108.047 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.55 -108.57 1.73 Allowed Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.678 1.132 . . . . 61.13 111.523 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.53 -2.72 57.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.871 2.068 . . . . 74.43 115.5 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.34 137.46 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.079 -1.082 . . . . 44.24 108.079 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.65 88.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 123.944 0.778 . . . . 72.05 109.298 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -67.4 139.58 57.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.217 1.007 . . . . 63.23 112.073 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -133.61 148.83 51.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.564 1.545 . . . . 61.44 109.955 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -157.32 108.88 2.35 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.811 1.244 . . . . 72.2 108.715 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -100.98 135.09 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.304 1.442 . . . . 74.43 107.773 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.7 m -136.11 159.01 43.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 71.2 109.971 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -143.66 144.12 31.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.982 0.913 . . . . 73.22 110.697 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -65.48 136.92 57.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.704 2.002 . . . . 75.52 113.933 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 6' ' ' LYS . 3.1 mt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 124.915 2.293 . . . . 74.44 107.798 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' ILE . 38.4 m-85 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 117.101 2.26 . . . . 61.34 117.101 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -63.18 147.42 50.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.114 1.524 . . . . 73.1 115.114 -170.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.66 168.0 12.14 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.467 1.508 . . . . 70.14 110.646 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -89.71 152.86 21.12 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.902 1.281 . . . . 73.45 112.369 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -143.78 134.71 25.37 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.963 1.705 . . . . 71.04 107.782 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.25 154.02 22.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.919 0.781 . . . . 74.2 109.458 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.24 130.17 40.16 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.615 0.572 . . . . 53.02 109.649 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -103.57 -61.38 1.43 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.292 1.037 . . . . 73.23 110.797 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 m -143.62 155.08 44.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.384 1.073 . . . . 60.01 110.902 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.57 147.66 48.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 74.33 109.062 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -129.85 136.98 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.829 1.652 . . . . 74.05 108.333 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 56.44 28.18 13.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.861 1.665 . . . . 73.45 112.54 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.78 -63.33 1.28 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.514 1.126 . . . . 74.31 112.608 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -64.02 -37.49 87.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.543 1.152 . . . . 62.3 113.128 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.21 -44.31 88.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.414 1.086 . . . . 64.44 113.171 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.12 -43.46 67.59 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.241 1.416 . . . . 72.24 114.032 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.4 mmt -67.83 -38.27 82.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.177 0.991 . . . . 55.3 112.683 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.8 mptt -64.79 -40.38 95.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.867 0.867 . . . . 73.32 112.721 167.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.28 -27.92 64.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.963 1.468 . . . . 70.25 114.963 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -84.97 -8.3 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.104 0.779 . . . . 74.23 113.104 171.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.7 24.73 22.62 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.07 -1.406 . . . . 54.2 113.54 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.98 149.75 97.77 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.675 1.737 . . . . 71.32 111.29 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.96 152.22 62.91 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.329 2.019 . . . . 64.41 111.847 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -52.66 -34.45 51.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.025 1.33 . . . . 71.15 114.31 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -49.55 -54.83 15.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.73 2.012 . . . . 75.2 113.258 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.11 -26.13 62.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.506 1.523 . . . . 71.15 112.857 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 20' ' ' LYS . 62.2 mt -75.13 -45.94 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.125 0.97 . . . . 63.41 111.849 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.24 -37.41 74.97 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.307 1.225 . . . . 73.04 114.307 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -18.25 49.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.648 -0.692 . . . . 61.25 112.506 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -38.0 11.07 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.732 -1.038 . . . . 51.5 111.517 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -36.02 61.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.592 1.196 . . . . 73.42 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.81 -65.74 0.79 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.104 1.361 . . . . 73.22 110.661 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -76.83 121.36 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.563 1.165 . . . . 53.41 109.234 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -78.42 127.91 32.86 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.231 0.957 . . . . 71.21 109.716 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.06 -156.86 28.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.791 1.307 . . . . 34.23 111.127 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.89 164.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.865 1.266 . . . . 73.42 108.745 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.12 155.75 47.65 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.017 1.727 . . . . 61.43 107.819 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.13 145.53 31.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.905 -1.517 . . . . 53.23 106.905 167.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 3' ' ' PHE . 98.8 mt -126.78 135.74 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.505 -1.665 . . . . 73.42 106.505 166.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.2 87.06 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.965 -1.124 . . . . 70.04 107.965 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -71.5 131.23 43.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.511 -0.768 . . . . 74.35 109.205 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.65 74.16 1.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.36 -1.348 . . . . 73.01 107.36 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.54 -125.27 9.22 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 108.993 -1.643 . . . . 72.23 108.993 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -72.22 -29.14 63.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.216 1.406 . . . . 74.42 114.266 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.95 152.63 42.37 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.117 0.885 . . . . 74.35 110.975 169.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -152.94 133.87 14.0 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.354 -1.35 . . . . 75.01 107.354 -171.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -119.29 148.06 43.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.106 1.362 . . . . 72.32 108.245 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.7 102.8 3.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.94 -1.504 . . . . 73.22 106.94 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.2 m -109.48 92.26 3.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.762 0.825 . . . . 72.25 109.397 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.6 mt -102.85 129.61 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.07 0.948 . . . . 74.01 109.093 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -126.29 150.07 48.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.501 1.12 . . . . 63.33 110.745 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.64 -152.32 0.4 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.374 1.87 . . . . 75.44 109.812 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.12 -0.92 82.53 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.98 -1.456 . . . . 72.42 113.191 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -157.93 9.3 0.16 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.681 1.74 . . . . 51.21 114.094 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -167.41 155.27 9.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.943 0.897 . . . . 74.54 111.928 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.75 144.78 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.598 1.559 . . . . 72.31 109.512 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -119.2 140.44 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.371 1.868 . . . . 63.31 106.48 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.2 123.85 39.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.742 0.817 . . . . 71.21 109.323 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -120.98 150.43 41.12 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.144 1.378 . . . . 74.13 108.983 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -147.56 143.14 27.56 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.707 1.255 . . . . 64.34 108.713 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.65 167.56 29.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.021 1.328 . . . . 72.14 110.55 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -119.25 128.34 54.09 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.419 -1.326 . . . . 74.12 107.419 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.36 103.78 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.436 1.094 . . . . 72.44 110.281 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.0 -7.07 11.97 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 117.85 -1.528 . . . . 55.35 112.621 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -123.95 156.66 35.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.374 1.587 . . . . 70.23 111.518 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -74.36 123.09 23.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.614 1.565 . . . . 64.11 110.717 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.9 m -142.02 156.34 45.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.333 1.453 . . . . 70.35 108.4 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.95 124.24 42.31 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.004 0.921 . . . . 62.11 110.14 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 81' ' ' THR . 3.9 mm? -107.26 125.42 51.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.985 1.714 . . . . 63.25 108.981 -172.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -78.89 128.32 33.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.586 1.154 . . . . 41.41 110.876 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -90.45 166.18 13.4 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.253 1.821 . . . . 73.14 110.329 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 mtt -49.47 -38.16 28.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.954 1.835 . . . . 71.13 115.954 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 p -80.71 -7.37 59.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.965 1.706 . . . . 73.34 113.978 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.05 86.85 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 118.552 -1.138 . . . . 72.12 111.549 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.94 148.25 50.0 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.033 1.333 . . . . 62.44 110.043 163.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -135.57 142.96 45.42 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.768 0.668 . . . . 62.24 109.487 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.96 131.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.576 1.151 . . . . 74.43 110.826 -173.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -81.91 142.84 32.11 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.383 1.073 . . . . 75.41 112.004 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -169.86 160.74 8.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.634 1.574 . . . . 71.1 109.044 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.6 t -104.4 125.21 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.709 -1.219 . . . . 75.14 107.709 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.03 138.64 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.118 0.886 . . . . 72.03 108.792 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -125.74 173.85 8.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.023 1.729 . . . . 70.34 111.204 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.45 127.34 19.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.414 1.485 . . . . 65.52 107.414 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.02 26.19 2.56 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.618 1.34 . . . . 63.23 114.618 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.8 -0.29 78.23 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.258 1.409 . . . . 62.21 114.586 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.05 61.38 1.65 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.35 1.575 . . . . 73.41 108.519 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.99 34.99 3.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.196 2.198 . . . . 72.33 115.331 171.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -128.26 109.76 11.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.875 1.67 . . . . 70.41 108.598 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -83.2 131.4 35.11 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.767 1.292 . . . . 73.5 109.587 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -124.34 137.47 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.761 1.224 . . . . 73.14 109.143 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -157.3 146.41 19.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.611 0.764 . . . . 65.32 110.644 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -138.14 110.09 7.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.398 1.479 . . . . 73.32 107.84 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -72.42 -59.6 2.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.312 1.045 . . . . 64.5 111.79 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -145.97 -61.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.974 1.31 . . . . 75.14 109.314 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -141.27 7.98 2.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.213 1.805 . . . . 75.11 111.64 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.43 HG12 HD12 ' A' ' 115' ' ' LEU . 9.5 mt -115.73 113.79 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.021 1.728 . . . . 63.21 106.795 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.241 0.963 . . . . 53.13 108.853 168.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -143.31 119.66 10.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.384 -1.339 . . . . 70.42 107.384 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -127.59 97.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 124.983 1.427 . . . . 63.2 107.376 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.3 m -78.17 146.35 35.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.614 1.166 . . . . 75.43 109.257 168.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -138.82 112.14 8.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.915 1.686 . . . . 73.42 108.193 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.7 tp -83.44 124.17 30.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.624 1.17 . . . . 75.11 108.521 165.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.45 83.14 2.05 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.301 1.84 . . . . 74.43 106.135 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.4 -109.73 3.07 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 109.999 -1.241 . . . . 71.31 109.999 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.3 2.85 56.42 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 74.01 113.846 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -113.96 136.08 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.03 0.932 . . . . 64.11 109.326 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mm -118.17 105.09 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.974 1.31 . . . . 71.12 108.267 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 m -86.17 144.64 27.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.05 -1.093 . . . . 75.51 108.05 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -144.45 95.6 2.74 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 107.83 -1.174 . . . . 72.52 107.83 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.1 m -82.17 137.91 34.83 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 125.205 1.566 . . . . 71.42 109.509 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 mtm -127.56 155.83 43.19 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.275 1.03 . . . . 63.21 109.562 168.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.1 m -140.34 101.85 4.22 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.097 0.873 . . . . 43.55 110.03 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD12 HG12 ' A' ' 98' ' ' ILE . 6.4 tt -99.98 110.31 22.63 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.731 1.212 . . . . 64.31 107.888 171.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.33 -89.68 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.183 1.373 . . . . 61.13 112.943 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -132.2 36.97 3.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.444 1.898 . . . . 74.43 109.847 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.4 mm -133.92 137.98 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.947 1.699 . . . . 44.24 106.972 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.8 90.25 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 124.06 0.85 . . . . 72.05 108.932 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -78.76 143.79 35.81 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.052 1.341 . . . . 63.23 111.406 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.79 152.73 51.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.183 0.993 . . . . 61.44 109.587 164.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -146.08 126.33 13.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.236 1.414 . . . . 72.2 107.988 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -116.17 128.3 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 125.025 1.453 . . . . 74.43 107.397 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 56.3 m -127.82 157.68 39.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.755 . . . . 71.2 108.83 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -141.91 143.23 33.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.277 1.031 . . . . 73.22 110.875 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -51.32 140.96 16.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.42 2.288 . . . . 75.52 113.558 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 125.181 2.42 . . . . 74.44 108.334 -179.446 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.914 1.079 . . . . 61.34 113.914 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.0 p -60.7 110.16 1.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.371 1.868 . . . . 73.1 114.454 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.81 169.26 34.41 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 110.08 -1.208 . . . . 70.14 110.08 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -119.0 141.93 48.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.405 1.482 . . . . 73.45 108.542 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -137.18 159.1 42.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.228 1.811 . . . . 71.04 110.559 -168.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -121.27 143.41 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.287 1.435 . . . . 74.2 108.257 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 37' ' ' GLY . 37.5 tp -61.1 139.57 58.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.845 1.258 . . . . 53.02 111.608 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -122.79 -43.97 2.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.65 1.18 . . . . 73.23 111.334 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -155.49 156.14 34.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.295 1.038 . . . . 60.01 111.336 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -135.33 155.25 50.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.103 1.361 . . . . 74.33 109.332 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -131.31 144.42 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.707 1.203 . . . . 74.05 108.34 171.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 57.23 22.51 7.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.165 1.786 . . . . 73.45 114.227 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -56.32 -59.22 5.26 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.518 1.127 . . . . 74.31 113.478 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.61 -39.28 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.228 0.955 . . . . 62.3 112.909 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.84 76.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.561 1.144 . . . . 64.44 112.81 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.65 -49.24 74.0 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.321 1.448 . . . . 72.24 113.489 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.17 -37.19 85.03 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 124.512 1.132 . . . . 55.3 113.768 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -73.37 -27.46 61.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.272 -0.87 . . . . 73.32 112.768 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.67 63.75 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.454 1.102 . . . . 70.25 113.839 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG13 HD23 ' A' ' 24' ' ' LEU . 42.4 pt -80.67 -6.57 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 113.457 0.91 . . . . 74.23 113.457 170.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.75 28.95 27.78 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 118.759 -1.023 . . . . 54.2 113.379 167.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -72.84 147.26 88.72 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 118.774 1.287 . . . . 71.32 110.541 175.039 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.29 149.55 63.65 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.742 2.295 . . . . 64.41 112.588 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.74 -35.54 22.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.242 1.817 . . . . 71.15 114.988 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -51.07 -60.71 2.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.872 1.669 . . . . 75.2 112.614 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.5 -26.13 67.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.71 1.604 . . . . 71.15 113.917 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.6 -58.51 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 CA-C-O 118.233 -0.889 . . . . 63.41 110.691 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -63.98 -34.14 77.31 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.078 1.51 . . . . 73.04 115.078 -173.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -20.23 35.17 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.175 -0.917 . . . . 61.25 112.513 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -34.67 21.05 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.104 -0.831 . . . . 51.5 111.603 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -26.18 42.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.593 1.157 . . . . 73.42 112.769 170.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.67 -67.53 0.63 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.28 1.032 . . . . 73.22 110.52 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.79 108.74 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.572 1.17 . . . . 53.41 109.794 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -63.84 116.2 5.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.425 1.89 . . . . 71.21 109.908 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' H ' HD23 ' A' ' 9' ' ' LEU . . . -75.68 171.98 54.11 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 124.557 1.161 . . . . 34.23 111.834 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.96 149.24 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.189 -1.412 . . . . 73.42 107.189 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.2 t -142.66 149.65 39.17 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.566 0.746 . . . . 61.43 109.71 -172.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.56 140.54 26.19 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.215 1.006 . . . . 53.23 108.298 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -140.4 140.28 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.583 -1.636 . . . . 73.42 106.583 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.4 t -141.69 120.94 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.661 -0.866 . . . . 70.04 108.661 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -95.46 136.35 35.95 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.069 0.856 . . . . 74.35 108.987 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.72 49.57 2.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.155 1.382 . . . . 73.01 110.251 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -70.99 3.0 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.835 1.207 . . . . 72.23 110.858 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -120.74 -34.39 3.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.861 1.664 . . . . 74.42 110.794 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.99 165.45 24.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.316 1.046 . . . . 74.35 111.28 169.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -158.98 136.58 10.13 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.095 -1.446 . . . . 75.01 107.095 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -118.49 152.2 36.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.035 1.334 . . . . 72.32 110.795 168.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.24 137.69 39.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.394 -2.076 . . . . 73.22 105.394 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -143.35 127.13 17.15 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.667 1.187 . . . . 72.25 107.916 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.6 122.43 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.641 -0.874 . . . . 74.01 108.641 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -95.66 114.35 26.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.449 1.5 . . . . 63.33 109.67 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.83 -179.73 6.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.455 1.502 . . . . 75.44 110.487 167.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 17.6 1.59 Allowed Glycine 0 CA--C 1.545 1.939 0 C-N-CA 125.27 1.414 . . . . 72.42 114.99 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -150.03 -40.13 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 51.21 112.261 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 170.56 17.5 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.838 1.255 . . . . 74.54 110.749 -161.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.8 130.43 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.516 1.135 . . . . 72.31 108.825 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.67 144.01 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.525 1.13 . . . . 63.31 108.257 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.42 149.41 45.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 71.21 110.618 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -135.67 163.14 30.82 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.335 1.454 . . . . 74.13 109.44 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -145.39 139.09 26.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.263 -1.335 . . . . 64.34 108.539 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.73 167.18 31.23 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 124.229 0.956 . . . . 72.14 111.343 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.2 126.66 54.84 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.706 1.254 . . . . 74.12 108.271 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.44 123.8 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.093 0.957 . . . . 72.44 111.02 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.5 73.18 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.163 -1.354 . . . . 55.35 113.243 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -125.93 153.17 44.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.01 1.405 . . . . 70.23 109.825 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -72.76 136.92 45.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.096 0.959 . . . . 64.11 112.561 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 m -152.8 153.18 32.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.115 1.766 . . . . 70.35 108.343 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.66 113.55 25.64 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.244 0.965 . . . . 62.11 110.641 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.27 146.72 23.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.573 1.549 . . . . 63.25 109.267 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -112.44 130.58 55.93 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.262 1.025 . . . . 41.41 110.463 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.9 m -78.09 158.91 28.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.47 1.908 . . . . 73.14 110.747 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.38 -18.29 58.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.785 1.772 . . . . 71.13 115.785 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.9 p -76.23 -40.4 52.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.489 1.515 . . . . 73.34 112.38 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.38 2.26 13.49 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.535 -1.703 . . . . 72.12 112.052 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.36 125.72 26.52 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.291 2.046 . . . . 62.44 110.119 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -107.95 120.24 41.73 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.617 1.198 . . . . 62.24 108.617 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.49 127.95 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.337 1.455 . . . . 74.43 111.278 -167.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -80.1 141.42 35.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.091 1.357 . . . . 75.41 112.656 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -167.89 170.94 10.25 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.28 1.432 . . . . 71.1 110.034 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -108.84 137.78 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.454 1.502 . . . . 75.14 108.459 170.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.72 142.15 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 124.082 0.864 . . . . 72.03 108.912 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -126.98 173.04 9.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.811 2.044 . . . . 70.34 111.213 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.39 132.2 35.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 65.52 107.275 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.07 16.73 6.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.706 1.203 . . . . 63.23 113.889 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.29 5.73 77.87 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.042 1.782 . . . . 62.21 114.019 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -131.32 50.53 2.22 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.843 1.322 . . . . 73.41 109.625 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.32 0.4 OUTLIER 41.43 35.95 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 72.33 115.694 -174.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -137.92 122.84 18.95 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 126.021 1.728 . . . . 70.41 107.859 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.86 152.04 22.39 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.35 1.031 . . . . 73.5 109.586 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.53 139.28 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.928 1.291 . . . . 73.14 107.834 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -154.7 165.37 36.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.515 0.726 . . . . 65.32 109.703 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 95' ' ' PHE . 2.5 m -139.06 -176.57 4.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.956 1.302 . . . . 73.32 108.476 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' H ' HG22 ' A' ' 94' ' ' THR . 93.7 m-85 -135.62 -106.47 0.21 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.128 -1.804 . . . . 64.5 106.128 165.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.84 -40.16 6.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.775 1.23 . . . . 75.14 111.259 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -149.11 5.4 0.65 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.144 1.378 . . . . 75.11 112.78 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -124.16 107.79 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.59 -1.263 . . . . 63.21 107.59 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -80.09 165.07 22.86 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 123.975 0.797 . . . . 53.13 110.209 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.4 t -152.74 133.17 13.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.225 1.81 . . . . 70.42 108.483 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -139.03 105.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.941 1.697 . . . . 63.2 106.791 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.8 m -88.52 154.8 20.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.008 1.323 . . . . 75.43 109.746 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -137.19 143.32 42.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.863 1.265 . . . . 73.42 108.786 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.6 tp -120.39 117.46 27.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.33 1.852 . . . . 75.11 106.375 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 86.93 2.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.715 -1.587 . . . . 74.43 106.715 173.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.99 -106.43 2.02 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.385 -1.486 . . . . 71.31 109.385 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -96.7 -19.68 18.8 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 74.01 112.605 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -80.76 133.16 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.475 1.11 . . . . 64.11 109.776 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mm -121.29 103.49 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.03 -1.1 . . . . 71.12 108.03 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.5 m -104.53 97.37 7.29 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.169 0.918 . . . . 75.51 109.845 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.21 143.96 25.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.852 1.261 . . . . 72.52 110.226 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.1 m -145.67 122.8 11.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.655 1.182 . . . . 71.42 109.493 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.04 162.56 16.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.366 1.466 . . . . 63.21 110.091 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 m -144.85 92.2 2.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.566 0.746 . . . . 43.55 110.812 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.6 tp -88.36 114.17 24.71 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 124.28 1.032 . . . . 64.31 109.135 168.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.59 -103.06 0.23 Allowed Glycine 0 CA--C 1.535 1.29 0 O-C-N 125.158 1.536 . . . . 61.13 111.904 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.95 -13.24 25.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.901 2.08 . . . . 74.43 113.835 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.0 mt -119.07 121.98 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.068 0.849 . . . . 44.24 110.863 -166.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.6 96.48 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 O-C-N 124.727 1.267 . . . . 72.05 109.089 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.61 145.63 43.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.444 1.098 . . . . 63.23 111.853 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 154.33 51.27 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 123.411 0.684 . . . . 61.44 110.925 168.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -139.87 125.47 19.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.336 1.454 . . . . 72.2 108.384 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.72 133.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.924 1.289 . . . . 74.43 107.96 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.41 162.5 35.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.979 1.312 . . . . 71.2 110.2 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -138.87 146.93 41.77 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.308 1.443 . . . . 73.22 109.449 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -60.25 145.02 48.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.473 1.509 . . . . 75.52 114.239 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 105.818 -1.919 . . . . 74.44 105.818 174.743 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 114.823 1.416 . . . . 61.34 114.823 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 m -65.53 120.69 13.34 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.846 1.259 . . . . 73.1 113.352 -174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.94 175.98 28.49 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.398 0.999 . . . . 70.14 110.701 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 23.8 ttmt -115.7 144.72 43.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.958 1.303 . . . . 73.45 109.951 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -139.84 141.17 36.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.158 1.783 . . . . 71.04 110.207 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -97.72 152.58 18.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.037 1.335 . . . . 74.2 109.66 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD21 ' HE ' ' A' ' 122' ' ' ARG . 4.7 mt -64.85 143.5 57.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.248 0.619 . . . . 53.02 111.782 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -119.21 -61.45 1.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.383 1.473 . . . . 73.23 108.767 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 m -135.5 158.69 43.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.669 1.188 . . . . 60.01 110.521 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -144.12 162.42 36.32 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.779 1.632 . . . . 74.33 108.589 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.75 138.48 14.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.422 -0.585 . . . . 74.05 109.422 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.93 30.05 19.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.475 1.91 . . . . 73.45 112.559 -165.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.97 -57.17 13.76 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.106 0.962 . . . . 74.31 112.433 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.77 -43.68 95.64 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.606 1.191 . . . . 62.3 112.253 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.73 -47.67 76.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.827 1.251 . . . . 64.44 113.491 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.72 -47.0 73.7 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.005 1.322 . . . . 72.24 113.348 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.0 mmt -67.91 -35.56 78.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.909 1.077 . . . . 55.3 113.909 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -71.03 -30.67 66.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.282 -0.866 . . . . 73.32 112.115 171.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.71 -37.77 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.515 1.126 . . . . 70.25 113.605 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.4 pt -83.86 -1.25 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 113.623 0.972 . . . . 74.23 113.623 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 27.96 50.46 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.738 -1.034 . . . . 54.2 114.088 164.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 147.32 99.0 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.683 1.242 . . . . 71.32 111.055 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.26 141.3 81.57 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 64.41 111.556 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -55.21 -30.41 59.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.909 1.284 . . . . 71.15 114.194 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -51.72 -54.04 32.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 75.2 113.568 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.31 -25.84 66.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.422 1.489 . . . . 71.15 113.004 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.9 mt -75.18 -49.73 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.02 0.928 . . . . 63.41 111.168 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -62.61 -42.78 99.78 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.972 0.909 . . . . 73.04 113.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.18 -13.49 58.55 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.37 1.044 . . . . 61.25 113.057 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.99 -18.83 45.36 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-O 118.263 -1.298 . . . . 51.5 112.183 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -35.01 11.2 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 116.913 -1.518 . . . . 73.42 113.549 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -78.15 -56.04 4.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.72 1.145 . . . . 73.22 111.085 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.4 124.99 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.436 1.494 . . . . 53.41 107.725 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.52 131.22 34.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 124.461 1.101 . . . . 71.21 109.375 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.06 -176.35 34.4 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 124.697 1.248 . . . . 34.23 111.574 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.96 156.38 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.816 1.646 . . . . 73.42 107.283 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -148.56 141.39 24.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.054 0.941 . . . . 61.43 109.162 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -124.24 144.0 50.21 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.242 -1.021 . . . . 53.23 108.242 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -129.54 139.01 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 106.442 -1.688 . . . . 73.42 106.442 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.07 112.32 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 107.321 -1.363 . . . . 70.04 107.321 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.32 121.47 40.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.153 1.381 . . . . 74.35 109.116 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -122.56 44.01 2.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 73.01 110.36 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -117.52 5.37 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.963 -2.055 . . . . 72.23 107.963 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -73.84 -29.52 62.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.555 1.317 . . . . 74.42 114.555 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 154.51 35.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.524 0.602 . . . . 74.35 110.526 169.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -151.94 137.76 18.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.575 -1.268 . . . . 75.01 107.575 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -125.01 150.4 46.77 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 124.587 1.18 . . . . 72.32 110.128 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 128.24 20.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.491 -1.67 . . . . 73.22 106.491 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 m -111.05 129.91 55.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.291 -1.374 . . . . 72.25 107.291 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.61 109.38 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.974 -1.861 . . . . 74.01 105.974 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 47.4 m -113.87 105.45 13.28 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.375 1.047 . . . . 63.33 109.414 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.04 -173.21 0.99 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 75.44 111.931 169.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.6 46.38 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.277 1.417 . . . . 72.42 114.915 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.1 p -159.04 20.2 0.19 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.201 1.4 . . . . 51.21 113.101 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 153.67 41.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.204 1.402 . . . . 74.54 109.562 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.54 129.81 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.331 1.052 . . . . 72.31 108.302 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -124.23 131.15 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.928 1.691 . . . . 63.31 107.404 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.06 130.54 50.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.252 1.021 . . . . 71.21 109.312 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -138.79 145.07 39.7 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.183 1.393 . . . . 74.13 109.46 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 146.35 51.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.763 1.625 . . . . 64.34 109.041 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -160.21 162.08 33.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.312 1.045 . . . . 72.14 111.663 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.2 m -96.84 128.28 43.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.564 1.165 . . . . 74.12 108.448 168.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.4 t -66.08 134.02 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.725 1.61 . . . . 72.44 110.737 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.13 -13.14 60.39 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.04 1.305 . . . . 55.35 113.049 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -105.67 145.93 30.4 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.461 1.504 . . . . 70.23 109.639 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.55 139.38 58.26 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.727 1.211 . . . . 64.11 112.244 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.08 161.53 42.38 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 124.792 1.307 . . . . 70.35 109.728 -170.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.84 118.05 30.98 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 124.358 1.036 . . . . 62.11 108.628 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.04 148.64 29.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.66 1.584 . . . . 63.25 109.097 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.67 125.25 43.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.588 1.155 . . . . 41.41 110.257 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -74.83 162.82 28.31 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.817 1.647 . . . . 73.14 110.626 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.05 -26.83 62.99 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.253 1.575 . . . . 71.13 115.253 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 -13.46 61.11 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.224 1.81 . . . . 73.34 113.901 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.98 -3.15 82.6 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.122 -1.377 . . . . 72.12 111.773 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.24 116.07 8.42 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 119.541 1.67 . . . . 62.44 111.087 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -87.12 123.77 32.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 124.809 1.318 . . . . 62.24 110.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.59 129.37 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.071 1.748 . . . . 74.43 109.966 -168.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -74.4 141.61 45.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.355 1.062 . . . . 75.41 111.741 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 t -166.07 166.65 17.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.185 1.394 . . . . 71.1 110.015 -168.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.07 146.54 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 75.14 107.643 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.75 145.41 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.23 1.012 . . . . 72.03 108.92 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.82 149.85 51.4 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.414 1.485 . . . . 70.34 109.837 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.5 tt -106.21 124.63 49.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.24 1.416 . . . . 65.52 107.524 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -86.55 12.44 10.44 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.945 1.298 . . . . 63.23 114.428 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.638 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 82.5 -10.49 55.25 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.224 1.869 . . . . 62.21 113.872 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.9 49.77 1.14 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.517 1.527 . . . . 73.41 110.973 -169.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.291 0.6 OUTLIER 46.9 43.12 13.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.003 2.121 . . . . 72.33 114.054 -177.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -143.39 141.17 30.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.324 1.85 . . . . 70.41 108.642 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -115.94 148.07 40.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.539 1.535 . . . . 73.5 108.14 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -130.03 133.56 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.867 -1.16 . . . . 73.14 107.867 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -148.77 143.95 26.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.36 1.064 . . . . 65.32 111.219 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 p -139.51 127.91 22.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.363 1.465 . . . . 73.32 108.834 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.5 -98.88 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.495 1.918 . . . . 64.5 108.588 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -106.01 -53.13 2.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.827 1.251 . . . . 75.14 110.51 167.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -143.06 13.94 1.86 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.878 1.271 . . . . 75.11 112.7 -170.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 115' ' ' LEU . 72.0 mt -113.65 99.15 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.074 -1.454 . . . . 63.21 107.074 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -87.83 105.58 17.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.071 0.948 . . . . 53.13 109.236 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 t -112.79 117.72 32.96 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.172 1.389 . . . . 70.42 110.631 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.34 128.31 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.227 -1.397 . . . . 63.2 107.227 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 m -109.11 146.19 34.45 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -142.24 148.41 38.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.808 0.843 . . . . 73.42 110.743 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.89 122.47 38.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.992 2.117 . . . . 75.11 107.486 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.14 79.74 1.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 74.43 107.376 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.67 -116.85 6.27 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 109.402 -1.479 . . . . 71.31 109.402 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.1 -10.09 51.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.319 1.448 . . . . 74.01 114.187 172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.25 139.86 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.698 0.799 . . . . 64.11 109.052 175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.31 144.72 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.283 1.433 . . . . 71.12 108.599 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -127.21 148.79 50.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.442 1.897 . . . . 75.51 108.23 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.94 145.79 33.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.922 0.889 . . . . 72.52 109.121 172.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.7 m -144.77 86.73 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.674 1.59 . . . . 71.42 107.927 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mtm -84.66 139.34 32.11 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.016 0.927 . . . . 63.21 109.747 170.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.1 m -130.82 103.08 6.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.662 1.185 . . . . 43.55 108.277 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 98' ' ' ILE . 35.5 tp -118.36 119.56 34.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.334 1.454 . . . . 64.31 108.775 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.79 -105.49 1.34 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.138 -1.585 . . . . 61.13 109.138 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.4 0.05 10.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.681 1.993 . . . . 74.43 112.292 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.6 mt -99.3 142.59 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.96 1.704 . . . . 44.24 109.291 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -121.67 92.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.791 0.837 . . . . 72.05 109.574 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.87 112.09 7.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 63.23 112.307 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -94.5 146.6 23.98 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.289 1.435 . . . . 61.44 110.62 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 9' ' ' LEU . 72.0 mtp180 -134.85 148.93 50.26 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.816 1.322 . . . . 72.2 108.019 161.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.82 131.06 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 105.954 -1.869 . . . . 74.43 105.954 169.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.2 m -131.93 165.3 24.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.16 1.384 . . . . 71.2 109.682 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -147.64 143.11 27.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.823 0.849 . . . . 73.22 110.799 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -54.5 140.09 35.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.629 2.372 . . . . 75.52 113.133 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.3 mt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 124.605 2.145 . . . . 74.44 107.263 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 115.083 1.512 . . . . 61.34 115.083 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -59.83 116.25 3.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.165 1.786 . . . . 73.1 113.715 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.82 170.86 29.32 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.627 -0.989 . . . . 70.14 110.627 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HD2' HD12 ' A' ' 127' ' ' ILE . 6.1 ttmt -112.92 140.46 47.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.981 1.312 . . . . 73.45 107.993 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.41 125.52 26.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.165 1.386 . . . . 71.04 110.34 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.58 152.36 30.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.973 0.909 . . . . 74.2 110.318 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.67 126.64 30.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.712 0.805 . . . . 53.02 109.033 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -95.79 -56.52 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.37 1.068 . . . . 73.23 110.917 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -156.89 163.36 39.26 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.079 1.352 . . . . 60.01 110.39 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -160.09 151.12 19.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.518 1.127 . . . . 74.33 109.59 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.59 143.95 43.86 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.204 1.401 . . . . 74.05 109.18 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.11 16.84 10.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.555 1.942 . . . . 73.45 114.783 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.79 -50.65 69.91 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.669 1.588 . . . . 74.31 113.189 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.17 -59.51 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.296 1.838 . . . . 62.3 112.782 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.5 83.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.213 1.405 . . . . 64.44 113.787 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.69 -52.71 49.26 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.987 1.315 . . . . 72.24 112.835 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 mmt -68.08 -35.35 78.05 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.373 1.046 . . . . 55.3 113.702 -176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' HD3' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.0 -44.42 97.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.644 0.777 . . . . 73.32 112.314 168.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.45 79.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.322 1.23 . . . . 70.25 114.322 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 pt -80.95 -5.0 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.043 1.127 . . . . 74.23 114.043 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.99 19.33 26.81 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.229 -1.317 . . . . 54.2 114.646 161.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.25 142.63 97.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 119.54 1.67 . . . . 71.32 110.319 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.54 141.18 59.92 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.143 1.895 . . . . 64.41 111.65 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' HD12 ' A' ' 29' ' ' ILE 0.31 27.3 tt0 -65.93 -14.3 61.3 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.668 1.729 . . . . 71.15 115.668 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.04 -53.17 61.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.616 1.167 . . . . 75.2 112.556 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.47 -26.01 66.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.563 1.545 . . . . 71.15 112.86 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.534 HD13 ' HD3' ' A' ' 20' ' ' LYS . 47.7 mt -78.85 -47.43 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 117.55 -1.214 . . . . 63.41 111.161 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -65.36 -39.48 92.38 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 113.731 1.011 . . . . 73.04 113.731 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -16.67 57.78 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.256 -0.878 . . . . 61.25 112.472 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.18 -37.74 10.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.974 -0.903 . . . . 51.5 111.35 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -26.27 34.73 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.465 1.106 . . . . 73.42 113.584 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -84.95 -62.82 1.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 124.163 0.914 . . . . 73.22 110.304 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.56 120.15 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.866 0.866 . . . . 53.41 108.914 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -66.33 127.58 32.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.051 0.94 . . . . 71.21 111.334 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.3 -172.57 48.87 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 124.712 1.258 . . . . 34.23 110.554 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.0 t -137.59 152.97 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.6 1.56 . . . . 73.42 107.389 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -135.77 155.61 50.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.257 1.023 . . . . 61.43 109.112 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -137.72 140.4 40.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.178 -0.675 . . . . 53.23 109.178 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' A' ' 48' ' ' PHE . 84.6 mt -123.61 129.61 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.863 1.352 . . . . 73.42 107.477 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.92 90.53 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -74.29 136.46 42.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.698 0.799 . . . . 74.35 110.223 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.07 86.22 1.43 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.233 1.013 . . . . 73.01 109.845 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.64 -114.29 4.06 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 109.526 -1.429 . . . . 72.23 109.526 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -91.58 -15.81 28.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.998 1.319 . . . . 74.42 111.874 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -86.15 147.65 26.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.322 1.449 . . . . 74.35 112.49 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.531 ' CE2' HD11 ' A' ' 91' ' ' LEU . 12.7 t80 -133.33 118.99 19.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.793 1.637 . . . . 75.01 107.828 176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -87.6 131.93 34.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.046 1.338 . . . . 72.32 108.567 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.24 109.36 12.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.162 -1.792 . . . . 73.22 106.162 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -106.15 141.88 36.78 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.158 1.383 . . . . 72.25 109.536 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.91 107.41 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.145 1.378 . . . . 74.01 108.016 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.5 m -87.64 132.04 34.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.566 1.546 . . . . 63.33 109.068 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.88 4.64 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.653 . . . . 75.44 110.225 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.83 -86.93 0.86 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 109.674 -1.37 . . . . 72.42 109.674 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 t -150.25 21.56 0.85 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.996 1.318 . . . . 51.21 111.781 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmm? -129.25 149.39 51.06 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.475 1.51 . . . . 74.54 109.818 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.91 111.68 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 124.198 0.936 . . . . 72.31 109.567 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.2 mt -84.19 144.61 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.77 1.228 . . . . 63.31 107.988 166.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.29 141.68 23.34 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 123.955 0.784 . . . . 71.21 110.762 165.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.79 158.52 41.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.455 1.902 . . . . 74.13 107.817 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.37 145.83 39.47 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 124.081 0.863 . . . . 64.34 109.909 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -139.62 149.91 44.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.829 1.331 . . . . 72.14 110.175 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -94.03 126.1 39.05 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.915 1.384 . . . . 74.12 108.094 168.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.23 130.45 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.862 0.865 . . . . 72.44 111.675 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.74 -5.47 81.84 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.21 -1.328 . . . . 55.35 113.672 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.49 157.03 21.6 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.122 1.461 . . . . 70.23 109.71 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.62 143.75 46.21 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.057 0.848 . . . . 64.11 111.794 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.11 -173.01 3.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.633 2.373 . . . . 70.35 107.576 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.69 129.47 38.8 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.146 -0.687 . . . . 62.11 109.146 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mp -104.71 161.42 14.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.877 1.671 . . . . 63.25 109.448 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.22 142.58 39.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.233 1.413 . . . . 41.41 109.013 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 m -109.03 142.89 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.562 1.145 . . . . 73.14 108.035 168.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.1 mtt -44.53 -32.07 1.31 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 118.769 2.877 . . . . 71.13 118.769 -163.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -71.05 -22.43 62.13 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.12 1.368 . . . . 73.34 114.262 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.27 5.57 10.38 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.209 -1.328 . . . . 72.12 112.298 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.18 147.03 52.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.448 1.624 . . . . 62.44 111.923 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 124.39 44.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.442 1.497 . . . . 62.24 107.732 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.33 128.62 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.196 0.998 . . . . 74.43 111.928 -169.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 148.4 48.9 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.89 1.276 . . . . 75.41 111.791 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -169.46 162.87 10.34 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.548 1.155 . . . . 71.1 111.039 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.06 150.62 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 126.047 1.739 . . . . 75.14 107.465 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.03 139.65 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.847 -0.798 . . . . 72.03 108.847 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -125.35 152.03 45.29 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.73 1.612 . . . . 70.34 110.86 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.75 118.11 35.26 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 65.52 106.513 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.05 11.65 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.22 1.563 . . . . 63.23 115.22 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.76 11.16 85.7 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.04 1.305 . . . . 62.21 112.596 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -134.04 35.78 3.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.391 1.476 . . . . 73.41 109.702 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.318 0.5 OUTLIER 53.51 27.08 6.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.469 1.908 . . . . 72.33 114.785 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -124.93 126.35 45.37 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.834 1.654 . . . . 70.41 108.832 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 48' ' ' PHE . 45.6 mt -94.05 127.51 39.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.157 0.983 . . . . 73.5 109.639 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.69 134.89 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 73.14 108.684 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 t -160.9 151.26 17.92 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.222 1.009 . . . . 65.32 111.362 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -161.23 141.24 10.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.74 1.216 . . . . 73.32 110.861 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -83.65 -61.32 1.86 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.227 0.954 . . . . 64.5 109.18 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -129.72 -52.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.75 1.62 . . . . 75.14 110.241 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -147.56 -5.98 0.47 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.089 -0.958 . . . . 75.11 113.341 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG12 HD23 ' A' ' 115' ' ' LEU . 56.2 mt -78.43 85.65 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.787 1.235 . . . . 63.21 109.761 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.06 93.91 1.45 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.745 1.618 . . . . 53.13 111.725 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 t -85.28 128.41 34.68 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.496 1.123 . . . . 70.42 108.952 169.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.56 96.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.877 -1.527 . . . . 63.2 106.877 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -77.53 150.34 34.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.471 1.108 . . . . 75.43 109.665 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -132.6 128.85 38.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.733 2.013 . . . . 73.42 107.643 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.37 123.18 43.43 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.459 -1.312 . . . . 75.11 107.459 165.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.58 69.31 1.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.148 -1.797 . . . . 74.43 106.148 170.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.51 8.8 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.852 -1.299 . . . . 71.31 109.852 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.06 7.36 5.04 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.223 1.564 . . . . 74.01 115.223 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.44 138.05 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.141 0.976 . . . . 64.11 108.983 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 mm -123.62 98.52 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.05 1.34 . . . . 71.12 108.024 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -88.36 154.67 20.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.137 -0.69 . . . . 75.51 109.137 167.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -154.21 143.27 21.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.788 1.235 . . . . 72.52 108.343 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.8 m -130.56 126.76 37.58 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.832 1.332 . . . . 71.42 108.672 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mmm -119.08 105.55 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.266 2.227 . . . . 63.21 108.929 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.0 m -101.3 115.76 31.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.667 0.787 . . . . 43.55 110.275 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -126.96 110.16 12.7 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.422 1.889 . . . . 64.31 107.203 177.123 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.33 -135.74 47.95 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 109.893 -1.283 . . . . 61.13 109.893 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.73 3.38 37.66 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.845 1.258 . . . . 74.43 113.733 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.4 mt -93.63 132.75 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.402 -0.962 . . . . 44.24 108.402 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.88 95.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.439 -0.948 . . . . 72.05 108.439 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -78.48 136.15 37.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.472 1.909 . . . . 63.23 111.279 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.8 146.1 46.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.566 1.146 . . . . 61.44 109.698 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -130.9 140.79 50.24 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.881 1.672 . . . . 72.2 108.213 168.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.74 131.12 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.076 -1.824 . . . . 74.43 106.076 169.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m -136.71 159.05 42.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.79 1.636 . . . . 71.2 108.745 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -140.39 140.42 35.51 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.933 0.893 . . . . 73.22 110.381 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.73 136.51 57.02 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.308 2.243 . . . . 75.52 111.463 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 6' ' ' LYS . 19.1 mt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.339 -2.467 . . . . 74.44 104.339 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 104.269 -2.493 . . . . 50.05 104.269 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 58.63 61.86 2.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.198 2.199 . . . . 75.54 111.594 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.85 173.5 16.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.834 1.654 . . . . 64.31 109.739 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 66.94 76.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.435 1.894 . . . . 70.33 111.766 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -78.74 72.79 5.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.652 1.581 . . . . 74.24 110.703 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 46.8 m170 65.46 18.24 11.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.466 2.306 . . . . 62.12 114.376 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.94 123.19 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.982 1.313 . . . . 64.25 109.936 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -141.16 168.62 19.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.76 1.624 . . . . 75.33 110.101 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mmm 70.44 145.5 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.805 2.442 . . . . 75.42 112.286 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p -150.87 115.35 5.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.804 -0.634 . . . . 70.03 110.689 -170.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -66.6 -14.42 62.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.591 1.556 . . . . 61.34 114.568 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 115.7 6.7 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.992 1.317 . . . . 73.1 112.359 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.18 173.4 35.38 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 110.283 -1.127 . . . . 70.14 110.283 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -117.62 145.45 44.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.044 0.937 . . . . 73.45 109.046 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -135.82 172.77 12.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.144 2.178 . . . . 71.04 110.579 -169.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -151.69 119.66 6.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.582 1.153 . . . . 74.2 108.04 -164.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' HE ' ' A' ' 122' ' ' ARG . 46.7 tp -57.57 122.98 14.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.975 1.31 . . . . 53.02 112.177 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -100.22 -49.69 4.19 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 124.921 1.388 . . . . 73.23 110.436 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -161.41 159.77 28.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.57 1.148 . . . . 60.01 110.6 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -160.56 142.37 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.34 1.056 . . . . 74.33 110.661 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -127.65 148.59 50.38 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.233 1.813 . . . . 74.05 108.799 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.17 16.13 6.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.886 1.675 . . . . 73.45 113.509 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.54 -56.68 18.27 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.188 1.395 . . . . 74.31 112.909 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -60.99 -48.23 82.8 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.397 1.061 . . . . 62.3 112.767 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.85 -42.64 76.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.727 1.211 . . . . 64.44 113.794 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -68.6 -46.86 68.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.256 1.422 . . . . 72.24 113.241 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mmt -66.13 -41.23 90.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.646 1.178 . . . . 55.3 113.144 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.5 mptm? -60.89 -40.78 94.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.39 1.076 . . . . 73.32 112.226 169.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.59 66.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.885 1.439 . . . . 70.25 114.885 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 pt -86.84 0.96 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 113.214 0.82 . . . . 74.23 113.214 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.91 22.57 38.43 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.381 -1.233 . . . . 54.2 113.774 166.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.16 145.93 70.07 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 119.278 1.539 . . . . 71.32 110.859 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 149.65 58.45 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.25 . . . . 64.41 111.998 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 29' ' ' ILE . 51.8 tt0 -55.52 -29.18 58.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.366 1.466 . . . . 71.15 114.693 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.31 -54.08 51.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.475 1.51 . . . . 75.2 113.257 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.69 -22.75 66.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.892 1.277 . . . . 71.15 113.698 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.571 HD13 ' HD2' ' A' ' 20' ' ' LYS . 66.2 mt -78.25 -49.56 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.444 1.098 . . . . 63.41 111.366 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -65.74 -36.56 83.92 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.247 1.203 . . . . 73.04 114.247 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -27.67 55.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 118.524 -0.75 . . . . 61.25 112.28 171.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.3 -29.38 56.32 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.754 -1.026 . . . . 51.5 112.361 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.19 -30.12 18.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.436 1.095 . . . . 73.42 112.797 175.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.34 -59.86 2.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.738 0.815 . . . . 73.22 110.436 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.64 109.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.451 1.094 . . . . 53.41 108.822 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.14 115.77 8.82 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 124.12 0.887 . . . . 71.21 110.191 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.43 179.66 50.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.974 1.421 . . . . 34.23 111.674 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 t -116.93 160.01 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.613 1.565 . . . . 73.42 106.81 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 t -148.15 149.83 32.7 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 108.713 -0.847 . . . . 61.43 108.713 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -147.07 139.56 24.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.628 -0.878 . . . . 53.23 108.628 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.5 mt -136.29 140.41 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.306 -1.368 . . . . 73.42 107.306 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.25 107.56 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.192 -1.04 . . . . 70.04 108.192 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -76.89 131.6 38.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.309 -0.997 . . . . 74.35 108.309 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -130.41 51.21 2.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.988 1.315 . . . . 73.01 108.79 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.25 -115.56 5.17 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.667 -1.773 . . . . 72.23 108.667 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 74.42 112.908 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.33 155.29 39.57 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.972 1.309 . . . . 74.35 112.134 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -147.36 128.27 14.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.621 1.569 . . . . 75.01 107.78 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -106.26 136.0 46.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.657 1.583 . . . . 72.32 108.707 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.74 134.48 55.22 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.083 -1.451 . . . . 73.22 107.083 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.89 122.94 15.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.059 1.343 . . . . 72.25 107.991 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.22 113.7 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.873 -1.158 . . . . 74.01 107.873 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -90.94 104.77 17.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.552 1.141 . . . . 63.33 109.695 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.61 174.99 11.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.644 1.178 . . . . 75.44 110.658 166.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.79 21.15 0.98 Allowed Glycine 0 CA--C 1.544 1.859 0 C-N-CA 125.714 1.626 . . . . 72.42 115.174 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.8 p -158.22 -30.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.578 1.689 . . . . 51.21 113.459 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -151.23 165.07 35.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.195 0.998 . . . . 74.54 110.742 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -108.73 139.72 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 124.462 1.101 . . . . 72.31 108.723 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 117.33 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 106.666 -1.605 . . . . 63.31 106.666 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.66 140.91 39.97 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.348 1.03 . . . . 71.21 109.016 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -144.42 158.97 43.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.954 1.702 . . . . 74.13 109.043 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -145.35 146.82 31.74 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.273 0.983 . . . . 64.34 109.563 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -148.4 171.27 16.3 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.436 1.494 . . . . 72.14 109.474 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.2 m -118.07 132.7 56.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.46 -1.311 . . . . 74.12 107.46 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.91 129.87 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 72.44 110.876 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.21 -7.96 49.16 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 118.179 -1.345 . . . . 55.35 113.821 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -101.62 152.37 20.89 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.202 1.501 . . . . 70.23 109.032 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.63 104.41 16.34 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.098 0.959 . . . . 64.11 110.879 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.7 m -125.18 -162.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.483 1.913 . . . . 70.35 109.067 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.06 155.74 49.76 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.707 1.203 . . . . 62.11 111.522 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.9 mt -132.03 139.04 48.44 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.792 1.637 . . . . 63.25 108.647 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.03 132.86 44.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.069 1.347 . . . . 41.41 109.892 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 m -83.72 162.41 20.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.432 1.493 . . . . 73.14 110.439 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.8 mtt -56.75 -30.1 63.22 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.94 1.459 . . . . 71.13 114.94 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.9 t -71.84 -11.33 60.75 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.427 1.491 . . . . 73.34 114.211 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.49 1.97 70.87 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.88 1.229 . . . . 72.12 112.028 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.89 132.52 47.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.303 1.441 . . . . 62.44 110.881 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -101.29 128.64 47.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.431 1.492 . . . . 62.24 108.375 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.97 126.15 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 124.038 0.836 . . . . 74.43 111.228 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.24 144.52 40.33 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.827 1.651 . . . . 75.41 111.729 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -171.88 179.59 2.69 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.113 1.365 . . . . 71.1 111.069 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.49 145.8 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 126.52 1.928 . . . . 75.14 107.557 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.21 143.33 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.111 0.964 . . . . 72.03 109.474 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -125.06 166.44 16.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.305 1.842 . . . . 70.34 111.216 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.11 135.77 41.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.659 1.584 . . . . 65.52 107.112 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.71 18.99 7.97 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.642 1.177 . . . . 63.23 113.74 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.48 9.18 64.27 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.991 1.758 . . . . 62.21 113.893 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -132.05 46.09 2.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.88 1.272 . . . . 73.41 109.574 -166.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.288 0.9 OUTLIER 49.65 32.06 4.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.071 2.148 . . . . 72.33 114.884 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -137.48 119.82 15.79 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.044 1.738 . . . . 70.41 108.572 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.22 146.42 23.73 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.204 0.94 . . . . 73.5 109.496 171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.72 138.0 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.914 1.286 . . . . 73.14 108.501 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 t -153.43 146.38 24.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.964 0.906 . . . . 65.32 109.51 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.9 p -120.14 174.29 6.58 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.758 1.223 . . . . 73.32 109.007 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.85 -85.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.412 -0.958 . . . . 64.5 108.412 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -51.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.809 1.244 . . . . 75.14 109.11 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.6 12.87 1.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.128 1.771 . . . . 75.11 111.601 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.7 mt -112.21 118.98 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.451 1.9 . . . . 63.21 106.683 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -111.08 102.08 10.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.611 1.164 . . . . 53.13 108.736 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.7 m -99.48 129.18 45.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.293 1.437 . . . . 70.42 110.344 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -133.06 108.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.589 1.156 . . . . 63.2 108.608 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.7 m -85.92 148.49 25.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.456 1.102 . . . . 75.43 109.221 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.85 118.01 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.999 1.32 . . . . 73.42 109.262 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.92 127.28 41.8 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.522 -0.918 . . . . 75.11 108.522 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.14 81.52 2.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.279 1.832 . . . . 74.43 107.729 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.95 -110.38 3.45 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.927 1.251 . . . . 71.31 110.922 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.81 21.24 9.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.562 1.545 . . . . 74.01 111.99 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -129.4 141.38 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.747 1.219 . . . . 64.11 108.646 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.07 107.97 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.941 1.296 . . . . 71.12 107.89 172.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 m -85.9 144.2 27.79 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.835 1.254 . . . . 75.51 108.283 165.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.3 122.43 8.89 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.209 -1.404 . . . . 72.52 107.209 -178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.93 120.33 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.513 1.133 . . . . 71.42 108.87 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.4 mtp -118.43 142.59 47.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.894 1.678 . . . . 63.21 109.216 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -133.71 95.74 3.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 43.55 109.905 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -96.08 106.37 18.54 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 125.038 1.335 . . . . 64.31 108.287 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.47 -109.84 3.08 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 110.218 -1.153 . . . . 61.13 110.218 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.78 -9.06 20.3 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.527 1.531 . . . . 74.43 112.014 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.24 130.87 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.05 1.34 . . . . 44.24 108.956 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.49 82.24 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 124.168 0.918 . . . . 72.05 109.621 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.96 131.91 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.434 1.093 . . . . 63.23 112.534 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -127.97 152.24 48.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.038 1.335 . . . . 61.44 109.577 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HE ' HD13 ' A' ' 9' ' ' LEU . 50.6 ttt-85 -155.79 130.22 8.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.605 1.162 . . . . 72.2 109.401 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.43 131.69 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.096 1.358 . . . . 74.43 107.497 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m -131.02 159.29 37.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.412 1.485 . . . . 71.2 108.924 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -129.2 131.57 47.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.558 1.143 . . . . 73.22 110.016 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -69.33 119.96 14.4 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.852 2.061 . . . . 75.52 110.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 124.098 1.904 . . . . 74.44 108.425 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 . . . . . 0 N--CA 1.504 2.251 0 N-CA-C 104.777 -2.305 . . . . 50.05 104.777 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -149.4 123.39 9.4 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 118.97 0.804 . . . . 75.54 109.296 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -170.64 -56.62 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.102 1.761 . . . . 64.31 108.479 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 45.06 32.47 0.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.641 2.776 . . . . 70.33 115.658 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -28.15 67.92 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 116.355 1.983 . . . . 74.24 116.355 -165.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 58.81 42.59 19.68 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.144 1.778 . . . . 62.12 113.294 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.81 -25.57 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 64.25 113.495 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -171.17 149.44 2.85 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.249 1.419 . . . . 75.33 109.649 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt -96.8 143.11 28.02 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 124.472 1.107 . . . . 75.42 109.507 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -151.66 116.85 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 124.3 1.0 . . . . 70.03 109.957 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.65 -6.88 40.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.993 1.717 . . . . 61.34 114.447 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -57.01 120.78 8.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.329 2.252 . . . . 73.1 112.837 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.62 169.8 21.02 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 109.944 -1.262 . . . . 70.14 109.944 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.3 ttmt -121.22 133.03 55.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.974 1.309 . . . . 73.45 108.88 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -134.04 122.92 23.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.198 1.399 . . . . 71.04 110.217 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.68 153.31 37.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.264 1.025 . . . . 74.2 110.061 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' A' ' 122' ' ' ARG . 1.3 mt -70.65 137.02 49.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.195 0.309 . . . . 53.02 110.726 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -109.17 -48.57 3.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.744 1.277 . . . . 73.23 110.095 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.55 160.24 25.74 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 124.255 0.972 . . . . 60.01 111.786 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.27 153.45 50.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.826 1.65 . . . . 74.33 107.628 172.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -129.87 142.03 50.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.968 0.907 . . . . 74.05 109.613 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 58.86 25.37 13.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.346 1.858 . . . . 73.45 113.495 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -53.83 -55.15 29.19 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.159 1.384 . . . . 74.31 112.794 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.37 -45.24 76.87 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 124.791 1.307 . . . . 62.3 112.946 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.75 86.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.359 1.064 . . . . 64.44 113.577 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.98 -45.4 67.43 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.698 1.199 . . . . 72.24 112.815 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 16.3 mmt -65.82 -40.44 91.83 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.514 1.134 . . . . 55.3 112.945 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.4 mptt -59.34 -39.48 83.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.436 1.094 . . . . 73.32 113.014 168.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.68 72.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.614 1.339 . . . . 70.25 114.614 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.571 HG13 HD23 ' A' ' 24' ' ' LEU . 45.9 pt -77.16 -1.54 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 113.682 0.993 . . . . 74.23 113.682 171.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.56 38.07 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.83 -0.983 . . . . 54.2 113.146 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.571 HD23 HG13 ' A' ' 22' ' ' ILE . 1.1 mm? -74.57 142.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 118.581 1.19 . . . . 71.32 109.276 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.02 149.49 77.18 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.58 2.187 . . . . 64.41 111.565 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 29' ' ' ILE . 59.2 tt0 -59.74 -24.85 64.37 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.1 1.519 . . . . 71.15 115.1 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.97 -46.39 78.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.575 0.954 . . . . 75.2 113.575 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -67.97 -25.7 65.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.352 -0.832 . . . . 71.15 113.001 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 26' ' ' GLU . 56.2 mt -72.73 -53.16 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 117.86 -1.067 . . . . 63.41 111.009 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -62.96 -43.13 99.64 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.025 1.12 . . . . 73.04 114.025 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -23.22 63.3 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.735 0.647 . . . . 61.25 111.926 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.57 -28.36 47.8 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.127 -1.374 . . . . 51.5 112.469 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.37 -28.34 16.96 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 116.756 -1.592 . . . . 73.42 113.79 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -80.35 -34.95 36.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.865 1.212 . . . . 73.22 110.942 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.3 mt -93.47 122.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.361 1.065 . . . . 53.41 108.883 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.71 144.91 29.05 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.983 0.802 . . . . 71.21 110.668 165.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.3 -162.75 26.42 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 124.603 1.19 . . . . 34.23 110.725 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -143.86 152.64 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.607 1.963 . . . . 73.42 107.5 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -132.88 149.21 52.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.841 0.856 . . . . 61.43 109.598 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.14 136.91 54.98 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.023 -1.103 . . . . 53.23 108.023 166.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.63 128.42 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.509 -2.034 . . . . 73.42 105.509 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.92 99.11 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 124.162 0.914 . . . . 70.04 108.738 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -78.51 120.31 23.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.574 1.15 . . . . 74.35 109.685 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -117.45 54.83 0.87 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.381 1.472 . . . . 73.01 109.831 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -118.1 6.47 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.526 -1.83 . . . . 72.23 108.526 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -31.58 60.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.262 1.025 . . . . 74.42 112.829 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 161.92 29.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.339 1.056 . . . . 74.35 111.078 169.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -155.55 138.31 15.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.584 -1.265 . . . . 75.01 107.584 -175.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.98 144.7 48.37 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 125.53 1.532 . . . . 72.32 109.894 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.59 123.41 27.85 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.864 -1.902 . . . . 73.22 105.864 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -116.6 135.52 53.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.313 1.845 . . . . 72.25 108.525 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.52 105.26 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.325 -0.991 . . . . 74.01 108.325 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -97.02 114.84 26.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.824 1.649 . . . . 63.33 109.125 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.86 147.97 17.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.584 0.754 . . . . 75.44 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.63 -105.58 1.96 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 107.608 -2.197 . . . . 72.42 107.608 -173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -147.79 34.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.017 1.327 . . . . 51.21 110.912 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.03 164.4 30.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.0 1.72 . . . . 74.54 109.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.31 129.91 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.977 0.798 . . . . 72.31 109.0 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.27 133.8 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.396 -1.335 . . . . 63.31 107.396 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -122.82 124.38 43.17 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.245 -1.391 . . . . 71.21 107.245 173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -123.33 150.71 43.27 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 124.645 1.216 . . . . 74.13 109.014 172.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.66 142.27 41.15 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 125.205 1.566 . . . . 64.34 108.99 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.81 162.3 40.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.063 1.345 . . . . 72.14 109.756 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.5 m -109.51 135.46 50.48 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.309 -1.367 . . . . 74.12 107.309 166.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.5 130.46 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.953 0.901 . . . . 72.44 111.032 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.88 -7.97 64.48 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 117.941 -1.477 . . . . 55.35 114.092 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -98.75 136.09 39.29 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.538 1.669 . . . . 70.23 110.08 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.66 136.12 45.58 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.364 1.04 . . . . 64.11 111.068 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -167.63 159.17 11.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.853 1.261 . . . . 70.35 109.403 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -100.94 124.23 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.236 0.96 . . . . 62.11 110.915 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 81' ' ' THR . 4.5 mm? -105.67 168.66 8.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.941 2.096 . . . . 63.25 109.787 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -129.79 157.96 40.74 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.954 1.301 . . . . 41.41 110.545 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.6 p -124.11 173.09 8.52 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.093 1.757 . . . . 73.14 109.703 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -59.82 -20.39 56.61 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.509 1.67 . . . . 71.13 115.509 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 24' ' ' LEU . 54.3 p -78.57 -14.88 59.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.159 1.783 . . . . 73.34 113.842 172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.15 -2.08 83.35 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.996 1.284 . . . . 72.12 112.653 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -65.2 135.74 55.8 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 119.121 1.46 . . . . 62.44 112.559 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -103.93 143.14 33.26 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 125.126 1.516 . . . . 62.24 110.93 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.48 123.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.747 1.219 . . . . 74.43 111.272 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -71.43 137.92 48.66 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.738 1.215 . . . . 75.41 111.582 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 71' ' ' LEU . 13.8 t -167.41 169.67 12.07 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.677 1.236 . . . . 71.1 110.315 -172.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.71 132.2 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.866 1.266 . . . . 75.14 107.998 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.41 140.88 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 124.11 0.881 . . . . 72.03 109.524 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -131.59 168.58 17.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 70.34 111.373 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -122.44 127.2 49.35 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.006 -1.479 . . . . 65.52 107.006 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -84.9 18.55 2.4 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.596 1.332 . . . . 63.23 114.596 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 18.16 78.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.98 1.276 . . . . 62.21 113.719 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -143.43 48.14 1.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.605 1.162 . . . . 73.41 109.47 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.29 0.7 OUTLIER 47.21 37.58 5.79 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.695 1.998 . . . . 72.33 114.178 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -137.47 121.34 17.61 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.862 1.665 . . . . 70.41 109.072 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.58 140.77 29.44 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.556 1.16 . . . . 73.5 109.725 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.22 138.68 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.326 1.45 . . . . 73.14 108.476 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -160.11 143.62 13.99 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.959 0.787 . . . . 65.32 110.85 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.4 p -129.17 117.35 20.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.243 1.417 . . . . 73.32 107.343 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -69.33 -52.3 28.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.268 1.027 . . . . 64.5 110.604 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -149.26 -101.71 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.828 -2.286 . . . . 75.14 104.828 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -76.72 -20.23 56.79 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.481 2.312 . . . . 75.11 113.674 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 HD13 ' A' ' 115' ' ' LEU . 68.5 mt -81.69 102.31 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.312 1.045 . . . . 63.21 108.636 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.84 146.89 24.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.105 1.362 . . . . 53.13 109.838 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 m -138.71 126.89 22.73 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.462 1.505 . . . . 70.42 107.43 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.59 97.71 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.173 -1.418 . . . . 63.2 107.173 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 m -94.54 152.91 18.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.157 1.383 . . . . 75.43 110.156 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -141.32 139.48 33.62 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.7 2.0 . . . . 73.42 108.545 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.11 137.38 47.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 75.11 107.556 162.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -142.11 77.22 1.57 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.927 1.691 . . . . 74.43 106.8 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.88 -98.31 0.48 Allowed Glycine 0 C--N 1.346 1.115 0 C-N-CA 125.435 1.493 . . . . 71.31 110.752 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -87.76 -13.69 41.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.335 1.454 . . . . 74.01 113.133 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.89 140.23 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 119.798 1.181 . . . . 64.11 110.754 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.7 mm -119.5 107.66 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.088 1.355 . . . . 71.12 107.855 168.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -96.04 138.23 33.97 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.154 -1.054 . . . . 75.51 108.154 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -147.0 91.45 2.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.389 0.676 . . . . 72.52 109.252 -170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -82.97 144.24 30.12 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.7 1.25 . . . . 71.42 110.616 173.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 92.9 mtp -130.64 153.09 49.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.519 1.527 . . . . 63.21 108.491 168.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 m -141.03 114.03 8.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.842 0.857 . . . . 43.55 108.737 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.564 HD13 HG12 ' A' ' 98' ' ' ILE . 9.3 tp -123.95 125.08 43.97 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.568 1.547 . . . . 64.31 107.915 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.22 -101.44 0.38 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 124.983 1.427 . . . . 61.13 110.674 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.2 0.18 12.23 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.586 1.955 . . . . 74.43 112.951 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.76 137.79 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.878 1.271 . . . . 44.24 109.817 -172.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.16 102.24 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.544 1.138 . . . . 72.05 109.324 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -84.85 150.99 24.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.539 1.536 . . . . 63.23 111.515 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -136.52 157.24 47.25 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.946 0.898 . . . . 61.44 110.199 167.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.521 ' HG2' HD21 ' A' ' 9' ' ' LEU . 5.3 ttp180 -137.46 143.64 41.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.531 1.533 . . . . 72.2 108.645 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.72 123.25 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.428 -1.693 . . . . 74.43 106.428 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -130.32 152.56 49.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.365 1.466 . . . . 71.2 108.988 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -133.29 138.28 46.35 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.85 0.86 . . . . 73.22 110.665 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -64.27 135.99 56.76 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.856 2.062 . . . . 75.52 112.526 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.59 HD12 ' HD2' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 C--N 1.343 0.319 0 N-CA-C 103.369 -2.826 . . . . 74.44 103.369 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.9 m170 . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 104.116 -2.549 . . . . 50.05 104.116 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -170.56 -43.26 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.353 2.661 . . . . 75.54 107.956 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -65.74 162.69 18.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.821 1.648 . . . . 64.31 112.324 168.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -163.08 156.0 19.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.305 1.442 . . . . 70.33 108.948 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -155.51 149.27 25.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.195 0.998 . . . . 74.24 109.968 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -170.06 -12.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.238 1.415 . . . . 62.12 112.495 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.0 m -75.19 78.47 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.059 1.744 . . . . 64.25 112.05 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -148.86 166.63 27.94 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.308 1.843 . . . . 75.33 109.624 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm 64.12 -175.62 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.446 1.899 . . . . 75.42 113.501 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -173.23 136.35 0.62 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.443 1.897 . . . . 70.03 107.444 170.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -88.91 64.37 7.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 61.34 109.581 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.3 p -128.56 124.86 37.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.763 1.225 . . . . 73.1 109.05 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.42 174.21 27.82 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 109.63 -1.388 . . . . 70.14 109.63 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.2 ttmt -130.25 134.01 46.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 73.45 108.98 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.27 130.7 33.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.509 1.524 . . . . 71.04 110.04 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.73 152.47 21.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.273 1.029 . . . . 74.2 110.009 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.62 149.3 50.31 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.838 1.255 . . . . 53.02 112.011 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -125.99 -46.11 1.69 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.697 1.199 . . . . 73.23 111.126 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -162.43 155.71 20.27 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.303 1.041 . . . . 60.01 111.405 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -137.48 140.38 41.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.239 1.415 . . . . 74.33 108.522 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -116.33 149.33 39.48 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.084 0.954 . . . . 74.05 109.208 167.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.93 26.22 14.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.321 1.848 . . . . 73.45 113.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.34 -61.4 2.6 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 124.583 1.153 . . . . 74.31 113.373 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.43 -32.99 74.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.151 -0.928 . . . . 62.3 113.284 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.78 95.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.101 0.961 . . . . 64.44 113.112 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -68.56 -51.01 47.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.419 1.488 . . . . 72.24 113.42 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 mmt -63.37 -42.74 98.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.006 1.322 . . . . 55.3 112.966 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -74.91 -26.54 59.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.036 -0.983 . . . . 73.32 113.071 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.28 66.47 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 118.21 -0.9 . . . . 70.25 113.327 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.24 -13.31 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.968 0.792 . . . . 74.23 112.77 170.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.34 17.88 27.91 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 117.998 -1.446 . . . . 54.2 113.849 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.3 mt -61.56 142.22 94.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 119.694 1.747 . . . . 71.32 112.112 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.15 143.51 90.26 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.502 2.135 . . . . 64.41 111.742 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.73 -24.43 64.01 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.839 1.422 . . . . 71.15 114.839 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.09 -47.39 83.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.418 1.487 . . . . 75.2 113.397 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.6 -27.43 66.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.83 1.252 . . . . 71.15 112.642 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.15 -54.72 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 117.764 -1.112 . . . . 63.41 111.085 168.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -60.96 -42.92 99.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.6 1.333 . . . . 73.04 114.6 -175.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -13.23 59.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.36 -0.829 . . . . 61.25 112.986 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.09 -35.67 9.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.847 -0.974 . . . . 51.5 111.443 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -33.39 23.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.451 1.125 . . . . 73.42 112.874 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -71.96 -60.1 2.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.833 0.853 . . . . 73.22 110.542 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.48 114.99 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 124.339 1.024 . . . . 53.41 109.371 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.97 110.82 3.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.68 1.592 . . . . 71.21 109.415 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.29 -178.68 45.54 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.756 1.169 . . . . 34.23 111.893 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.97 158.3 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.241 1.416 . . . . 73.42 108.846 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -144.32 146.39 32.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.107 1.363 . . . . 61.43 109.76 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -128.38 138.22 52.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.75 1.22 . . . . 53.23 108.318 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -126.46 130.9 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.671 -1.603 . . . . 73.42 106.671 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.31 90.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.844 0.715 . . . . 70.04 109.729 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -76.36 136.32 39.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.325 0.65 . . . . 74.35 110.241 167.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.98 79.07 1.68 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.617 1.567 . . . . 73.01 107.477 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 -126.05 12.53 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.28 -1.528 . . . . 72.23 109.28 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -68.4 -29.35 68.02 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.558 1.318 . . . . 74.42 114.558 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 151.5 39.11 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.913 0.758 . . . . 74.35 111.493 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.06 137.35 23.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.164 1.786 . . . . 75.01 107.382 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -121.75 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.547 1.154 . . . . 72.32 108.85 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.61 103.4 5.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.75 -1.945 . . . . 73.22 105.75 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -92.93 138.7 31.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.698 1.199 . . . . 72.25 108.466 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.78 111.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.786 1.234 . . . . 74.01 107.774 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -86.64 107.3 18.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.873 1.269 . . . . 63.33 108.59 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 -173.63 1.68 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.825 1.65 . . . . 75.44 111.872 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.66 -31.54 63.98 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.783 1.182 . . . . 72.42 114.621 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -162.11 46.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.99 1.316 . . . . 51.21 109.324 167.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.34 160.85 43.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.495 1.518 . . . . 74.54 108.53 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.48 128.79 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.311 -0.996 . . . . 72.31 108.311 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -127.71 141.89 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.748 -1.575 . . . . 63.31 106.748 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.32 137.52 37.47 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.898 0.749 . . . . 71.21 110.766 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -124.17 158.13 33.09 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 125.475 1.734 . . . . 74.13 108.872 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.62 141.71 28.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 124.759 1.287 . . . . 64.34 108.972 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.69 160.67 42.44 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.48 1.112 . . . . 72.14 110.635 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 m -109.48 130.61 55.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.869 -1.16 . . . . 74.12 107.869 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.4 117.21 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.893 0.877 . . . . 72.44 110.242 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.68 56.58 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.74 -1.589 . . . . 55.35 112.759 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -119.16 150.77 39.48 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.502 1.651 . . . . 70.23 110.063 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.8 122.09 24.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.766 1.226 . . . . 64.11 110.732 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.7 m -144.97 151.9 39.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.966 1.306 . . . . 70.35 109.712 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -100.09 134.4 43.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.665 1.186 . . . . 62.11 110.857 -165.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.48 106.65 9.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.013 1.325 . . . . 63.25 109.67 -165.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.78 125.75 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.494 1.518 . . . . 41.41 111.664 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.7 m -82.3 166.38 19.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.728 1.611 . . . . 73.14 111.179 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.12 -27.42 14.14 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.579 1.952 . . . . 71.13 115.488 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -86.44 -17.19 34.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.266 1.826 . . . . 73.34 114.255 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.34 -16.08 45.69 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.785 1.183 . . . . 72.12 112.123 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -62.19 136.7 58.05 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.501 1.52 . . . . 62.44 110.4 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -133.65 153.76 51.43 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 124.382 1.051 . . . . 62.24 111.25 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -150.58 140.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.565 1.946 . . . . 74.43 108.517 -168.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -109.17 134.57 51.56 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.485 1.116 . . . . 75.41 109.867 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 t -168.21 161.05 12.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.327 1.051 . . . . 71.1 111.124 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.78 117.94 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.867 1.267 . . . . 75.14 109.302 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.52 138.15 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.906 0.883 . . . . 72.03 108.818 171.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -129.92 153.93 47.84 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.979 1.312 . . . . 70.34 111.821 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.9 tt -97.74 132.41 43.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.929 1.292 . . . . 65.52 109.565 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -93.54 27.28 2.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.757 1.623 . . . . 63.23 113.607 -170.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 69.9 6.13 54.96 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.88 1.705 . . . . 62.21 115.304 171.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.26 57.36 0.89 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.329 1.565 . . . . 73.41 109.012 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.341 0.0 OUTLIER 49.4 32.6 4.72 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.337 1.855 . . . . 72.33 114.92 178.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -124.43 138.62 54.34 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 126.532 1.933 . . . . 70.41 108.641 -174.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.5 mt -114.34 125.15 53.54 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 124.342 1.026 . . . . 73.5 108.896 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.0 141.7 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.425 1.49 . . . . 73.14 108.718 173.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.8 t -150.78 140.53 21.76 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.212 0.945 . . . . 65.32 110.141 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 76.6 p -135.74 160.09 39.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.347 1.859 . . . . 73.32 108.743 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -127.71 -56.81 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.005 -0.739 . . . . 64.5 109.005 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -140.62 -63.1 0.48 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.697 1.599 . . . . 75.14 109.414 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -127.13 -26.36 3.13 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.633 1.208 . . . . 75.11 112.068 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.1 mt -74.07 100.58 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 124.032 0.933 . . . . 63.21 109.58 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -74.57 148.97 40.35 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.595 1.184 . . . . 53.13 109.01 165.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -149.75 125.11 10.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.812 -1.551 . . . . 70.42 106.812 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.2 t -127.06 100.43 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.82 -1.548 . . . . 63.2 106.82 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 96.1 m -77.99 147.75 34.73 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.463 1.102 . . . . 75.43 108.578 165.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -149.33 114.61 5.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.555 1.142 . . . . 73.42 109.498 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.7 124.25 38.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.439 1.496 . . . . 75.11 109.145 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -129.78 67.65 1.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.235 -1.765 . . . . 74.43 106.235 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.78 -106.4 1.55 Allowed Glycine 0 C--N 1.348 1.202 0 C-N-CA 125.394 1.474 . . . . 71.31 110.278 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.72 -10.82 59.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.459 1.281 . . . . 74.01 114.459 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.58 137.0 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.199 1.0 . . . . 64.11 109.847 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.9 mm -124.77 104.82 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.023 1.329 . . . . 71.12 107.861 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.5 m -94.74 135.31 36.37 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.564 -1.273 . . . . 75.51 107.564 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.73 95.74 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.81 -0.811 . . . . 72.52 108.81 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.1 m -88.96 138.89 31.0 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.618 1.199 . . . . 71.42 109.653 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.7 mtp -130.67 154.37 47.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.425 1.49 . . . . 63.21 109.195 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.1 m -147.64 88.17 1.68 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.819 0.447 . . . . 43.55 111.474 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.09 107.48 16.46 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.502 1.121 . . . . 64.31 108.373 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.23 -99.14 0.22 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.782 1.182 . . . . 61.13 111.685 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.33 -3.81 15.98 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.22 1.808 . . . . 74.43 111.95 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.71 102.29 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.159 1.383 . . . . 44.24 109.075 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.69 84.34 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.498 1.119 . . . . 72.05 109.681 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -70.8 148.55 47.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.633 1.173 . . . . 63.23 112.261 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.28 156.02 49.17 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.722 0.809 . . . . 61.44 110.323 167.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -141.26 136.46 31.68 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.045 1.738 . . . . 72.2 107.339 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.38 132.77 70.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.129 -1.804 . . . . 74.43 106.129 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -139.64 155.26 47.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.616 1.567 . . . . 71.2 109.284 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -142.15 145.57 34.36 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.069 0.948 . . . . 73.22 110.883 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpt85 -51.4 141.09 16.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.023 2.929 . . . . 75.52 113.993 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.1 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 104.103 -2.555 . . . . 74.44 104.103 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 102.696 -3.076 . . . . 50.05 102.696 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.8 119.12 8.96 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.231 1.412 . . . . 75.54 109.112 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -69.84 158.17 36.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.5 1.52 . . . . 64.31 111.975 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.4 125.56 52.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.292 1.037 . . . . 70.33 108.517 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -129.43 146.04 51.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.673 1.189 . . . . 74.24 110.151 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -158.52 -32.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.245 1.818 . . . . 62.12 111.042 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 16.9 t 61.43 53.1 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.966 2.106 . . . . 64.25 109.935 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -168.4 151.32 5.44 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.758 1.623 . . . . 75.33 109.54 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.29 138.16 41.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.225 0.953 . . . . 75.42 111.216 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -164.29 142.71 7.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.49 1.516 . . . . 70.03 108.72 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' HA ' HD22 ' A' ' 104' ' ' LEU . 66.3 m-85 -75.72 -2.75 31.09 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.504 1.668 . . . . 61.34 115.504 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -59.01 127.2 31.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.929 1.692 . . . . 73.1 113.725 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.11 174.58 27.0 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.9 -0.88 . . . . 70.14 110.9 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' HD2' HD12 ' A' ' 127' ' ' ILE . 10.8 ttmm -125.23 137.01 54.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.863 1.665 . . . . 73.45 108.094 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.47 127.88 26.5 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.397 1.479 . . . . 71.04 110.527 -166.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.96 152.0 28.23 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.734 0.814 . . . . 74.2 110.046 168.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.39 146.94 50.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.194 0.598 . . . . 53.02 110.409 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -120.39 -60.63 1.66 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.442 1.097 . . . . 73.23 109.779 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 m -143.17 157.28 44.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.69 1.196 . . . . 60.01 110.982 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -142.86 149.97 39.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.289 1.435 . . . . 74.33 109.36 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -125.7 148.96 48.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.059 0.944 . . . . 74.05 109.38 165.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 54.33 33.1 17.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.819 2.048 . . . . 73.45 112.402 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -61.51 -64.61 0.89 Allowed 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.572 1.149 . . . . 74.31 111.318 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.85 -38.99 90.31 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 124.446 1.091 . . . . 62.3 113.062 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.45 78.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.546 1.139 . . . . 64.44 113.476 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -74.39 -40.79 61.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.541 1.136 . . . . 72.24 113.322 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.1 mmt -68.08 -36.64 80.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.492 1.117 . . . . 55.3 113.395 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -65.0 -40.66 95.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.846 0.858 . . . . 73.32 112.313 167.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.85 -33.18 70.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.081 1.511 . . . . 70.25 115.081 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -75.87 -14.12 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 113.371 0.878 . . . . 74.23 113.371 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.7 20.69 39.43 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.593 -1.115 . . . . 54.2 112.719 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.7 135.55 96.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 118.909 1.354 . . . . 71.32 109.296 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.77 153.25 78.73 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.338 2.025 . . . . 64.41 112.268 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 29' ' ' ILE . 45.1 tt0 -56.97 -27.66 61.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.131 1.53 . . . . 71.15 115.131 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.78 -52.99 61.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.087 -0.958 . . . . 75.2 112.546 169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.62 -22.9 67.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.643 1.177 . . . . 71.15 114.059 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' GLU . 49.2 mt -75.04 -56.65 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 63.41 110.197 171.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -66.08 -36.38 83.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.702 1.371 . . . . 73.04 114.702 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -13.78 49.44 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.722 0.638 . . . . 61.25 112.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.74 -21.5 76.65 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 118.698 -1.056 . . . . 51.5 111.424 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -103.35 -22.33 13.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 116.365 -1.778 . . . . 73.42 113.86 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.25 20.0 p-10 -70.46 -51.68 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.127 1.33 . . . . 73.22 110.778 -173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.4 mm -97.96 122.98 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.606 1.562 . . . . 53.41 107.418 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.1 126.46 29.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.392 1.057 . . . . 71.21 109.553 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.79 -168.76 10.31 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 124.598 1.186 . . . . 34.23 112.172 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.2 153.86 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 107.801 -1.185 . . . . 73.42 107.801 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -135.98 148.99 48.68 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.11 1.364 . . . . 61.43 108.79 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -138.47 135.78 35.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.9 0.88 . . . . 53.23 108.727 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.96 130.84 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.358 -1.349 . . . . 73.42 107.358 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -136.23 97.81 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.329 -0.989 . . . . 70.04 108.329 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -76.28 143.12 41.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.873 0.869 . . . . 74.35 109.808 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -145.24 83.07 1.67 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.87 -1.159 . . . . 73.01 107.87 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.72 -120.3 10.92 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.292 -1.523 . . . . 72.23 109.292 -175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -77.67 -24.79 49.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 74.42 114.243 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.69 154.13 36.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.305 1.042 . . . . 74.35 111.678 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.78 119.8 6.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.775 1.23 . . . . 75.01 108.39 -173.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -99.69 137.48 38.1 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.413 1.071 . . . . 72.32 108.901 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.71 140.86 51.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.336 -1.727 . . . . 73.22 106.336 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 m -140.09 136.95 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.966 1.706 . . . . 72.25 107.929 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.26 114.15 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.635 1.574 . . . . 74.01 106.806 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.3 m -96.8 130.63 44.03 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.296 1.439 . . . . 63.33 109.608 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.39 172.55 8.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.615 1.566 . . . . 75.44 109.365 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.23 7.5 8.02 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 118.249 -1.306 . . . . 72.42 114.638 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -36.9 1.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.23 1.515 . . . . 51.21 112.062 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.5 168.92 22.77 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.967 1.307 . . . . 74.54 110.401 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.73 138.31 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 124.56 1.163 . . . . 72.31 108.242 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.58 127.41 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.197 1.799 . . . . 63.31 106.778 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.18 144.3 30.79 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.737 0.648 . . . . 71.21 111.41 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -146.45 161.18 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.597 1.959 . . . . 74.13 108.857 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -133.81 144.46 49.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.033 0.933 . . . . 64.34 109.88 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.08 171.41 18.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.24 1.416 . . . . 72.14 110.122 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.8 m -112.83 132.09 55.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.59 1.156 . . . . 74.12 108.204 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.39 133.28 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.163 0.985 . . . . 72.44 110.307 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.15 -26.84 13.11 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.59 -1.117 . . . . 55.35 111.593 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.37 153.12 21.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.972 1.309 . . . . 70.23 110.172 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.26 158.0 24.96 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.408 1.067 . . . . 64.11 110.721 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.33 165.01 27.13 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.755 1.222 . . . . 70.35 110.145 -165.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.99 117.23 30.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.736 1.214 . . . . 62.11 109.187 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.06 166.36 11.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 63.25 110.645 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -115.38 148.13 39.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.5 1.92 . . . . 41.41 109.481 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p -111.79 173.88 6.14 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.715 1.606 . . . . 73.14 110.361 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -55.3 -28.73 55.53 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 116.52 2.044 . . . . 71.13 116.52 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.7 p -85.75 -15.87 40.73 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.371 1.068 . . . . 73.34 113.411 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.16 65.35 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 118.339 -1.256 . . . . 72.12 111.542 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.18 129.69 41.94 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 119.261 1.531 . . . . 62.44 109.868 164.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -108.43 150.4 27.46 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 124.792 1.308 . . . . 62.24 110.5 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.31 127.11 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.088 -1.415 . . . . 74.43 109.317 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -74.87 143.14 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.084 0.865 . . . . 75.41 110.663 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 t -160.74 161.0 32.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.12 1.368 . . . . 71.1 109.588 -166.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.36 144.61 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.918 -1.141 . . . . 75.14 107.918 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 91' ' ' LEU . 40.2 t -130.18 132.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.098 0.959 . . . . 72.03 109.472 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -134.53 150.73 50.79 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.232 1.413 . . . . 70.34 110.751 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 12.9 tp -80.05 137.85 36.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.275 1.03 . . . . 65.52 110.267 171.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -85.59 6.49 27.07 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.769 1.228 . . . . 63.23 112.441 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.479 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 73.6 5.07 67.29 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.695 1.617 . . . . 62.21 113.42 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -127.41 42.31 3.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.356 1.862 . . . . 73.41 108.922 -169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.337 0.2 OUTLIER 47.15 38.52 6.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.456 1.902 . . . . 72.33 113.904 -172.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -134.14 138.94 45.55 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.677 1.991 . . . . 70.41 108.993 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.407 HD22 HG12 ' A' ' 83' ' ' VAL . 59.8 mt -101.28 143.42 31.37 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 124.632 1.207 . . . . 73.5 108.618 164.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -121.84 134.38 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.098 -1.445 . . . . 73.14 107.098 170.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -151.09 150.17 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 65.32 110.898 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.1 p -140.87 126.28 18.75 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.241 1.416 . . . . 73.32 108.216 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.54 -87.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.885 1.366 . . . . 64.5 109.493 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.19 -43.44 1.79 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.245 1.418 . . . . 75.14 111.181 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -157.22 26.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.588 1.155 . . . . 75.11 111.533 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.6 mt -130.41 102.74 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.489 -1.3 . . . . 63.21 107.489 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -65.55 132.85 49.89 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.819 0.7 . . . . 53.13 109.518 167.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -142.27 108.81 5.33 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 124.683 1.239 . . . . 70.42 108.129 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -116.98 131.53 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.669 1.188 . . . . 63.2 108.67 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.6 m -113.53 151.83 31.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.251 1.821 . . . . 75.43 108.713 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.87 144.34 37.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.853 1.661 . . . . 73.42 108.534 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.9 tp -117.92 124.29 47.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.789 2.035 . . . . 75.11 106.725 167.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.17 85.44 2.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.28 1.832 . . . . 74.43 106.844 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.28 -106.69 2.09 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.767 -1.333 . . . . 71.31 109.767 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.46 -20.68 19.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.92 1.288 . . . . 74.01 112.452 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.18 135.02 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.231 1.013 . . . . 64.11 110.52 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mm -119.54 95.1 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.01 1.324 . . . . 71.12 107.707 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.5 m -86.26 127.36 34.75 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.182 0.926 . . . . 75.51 108.858 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.11 141.26 51.81 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.732 -0.84 . . . . 72.52 108.732 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 m -140.93 120.6 13.36 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.715 1.206 . . . . 71.42 108.723 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 83.3 mtp -116.53 156.27 27.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 63.21 109.289 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.4 m -143.76 114.26 7.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.319 1.048 . . . . 43.55 109.557 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.67 105.03 11.17 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.506 1.922 . . . . 64.31 107.162 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.01 -128.91 43.13 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 110.483 -1.047 . . . . 61.13 110.483 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -73.75 -13.83 61.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.83 1.652 . . . . 74.43 114.139 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.4 mt -97.69 132.71 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.854 1.262 . . . . 44.24 109.469 -171.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.63 85.63 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 124.383 1.052 . . . . 72.05 109.458 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -68.47 139.6 55.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.078 1.351 . . . . 63.23 113.052 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 152.45 50.27 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.62 1.168 . . . . 61.44 111.104 173.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -130.45 151.18 51.22 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.663 1.585 . . . . 72.2 108.659 161.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 124.44 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.246 -2.131 . . . . 74.43 105.246 160.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -122.86 157.45 32.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 71.2 108.332 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -134.49 142.08 46.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.862 0.865 . . . . 73.22 110.45 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.7 ttp85 -61.73 138.21 58.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.692 1.997 . . . . 75.52 112.627 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 125.04 2.352 . . . . 74.44 107.996 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 104.063 -2.569 . . . . 50.05 104.063 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 48.49 56.5 7.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.648 2.379 . . . . 75.54 114.075 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -66.86 144.74 56.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.388 1.075 . . . . 64.31 111.224 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -67.52 149.01 50.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.306 1.004 . . . . 70.33 112.54 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.95 159.13 26.2 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.703 2.001 . . . . 74.24 108.313 -171.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -82.59 36.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.451 1.1 . . . . 62.12 113.324 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.39 120.3 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.142 1.777 . . . . 64.25 108.032 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -82.27 167.02 19.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.107 1.363 . . . . 75.33 111.426 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt 64.92 -169.53 0.2 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 75.42 113.404 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -144.24 117.0 8.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.777 1.631 . . . . 70.03 107.603 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 104' ' ' LEU . 81.5 m-85 -78.38 46.24 0.61 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.529 1.532 . . . . 61.34 112.175 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -132.77 114.1 13.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.172 1.789 . . . . 73.1 109.183 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 165.97 18.6 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 109.187 -1.565 . . . . 70.14 109.187 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HD2' HD12 ' A' ' 127' ' ' ILE . 3.8 tmmt? -120.29 138.46 53.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 73.45 109.744 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -133.64 151.35 51.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.337 1.855 . . . . 71.04 110.59 -164.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.38 149.98 30.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.936 1.294 . . . . 74.2 109.086 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.26 49.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.883 0.873 . . . . 53.02 110.398 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -102.48 -67.86 0.86 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.849 1.26 . . . . 73.23 109.117 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -141.56 167.88 21.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.649 1.18 . . . . 60.01 111.397 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.805 1.242 . . . . 74.33 110.133 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.85 146.46 50.27 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.681 1.592 . . . . 74.05 108.694 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 59.3 20.56 8.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.909 1.684 . . . . 73.45 113.679 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -57.96 -62.07 2.08 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.735 1.214 . . . . 74.31 112.793 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.89 -36.33 82.97 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.332 1.02 . . . . 62.3 112.987 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.16 78.71 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.368 1.067 . . . . 64.44 113.057 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -66.79 -47.06 73.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.266 1.426 . . . . 72.24 113.618 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.6 mmt -66.19 -36.58 83.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.874 1.269 . . . . 55.3 113.346 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -75.7 -28.99 58.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.383 1.073 . . . . 73.32 112.746 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.22 -38.96 71.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.134 0.973 . . . . 70.25 113.135 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.16 -9.73 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 113.174 0.805 . . . . 74.23 113.174 172.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 30.34 22.36 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.48 -1.178 . . . . 54.2 113.968 164.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.46 152.73 95.93 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 119.135 1.467 . . . . 71.32 111.367 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.11 145.74 68.0 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.516 2.144 . . . . 64.41 112.221 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -33.14 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.333 1.853 . . . . 71.15 114.801 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -53.54 -55.46 25.33 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.979 1.712 . . . . 75.2 113.18 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.64 -28.48 68.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.827 1.251 . . . . 71.15 113.87 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.56 -52.06 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 118.085 -0.96 . . . . 63.41 111.526 170.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -67.02 -36.41 82.08 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.696 1.369 . . . . 73.04 114.696 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -23.93 49.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.183 -0.913 . . . . 61.25 111.809 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.03 -32.43 32.24 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.765 -1.02 . . . . 51.5 111.972 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -29.11 30.87 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 118.442 1.121 . . . . 73.42 112.96 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -85.12 -60.36 2.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.062 0.945 . . . . 73.22 109.98 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.4 mm -85.21 128.24 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.141 0.976 . . . . 53.41 109.31 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -81.79 138.57 35.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.339 1.056 . . . . 71.21 110.737 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.32 -171.09 47.58 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 124.586 1.179 . . . . 34.23 111.065 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.1 t -136.78 152.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.852 1.661 . . . . 73.42 107.123 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -144.23 147.63 33.85 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.515 0.726 . . . . 61.43 109.794 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.57 146.15 50.92 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 108.348 -0.982 . . . . 53.23 108.348 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 mt -123.2 138.01 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 105.667 -1.975 . . . . 73.42 105.667 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.84 137.97 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.099 -1.074 . . . . 70.04 108.099 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -129.04 128.9 44.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.988 1.315 . . . . 74.35 108.601 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -137.57 78.63 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.816 1.322 . . . . 73.01 107.759 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.05 -126.64 13.76 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 109.212 -1.555 . . . . 72.23 109.212 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -66.8 -24.73 66.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.512 1.525 . . . . 74.42 114.535 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 146.4 37.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.349 1.06 . . . . 74.35 112.036 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.11 136.69 36.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.65 1.98 . . . . 75.01 107.801 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -125.42 149.22 48.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.67 1.988 . . . . 72.32 108.298 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.92 101.11 3.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.391 0.676 . . . . 73.22 109.544 -174.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -83.44 135.53 34.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.209 1.404 . . . . 72.25 109.878 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.7 mt -137.73 99.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.615 -1.254 . . . . 74.01 107.615 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -92.97 138.15 31.74 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.861 2.064 . . . . 63.33 110.373 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.13 -145.96 0.4 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 75.44 109.401 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.2 85.79 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.2 -0.778 . . . . 72.42 112.52 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -140.9 -62.03 0.48 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.055 1.342 . . . . 51.21 109.477 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -61.68 143.74 55.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.516 1.526 . . . . 74.54 114.157 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.89 144.15 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.767 1.292 . . . . 72.31 108.886 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.5 mt -122.57 127.07 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.868 -1.53 . . . . 63.31 106.868 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 91.36 3.27 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.903 0.881 . . . . 71.21 110.433 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -84.48 155.01 22.38 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.126 1.37 . . . . 74.13 111.42 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.99 138.91 28.76 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 124.851 1.345 . . . . 64.34 110.09 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.91 167.98 27.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.624 1.17 . . . . 72.14 111.032 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.7 m -118.89 128.36 54.36 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 124.704 1.253 . . . . 74.12 107.797 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.92 128.93 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.135 0.974 . . . . 72.44 111.801 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -3.38 86.19 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-O 117.979 -1.456 . . . . 55.35 113.303 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -117.42 147.05 43.04 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.304 1.552 . . . . 70.23 110.936 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.37 119.5 14.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.317 1.847 . . . . 64.11 111.901 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -140.13 169.57 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.047 1.739 . . . . 70.35 109.254 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.6 127.71 55.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.146 0.978 . . . . 62.11 110.33 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 81' ' ' THR . 3.8 mm? -115.39 141.86 47.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.695 1.598 . . . . 63.25 110.002 -170.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -122.27 142.09 50.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.466 1.907 . . . . 41.41 110.383 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -116.7 -178.96 3.55 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.638 1.575 . . . . 73.14 111.132 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -65.94 -24.23 66.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.423 1.489 . . . . 71.13 114.983 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.3 p -81.47 -11.58 59.17 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.261 1.424 . . . . 73.34 112.045 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.85 88.09 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.114 1.34 . . . . 72.12 112.615 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.89 120.18 10.24 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 125.401 1.481 . . . . 62.44 111.364 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -97.8 126.94 43.43 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 124.953 1.408 . . . . 62.24 110.37 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.53 123.57 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.924 1.69 . . . . 74.43 108.801 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -76.01 137.11 40.03 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 124.206 0.941 . . . . 75.41 111.495 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.425 HG22 HD23 ' A' ' 71' ' ' LEU . 12.7 t -165.24 -175.94 3.85 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 124.993 1.433 . . . . 71.1 109.834 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.18 144.61 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.716 1.606 . . . . 75.14 107.765 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.02 133.09 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.861 0.864 . . . . 72.03 108.707 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.34 174.96 5.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.193 1.797 . . . . 70.34 111.509 177.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 13.2 tp -124.96 136.04 53.37 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 65.52 107.178 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -89.0 9.23 25.92 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.231 1.197 . . . . 63.23 114.231 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.474 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 84.79 3.3 88.17 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-O 118.147 -1.363 . . . . 62.21 113.86 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -124.64 50.28 1.73 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.08 1.44 . . . . 73.41 108.817 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.333 0.1 OUTLIER 51.19 27.3 3.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.648 1.979 . . . . 72.33 115.297 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -121.73 111.97 17.82 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.329 1.852 . . . . 70.41 109.446 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.53 143.61 46.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.743 1.277 . . . . 73.5 110.336 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.4 135.01 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.515 1.126 . . . . 73.14 108.73 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -158.36 161.57 37.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.935 0.894 . . . . 65.32 110.716 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.8 p -135.37 -178.87 5.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.178 1.791 . . . . 73.32 108.297 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -139.3 -76.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 64.5 109.284 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -133.4 -50.2 0.86 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.72 1.608 . . . . 75.14 109.406 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -148.29 1.86 0.64 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 75.11 111.923 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 115' ' ' LEU . 58.5 mt -105.76 120.46 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.841 1.656 . . . . 63.21 107.155 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -108.27 113.46 26.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.818 1.247 . . . . 53.13 108.661 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -113.26 129.41 56.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.842 1.339 . . . . 70.42 109.835 -174.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.97 120.2 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.98 -1.119 . . . . 63.2 107.98 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.9 m -102.74 156.15 17.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.794 1.238 . . . . 75.43 109.205 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.82 142.25 38.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.7 2.0 . . . . 73.42 108.812 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 3' ' ' PHE . 4.0 tt -120.48 119.8 34.03 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.451 -1.685 . . . . 75.11 106.451 171.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -129.45 83.56 2.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.535 1.534 . . . . 74.43 107.156 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.85 -111.88 3.95 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.913 1.244 . . . . 71.31 110.538 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -79.59 -24.2 42.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.18 1.392 . . . . 74.01 112.974 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -87.62 136.75 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.126 0.97 . . . . 64.11 110.709 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.23 107.62 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.895 1.278 . . . . 71.12 107.83 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -99.02 151.74 20.6 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 124.214 0.946 . . . . 75.51 109.328 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -146.7 141.46 26.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.926 1.29 . . . . 72.52 108.288 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 93.1 m -132.5 132.23 42.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.012 1.725 . . . . 71.42 108.239 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.2 mtp -131.12 119.07 21.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.444 1.497 . . . . 63.21 108.911 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -104.26 110.41 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.257 0.973 . . . . 43.55 109.116 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 98' ' ' ILE . 19.8 tp -116.16 98.55 6.67 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 106.816 -1.55 . . . . 64.31 106.816 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.49 -130.59 40.69 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 109.768 -1.333 . . . . 61.13 109.768 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.45 8.74 20.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 74.43 114.013 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 74.3 mt -108.88 123.0 64.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 108.511 -0.922 . . . . 44.24 108.511 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.57 85.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.524 1.14 . . . . 72.05 108.366 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.32 137.81 58.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.821 1.248 . . . . 63.23 111.753 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -134.03 148.5 51.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.012 1.325 . . . . 61.44 109.715 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -143.78 141.54 30.46 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.633 1.173 . . . . 72.2 108.83 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.91 134.1 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.665 -1.235 . . . . 74.43 107.665 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.5 m -133.1 161.02 35.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.782 1.633 . . . . 71.2 109.516 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.73 142.73 33.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.467 1.107 . . . . 73.22 110.741 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -63.44 138.39 58.5 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.222 1.809 . . . . 75.52 113.681 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 104.595 -2.372 . . . . 74.44 104.595 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 101.822 -3.399 . . . . 50.05 101.822 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -174.71 19.63 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.762 2.025 . . . . 75.54 111.311 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -153.76 175.62 13.08 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.364 1.466 . . . . 64.31 109.799 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -135.05 -87.71 0.37 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.441 -1.318 . . . . 70.33 107.441 170.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -148.68 115.51 6.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.307 -1.368 . . . . 74.24 107.307 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -157.75 119.77 3.72 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.834 -1.173 . . . . 62.12 107.834 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 86.8 t -123.48 86.19 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 124.696 1.247 . . . . 64.25 107.885 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -162.8 152.71 15.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.133 1.773 . . . . 75.33 108.561 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.28 148.81 45.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.954 1.302 . . . . 75.42 110.124 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.8 m -139.25 118.61 12.83 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.728 1.267 . . . . 70.03 109.701 -171.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -68.06 -29.14 68.04 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.041 0.838 . . . . 61.34 112.913 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -60.44 112.78 2.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.296 1.839 . . . . 73.1 112.69 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.96 173.44 32.63 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.092 -1.603 . . . . 70.14 109.092 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 127' ' ' ILE . 16.9 ttmt -127.03 138.96 53.32 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.875 0.87 . . . . 73.45 109.322 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -134.55 139.94 45.76 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.463 1.505 . . . . 71.04 109.634 -168.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.99 152.8 18.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.46 1.104 . . . . 74.2 109.36 171.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.34 140.82 57.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.839 0.856 . . . . 53.02 110.031 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -118.18 -48.1 2.54 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.95 1.3 . . . . 73.23 110.887 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -152.15 152.23 32.03 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.761 1.224 . . . . 60.01 109.868 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -149.6 136.58 19.62 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.356 1.062 . . . . 74.33 110.142 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -128.64 147.07 50.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.965 1.706 . . . . 74.05 110.046 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 55.94 24.91 8.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.305 1.842 . . . . 73.45 112.712 -167.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.61 -62.66 1.63 Allowed 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.556 1.142 . . . . 74.31 112.136 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.87 -43.1 99.52 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.298 0.998 . . . . 62.3 113.173 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.31 75.82 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.685 1.194 . . . . 64.44 113.602 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.06 -46.93 76.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.456 1.502 . . . . 72.24 113.271 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.92 -40.05 79.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.563 1.145 . . . . 55.3 113.183 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.65 -37.67 88.38 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 73.32 112.419 169.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.6 74.03 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.235 1.198 . . . . 70.25 114.235 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.9 pt -79.72 -5.19 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.262 0.838 . . . . 74.23 113.262 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.34 22.52 26.75 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.239 -1.312 . . . . 54.2 113.79 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -69.96 146.11 94.85 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.478 1.639 . . . . 71.32 111.38 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 146.96 77.12 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.474 2.116 . . . . 64.41 111.864 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -30.23 64.04 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.829 1.418 . . . . 71.15 114.829 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.2 -51.52 69.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.387 1.075 . . . . 75.2 112.995 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.8 -24.42 67.75 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.616 1.167 . . . . 71.15 113.207 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.99 -45.55 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 118.005 -0.998 . . . . 63.41 111.073 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -67.28 -33.19 74.78 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.498 1.295 . . . . 73.04 114.498 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.8 -11.15 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.123 0.969 . . . . 61.25 112.56 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 -28.0 8.82 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.75 -1.028 . . . . 51.5 111.549 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -32.68 37.53 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.49 1.145 . . . . 73.42 113.366 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -83.61 -51.9 6.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.783 0.833 . . . . 73.22 111.301 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.26 113.04 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.411 1.084 . . . . 53.41 108.854 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -67.55 130.35 42.77 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.584 1.178 . . . . 71.21 110.561 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.63 31.25 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 124.834 1.334 . . . . 34.23 111.403 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 t -141.02 154.09 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.398 -1.334 . . . . 73.42 107.398 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -142.72 120.19 11.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.351 1.061 . . . . 61.43 109.922 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -99.8 131.27 45.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 124.302 1.001 . . . . 53.23 108.704 167.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.1 133.58 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.669 -1.604 . . . . 73.42 106.669 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.4 128.56 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 123.485 0.49 . . . . 70.04 109.823 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -88.94 128.6 35.69 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.725 -1.213 . . . . 74.35 107.725 165.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.83 53.11 1.4 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.896 1.278 . . . . 73.01 109.942 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.26 -119.82 5.27 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.035 -2.026 . . . . 72.23 108.035 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -77.2 -29.82 54.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.441 0.696 . . . . 74.42 111.923 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -69.37 164.25 23.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.417 1.087 . . . . 74.35 112.266 169.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -156.32 140.96 16.93 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.133 -1.803 . . . . 75.01 106.133 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -118.07 134.05 55.35 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.75 1.22 . . . . 72.32 109.957 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.59 112.93 18.59 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 125.115 1.509 . . . . 73.22 107.485 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -114.15 124.78 52.92 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.145 -1.428 . . . . 72.25 107.145 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.46 143.52 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.517 1.127 . . . . 74.01 108.601 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -133.74 153.86 51.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 63.33 110.821 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.94 139.66 19.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.096 1.758 . . . . 75.44 108.807 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.44 -98.66 0.68 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.057 -1.617 . . . . 72.42 109.057 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -149.66 39.05 0.78 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.897 1.279 . . . . 51.21 111.314 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -142.2 135.47 28.95 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.121 0.968 . . . . 74.54 110.921 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.61 144.63 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.269 1.428 . . . . 72.31 109.938 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.51 139.32 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.683 1.593 . . . . 63.31 108.095 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -120.55 132.36 55.13 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.805 1.242 . . . . 71.21 108.075 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.37 158.45 42.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.887 1.275 . . . . 74.13 109.952 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -137.9 148.56 45.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 125.181 1.551 . . . . 64.34 108.853 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.46 157.52 41.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.329 1.452 . . . . 72.14 109.867 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.11 53.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.637 1.175 . . . . 74.12 108.084 171.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.76 113.06 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.648 1.179 . . . . 72.44 110.494 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.02 -11.45 60.52 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.118 -1.379 . . . . 55.35 112.994 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -97.62 144.02 27.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.248 1.524 . . . . 70.23 110.08 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -73.67 134.59 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.572 1.149 . . . . 64.11 110.74 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.0 p -164.62 160.0 19.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.979 1.312 . . . . 70.35 109.619 -171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.44 114.97 28.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.376 1.07 . . . . 62.11 109.972 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.65 136.22 43.76 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.797 1.639 . . . . 63.25 110.339 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.56 154.88 26.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.869 1.268 . . . . 41.41 111.267 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -117.17 169.34 9.52 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.647 1.979 . . . . 73.14 109.286 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -54.13 -32.75 56.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.145 1.535 . . . . 71.13 115.145 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 p -77.6 -11.15 59.83 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.293 2.237 . . . . 73.34 113.976 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.36 81.2 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.431 -1.205 . . . . 72.12 112.361 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.81 126.23 27.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.276 1.83 . . . . 62.44 110.668 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -112.89 119.33 37.58 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.165 0.916 . . . . 62.24 108.931 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.78 130.09 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.118 1.367 . . . . 74.43 111.928 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -73.93 142.19 45.95 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.194 1.397 . . . . 75.41 113.536 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -174.35 177.11 2.29 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 125.394 1.684 . . . . 71.1 110.615 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.95 148.72 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.773 2.029 . . . . 75.14 107.866 166.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.2 t -112.66 139.43 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.707 -0.849 . . . . 72.03 108.707 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -128.31 155.76 44.11 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.452 1.501 . . . . 70.34 111.102 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.666 HD13 ' H ' ' A' ' 87' ' ' GLY . 2.3 tm? -114.18 117.48 31.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 65.52 107.148 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.67 14.15 4.96 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.058 1.503 . . . . 63.23 115.058 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.666 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 82.11 -7.0 64.86 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.423 1.487 . . . . 62.21 113.816 174.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -110.78 38.1 2.59 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.004 1.721 . . . . 73.41 111.568 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.312 0.2 OUTLIER 52.75 40.65 30.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.275 1.83 . . . . 72.33 112.96 -177.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -137.95 127.07 24.33 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.438 1.495 . . . . 70.41 109.553 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.1 mt -91.64 144.4 25.57 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.71 1.256 . . . . 73.5 109.11 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -130.97 138.39 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.204 1.402 . . . . 73.14 108.61 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -160.01 159.57 32.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.479 1.111 . . . . 65.32 109.971 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 73.9 p -130.85 -179.25 5.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 73.32 108.443 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -143.53 -55.02 0.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.645 0.657 . . . . 64.5 111.621 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -157.02 -54.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.524 1.13 . . . . 75.14 109.003 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -146.68 2.58 0.83 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.687 1.595 . . . . 75.11 111.699 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.31 102.08 13.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 C-N-CA 125.591 1.557 . . . . 63.21 107.582 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -76.01 144.69 40.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.525 -0.916 . . . . 53.13 108.525 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -143.31 106.61 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.312 1.045 . . . . 70.42 108.466 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -115.12 110.0 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 124.866 1.354 . . . . 63.2 108.018 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -97.67 152.48 19.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.845 1.258 . . . . 75.43 109.539 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.14 146.89 39.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.997 1.719 . . . . 73.42 109.697 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -119.78 137.8 53.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.093 2.157 . . . . 75.11 107.788 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -138.35 64.46 1.5 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.122 2.169 . . . . 74.43 106.561 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.47 -105.0 1.32 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.795 1.188 . . . . 71.31 111.014 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.01 -7.95 59.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.784 1.234 . . . . 74.01 113.095 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.39 146.46 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.579 1.152 . . . . 64.11 109.146 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.4 mm -130.39 143.61 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.478 1.511 . . . . 71.12 108.39 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -127.94 148.76 50.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.398 1.061 . . . . 75.51 108.315 168.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -140.17 117.27 11.18 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.347 -1.723 . . . . 72.52 106.347 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.2 m -120.95 102.01 8.07 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.858 1.349 . . . . 71.42 107.845 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 mtm -93.76 155.39 17.25 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.25 0.969 . . . . 63.21 110.45 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -134.6 97.2 3.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.507 1.123 . . . . 43.55 108.846 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt -85.99 95.06 9.38 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.526 1.13 . . . . 64.31 108.047 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.55 -108.57 1.73 Allowed Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.678 1.132 . . . . 61.13 111.523 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.53 -2.72 57.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.871 2.068 . . . . 74.43 115.5 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.34 137.46 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.079 -1.082 . . . . 44.24 108.079 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.65 88.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 123.944 0.778 . . . . 72.05 109.298 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -67.4 139.58 57.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.217 1.007 . . . . 63.23 112.073 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -133.61 148.83 51.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.564 1.545 . . . . 61.44 109.955 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -157.32 108.88 2.35 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.811 1.244 . . . . 72.2 108.715 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -100.98 135.09 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.304 1.442 . . . . 74.43 107.773 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.7 m -136.11 159.01 43.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 71.2 109.971 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -143.66 144.12 31.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.982 0.913 . . . . 73.22 110.697 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -65.48 136.92 57.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.704 2.002 . . . . 75.52 113.933 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 6' ' ' LYS . 3.1 mt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 124.915 2.293 . . . . 74.44 107.798 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 108.346 -0.983 . . . . 50.05 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -73.61 146.6 44.52 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 124.392 1.077 . . . . 75.54 111.562 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -158.59 -55.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.694 1.246 . . . . 64.31 109.837 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 68.32 -15.68 0.22 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.924 2.489 . . . . 70.33 115.095 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -164.64 158.91 18.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.831 2.852 . . . . 74.24 107.563 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -77.88 145.42 36.24 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.586 0.554 . . . . 62.12 110.545 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.64 14.1 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.114 1.366 . . . . 64.25 111.744 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 67.79 177.26 0.25 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.724 2.409 . . . . 75.33 112.179 -168.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtm -76.12 151.34 37.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 111.888 0.329 . . . . 75.42 111.888 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.5 m -89.59 107.23 18.96 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.591 1.557 . . . . 70.03 110.483 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' ILE . 38.4 m-85 -65.7 -25.21 67.21 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 117.101 2.26 . . . . 61.34 117.101 -174.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -63.18 147.42 50.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.114 1.524 . . . . 73.1 115.114 -170.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.66 168.0 12.14 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.467 1.508 . . . . 70.14 110.646 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -89.71 152.86 21.12 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.902 1.281 . . . . 73.45 112.369 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -143.78 134.71 25.37 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.963 1.705 . . . . 71.04 107.782 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.25 154.02 22.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.919 0.781 . . . . 74.2 109.458 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.24 130.17 40.16 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.615 0.572 . . . . 53.02 109.649 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -103.57 -61.38 1.43 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.292 1.037 . . . . 73.23 110.797 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 m -143.62 155.08 44.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.384 1.073 . . . . 60.01 110.902 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.57 147.66 48.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 74.33 109.062 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -129.85 136.98 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.829 1.652 . . . . 74.05 108.333 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 56.44 28.18 13.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.861 1.665 . . . . 73.45 112.54 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.78 -63.33 1.28 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.514 1.126 . . . . 74.31 112.608 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -64.02 -37.49 87.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.543 1.152 . . . . 62.3 113.128 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.21 -44.31 88.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.414 1.086 . . . . 64.44 113.171 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.12 -43.46 67.59 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.241 1.416 . . . . 72.24 114.032 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.4 mmt -67.83 -38.27 82.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.177 0.991 . . . . 55.3 112.683 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.8 mptt -64.79 -40.38 95.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.867 0.867 . . . . 73.32 112.721 167.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.28 -27.92 64.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.963 1.468 . . . . 70.25 114.963 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -84.97 -8.3 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.104 0.779 . . . . 74.23 113.104 171.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.7 24.73 22.62 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.07 -1.406 . . . . 54.2 113.54 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.98 149.75 97.77 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.675 1.737 . . . . 71.32 111.29 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.96 152.22 62.91 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.329 2.019 . . . . 64.41 111.847 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -52.66 -34.45 51.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.025 1.33 . . . . 71.15 114.31 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -49.55 -54.83 15.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.73 2.012 . . . . 75.2 113.258 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.11 -26.13 62.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.506 1.523 . . . . 71.15 112.857 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 20' ' ' LYS . 62.2 mt -75.13 -45.94 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.125 0.97 . . . . 63.41 111.849 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.24 -37.41 74.97 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.307 1.225 . . . . 73.04 114.307 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -18.25 49.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.648 -0.692 . . . . 61.25 112.506 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -38.0 11.07 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.732 -1.038 . . . . 51.5 111.517 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -36.02 61.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.592 1.196 . . . . 73.42 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.81 -65.74 0.79 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.104 1.361 . . . . 73.22 110.661 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -76.83 121.36 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.563 1.165 . . . . 53.41 109.234 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -78.42 127.91 32.86 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.231 0.957 . . . . 71.21 109.716 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.06 -156.86 28.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.791 1.307 . . . . 34.23 111.127 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.89 164.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.865 1.266 . . . . 73.42 108.745 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.12 155.75 47.65 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.017 1.727 . . . . 61.43 107.819 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.13 145.53 31.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.905 -1.517 . . . . 53.23 106.905 167.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 3' ' ' PHE . 98.8 mt -126.78 135.74 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.505 -1.665 . . . . 73.42 106.505 166.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.2 87.06 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.965 -1.124 . . . . 70.04 107.965 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -71.5 131.23 43.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.511 -0.768 . . . . 74.35 109.205 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.65 74.16 1.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.36 -1.348 . . . . 73.01 107.36 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.54 -125.27 9.22 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 108.993 -1.643 . . . . 72.23 108.993 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -72.22 -29.14 63.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.216 1.406 . . . . 74.42 114.266 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.95 152.63 42.37 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.117 0.885 . . . . 74.35 110.975 169.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -152.94 133.87 14.0 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.354 -1.35 . . . . 75.01 107.354 -171.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -119.29 148.06 43.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.106 1.362 . . . . 72.32 108.245 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.7 102.8 3.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.94 -1.504 . . . . 73.22 106.94 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.2 m -109.48 92.26 3.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.762 0.825 . . . . 72.25 109.397 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.6 mt -102.85 129.61 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.07 0.948 . . . . 74.01 109.093 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -126.29 150.07 48.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.501 1.12 . . . . 63.33 110.745 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.64 -152.32 0.4 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.374 1.87 . . . . 75.44 109.812 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.12 -0.92 82.53 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.98 -1.456 . . . . 72.42 113.191 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -157.93 9.3 0.16 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.681 1.74 . . . . 51.21 114.094 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -167.41 155.27 9.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.943 0.897 . . . . 74.54 111.928 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.75 144.78 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.598 1.559 . . . . 72.31 109.512 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -119.2 140.44 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.371 1.868 . . . . 63.31 106.48 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.2 123.85 39.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.742 0.817 . . . . 71.21 109.323 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -120.98 150.43 41.12 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.144 1.378 . . . . 74.13 108.983 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -147.56 143.14 27.56 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.707 1.255 . . . . 64.34 108.713 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.65 167.56 29.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.021 1.328 . . . . 72.14 110.55 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -119.25 128.34 54.09 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.419 -1.326 . . . . 74.12 107.419 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.36 103.78 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.436 1.094 . . . . 72.44 110.281 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.0 -7.07 11.97 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 117.85 -1.528 . . . . 55.35 112.621 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -123.95 156.66 35.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.374 1.587 . . . . 70.23 111.518 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -74.36 123.09 23.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.614 1.565 . . . . 64.11 110.717 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.9 m -142.02 156.34 45.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.333 1.453 . . . . 70.35 108.4 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.95 124.24 42.31 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.004 0.921 . . . . 62.11 110.14 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 81' ' ' THR . 3.9 mm? -107.26 125.42 51.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.985 1.714 . . . . 63.25 108.981 -172.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -78.89 128.32 33.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.586 1.154 . . . . 41.41 110.876 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -90.45 166.18 13.4 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.253 1.821 . . . . 73.14 110.329 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 mtt -49.47 -38.16 28.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.954 1.835 . . . . 71.13 115.954 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 p -80.71 -7.37 59.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.965 1.706 . . . . 73.34 113.978 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.05 86.85 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 118.552 -1.138 . . . . 72.12 111.549 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.94 148.25 50.0 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.033 1.333 . . . . 62.44 110.043 163.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -135.57 142.96 45.42 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.768 0.668 . . . . 62.24 109.487 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.96 131.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.576 1.151 . . . . 74.43 110.826 -173.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -81.91 142.84 32.11 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.383 1.073 . . . . 75.41 112.004 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -169.86 160.74 8.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.634 1.574 . . . . 71.1 109.044 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.6 t -104.4 125.21 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.709 -1.219 . . . . 75.14 107.709 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.03 138.64 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.118 0.886 . . . . 72.03 108.792 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -125.74 173.85 8.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.023 1.729 . . . . 70.34 111.204 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.45 127.34 19.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.414 1.485 . . . . 65.52 107.414 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.02 26.19 2.56 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.618 1.34 . . . . 63.23 114.618 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.8 -0.29 78.23 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.258 1.409 . . . . 62.21 114.586 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.05 61.38 1.65 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.35 1.575 . . . . 73.41 108.519 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.99 34.99 3.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.196 2.198 . . . . 72.33 115.331 171.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -128.26 109.76 11.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.875 1.67 . . . . 70.41 108.598 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -83.2 131.4 35.11 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.767 1.292 . . . . 73.5 109.587 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -124.34 137.47 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.761 1.224 . . . . 73.14 109.143 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -157.3 146.41 19.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.611 0.764 . . . . 65.32 110.644 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -138.14 110.09 7.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.398 1.479 . . . . 73.32 107.84 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -72.42 -59.6 2.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.312 1.045 . . . . 64.5 111.79 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -145.97 -61.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.974 1.31 . . . . 75.14 109.314 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -141.27 7.98 2.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.213 1.805 . . . . 75.11 111.64 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.43 HG12 HD12 ' A' ' 115' ' ' LEU . 9.5 mt -115.73 113.79 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.021 1.728 . . . . 63.21 106.795 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.241 0.963 . . . . 53.13 108.853 168.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -143.31 119.66 10.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.384 -1.339 . . . . 70.42 107.384 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -127.59 97.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 124.983 1.427 . . . . 63.2 107.376 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.3 m -78.17 146.35 35.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.614 1.166 . . . . 75.43 109.257 168.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -138.82 112.14 8.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.915 1.686 . . . . 73.42 108.193 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.7 tp -83.44 124.17 30.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.624 1.17 . . . . 75.11 108.521 165.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.45 83.14 2.05 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.301 1.84 . . . . 74.43 106.135 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.4 -109.73 3.07 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 109.999 -1.241 . . . . 71.31 109.999 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.3 2.85 56.42 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 74.01 113.846 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -113.96 136.08 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.03 0.932 . . . . 64.11 109.326 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mm -118.17 105.09 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.974 1.31 . . . . 71.12 108.267 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 m -86.17 144.64 27.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.05 -1.093 . . . . 75.51 108.05 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -144.45 95.6 2.74 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 107.83 -1.174 . . . . 72.52 107.83 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.1 m -82.17 137.91 34.83 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 125.205 1.566 . . . . 71.42 109.509 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 mtm -127.56 155.83 43.19 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.275 1.03 . . . . 63.21 109.562 168.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.1 m -140.34 101.85 4.22 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.097 0.873 . . . . 43.55 110.03 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD12 HG12 ' A' ' 98' ' ' ILE . 6.4 tt -99.98 110.31 22.63 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.731 1.212 . . . . 64.31 107.888 171.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.33 -89.68 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.183 1.373 . . . . 61.13 112.943 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -132.2 36.97 3.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.444 1.898 . . . . 74.43 109.847 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.4 mm -133.92 137.98 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.947 1.699 . . . . 44.24 106.972 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.8 90.25 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 124.06 0.85 . . . . 72.05 108.932 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -78.76 143.79 35.81 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.052 1.341 . . . . 63.23 111.406 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.79 152.73 51.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.183 0.993 . . . . 61.44 109.587 164.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -146.08 126.33 13.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.236 1.414 . . . . 72.2 107.988 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -116.17 128.3 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 125.025 1.453 . . . . 74.43 107.397 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 56.3 m -127.82 157.68 39.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.755 . . . . 71.2 108.83 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -141.91 143.23 33.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.277 1.031 . . . . 73.22 110.875 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -51.32 140.96 16.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.42 2.288 . . . . 75.52 113.558 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 125.181 2.42 . . . . 74.44 108.334 -179.446 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 78.7 t60 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 103.464 -2.791 . . . . 50.05 103.464 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -117.36 148.39 41.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.61 1.564 . . . . 75.54 109.159 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -159.2 79.75 0.75 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.838 0.855 . . . . 64.31 109.583 -167.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -148.49 157.49 43.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.308 1.043 . . . . 70.33 111.26 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' HIS . . . . . 0.482 ' CG ' ' H ' ' A' ' -2' ' ' HIS . 7.2 p80 -105.23 -66.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.561 1.945 . . . . 74.24 109.879 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' -2' ' ' HIS . . . . . 0.482 ' H ' ' CG ' ' A' ' -3' ' ' HIS . 48.1 t-80 -152.07 84.49 1.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.703 2.001 . . . . 62.12 106.221 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 2.5 m -155.95 -52.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.208 1.403 . . . . 64.25 109.825 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 61.32 165.53 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.839 2.056 . . . . 75.33 112.224 -160.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.43 177.36 0.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.311 1.444 . . . . 75.42 114.356 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t -169.99 141.37 2.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.454 1.901 . . . . 70.03 107.67 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -86.24 3.01 44.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.919 1.288 . . . . 61.34 113.914 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.0 p -60.7 110.16 1.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.371 1.868 . . . . 73.1 114.454 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.81 169.26 34.41 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 110.08 -1.208 . . . . 70.14 110.08 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -119.0 141.93 48.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.405 1.482 . . . . 73.45 108.542 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -137.18 159.1 42.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.228 1.811 . . . . 71.04 110.559 -168.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -121.27 143.41 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.287 1.435 . . . . 74.2 108.257 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 37' ' ' GLY . 37.5 tp -61.1 139.57 58.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.845 1.258 . . . . 53.02 111.608 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -122.79 -43.97 2.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.65 1.18 . . . . 73.23 111.334 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -155.49 156.14 34.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.295 1.038 . . . . 60.01 111.336 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -135.33 155.25 50.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.103 1.361 . . . . 74.33 109.332 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -131.31 144.42 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.707 1.203 . . . . 74.05 108.34 171.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 57.23 22.51 7.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.165 1.786 . . . . 73.45 114.227 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -56.32 -59.22 5.26 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.518 1.127 . . . . 74.31 113.478 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.61 -39.28 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.228 0.955 . . . . 62.3 112.909 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.84 76.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.561 1.144 . . . . 64.44 112.81 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.65 -49.24 74.0 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.321 1.448 . . . . 72.24 113.489 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.17 -37.19 85.03 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 124.512 1.132 . . . . 55.3 113.768 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -73.37 -27.46 61.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.272 -0.87 . . . . 73.32 112.768 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.67 63.75 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.454 1.102 . . . . 70.25 113.839 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG13 HD23 ' A' ' 24' ' ' LEU . 42.4 pt -80.67 -6.57 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 113.457 0.91 . . . . 74.23 113.457 170.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.75 28.95 27.78 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 118.759 -1.023 . . . . 54.2 113.379 167.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -72.84 147.26 88.72 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 118.774 1.287 . . . . 71.32 110.541 175.039 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.29 149.55 63.65 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.742 2.295 . . . . 64.41 112.588 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.74 -35.54 22.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.242 1.817 . . . . 71.15 114.988 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -51.07 -60.71 2.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.872 1.669 . . . . 75.2 112.614 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.5 -26.13 67.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.71 1.604 . . . . 71.15 113.917 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.6 -58.51 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 CA-C-O 118.233 -0.889 . . . . 63.41 110.691 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -63.98 -34.14 77.31 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.078 1.51 . . . . 73.04 115.078 -173.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -20.23 35.17 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.175 -0.917 . . . . 61.25 112.513 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -34.67 21.05 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.104 -0.831 . . . . 51.5 111.603 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -26.18 42.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.593 1.157 . . . . 73.42 112.769 170.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.67 -67.53 0.63 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.28 1.032 . . . . 73.22 110.52 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.79 108.74 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.572 1.17 . . . . 53.41 109.794 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -63.84 116.2 5.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.425 1.89 . . . . 71.21 109.908 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' H ' HD23 ' A' ' 9' ' ' LEU . . . -75.68 171.98 54.11 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 124.557 1.161 . . . . 34.23 111.834 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.96 149.24 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.189 -1.412 . . . . 73.42 107.189 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.2 t -142.66 149.65 39.17 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.566 0.746 . . . . 61.43 109.71 -172.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.56 140.54 26.19 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.215 1.006 . . . . 53.23 108.298 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -140.4 140.28 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.583 -1.636 . . . . 73.42 106.583 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.4 t -141.69 120.94 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.661 -0.866 . . . . 70.04 108.661 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -95.46 136.35 35.95 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.069 0.856 . . . . 74.35 108.987 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.72 49.57 2.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.155 1.382 . . . . 73.01 110.251 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -70.99 3.0 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.835 1.207 . . . . 72.23 110.858 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -120.74 -34.39 3.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.861 1.664 . . . . 74.42 110.794 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.99 165.45 24.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.316 1.046 . . . . 74.35 111.28 169.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -158.98 136.58 10.13 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.095 -1.446 . . . . 75.01 107.095 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -118.49 152.2 36.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.035 1.334 . . . . 72.32 110.795 168.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.24 137.69 39.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.394 -2.076 . . . . 73.22 105.394 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -143.35 127.13 17.15 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.667 1.187 . . . . 72.25 107.916 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.6 122.43 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.641 -0.874 . . . . 74.01 108.641 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -95.66 114.35 26.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.449 1.5 . . . . 63.33 109.67 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.83 -179.73 6.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.455 1.502 . . . . 75.44 110.487 167.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 17.6 1.59 Allowed Glycine 0 CA--C 1.545 1.939 0 C-N-CA 125.27 1.414 . . . . 72.42 114.99 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -150.03 -40.13 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 51.21 112.261 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 170.56 17.5 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.838 1.255 . . . . 74.54 110.749 -161.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.8 130.43 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.516 1.135 . . . . 72.31 108.825 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.67 144.01 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.525 1.13 . . . . 63.31 108.257 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.42 149.41 45.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 71.21 110.618 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -135.67 163.14 30.82 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.335 1.454 . . . . 74.13 109.44 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -145.39 139.09 26.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.263 -1.335 . . . . 64.34 108.539 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.73 167.18 31.23 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 124.229 0.956 . . . . 72.14 111.343 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.2 126.66 54.84 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.706 1.254 . . . . 74.12 108.271 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.44 123.8 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.093 0.957 . . . . 72.44 111.02 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.5 73.18 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.163 -1.354 . . . . 55.35 113.243 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -125.93 153.17 44.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.01 1.405 . . . . 70.23 109.825 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -72.76 136.92 45.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.096 0.959 . . . . 64.11 112.561 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 m -152.8 153.18 32.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.115 1.766 . . . . 70.35 108.343 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.66 113.55 25.64 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.244 0.965 . . . . 62.11 110.641 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.27 146.72 23.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.573 1.549 . . . . 63.25 109.267 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -112.44 130.58 55.93 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.262 1.025 . . . . 41.41 110.463 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.9 m -78.09 158.91 28.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.47 1.908 . . . . 73.14 110.747 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.38 -18.29 58.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.785 1.772 . . . . 71.13 115.785 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.9 p -76.23 -40.4 52.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.489 1.515 . . . . 73.34 112.38 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.38 2.26 13.49 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.535 -1.703 . . . . 72.12 112.052 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.36 125.72 26.52 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.291 2.046 . . . . 62.44 110.119 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -107.95 120.24 41.73 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.617 1.198 . . . . 62.24 108.617 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.49 127.95 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.337 1.455 . . . . 74.43 111.278 -167.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -80.1 141.42 35.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.091 1.357 . . . . 75.41 112.656 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -167.89 170.94 10.25 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.28 1.432 . . . . 71.1 110.034 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -108.84 137.78 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.454 1.502 . . . . 75.14 108.459 170.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.72 142.15 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 124.082 0.864 . . . . 72.03 108.912 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -126.98 173.04 9.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.811 2.044 . . . . 70.34 111.213 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.39 132.2 35.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 65.52 107.275 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.07 16.73 6.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.706 1.203 . . . . 63.23 113.889 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.29 5.73 77.87 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.042 1.782 . . . . 62.21 114.019 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -131.32 50.53 2.22 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.843 1.322 . . . . 73.41 109.625 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.32 0.4 OUTLIER 41.43 35.95 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 72.33 115.694 -174.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -137.92 122.84 18.95 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 126.021 1.728 . . . . 70.41 107.859 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.86 152.04 22.39 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.35 1.031 . . . . 73.5 109.586 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.53 139.28 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.928 1.291 . . . . 73.14 107.834 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -154.7 165.37 36.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.515 0.726 . . . . 65.32 109.703 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 95' ' ' PHE . 2.5 m -139.06 -176.57 4.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.956 1.302 . . . . 73.32 108.476 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' H ' HG22 ' A' ' 94' ' ' THR . 93.7 m-85 -135.62 -106.47 0.21 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.128 -1.804 . . . . 64.5 106.128 165.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.84 -40.16 6.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.775 1.23 . . . . 75.14 111.259 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -149.11 5.4 0.65 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.144 1.378 . . . . 75.11 112.78 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -124.16 107.79 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.59 -1.263 . . . . 63.21 107.59 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -80.09 165.07 22.86 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 123.975 0.797 . . . . 53.13 110.209 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.4 t -152.74 133.17 13.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.225 1.81 . . . . 70.42 108.483 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -139.03 105.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.941 1.697 . . . . 63.2 106.791 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.8 m -88.52 154.8 20.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.008 1.323 . . . . 75.43 109.746 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -137.19 143.32 42.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.863 1.265 . . . . 73.42 108.786 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.6 tp -120.39 117.46 27.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.33 1.852 . . . . 75.11 106.375 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 86.93 2.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.715 -1.587 . . . . 74.43 106.715 173.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.99 -106.43 2.02 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.385 -1.486 . . . . 71.31 109.385 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -96.7 -19.68 18.8 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 74.01 112.605 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -80.76 133.16 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.475 1.11 . . . . 64.11 109.776 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mm -121.29 103.49 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.03 -1.1 . . . . 71.12 108.03 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.5 m -104.53 97.37 7.29 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.169 0.918 . . . . 75.51 109.845 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.21 143.96 25.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.852 1.261 . . . . 72.52 110.226 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.1 m -145.67 122.8 11.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.655 1.182 . . . . 71.42 109.493 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.04 162.56 16.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.366 1.466 . . . . 63.21 110.091 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 m -144.85 92.2 2.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.566 0.746 . . . . 43.55 110.812 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.6 tp -88.36 114.17 24.71 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 124.28 1.032 . . . . 64.31 109.135 168.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.59 -103.06 0.23 Allowed Glycine 0 CA--C 1.535 1.29 0 O-C-N 125.158 1.536 . . . . 61.13 111.904 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.95 -13.24 25.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.901 2.08 . . . . 74.43 113.835 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.0 mt -119.07 121.98 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.068 0.849 . . . . 44.24 110.863 -166.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.6 96.48 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 O-C-N 124.727 1.267 . . . . 72.05 109.089 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.61 145.63 43.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.444 1.098 . . . . 63.23 111.853 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 154.33 51.27 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 123.411 0.684 . . . . 61.44 110.925 168.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -139.87 125.47 19.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.336 1.454 . . . . 72.2 108.384 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.72 133.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.924 1.289 . . . . 74.43 107.96 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.41 162.5 35.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.979 1.312 . . . . 71.2 110.2 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -138.87 146.93 41.77 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.308 1.443 . . . . 73.22 109.449 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -60.25 145.02 48.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.473 1.509 . . . . 75.52 114.239 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 105.818 -1.919 . . . . 74.44 105.818 174.743 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 103.454 -2.795 . . . . 50.05 103.454 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -144.99 143.94 30.78 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.027 1.731 . . . . 75.54 108.688 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 67.99 169.85 0.27 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.796 2.038 . . . . 64.31 112.624 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -168.55 157.44 8.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.173 0.989 . . . . 70.33 110.661 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -146.69 119.22 8.48 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.119 1.368 . . . . 74.24 107.874 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -167.67 150.05 5.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.484 1.113 . . . . 62.12 110.031 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.84 76.7 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 106.83 -1.544 . . . . 64.25 106.83 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -170.84 176.76 4.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.608 1.963 . . . . 75.33 109.49 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -117.58 165.32 13.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.953 1.301 . . . . 75.42 110.194 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t -165.58 142.84 5.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.065 1.346 . . . . 70.03 108.634 165.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.823 1.416 . . . . 61.34 114.823 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 m -65.53 120.69 13.34 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.846 1.259 . . . . 73.1 113.352 -174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.94 175.98 28.49 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.398 0.999 . . . . 70.14 110.701 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 23.8 ttmt -115.7 144.72 43.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.958 1.303 . . . . 73.45 109.951 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -139.84 141.17 36.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.158 1.783 . . . . 71.04 110.207 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -97.72 152.58 18.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.037 1.335 . . . . 74.2 109.66 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD21 ' HE ' ' A' ' 122' ' ' ARG . 4.7 mt -64.85 143.5 57.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.248 0.619 . . . . 53.02 111.782 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -119.21 -61.45 1.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.383 1.473 . . . . 73.23 108.767 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 m -135.5 158.69 43.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.669 1.188 . . . . 60.01 110.521 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -144.12 162.42 36.32 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.779 1.632 . . . . 74.33 108.589 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.75 138.48 14.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.422 -0.585 . . . . 74.05 109.422 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.93 30.05 19.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.475 1.91 . . . . 73.45 112.559 -165.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.97 -57.17 13.76 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.106 0.962 . . . . 74.31 112.433 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.77 -43.68 95.64 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.606 1.191 . . . . 62.3 112.253 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.73 -47.67 76.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.827 1.251 . . . . 64.44 113.491 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.72 -47.0 73.7 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.005 1.322 . . . . 72.24 113.348 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.0 mmt -67.91 -35.56 78.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.909 1.077 . . . . 55.3 113.909 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -71.03 -30.67 66.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.282 -0.866 . . . . 73.32 112.115 171.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.71 -37.77 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.515 1.126 . . . . 70.25 113.605 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.4 pt -83.86 -1.25 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 113.623 0.972 . . . . 74.23 113.623 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 27.96 50.46 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.738 -1.034 . . . . 54.2 114.088 164.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 147.32 99.0 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.683 1.242 . . . . 71.32 111.055 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.26 141.3 81.57 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 64.41 111.556 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -55.21 -30.41 59.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.909 1.284 . . . . 71.15 114.194 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -51.72 -54.04 32.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 75.2 113.568 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.31 -25.84 66.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.422 1.489 . . . . 71.15 113.004 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.9 mt -75.18 -49.73 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.02 0.928 . . . . 63.41 111.168 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -62.61 -42.78 99.78 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.972 0.909 . . . . 73.04 113.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.18 -13.49 58.55 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.37 1.044 . . . . 61.25 113.057 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.99 -18.83 45.36 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-O 118.263 -1.298 . . . . 51.5 112.183 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -35.01 11.2 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 116.913 -1.518 . . . . 73.42 113.549 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -78.15 -56.04 4.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.72 1.145 . . . . 73.22 111.085 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.4 124.99 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.436 1.494 . . . . 53.41 107.725 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.52 131.22 34.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 124.461 1.101 . . . . 71.21 109.375 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.06 -176.35 34.4 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 124.697 1.248 . . . . 34.23 111.574 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.96 156.38 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.816 1.646 . . . . 73.42 107.283 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -148.56 141.39 24.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.054 0.941 . . . . 61.43 109.162 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -124.24 144.0 50.21 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.242 -1.021 . . . . 53.23 108.242 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -129.54 139.01 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 106.442 -1.688 . . . . 73.42 106.442 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.07 112.32 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 107.321 -1.363 . . . . 70.04 107.321 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.32 121.47 40.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.153 1.381 . . . . 74.35 109.116 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -122.56 44.01 2.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 73.01 110.36 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -117.52 5.37 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.963 -2.055 . . . . 72.23 107.963 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -73.84 -29.52 62.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.555 1.317 . . . . 74.42 114.555 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 154.51 35.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.524 0.602 . . . . 74.35 110.526 169.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -151.94 137.76 18.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.575 -1.268 . . . . 75.01 107.575 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -125.01 150.4 46.77 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 124.587 1.18 . . . . 72.32 110.128 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 128.24 20.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.491 -1.67 . . . . 73.22 106.491 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 m -111.05 129.91 55.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.291 -1.374 . . . . 72.25 107.291 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.61 109.38 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.974 -1.861 . . . . 74.01 105.974 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 47.4 m -113.87 105.45 13.28 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.375 1.047 . . . . 63.33 109.414 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.04 -173.21 0.99 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 75.44 111.931 169.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.6 46.38 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.277 1.417 . . . . 72.42 114.915 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.1 p -159.04 20.2 0.19 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.201 1.4 . . . . 51.21 113.101 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 153.67 41.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.204 1.402 . . . . 74.54 109.562 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.54 129.81 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.331 1.052 . . . . 72.31 108.302 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -124.23 131.15 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.928 1.691 . . . . 63.31 107.404 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.06 130.54 50.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.252 1.021 . . . . 71.21 109.312 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -138.79 145.07 39.7 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.183 1.393 . . . . 74.13 109.46 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 146.35 51.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.763 1.625 . . . . 64.34 109.041 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -160.21 162.08 33.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.312 1.045 . . . . 72.14 111.663 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.2 m -96.84 128.28 43.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.564 1.165 . . . . 74.12 108.448 168.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.4 t -66.08 134.02 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.725 1.61 . . . . 72.44 110.737 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.13 -13.14 60.39 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.04 1.305 . . . . 55.35 113.049 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -105.67 145.93 30.4 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.461 1.504 . . . . 70.23 109.639 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.55 139.38 58.26 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.727 1.211 . . . . 64.11 112.244 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.08 161.53 42.38 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 124.792 1.307 . . . . 70.35 109.728 -170.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.84 118.05 30.98 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 124.358 1.036 . . . . 62.11 108.628 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.04 148.64 29.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.66 1.584 . . . . 63.25 109.097 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.67 125.25 43.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.588 1.155 . . . . 41.41 110.257 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -74.83 162.82 28.31 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.817 1.647 . . . . 73.14 110.626 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.05 -26.83 62.99 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.253 1.575 . . . . 71.13 115.253 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 -13.46 61.11 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.224 1.81 . . . . 73.34 113.901 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.98 -3.15 82.6 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.122 -1.377 . . . . 72.12 111.773 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.24 116.07 8.42 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 119.541 1.67 . . . . 62.44 111.087 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -87.12 123.77 32.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 124.809 1.318 . . . . 62.24 110.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.59 129.37 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.071 1.748 . . . . 74.43 109.966 -168.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -74.4 141.61 45.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.355 1.062 . . . . 75.41 111.741 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 t -166.07 166.65 17.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.185 1.394 . . . . 71.1 110.015 -168.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.07 146.54 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 75.14 107.643 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.75 145.41 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.23 1.012 . . . . 72.03 108.92 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.82 149.85 51.4 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.414 1.485 . . . . 70.34 109.837 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.5 tt -106.21 124.63 49.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.24 1.416 . . . . 65.52 107.524 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -86.55 12.44 10.44 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.945 1.298 . . . . 63.23 114.428 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.638 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 82.5 -10.49 55.25 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.224 1.869 . . . . 62.21 113.872 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.9 49.77 1.14 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.517 1.527 . . . . 73.41 110.973 -169.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.291 0.6 OUTLIER 46.9 43.12 13.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.003 2.121 . . . . 72.33 114.054 -177.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -143.39 141.17 30.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.324 1.85 . . . . 70.41 108.642 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -115.94 148.07 40.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.539 1.535 . . . . 73.5 108.14 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -130.03 133.56 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.867 -1.16 . . . . 73.14 107.867 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -148.77 143.95 26.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.36 1.064 . . . . 65.32 111.219 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 p -139.51 127.91 22.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.363 1.465 . . . . 73.32 108.834 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.5 -98.88 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.495 1.918 . . . . 64.5 108.588 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -106.01 -53.13 2.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.827 1.251 . . . . 75.14 110.51 167.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -143.06 13.94 1.86 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.878 1.271 . . . . 75.11 112.7 -170.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 115' ' ' LEU . 72.0 mt -113.65 99.15 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.074 -1.454 . . . . 63.21 107.074 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -87.83 105.58 17.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.071 0.948 . . . . 53.13 109.236 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 t -112.79 117.72 32.96 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.172 1.389 . . . . 70.42 110.631 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.34 128.31 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.227 -1.397 . . . . 63.2 107.227 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 m -109.11 146.19 34.45 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -142.24 148.41 38.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.808 0.843 . . . . 73.42 110.743 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.89 122.47 38.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.992 2.117 . . . . 75.11 107.486 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.14 79.74 1.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 74.43 107.376 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.67 -116.85 6.27 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 109.402 -1.479 . . . . 71.31 109.402 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.1 -10.09 51.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.319 1.448 . . . . 74.01 114.187 172.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.25 139.86 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.698 0.799 . . . . 64.11 109.052 175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.31 144.72 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.283 1.433 . . . . 71.12 108.599 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -127.21 148.79 50.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.442 1.897 . . . . 75.51 108.23 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.94 145.79 33.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.922 0.889 . . . . 72.52 109.121 172.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.7 m -144.77 86.73 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.674 1.59 . . . . 71.42 107.927 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mtm -84.66 139.34 32.11 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.016 0.927 . . . . 63.21 109.747 170.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.1 m -130.82 103.08 6.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.662 1.185 . . . . 43.55 108.277 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 98' ' ' ILE . 35.5 tp -118.36 119.56 34.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.334 1.454 . . . . 64.31 108.775 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.79 -105.49 1.34 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.138 -1.585 . . . . 61.13 109.138 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.4 0.05 10.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.681 1.993 . . . . 74.43 112.292 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.6 mt -99.3 142.59 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.96 1.704 . . . . 44.24 109.291 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -121.67 92.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.791 0.837 . . . . 72.05 109.574 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.87 112.09 7.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 63.23 112.307 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -94.5 146.6 23.98 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.289 1.435 . . . . 61.44 110.62 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 9' ' ' LEU . 72.0 mtp180 -134.85 148.93 50.26 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.816 1.322 . . . . 72.2 108.019 161.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.82 131.06 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 105.954 -1.869 . . . . 74.43 105.954 169.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.2 m -131.93 165.3 24.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.16 1.384 . . . . 71.2 109.682 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -147.64 143.11 27.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.823 0.849 . . . . 73.22 110.799 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -54.5 140.09 35.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.629 2.372 . . . . 75.52 113.133 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.3 mt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 124.605 2.145 . . . . 74.44 107.263 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 58.8 m170 . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 105.215 -2.142 . . . . 50.05 105.215 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -125.45 83.88 2.21 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 125.096 1.358 . . . . 75.54 107.864 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 51.4 m80 65.51 -82.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.856 2.462 . . . . 64.31 113.521 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -151.89 158.94 43.89 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.13 0.972 . . . . 70.33 110.789 -172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -156.08 77.13 0.94 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.701 1.2 . . . . 74.24 108.57 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 179.03 7.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.725 1.21 . . . . 62.12 111.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.28 18.58 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 125.588 1.555 . . . . 64.25 112.926 -175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -67.67 139.81 56.79 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.664 1.186 . . . . 75.33 111.844 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mmt -97.85 97.78 9.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.33 1.052 . . . . 75.42 109.072 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.7 m -118.87 118.81 32.55 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 125.201 1.563 . . . . 70.03 109.167 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.083 1.512 . . . . 61.34 115.083 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -59.83 116.25 3.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.165 1.786 . . . . 73.1 113.715 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.82 170.86 29.32 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.627 -0.989 . . . . 70.14 110.627 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HD2' HD12 ' A' ' 127' ' ' ILE . 6.1 ttmt -112.92 140.46 47.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.981 1.312 . . . . 73.45 107.993 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.41 125.52 26.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.165 1.386 . . . . 71.04 110.34 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.58 152.36 30.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.973 0.909 . . . . 74.2 110.318 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.67 126.64 30.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.712 0.805 . . . . 53.02 109.033 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -95.79 -56.52 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.37 1.068 . . . . 73.23 110.917 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -156.89 163.36 39.26 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.079 1.352 . . . . 60.01 110.39 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -160.09 151.12 19.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.518 1.127 . . . . 74.33 109.59 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.59 143.95 43.86 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.204 1.401 . . . . 74.05 109.18 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.11 16.84 10.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.555 1.942 . . . . 73.45 114.783 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.79 -50.65 69.91 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.669 1.588 . . . . 74.31 113.189 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.17 -59.51 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.296 1.838 . . . . 62.3 112.782 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.5 83.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.213 1.405 . . . . 64.44 113.787 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.69 -52.71 49.26 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.987 1.315 . . . . 72.24 112.835 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 mmt -68.08 -35.35 78.05 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.373 1.046 . . . . 55.3 113.702 -176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' HD3' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.0 -44.42 97.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.644 0.777 . . . . 73.32 112.314 168.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.45 79.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.322 1.23 . . . . 70.25 114.322 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 pt -80.95 -5.0 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.043 1.127 . . . . 74.23 114.043 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.99 19.33 26.81 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.229 -1.317 . . . . 54.2 114.646 161.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.25 142.63 97.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 119.54 1.67 . . . . 71.32 110.319 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.54 141.18 59.92 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.143 1.895 . . . . 64.41 111.65 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' HD12 ' A' ' 29' ' ' ILE 0.31 27.3 tt0 -65.93 -14.3 61.3 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.668 1.729 . . . . 71.15 115.668 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.04 -53.17 61.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.616 1.167 . . . . 75.2 112.556 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.47 -26.01 66.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.563 1.545 . . . . 71.15 112.86 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.534 HD13 ' HD3' ' A' ' 20' ' ' LYS . 47.7 mt -78.85 -47.43 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 117.55 -1.214 . . . . 63.41 111.161 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -65.36 -39.48 92.38 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 113.731 1.011 . . . . 73.04 113.731 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -16.67 57.78 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.256 -0.878 . . . . 61.25 112.472 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.18 -37.74 10.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.974 -0.903 . . . . 51.5 111.35 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -26.27 34.73 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.465 1.106 . . . . 73.42 113.584 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -84.95 -62.82 1.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 124.163 0.914 . . . . 73.22 110.304 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.56 120.15 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.866 0.866 . . . . 53.41 108.914 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -66.33 127.58 32.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.051 0.94 . . . . 71.21 111.334 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.3 -172.57 48.87 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 124.712 1.258 . . . . 34.23 110.554 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.0 t -137.59 152.97 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.6 1.56 . . . . 73.42 107.389 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -135.77 155.61 50.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.257 1.023 . . . . 61.43 109.112 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -137.72 140.4 40.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.178 -0.675 . . . . 53.23 109.178 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' A' ' 48' ' ' PHE . 84.6 mt -123.61 129.61 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.863 1.352 . . . . 73.42 107.477 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.92 90.53 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.087 -1.079 . . . . 70.04 108.087 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -74.29 136.46 42.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.698 0.799 . . . . 74.35 110.223 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.07 86.22 1.43 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.233 1.013 . . . . 73.01 109.845 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.64 -114.29 4.06 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 109.526 -1.429 . . . . 72.23 109.526 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -91.58 -15.81 28.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.998 1.319 . . . . 74.42 111.874 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -86.15 147.65 26.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.322 1.449 . . . . 74.35 112.49 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.531 ' CE2' HD11 ' A' ' 91' ' ' LEU . 12.7 t80 -133.33 118.99 19.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.793 1.637 . . . . 75.01 107.828 176.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -87.6 131.93 34.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.046 1.338 . . . . 72.32 108.567 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.24 109.36 12.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.162 -1.792 . . . . 73.22 106.162 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -106.15 141.88 36.78 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.158 1.383 . . . . 72.25 109.536 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.91 107.41 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.145 1.378 . . . . 74.01 108.016 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.5 m -87.64 132.04 34.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.566 1.546 . . . . 63.33 109.068 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.88 4.64 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.653 . . . . 75.44 110.225 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.83 -86.93 0.86 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 109.674 -1.37 . . . . 72.42 109.674 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 t -150.25 21.56 0.85 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.996 1.318 . . . . 51.21 111.781 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmm? -129.25 149.39 51.06 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.475 1.51 . . . . 74.54 109.818 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.91 111.68 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 124.198 0.936 . . . . 72.31 109.567 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.2 mt -84.19 144.61 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.77 1.228 . . . . 63.31 107.988 166.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.29 141.68 23.34 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 123.955 0.784 . . . . 71.21 110.762 165.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.79 158.52 41.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.455 1.902 . . . . 74.13 107.817 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.37 145.83 39.47 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 124.081 0.863 . . . . 64.34 109.909 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -139.62 149.91 44.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.829 1.331 . . . . 72.14 110.175 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -94.03 126.1 39.05 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.915 1.384 . . . . 74.12 108.094 168.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.23 130.45 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.862 0.865 . . . . 72.44 111.675 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.74 -5.47 81.84 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.21 -1.328 . . . . 55.35 113.672 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.49 157.03 21.6 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.122 1.461 . . . . 70.23 109.71 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.62 143.75 46.21 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.057 0.848 . . . . 64.11 111.794 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.11 -173.01 3.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.633 2.373 . . . . 70.35 107.576 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.69 129.47 38.8 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.146 -0.687 . . . . 62.11 109.146 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mp -104.71 161.42 14.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.877 1.671 . . . . 63.25 109.448 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.22 142.58 39.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.233 1.413 . . . . 41.41 109.013 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 m -109.03 142.89 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.562 1.145 . . . . 73.14 108.035 168.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.1 mtt -44.53 -32.07 1.31 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 118.769 2.877 . . . . 71.13 118.769 -163.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -71.05 -22.43 62.13 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.12 1.368 . . . . 73.34 114.262 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.27 5.57 10.38 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.209 -1.328 . . . . 72.12 112.298 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.18 147.03 52.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.448 1.624 . . . . 62.44 111.923 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 124.39 44.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.442 1.497 . . . . 62.24 107.732 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.33 128.62 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.196 0.998 . . . . 74.43 111.928 -169.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 148.4 48.9 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.89 1.276 . . . . 75.41 111.791 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -169.46 162.87 10.34 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.548 1.155 . . . . 71.1 111.039 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.06 150.62 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 126.047 1.739 . . . . 75.14 107.465 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.03 139.65 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.847 -0.798 . . . . 72.03 108.847 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -125.35 152.03 45.29 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.73 1.612 . . . . 70.34 110.86 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.75 118.11 35.26 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 65.52 106.513 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.05 11.65 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.22 1.563 . . . . 63.23 115.22 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.76 11.16 85.7 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.04 1.305 . . . . 62.21 112.596 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -134.04 35.78 3.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.391 1.476 . . . . 73.41 109.702 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.318 0.5 OUTLIER 53.51 27.08 6.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.469 1.908 . . . . 72.33 114.785 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -124.93 126.35 45.37 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.834 1.654 . . . . 70.41 108.832 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 48' ' ' PHE . 45.6 mt -94.05 127.51 39.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.157 0.983 . . . . 73.5 109.639 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.69 134.89 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 73.14 108.684 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 t -160.9 151.26 17.92 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.222 1.009 . . . . 65.32 111.362 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -161.23 141.24 10.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.74 1.216 . . . . 73.32 110.861 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -83.65 -61.32 1.86 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.227 0.954 . . . . 64.5 109.18 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -129.72 -52.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.75 1.62 . . . . 75.14 110.241 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -147.56 -5.98 0.47 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.089 -0.958 . . . . 75.11 113.341 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG12 HD23 ' A' ' 115' ' ' LEU . 56.2 mt -78.43 85.65 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.787 1.235 . . . . 63.21 109.761 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.06 93.91 1.45 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.745 1.618 . . . . 53.13 111.725 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 t -85.28 128.41 34.68 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.496 1.123 . . . . 70.42 108.952 169.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.56 96.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.877 -1.527 . . . . 63.2 106.877 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -77.53 150.34 34.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.471 1.108 . . . . 75.43 109.665 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -132.6 128.85 38.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.733 2.013 . . . . 73.42 107.643 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.37 123.18 43.43 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.459 -1.312 . . . . 75.11 107.459 165.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.58 69.31 1.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.148 -1.797 . . . . 74.43 106.148 170.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.51 8.8 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.852 -1.299 . . . . 71.31 109.852 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.06 7.36 5.04 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.223 1.564 . . . . 74.01 115.223 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.44 138.05 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.141 0.976 . . . . 64.11 108.983 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 mm -123.62 98.52 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.05 1.34 . . . . 71.12 108.024 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -88.36 154.67 20.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.137 -0.69 . . . . 75.51 109.137 167.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -154.21 143.27 21.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.788 1.235 . . . . 72.52 108.343 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.8 m -130.56 126.76 37.58 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.832 1.332 . . . . 71.42 108.672 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mmm -119.08 105.55 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.266 2.227 . . . . 63.21 108.929 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.0 m -101.3 115.76 31.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.667 0.787 . . . . 43.55 110.275 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -126.96 110.16 12.7 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.422 1.889 . . . . 64.31 107.203 177.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.33 -135.74 47.95 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 109.893 -1.283 . . . . 61.13 109.893 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.73 3.38 37.66 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.845 1.258 . . . . 74.43 113.733 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.4 mt -93.63 132.75 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.402 -0.962 . . . . 44.24 108.402 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.88 95.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.439 -0.948 . . . . 72.05 108.439 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -78.48 136.15 37.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.472 1.909 . . . . 63.23 111.279 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.8 146.1 46.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.566 1.146 . . . . 61.44 109.698 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -130.9 140.79 50.24 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.881 1.672 . . . . 72.2 108.213 168.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.74 131.12 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.076 -1.824 . . . . 74.43 106.076 169.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m -136.71 159.05 42.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.79 1.636 . . . . 71.2 108.745 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -140.39 140.42 35.51 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.933 0.893 . . . . 73.22 110.381 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.73 136.51 57.02 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.308 2.243 . . . . 75.52 111.463 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 6' ' ' LYS . 19.1 mt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.339 -2.467 . . . . 74.44 104.339 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 CA--C 1.541 0.601 0 N-CA-C 114.568 1.321 . . . . 61.340000000000003 114.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 115.7 6.7 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.992 1.317 . . . . 73.099999999999994 112.359 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.18 173.4 35.38 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 110.283 -1.127 . . . . 70.140000000000001 110.283 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -117.62 145.45 44.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.044 0.937 . . . . 73.450000000000003 109.046 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -135.82 172.77 12.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.144 2.178 . . . . 71.040000000000006 110.579 -169.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -151.69 119.66 6.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.582 1.153 . . . . 74.200000000000003 108.04 -164.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' HE ' ' A' ' 122' ' ' ARG . 46.7 tp -57.57 122.98 14.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.975 1.31 . . . . 53.020000000000003 112.177 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -100.22 -49.69 4.19 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 124.921 1.388 . . . . 73.230000000000004 110.436 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -161.41 159.77 28.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.57 1.148 . . . . 60.009999999999998 110.6 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -160.56 142.37 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.34 1.056 . . . . 74.329999999999998 110.661 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -127.65 148.59 50.38 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.233 1.813 . . . . 74.049999999999997 108.799 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.17 16.13 6.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.886 1.675 . . . . 73.450000000000003 113.509 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.54 -56.68 18.27 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.188 1.395 . . . . 74.310000000000002 112.909 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -60.99 -48.23 82.8 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.397 1.061 . . . . 62.299999999999997 112.767 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.85 -42.64 76.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.727 1.211 . . . . 64.439999999999998 113.794 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -68.6 -46.86 68.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.256 1.422 . . . . 72.239999999999995 113.241 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mmt -66.13 -41.23 90.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.646 1.178 . . . . 55.299999999999997 113.144 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.5 mptm? -60.89 -40.78 94.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.39 1.076 . . . . 73.319999999999993 112.226 169.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.59 66.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.885 1.439 . . . . 70.25 114.885 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 pt -86.84 0.96 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 113.214 0.82 . . . . 74.230000000000004 113.214 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.91 22.57 38.43 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.381 -1.233 . . . . 54.200000000000003 113.774 166.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.16 145.93 70.07 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 119.278 1.539 . . . . 71.319999999999993 110.859 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 149.65 58.45 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.25 . . . . 64.409999999999997 111.998 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 29' ' ' ILE . 51.8 tt0 -55.52 -29.18 58.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.366 1.466 . . . . 71.150000000000006 114.693 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.31 -54.08 51.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.475 1.51 . . . . 75.200000000000003 113.257 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.69 -22.75 66.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.892 1.277 . . . . 71.150000000000006 113.698 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.571 HD13 ' HD2' ' A' ' 20' ' ' LYS . 66.2 mt -78.25 -49.56 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.444 1.098 . . . . 63.409999999999997 111.366 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -65.74 -36.56 83.92 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.247 1.203 . . . . 73.040000000000006 114.247 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -27.67 55.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 118.524 -0.75 . . . . 61.25 112.28 171.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.3 -29.38 56.32 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.754 -1.026 . . . . 51.5 112.361 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.19 -30.12 18.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.436 1.095 . . . . 73.420000000000002 112.797 175.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.34 -59.86 2.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 110.436 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.64 109.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.451 1.094 . . . . 53.409999999999997 108.822 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.14 115.77 8.82 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 124.12 0.887 . . . . 71.209999999999994 110.191 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.43 179.66 50.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.974 1.421 . . . . 34.229999999999997 111.674 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 t -116.93 160.01 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.613 1.565 . . . . 73.420000000000002 106.81 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 t -148.15 149.83 32.7 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 108.713 -0.847 . . . . 61.43 108.713 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -147.07 139.56 24.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.628 -0.878 . . . . 53.229999999999997 108.628 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.5 mt -136.29 140.41 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.306 -1.368 . . . . 73.420000000000002 107.306 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.25 107.56 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.192 -1.04 . . . . 70.040000000000006 108.192 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -76.89 131.6 38.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.309 -0.997 . . . . 74.349999999999994 108.309 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -130.41 51.21 2.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.988 1.315 . . . . 73.010000000000005 108.79 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.25 -115.56 5.17 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.667 -1.773 . . . . 72.230000000000004 108.667 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 74.420000000000002 112.908 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.33 155.29 39.57 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.972 1.309 . . . . 74.349999999999994 112.134 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -147.36 128.27 14.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.621 1.569 . . . . 75.010000000000005 107.78 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -106.26 136.0 46.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.657 1.583 . . . . 72.319999999999993 108.707 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.74 134.48 55.22 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.083 -1.451 . . . . 73.219999999999999 107.083 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.89 122.94 15.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.059 1.343 . . . . 72.25 107.991 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.22 113.7 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.873 -1.158 . . . . 74.010000000000005 107.873 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -90.94 104.77 17.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.552 1.141 . . . . 63.329999999999998 109.695 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.61 174.99 11.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.644 1.178 . . . . 75.439999999999998 110.658 166.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.79 21.15 0.98 Allowed Glycine 0 CA--C 1.544 1.859 0 C-N-CA 125.714 1.626 . . . . 72.420000000000002 115.174 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.8 p -158.22 -30.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.578 1.689 . . . . 51.210000000000001 113.459 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -151.23 165.07 35.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.195 0.998 . . . . 74.540000000000006 110.742 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -108.73 139.72 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 124.462 1.101 . . . . 72.310000000000002 108.723 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 117.33 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 106.666 -1.605 . . . . 63.310000000000002 106.666 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.66 140.91 39.97 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.348 1.03 . . . . 71.209999999999994 109.016 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -144.42 158.97 43.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.954 1.702 . . . . 74.129999999999995 109.043 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -145.35 146.82 31.74 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.273 0.983 . . . . 64.340000000000003 109.563 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -148.4 171.27 16.3 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.436 1.494 . . . . 72.140000000000001 109.474 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.2 m -118.07 132.7 56.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.46 -1.311 . . . . 74.120000000000005 107.46 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.91 129.87 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 72.439999999999998 110.876 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.21 -7.96 49.16 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 118.179 -1.345 . . . . 55.350000000000001 113.821 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -101.62 152.37 20.89 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.202 1.501 . . . . 70.230000000000004 109.032 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.63 104.41 16.34 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.098 0.959 . . . . 64.109999999999999 110.879 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.7 m -125.18 -162.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.483 1.913 . . . . 70.349999999999994 109.067 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.06 155.74 49.76 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.707 1.203 . . . . 62.109999999999999 111.522 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.9 mt -132.03 139.04 48.44 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.792 1.637 . . . . 63.25 108.647 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.03 132.86 44.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.069 1.347 . . . . 41.409999999999997 109.892 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 m -83.72 162.41 20.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.432 1.493 . . . . 73.140000000000001 110.439 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.8 mtt -56.75 -30.1 63.22 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.94 1.459 . . . . 71.129999999999995 114.94 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.9 t -71.84 -11.33 60.75 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.427 1.491 . . . . 73.340000000000003 114.211 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.49 1.97 70.87 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.88 1.229 . . . . 72.120000000000005 112.028 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.89 132.52 47.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.303 1.441 . . . . 62.439999999999998 110.881 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -101.29 128.64 47.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.431 1.492 . . . . 62.240000000000002 108.375 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.97 126.15 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 124.038 0.836 . . . . 74.430000000000007 111.228 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.24 144.52 40.33 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.827 1.651 . . . . 75.409999999999997 111.729 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -171.88 179.59 2.69 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.113 1.365 . . . . 71.099999999999994 111.069 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.49 145.8 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 126.52 1.928 . . . . 75.140000000000001 107.557 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.21 143.33 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.111 0.964 . . . . 72.030000000000001 109.474 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -125.06 166.44 16.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.305 1.842 . . . . 70.340000000000003 111.216 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.11 135.77 41.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.659 1.584 . . . . 65.519999999999996 107.112 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.71 18.99 7.97 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.642 1.177 . . . . 63.229999999999997 113.74 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.48 9.18 64.27 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.991 1.758 . . . . 62.210000000000001 113.893 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -132.05 46.09 2.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.88 1.272 . . . . 73.409999999999997 109.574 -166.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.288 0.9 OUTLIER 49.65 32.06 4.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.071 2.148 . . . . 72.329999999999998 114.884 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -137.48 119.82 15.79 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.044 1.738 . . . . 70.409999999999997 108.572 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.22 146.42 23.73 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.204 0.94 . . . . 73.5 109.496 171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.72 138.0 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.914 1.286 . . . . 73.140000000000001 108.501 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 t -153.43 146.38 24.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.964 0.906 . . . . 65.319999999999993 109.51 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.9 p -120.14 174.29 6.58 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.758 1.223 . . . . 73.319999999999993 109.007 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.85 -85.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.412 -0.958 . . . . 64.5 108.412 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -51.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.809 1.244 . . . . 75.140000000000001 109.11 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.6 12.87 1.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.128 1.771 . . . . 75.109999999999999 111.601 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.7 mt -112.21 118.98 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.451 1.9 . . . . 63.210000000000001 106.683 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -111.08 102.08 10.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.611 1.164 . . . . 53.130000000000003 108.736 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.7 m -99.48 129.18 45.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.293 1.437 . . . . 70.420000000000002 110.344 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -133.06 108.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.589 1.156 . . . . 63.200000000000003 108.608 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.7 m -85.92 148.49 25.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.456 1.102 . . . . 75.430000000000007 109.221 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.85 118.01 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.999 1.32 . . . . 73.420000000000002 109.262 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.92 127.28 41.8 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.522 -0.918 . . . . 75.109999999999999 108.522 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.14 81.52 2.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.279 1.832 . . . . 74.430000000000007 107.729 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.95 -110.38 3.45 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.927 1.251 . . . . 71.310000000000002 110.922 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.81 21.24 9.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.562 1.545 . . . . 74.010000000000005 111.99 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -129.4 141.38 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.747 1.219 . . . . 64.109999999999999 108.646 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.07 107.97 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.941 1.296 . . . . 71.120000000000005 107.89 172.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 m -85.9 144.2 27.79 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.835 1.254 . . . . 75.510000000000005 108.283 165.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -149.3 122.43 8.89 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.209 -1.404 . . . . 72.519999999999996 107.209 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.93 120.33 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.513 1.133 . . . . 71.420000000000002 108.87 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.4 mtp -118.43 142.59 47.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.894 1.678 . . . . 63.210000000000001 109.216 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -133.71 95.74 3.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 43.549999999999997 109.905 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -96.08 106.37 18.54 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 125.038 1.335 . . . . 64.310000000000002 108.287 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.47 -109.84 3.08 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 110.218 -1.153 . . . . 61.130000000000003 110.218 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.78 -9.06 20.3 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.527 1.531 . . . . 74.430000000000007 112.014 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.24 130.87 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.05 1.34 . . . . 44.240000000000002 108.956 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.49 82.24 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 124.168 0.918 . . . . 72.049999999999997 109.621 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.96 131.91 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.434 1.093 . . . . 63.229999999999997 112.534 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -127.97 152.24 48.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.038 1.335 . . . . 61.439999999999998 109.577 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HE ' HD13 ' A' ' 9' ' ' LEU . 50.6 ttt-85 -155.79 130.22 8.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.605 1.162 . . . . 72.200000000000003 109.401 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.43 131.69 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.096 1.358 . . . . 74.430000000000007 107.497 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m -131.02 159.29 37.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.412 1.485 . . . . 71.200000000000003 108.924 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -129.2 131.57 47.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.558 1.143 . . . . 73.219999999999999 110.016 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -69.33 119.96 14.4 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.852 2.061 . . . . 75.519999999999996 110.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 124.098 1.904 . . . . 74.439999999999998 108.425 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 114.447 1.277 . . . . 61.340000000000003 114.447 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -57.01 120.78 8.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.329 2.252 . . . . 73.099999999999994 112.837 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.62 169.8 21.02 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 109.944 -1.262 . . . . 70.140000000000001 109.944 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.3 ttmt -121.22 133.03 55.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.974 1.309 . . . . 73.450000000000003 108.88 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -134.04 122.92 23.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.198 1.399 . . . . 71.040000000000006 110.217 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.68 153.31 37.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.264 1.025 . . . . 74.200000000000003 110.061 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' A' ' 122' ' ' ARG . 1.3 mt -70.65 137.02 49.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.195 0.309 . . . . 53.020000000000003 110.726 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -109.17 -48.57 3.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.744 1.277 . . . . 73.230000000000004 110.095 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.55 160.24 25.74 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 124.255 0.972 . . . . 60.009999999999998 111.786 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.27 153.45 50.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.826 1.65 . . . . 74.329999999999998 107.628 172.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -129.87 142.03 50.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.968 0.907 . . . . 74.049999999999997 109.613 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 58.86 25.37 13.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.346 1.858 . . . . 73.450000000000003 113.495 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -53.83 -55.15 29.19 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.159 1.384 . . . . 74.310000000000002 112.794 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.37 -45.24 76.87 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 124.791 1.307 . . . . 62.299999999999997 112.946 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.75 86.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.359 1.064 . . . . 64.439999999999998 113.577 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.98 -45.4 67.43 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.698 1.199 . . . . 72.239999999999995 112.815 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 16.3 mmt -65.82 -40.44 91.83 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.514 1.134 . . . . 55.299999999999997 112.945 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.4 mptt -59.34 -39.48 83.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.436 1.094 . . . . 73.319999999999993 113.014 168.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.68 72.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.614 1.339 . . . . 70.25 114.614 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.571 HG13 HD23 ' A' ' 24' ' ' LEU . 45.9 pt -77.16 -1.54 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 113.682 0.993 . . . . 74.230000000000004 113.682 171.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.56 38.07 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.83 -0.983 . . . . 54.200000000000003 113.146 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.571 HD23 HG13 ' A' ' 22' ' ' ILE . 1.1 mm? -74.57 142.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 118.581 1.19 . . . . 71.319999999999993 109.276 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.02 149.49 77.18 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.58 2.187 . . . . 64.409999999999997 111.565 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 29' ' ' ILE . 59.2 tt0 -59.74 -24.85 64.37 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.1 1.519 . . . . 71.150000000000006 115.1 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.97 -46.39 78.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.575 0.954 . . . . 75.200000000000003 113.575 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -67.97 -25.7 65.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.352 -0.832 . . . . 71.150000000000006 113.001 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 26' ' ' GLU . 56.2 mt -72.73 -53.16 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 117.86 -1.067 . . . . 63.409999999999997 111.009 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -62.96 -43.13 99.64 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.025 1.12 . . . . 73.040000000000006 114.025 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -23.22 63.3 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.735 0.647 . . . . 61.25 111.926 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.57 -28.36 47.8 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.127 -1.374 . . . . 51.5 112.469 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.37 -28.34 16.96 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 116.756 -1.592 . . . . 73.420000000000002 113.79 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -80.35 -34.95 36.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.865 1.212 . . . . 73.219999999999999 110.942 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.3 mt -93.47 122.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.361 1.065 . . . . 53.409999999999997 108.883 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.71 144.91 29.05 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.983 0.802 . . . . 71.209999999999994 110.668 165.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.3 -162.75 26.42 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 124.603 1.19 . . . . 34.229999999999997 110.725 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -143.86 152.64 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.607 1.963 . . . . 73.420000000000002 107.5 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -132.88 149.21 52.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.841 0.856 . . . . 61.43 109.598 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.14 136.91 54.98 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.023 -1.103 . . . . 53.229999999999997 108.023 166.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.63 128.42 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.509 -2.034 . . . . 73.420000000000002 105.509 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.92 99.11 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 124.162 0.914 . . . . 70.040000000000006 108.738 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -78.51 120.31 23.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.574 1.15 . . . . 74.349999999999994 109.685 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -117.45 54.83 0.87 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.381 1.472 . . . . 73.010000000000005 109.831 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -118.1 6.47 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.526 -1.83 . . . . 72.230000000000004 108.526 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -31.58 60.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 112.829 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 161.92 29.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.339 1.056 . . . . 74.349999999999994 111.078 169.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -155.55 138.31 15.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.584 -1.265 . . . . 75.010000000000005 107.584 -175.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.98 144.7 48.37 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 125.53 1.532 . . . . 72.319999999999993 109.894 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.59 123.41 27.85 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.864 -1.902 . . . . 73.219999999999999 105.864 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -116.6 135.52 53.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.313 1.845 . . . . 72.25 108.525 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.52 105.26 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.325 -0.991 . . . . 74.010000000000005 108.325 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -97.02 114.84 26.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.824 1.649 . . . . 63.329999999999998 109.125 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.86 147.97 17.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.584 0.754 . . . . 75.439999999999998 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.63 -105.58 1.96 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 107.608 -2.197 . . . . 72.420000000000002 107.608 -173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -147.79 34.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.017 1.327 . . . . 51.210000000000001 110.912 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.03 164.4 30.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.0 1.72 . . . . 74.540000000000006 109.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.31 129.91 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.977 0.798 . . . . 72.310000000000002 109.0 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.27 133.8 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.396 -1.335 . . . . 63.310000000000002 107.396 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.82 124.38 43.17 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.245 -1.391 . . . . 71.209999999999994 107.245 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.528 HD21 ' HB3' ' A' ' 72' ' ' GLU . 25.3 m120 -123.33 150.71 43.27 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 124.645 1.216 . . . . 74.129999999999995 109.014 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.66 142.27 41.15 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 125.205 1.566 . . . . 64.340000000000003 108.99 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.81 162.3 40.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.063 1.345 . . . . 72.140000000000001 109.756 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.5 m -109.51 135.46 50.48 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.309 -1.367 . . . . 74.120000000000005 107.309 166.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.5 130.46 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.953 0.901 . . . . 72.439999999999998 111.032 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.88 -7.97 64.48 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 117.941 -1.477 . . . . 55.350000000000001 114.092 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -98.75 136.09 39.29 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.538 1.669 . . . . 70.230000000000004 110.08 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.66 136.12 45.58 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.364 1.04 . . . . 64.109999999999999 111.068 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -167.63 159.17 11.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.853 1.261 . . . . 70.349999999999994 109.403 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -100.94 124.23 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.236 0.96 . . . . 62.109999999999999 110.915 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 81' ' ' THR . 4.5 mm? -105.67 168.66 8.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.941 2.096 . . . . 63.25 109.787 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HB3' HD21 ' A' ' 61' ' ' ASN . 35.0 tt0 -129.79 157.96 40.74 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.954 1.301 . . . . 41.409999999999997 110.545 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.6 p -124.11 173.09 8.52 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.093 1.757 . . . . 73.140000000000001 109.703 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -59.82 -20.39 56.61 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.509 1.67 . . . . 71.129999999999995 115.509 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 24' ' ' LEU . 54.3 p -78.57 -14.88 59.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.159 1.783 . . . . 73.340000000000003 113.842 172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.15 -2.08 83.35 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.996 1.284 . . . . 72.120000000000005 112.653 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -65.2 135.74 55.8 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 119.121 1.46 . . . . 62.439999999999998 112.559 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -103.93 143.14 33.26 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 125.126 1.516 . . . . 62.240000000000002 110.93 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.48 123.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.747 1.219 . . . . 74.430000000000007 111.272 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -71.43 137.92 48.66 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.738 1.215 . . . . 75.409999999999997 111.582 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 71' ' ' LEU . 13.8 t -167.41 169.67 12.07 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.677 1.236 . . . . 71.099999999999994 110.315 -172.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.71 132.2 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.866 1.266 . . . . 75.140000000000001 107.998 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.41 140.88 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 124.11 0.881 . . . . 72.030000000000001 109.524 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -131.59 168.58 17.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 70.340000000000003 111.373 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -122.44 127.2 49.35 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.006 -1.479 . . . . 65.519999999999996 107.006 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -84.9 18.55 2.4 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.596 1.332 . . . . 63.229999999999997 114.596 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 18.16 78.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.98 1.276 . . . . 62.210000000000001 113.719 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -143.43 48.14 1.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.605 1.162 . . . . 73.409999999999997 109.47 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.29 0.7 OUTLIER 47.21 37.58 5.79 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.695 1.998 . . . . 72.329999999999998 114.178 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -137.47 121.34 17.61 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.862 1.665 . . . . 70.409999999999997 109.072 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.58 140.77 29.44 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.556 1.16 . . . . 73.5 109.725 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.22 138.68 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.326 1.45 . . . . 73.140000000000001 108.476 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -160.11 143.62 13.99 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.959 0.787 . . . . 65.319999999999993 110.85 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.4 p -129.17 117.35 20.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.243 1.417 . . . . 73.319999999999993 107.343 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -69.33 -52.3 28.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.268 1.027 . . . . 64.5 110.604 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -149.26 -101.71 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.828 -2.286 . . . . 75.140000000000001 104.828 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -76.72 -20.23 56.79 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.481 2.312 . . . . 75.109999999999999 113.674 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 HD13 ' A' ' 115' ' ' LEU . 68.5 mt -81.69 102.31 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.312 1.045 . . . . 63.210000000000001 108.636 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.84 146.89 24.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.105 1.362 . . . . 53.130000000000003 109.838 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 m -138.71 126.89 22.73 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.462 1.505 . . . . 70.420000000000002 107.43 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.59 97.71 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.173 -1.418 . . . . 63.200000000000003 107.173 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 m -94.54 152.91 18.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.157 1.383 . . . . 75.430000000000007 110.156 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -141.32 139.48 33.62 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.7 2.0 . . . . 73.420000000000002 108.545 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.11 137.38 47.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 75.109999999999999 107.556 162.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -142.11 77.22 1.57 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.927 1.691 . . . . 74.430000000000007 106.8 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.88 -98.31 0.48 Allowed Glycine 0 C--N 1.346 1.115 0 C-N-CA 125.435 1.493 . . . . 71.310000000000002 110.752 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -87.76 -13.69 41.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.335 1.454 . . . . 74.010000000000005 113.133 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.89 140.23 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 119.798 1.181 . . . . 64.109999999999999 110.754 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.7 mm -119.5 107.66 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.088 1.355 . . . . 71.120000000000005 107.855 168.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -96.04 138.23 33.97 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.154 -1.054 . . . . 75.510000000000005 108.154 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -147.0 91.45 2.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.389 0.676 . . . . 72.519999999999996 109.252 -170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -82.97 144.24 30.12 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.7 1.25 . . . . 71.420000000000002 110.616 173.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 92.9 mtp -130.64 153.09 49.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.519 1.527 . . . . 63.210000000000001 108.491 168.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 m -141.03 114.03 8.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.842 0.857 . . . . 43.549999999999997 108.737 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.564 HD13 HG12 ' A' ' 98' ' ' ILE . 9.3 tp -123.95 125.08 43.97 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.568 1.547 . . . . 64.310000000000002 107.915 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.22 -101.44 0.38 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 124.983 1.427 . . . . 61.130000000000003 110.674 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.2 0.18 12.23 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.586 1.955 . . . . 74.430000000000007 112.951 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.76 137.79 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.878 1.271 . . . . 44.240000000000002 109.817 -172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.16 102.24 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.544 1.138 . . . . 72.049999999999997 109.324 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -84.85 150.99 24.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.539 1.536 . . . . 63.229999999999997 111.515 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -136.52 157.24 47.25 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.946 0.898 . . . . 61.439999999999998 110.199 167.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.521 ' HG2' HD21 ' A' ' 9' ' ' LEU . 5.3 ttp180 -137.46 143.64 41.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.531 1.533 . . . . 72.200000000000003 108.645 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.72 123.25 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.428 -1.693 . . . . 74.430000000000007 106.428 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -130.32 152.56 49.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.365 1.466 . . . . 71.200000000000003 108.988 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -133.29 138.28 46.35 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.85 0.86 . . . . 73.219999999999999 110.665 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -64.27 135.99 56.76 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.856 2.062 . . . . 75.519999999999996 112.526 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.59 HD12 ' HD2' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 C--N 1.343 0.319 0 N-CA-C 103.369 -2.826 . . . . 74.439999999999998 103.369 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 109.581 -0.526 . . . . 61.340000000000003 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.3 p -128.56 124.86 37.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.763 1.225 . . . . 73.099999999999994 109.05 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.42 174.21 27.82 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 109.63 -1.388 . . . . 70.140000000000001 109.63 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.2 ttmt -130.25 134.01 46.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 73.450000000000003 108.98 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.27 130.7 33.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.509 1.524 . . . . 71.040000000000006 110.04 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.73 152.47 21.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.273 1.029 . . . . 74.200000000000003 110.009 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.62 149.3 50.31 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.838 1.255 . . . . 53.020000000000003 112.011 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -125.99 -46.11 1.69 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.697 1.199 . . . . 73.230000000000004 111.126 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -162.43 155.71 20.27 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.303 1.041 . . . . 60.009999999999998 111.405 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -137.48 140.38 41.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.239 1.415 . . . . 74.329999999999998 108.522 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -116.33 149.33 39.48 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.084 0.954 . . . . 74.049999999999997 109.208 167.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.93 26.22 14.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.321 1.848 . . . . 73.450000000000003 113.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.34 -61.4 2.6 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 124.583 1.153 . . . . 74.310000000000002 113.373 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.43 -32.99 74.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.151 -0.928 . . . . 62.299999999999997 113.284 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.78 95.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.101 0.961 . . . . 64.439999999999998 113.112 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -68.56 -51.01 47.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.419 1.488 . . . . 72.239999999999995 113.42 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 mmt -63.37 -42.74 98.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.006 1.322 . . . . 55.299999999999997 112.966 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -74.91 -26.54 59.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.036 -0.983 . . . . 73.319999999999993 113.071 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.28 66.47 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 118.21 -0.9 . . . . 70.25 113.327 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.24 -13.31 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.968 0.792 . . . . 74.230000000000004 112.77 170.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.34 17.88 27.91 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 117.998 -1.446 . . . . 54.200000000000003 113.849 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.3 mt -61.56 142.22 94.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 119.694 1.747 . . . . 71.319999999999993 112.112 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.15 143.51 90.26 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.502 2.135 . . . . 64.409999999999997 111.742 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.73 -24.43 64.01 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.839 1.422 . . . . 71.150000000000006 114.839 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.09 -47.39 83.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.418 1.487 . . . . 75.200000000000003 113.397 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.6 -27.43 66.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.83 1.252 . . . . 71.150000000000006 112.642 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.15 -54.72 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 117.764 -1.112 . . . . 63.409999999999997 111.085 168.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -60.96 -42.92 99.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.6 1.333 . . . . 73.040000000000006 114.6 -175.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -13.23 59.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.36 -0.829 . . . . 61.25 112.986 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.09 -35.67 9.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.847 -0.974 . . . . 51.5 111.443 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -33.39 23.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.451 1.125 . . . . 73.420000000000002 112.874 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -71.96 -60.1 2.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.833 0.853 . . . . 73.219999999999999 110.542 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.48 114.99 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 124.339 1.024 . . . . 53.409999999999997 109.371 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.97 110.82 3.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.68 1.592 . . . . 71.209999999999994 109.415 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.29 -178.68 45.54 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.756 1.169 . . . . 34.229999999999997 111.893 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.97 158.3 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.241 1.416 . . . . 73.420000000000002 108.846 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -144.32 146.39 32.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.107 1.363 . . . . 61.43 109.76 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -128.38 138.22 52.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.75 1.22 . . . . 53.229999999999997 108.318 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -126.46 130.9 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.671 -1.603 . . . . 73.420000000000002 106.671 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.31 90.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.844 0.715 . . . . 70.040000000000006 109.729 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -76.36 136.32 39.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.325 0.65 . . . . 74.349999999999994 110.241 167.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.98 79.07 1.68 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.617 1.567 . . . . 73.010000000000005 107.477 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 -126.05 12.53 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.28 -1.528 . . . . 72.230000000000004 109.28 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -68.4 -29.35 68.02 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.558 1.318 . . . . 74.420000000000002 114.558 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 151.5 39.11 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.913 0.758 . . . . 74.349999999999994 111.493 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.06 137.35 23.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.164 1.786 . . . . 75.010000000000005 107.382 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -121.75 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.547 1.154 . . . . 72.319999999999993 108.85 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.61 103.4 5.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.75 -1.945 . . . . 73.219999999999999 105.75 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -92.93 138.7 31.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.698 1.199 . . . . 72.25 108.466 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.78 111.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.786 1.234 . . . . 74.010000000000005 107.774 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -86.64 107.3 18.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.873 1.269 . . . . 63.329999999999998 108.59 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 -173.63 1.68 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.825 1.65 . . . . 75.439999999999998 111.872 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.66 -31.54 63.98 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.783 1.182 . . . . 72.420000000000002 114.621 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -162.11 46.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.99 1.316 . . . . 51.210000000000001 109.324 167.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.34 160.85 43.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.495 1.518 . . . . 74.540000000000006 108.53 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.48 128.79 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.311 -0.996 . . . . 72.310000000000002 108.311 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -127.71 141.89 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.748 -1.575 . . . . 63.310000000000002 106.748 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.32 137.52 37.47 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.898 0.749 . . . . 71.209999999999994 110.766 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -124.17 158.13 33.09 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 125.475 1.734 . . . . 74.129999999999995 108.872 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.62 141.71 28.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 124.759 1.287 . . . . 64.340000000000003 108.972 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.69 160.67 42.44 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.48 1.112 . . . . 72.140000000000001 110.635 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 m -109.48 130.61 55.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.869 -1.16 . . . . 74.120000000000005 107.869 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.4 117.21 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.893 0.877 . . . . 72.439999999999998 110.242 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.68 56.58 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.74 -1.589 . . . . 55.350000000000001 112.759 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -119.16 150.77 39.48 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.502 1.651 . . . . 70.230000000000004 110.063 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.8 122.09 24.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.766 1.226 . . . . 64.109999999999999 110.732 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.7 m -144.97 151.9 39.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.966 1.306 . . . . 70.349999999999994 109.712 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -100.09 134.4 43.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.665 1.186 . . . . 62.109999999999999 110.857 -165.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.48 106.65 9.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.013 1.325 . . . . 63.25 109.67 -165.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.78 125.75 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.494 1.518 . . . . 41.409999999999997 111.664 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.7 m -82.3 166.38 19.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.728 1.611 . . . . 73.140000000000001 111.179 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.12 -27.42 14.14 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.579 1.952 . . . . 71.129999999999995 115.488 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -86.44 -17.19 34.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.266 1.826 . . . . 73.340000000000003 114.255 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.34 -16.08 45.69 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.785 1.183 . . . . 72.120000000000005 112.123 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -62.19 136.7 58.05 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.501 1.52 . . . . 62.439999999999998 110.4 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -133.65 153.76 51.43 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 124.382 1.051 . . . . 62.240000000000002 111.25 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -150.58 140.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.565 1.946 . . . . 74.430000000000007 108.517 -168.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -109.17 134.57 51.56 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.485 1.116 . . . . 75.409999999999997 109.867 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 t -168.21 161.05 12.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.327 1.051 . . . . 71.099999999999994 111.124 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.78 117.94 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.867 1.267 . . . . 75.140000000000001 109.302 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.52 138.15 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.906 0.883 . . . . 72.030000000000001 108.818 171.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -129.92 153.93 47.84 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.979 1.312 . . . . 70.340000000000003 111.821 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.9 tt -97.74 132.41 43.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.929 1.292 . . . . 65.519999999999996 109.565 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -93.54 27.28 2.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.757 1.623 . . . . 63.229999999999997 113.607 -170.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 69.9 6.13 54.96 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.88 1.705 . . . . 62.210000000000001 115.304 171.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.26 57.36 0.89 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.329 1.565 . . . . 73.409999999999997 109.012 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.341 0.0 OUTLIER 49.4 32.6 4.72 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.337 1.855 . . . . 72.329999999999998 114.92 178.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -124.43 138.62 54.34 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 126.532 1.933 . . . . 70.409999999999997 108.641 -174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.5 mt -114.34 125.15 53.54 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 124.342 1.026 . . . . 73.5 108.896 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.0 141.7 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.425 1.49 . . . . 73.140000000000001 108.718 173.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.8 t -150.78 140.53 21.76 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.212 0.945 . . . . 65.319999999999993 110.141 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 76.6 p -135.74 160.09 39.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.347 1.859 . . . . 73.319999999999993 108.743 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -127.71 -56.81 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.005 -0.739 . . . . 64.5 109.005 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -140.62 -63.1 0.48 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.697 1.599 . . . . 75.140000000000001 109.414 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -127.13 -26.36 3.13 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.633 1.208 . . . . 75.109999999999999 112.068 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.1 mt -74.07 100.58 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 124.032 0.933 . . . . 63.210000000000001 109.58 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -74.57 148.97 40.35 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.595 1.184 . . . . 53.130000000000003 109.01 165.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -149.75 125.11 10.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.812 -1.551 . . . . 70.420000000000002 106.812 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.2 t -127.06 100.43 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.82 -1.548 . . . . 63.200000000000003 106.82 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 96.1 m -77.99 147.75 34.73 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 108.578 165.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -149.33 114.61 5.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.555 1.142 . . . . 73.420000000000002 109.498 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.7 124.25 38.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.439 1.496 . . . . 75.109999999999999 109.145 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -129.78 67.65 1.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.235 -1.765 . . . . 74.430000000000007 106.235 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.78 -106.4 1.55 Allowed Glycine 0 C--N 1.348 1.202 0 C-N-CA 125.394 1.474 . . . . 71.310000000000002 110.278 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.72 -10.82 59.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.459 1.281 . . . . 74.010000000000005 114.459 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.58 137.0 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.199 1.0 . . . . 64.109999999999999 109.847 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.9 mm -124.77 104.82 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.023 1.329 . . . . 71.120000000000005 107.861 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.5 m -94.74 135.31 36.37 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.564 -1.273 . . . . 75.510000000000005 107.564 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.73 95.74 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.81 -0.811 . . . . 72.519999999999996 108.81 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.1 m -88.96 138.89 31.0 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.618 1.199 . . . . 71.420000000000002 109.653 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.7 mtp -130.67 154.37 47.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.425 1.49 . . . . 63.210000000000001 109.195 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.1 m -147.64 88.17 1.68 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.819 0.447 . . . . 43.549999999999997 111.474 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.09 107.48 16.46 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.502 1.121 . . . . 64.310000000000002 108.373 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.23 -99.14 0.22 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.782 1.182 . . . . 61.130000000000003 111.685 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.33 -3.81 15.98 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.22 1.808 . . . . 74.430000000000007 111.95 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.71 102.29 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.159 1.383 . . . . 44.240000000000002 109.075 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.69 84.34 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.498 1.119 . . . . 72.049999999999997 109.681 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -70.8 148.55 47.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.633 1.173 . . . . 63.229999999999997 112.261 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.28 156.02 49.17 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.722 0.809 . . . . 61.439999999999998 110.323 167.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -141.26 136.46 31.68 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.045 1.738 . . . . 72.200000000000003 107.339 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.38 132.77 70.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.129 -1.804 . . . . 74.430000000000007 106.129 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -139.64 155.26 47.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.616 1.567 . . . . 71.200000000000003 109.284 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -142.15 145.57 34.36 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.069 0.948 . . . . 73.219999999999999 110.883 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpt85 -51.4 141.09 16.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.023 2.929 . . . . 75.519999999999996 113.993 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.1 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 104.103 -2.555 . . . . 74.439999999999998 104.103 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' HA ' HD22 ' A' ' 104' ' ' LEU . 66.3 m-85 . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 115.504 1.668 . . . . 61.340000000000003 115.504 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -59.01 127.2 31.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.929 1.692 . . . . 73.099999999999994 113.725 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.11 174.58 27.0 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.9 -0.88 . . . . 70.140000000000001 110.9 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.524 ' HD2' HD12 ' A' ' 127' ' ' ILE . 10.8 ttmm -125.23 137.01 54.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.863 1.665 . . . . 73.450000000000003 108.094 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.47 127.88 26.5 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.397 1.479 . . . . 71.040000000000006 110.527 -166.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.96 152.0 28.23 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.734 0.814 . . . . 74.200000000000003 110.046 168.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.39 146.94 50.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.194 0.598 . . . . 53.020000000000003 110.409 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -120.39 -60.63 1.66 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.442 1.097 . . . . 73.230000000000004 109.779 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 m -143.17 157.28 44.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.69 1.196 . . . . 60.009999999999998 110.982 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -142.86 149.97 39.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.289 1.435 . . . . 74.329999999999998 109.36 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -125.7 148.96 48.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.059 0.944 . . . . 74.049999999999997 109.38 165.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 54.33 33.1 17.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.819 2.048 . . . . 73.450000000000003 112.402 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -61.51 -64.61 0.89 Allowed 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.572 1.149 . . . . 74.310000000000002 111.318 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.85 -38.99 90.31 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 124.446 1.091 . . . . 62.299999999999997 113.062 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.45 78.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.546 1.139 . . . . 64.439999999999998 113.476 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -74.39 -40.79 61.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.541 1.136 . . . . 72.239999999999995 113.322 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.1 mmt -68.08 -36.64 80.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.492 1.117 . . . . 55.299999999999997 113.395 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -65.0 -40.66 95.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.846 0.858 . . . . 73.319999999999993 112.313 167.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.85 -33.18 70.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.081 1.511 . . . . 70.25 115.081 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -75.87 -14.12 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 113.371 0.878 . . . . 74.230000000000004 113.371 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.7 20.69 39.43 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.593 -1.115 . . . . 54.200000000000003 112.719 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.7 135.55 96.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 118.909 1.354 . . . . 71.319999999999993 109.296 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.77 153.25 78.73 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.338 2.025 . . . . 64.409999999999997 112.268 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 29' ' ' ILE . 45.1 tt0 -56.97 -27.66 61.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.131 1.53 . . . . 71.150000000000006 115.131 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.78 -52.99 61.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.087 -0.958 . . . . 75.200000000000003 112.546 169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.62 -22.9 67.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.643 1.177 . . . . 71.150000000000006 114.059 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' GLU . 49.2 mt -75.04 -56.65 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 63.409999999999997 110.197 171.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -66.08 -36.38 83.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.702 1.371 . . . . 73.040000000000006 114.702 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -13.78 49.44 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.722 0.638 . . . . 61.25 112.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.74 -21.5 76.65 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 118.698 -1.056 . . . . 51.5 111.424 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -103.35 -22.33 13.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 116.365 -1.778 . . . . 73.420000000000002 113.86 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.25 20.0 p-10 -70.46 -51.68 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.127 1.33 . . . . 73.219999999999999 110.778 -173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.4 mm -97.96 122.98 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.606 1.562 . . . . 53.409999999999997 107.418 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.1 126.46 29.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.392 1.057 . . . . 71.209999999999994 109.553 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.79 -168.76 10.31 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 124.598 1.186 . . . . 34.229999999999997 112.172 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.2 153.86 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 107.801 -1.185 . . . . 73.420000000000002 107.801 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -135.98 148.99 48.68 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.11 1.364 . . . . 61.43 108.79 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -138.47 135.78 35.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.9 0.88 . . . . 53.229999999999997 108.727 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.96 130.84 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.358 -1.349 . . . . 73.420000000000002 107.358 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -136.23 97.81 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.329 -0.989 . . . . 70.040000000000006 108.329 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -76.28 143.12 41.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.873 0.869 . . . . 74.349999999999994 109.808 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -145.24 83.07 1.67 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.87 -1.159 . . . . 73.010000000000005 107.87 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.72 -120.3 10.92 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.292 -1.523 . . . . 72.230000000000004 109.292 -175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -77.67 -24.79 49.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 74.420000000000002 114.243 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.69 154.13 36.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.305 1.042 . . . . 74.349999999999994 111.678 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.78 119.8 6.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.775 1.23 . . . . 75.010000000000005 108.39 -173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -99.69 137.48 38.1 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.413 1.071 . . . . 72.319999999999993 108.901 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.71 140.86 51.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.336 -1.727 . . . . 73.219999999999999 106.336 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 m -140.09 136.95 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.966 1.706 . . . . 72.25 107.929 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.26 114.15 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.635 1.574 . . . . 74.010000000000005 106.806 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.3 m -96.8 130.63 44.03 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.296 1.439 . . . . 63.329999999999998 109.608 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.39 172.55 8.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.615 1.566 . . . . 75.439999999999998 109.365 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.23 7.5 8.02 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 118.249 -1.306 . . . . 72.420000000000002 114.638 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -36.9 1.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.23 1.515 . . . . 51.210000000000001 112.062 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.5 168.92 22.77 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.967 1.307 . . . . 74.540000000000006 110.401 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.73 138.31 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 124.56 1.163 . . . . 72.310000000000002 108.242 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.58 127.41 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.197 1.799 . . . . 63.310000000000002 106.778 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.18 144.3 30.79 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.737 0.648 . . . . 71.209999999999994 111.41 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -146.45 161.18 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.597 1.959 . . . . 74.129999999999995 108.857 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -133.81 144.46 49.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.033 0.933 . . . . 64.340000000000003 109.88 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.08 171.41 18.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.24 1.416 . . . . 72.140000000000001 110.122 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.8 m -112.83 132.09 55.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.59 1.156 . . . . 74.120000000000005 108.204 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.39 133.28 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.163 0.985 . . . . 72.439999999999998 110.307 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.15 -26.84 13.11 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.59 -1.117 . . . . 55.350000000000001 111.593 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.37 153.12 21.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.972 1.309 . . . . 70.230000000000004 110.172 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.26 158.0 24.96 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.408 1.067 . . . . 64.109999999999999 110.721 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.33 165.01 27.13 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.755 1.222 . . . . 70.349999999999994 110.145 -165.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.99 117.23 30.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.736 1.214 . . . . 62.109999999999999 109.187 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.06 166.36 11.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 63.25 110.645 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -115.38 148.13 39.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.5 1.92 . . . . 41.409999999999997 109.481 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p -111.79 173.88 6.14 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.715 1.606 . . . . 73.140000000000001 110.361 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -55.3 -28.73 55.53 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 116.52 2.044 . . . . 71.129999999999995 116.52 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.7 p -85.75 -15.87 40.73 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.371 1.068 . . . . 73.340000000000003 113.411 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.16 65.35 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 118.339 -1.256 . . . . 72.120000000000005 111.542 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.18 129.69 41.94 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 119.261 1.531 . . . . 62.439999999999998 109.868 164.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -108.43 150.4 27.46 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 124.792 1.308 . . . . 62.240000000000002 110.5 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.31 127.11 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.088 -1.415 . . . . 74.430000000000007 109.317 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -74.87 143.14 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.084 0.865 . . . . 75.409999999999997 110.663 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 t -160.74 161.0 32.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.12 1.368 . . . . 71.099999999999994 109.588 -166.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.36 144.61 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.918 -1.141 . . . . 75.140000000000001 107.918 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 91' ' ' LEU . 40.2 t -130.18 132.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.098 0.959 . . . . 72.030000000000001 109.472 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -134.53 150.73 50.79 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.232 1.413 . . . . 70.340000000000003 110.751 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 12.9 tp -80.05 137.85 36.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.275 1.03 . . . . 65.519999999999996 110.267 171.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -85.59 6.49 27.07 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.769 1.228 . . . . 63.229999999999997 112.441 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.479 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 73.6 5.07 67.29 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.695 1.617 . . . . 62.210000000000001 113.42 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -127.41 42.31 3.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.356 1.862 . . . . 73.409999999999997 108.922 -169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.337 0.2 OUTLIER 47.15 38.52 6.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.456 1.902 . . . . 72.329999999999998 113.904 -172.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -134.14 138.94 45.55 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.677 1.991 . . . . 70.409999999999997 108.993 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.407 HD22 HG12 ' A' ' 83' ' ' VAL . 59.8 mt -101.28 143.42 31.37 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 124.632 1.207 . . . . 73.5 108.618 164.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -121.84 134.38 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.098 -1.445 . . . . 73.140000000000001 107.098 170.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -151.09 150.17 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 65.319999999999993 110.898 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.1 p -140.87 126.28 18.75 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.241 1.416 . . . . 73.319999999999993 108.216 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.54 -87.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.885 1.366 . . . . 64.5 109.493 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.19 -43.44 1.79 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.245 1.418 . . . . 75.140000000000001 111.181 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -157.22 26.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.588 1.155 . . . . 75.109999999999999 111.533 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.6 mt -130.41 102.74 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.489 -1.3 . . . . 63.210000000000001 107.489 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -65.55 132.85 49.89 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.819 0.7 . . . . 53.130000000000003 109.518 167.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -142.27 108.81 5.33 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 124.683 1.239 . . . . 70.420000000000002 108.129 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -116.98 131.53 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.669 1.188 . . . . 63.200000000000003 108.67 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.6 m -113.53 151.83 31.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.251 1.821 . . . . 75.430000000000007 108.713 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.87 144.34 37.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.853 1.661 . . . . 73.420000000000002 108.534 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.9 tp -117.92 124.29 47.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.789 2.035 . . . . 75.109999999999999 106.725 167.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.17 85.44 2.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.28 1.832 . . . . 74.430000000000007 106.844 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.28 -106.69 2.09 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.767 -1.333 . . . . 71.310000000000002 109.767 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.46 -20.68 19.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.92 1.288 . . . . 74.010000000000005 112.452 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.18 135.02 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.231 1.013 . . . . 64.109999999999999 110.52 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mm -119.54 95.1 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.01 1.324 . . . . 71.120000000000005 107.707 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.5 m -86.26 127.36 34.75 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.182 0.926 . . . . 75.510000000000005 108.858 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.11 141.26 51.81 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.732 -0.84 . . . . 72.519999999999996 108.732 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 m -140.93 120.6 13.36 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.715 1.206 . . . . 71.420000000000002 108.723 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 83.3 mtp -116.53 156.27 27.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 63.210000000000001 109.289 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.4 m -143.76 114.26 7.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.319 1.048 . . . . 43.549999999999997 109.557 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.67 105.03 11.17 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.506 1.922 . . . . 64.310000000000002 107.162 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.01 -128.91 43.13 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 110.483 -1.047 . . . . 61.130000000000003 110.483 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -73.75 -13.83 61.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.83 1.652 . . . . 74.430000000000007 114.139 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.4 mt -97.69 132.71 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.854 1.262 . . . . 44.240000000000002 109.469 -171.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.63 85.63 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 124.383 1.052 . . . . 72.049999999999997 109.458 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -68.47 139.6 55.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.078 1.351 . . . . 63.229999999999997 113.052 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 152.45 50.27 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.62 1.168 . . . . 61.439999999999998 111.104 173.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -130.45 151.18 51.22 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.663 1.585 . . . . 72.200000000000003 108.659 161.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 124.44 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.246 -2.131 . . . . 74.430000000000007 105.246 160.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -122.86 157.45 32.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 71.200000000000003 108.332 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -134.49 142.08 46.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.862 0.865 . . . . 73.219999999999999 110.45 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.7 ttp85 -61.73 138.21 58.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.692 1.997 . . . . 75.519999999999996 112.627 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 125.04 2.352 . . . . 74.439999999999998 107.996 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 104' ' ' LEU . 81.5 m-85 . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 112.175 0.435 . . . . 61.340000000000003 112.175 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -132.77 114.1 13.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.172 1.789 . . . . 73.099999999999994 109.183 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 165.97 18.6 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 109.187 -1.565 . . . . 70.140000000000001 109.187 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HD2' HD12 ' A' ' 127' ' ' ILE . 3.8 tmmt? -120.29 138.46 53.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 73.450000000000003 109.744 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -133.64 151.35 51.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.337 1.855 . . . . 71.040000000000006 110.59 -164.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.38 149.98 30.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.936 1.294 . . . . 74.200000000000003 109.086 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.26 49.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.883 0.873 . . . . 53.020000000000003 110.398 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -102.48 -67.86 0.86 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.849 1.26 . . . . 73.230000000000004 109.117 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -141.56 167.88 21.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.649 1.18 . . . . 60.009999999999998 111.397 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.805 1.242 . . . . 74.329999999999998 110.133 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.85 146.46 50.27 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.681 1.592 . . . . 74.049999999999997 108.694 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 59.3 20.56 8.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.909 1.684 . . . . 73.450000000000003 113.679 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -57.96 -62.07 2.08 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.735 1.214 . . . . 74.310000000000002 112.793 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.89 -36.33 82.97 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.332 1.02 . . . . 62.299999999999997 112.987 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.16 78.71 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.368 1.067 . . . . 64.439999999999998 113.057 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -66.79 -47.06 73.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.266 1.426 . . . . 72.239999999999995 113.618 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.6 mmt -66.19 -36.58 83.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.874 1.269 . . . . 55.299999999999997 113.346 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -75.7 -28.99 58.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.383 1.073 . . . . 73.319999999999993 112.746 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.22 -38.96 71.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.134 0.973 . . . . 70.25 113.135 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.16 -9.73 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 113.174 0.805 . . . . 74.230000000000004 113.174 172.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 30.34 22.36 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.48 -1.178 . . . . 54.200000000000003 113.968 164.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.46 152.73 95.93 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 119.135 1.467 . . . . 71.319999999999993 111.367 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.11 145.74 68.0 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.516 2.144 . . . . 64.409999999999997 112.221 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -33.14 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.333 1.853 . . . . 71.150000000000006 114.801 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -53.54 -55.46 25.33 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.979 1.712 . . . . 75.200000000000003 113.18 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.64 -28.48 68.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.827 1.251 . . . . 71.150000000000006 113.87 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.56 -52.06 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 118.085 -0.96 . . . . 63.409999999999997 111.526 170.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -67.02 -36.41 82.08 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.696 1.369 . . . . 73.040000000000006 114.696 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -23.93 49.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.183 -0.913 . . . . 61.25 111.809 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.03 -32.43 32.24 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.765 -1.02 . . . . 51.5 111.972 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -29.11 30.87 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 118.442 1.121 . . . . 73.420000000000002 112.96 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -85.12 -60.36 2.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 109.98 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.4 mm -85.21 128.24 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.141 0.976 . . . . 53.409999999999997 109.31 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -81.79 138.57 35.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.339 1.056 . . . . 71.209999999999994 110.737 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.32 -171.09 47.58 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 124.586 1.179 . . . . 34.229999999999997 111.065 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.1 t -136.78 152.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.852 1.661 . . . . 73.420000000000002 107.123 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -144.23 147.63 33.85 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.515 0.726 . . . . 61.43 109.794 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.57 146.15 50.92 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 108.348 -0.982 . . . . 53.229999999999997 108.348 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 mt -123.2 138.01 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 105.667 -1.975 . . . . 73.420000000000002 105.667 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.84 137.97 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.099 -1.074 . . . . 70.040000000000006 108.099 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -129.04 128.9 44.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.988 1.315 . . . . 74.349999999999994 108.601 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -137.57 78.63 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.816 1.322 . . . . 73.010000000000005 107.759 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.05 -126.64 13.76 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 109.212 -1.555 . . . . 72.230000000000004 109.212 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -66.8 -24.73 66.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.512 1.525 . . . . 74.420000000000002 114.535 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 146.4 37.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 112.036 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.11 136.69 36.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.65 1.98 . . . . 75.010000000000005 107.801 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -125.42 149.22 48.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.67 1.988 . . . . 72.319999999999993 108.298 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.92 101.11 3.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.391 0.676 . . . . 73.219999999999999 109.544 -174.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -83.44 135.53 34.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.209 1.404 . . . . 72.25 109.878 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.7 mt -137.73 99.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.615 -1.254 . . . . 74.010000000000005 107.615 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -92.97 138.15 31.74 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.861 2.064 . . . . 63.329999999999998 110.373 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.13 -145.96 0.4 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 75.439999999999998 109.401 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.2 85.79 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.2 -0.778 . . . . 72.420000000000002 112.52 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -140.9 -62.03 0.48 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.055 1.342 . . . . 51.210000000000001 109.477 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -61.68 143.74 55.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.516 1.526 . . . . 74.540000000000006 114.157 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.89 144.15 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.767 1.292 . . . . 72.310000000000002 108.886 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.5 mt -122.57 127.07 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.868 -1.53 . . . . 63.310000000000002 106.868 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 91.36 3.27 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.903 0.881 . . . . 71.209999999999994 110.433 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -84.48 155.01 22.38 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.126 1.37 . . . . 74.129999999999995 111.42 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.99 138.91 28.76 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 124.851 1.345 . . . . 64.340000000000003 110.09 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.91 167.98 27.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.624 1.17 . . . . 72.140000000000001 111.032 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.7 m -118.89 128.36 54.36 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 124.704 1.253 . . . . 74.120000000000005 107.797 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.92 128.93 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.135 0.974 . . . . 72.439999999999998 111.801 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -3.38 86.19 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-O 117.979 -1.456 . . . . 55.350000000000001 113.303 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -117.42 147.05 43.04 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.304 1.552 . . . . 70.230000000000004 110.936 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.37 119.5 14.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.317 1.847 . . . . 64.109999999999999 111.901 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -140.13 169.57 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.047 1.739 . . . . 70.349999999999994 109.254 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.6 127.71 55.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.146 0.978 . . . . 62.109999999999999 110.33 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 81' ' ' THR . 3.8 mm? -115.39 141.86 47.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.695 1.598 . . . . 63.25 110.002 -170.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -122.27 142.09 50.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.466 1.907 . . . . 41.409999999999997 110.383 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -116.7 -178.96 3.55 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.638 1.575 . . . . 73.140000000000001 111.132 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -65.94 -24.23 66.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.423 1.489 . . . . 71.129999999999995 114.983 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.3 p -81.47 -11.58 59.17 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.261 1.424 . . . . 73.340000000000003 112.045 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.85 88.09 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.114 1.34 . . . . 72.120000000000005 112.615 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.89 120.18 10.24 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 125.401 1.481 . . . . 62.439999999999998 111.364 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -97.8 126.94 43.43 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 124.953 1.408 . . . . 62.240000000000002 110.37 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.53 123.57 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.924 1.69 . . . . 74.430000000000007 108.801 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -76.01 137.11 40.03 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 124.206 0.941 . . . . 75.409999999999997 111.495 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.425 HG22 HD23 ' A' ' 71' ' ' LEU . 12.7 t -165.24 -175.94 3.85 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 124.993 1.433 . . . . 71.099999999999994 109.834 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.18 144.61 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.716 1.606 . . . . 75.140000000000001 107.765 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.02 133.09 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.861 0.864 . . . . 72.030000000000001 108.707 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -115.34 174.96 5.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.193 1.797 . . . . 70.340000000000003 111.509 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 13.2 tp -124.96 136.04 53.37 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 65.519999999999996 107.178 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -89.0 9.23 25.92 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.231 1.197 . . . . 63.229999999999997 114.231 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.474 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 84.79 3.3 88.17 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-O 118.147 -1.363 . . . . 62.210000000000001 113.86 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -124.64 50.28 1.73 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.08 1.44 . . . . 73.409999999999997 108.817 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.333 0.1 OUTLIER 51.19 27.3 3.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.648 1.979 . . . . 72.329999999999998 115.297 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -121.73 111.97 17.82 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.329 1.852 . . . . 70.409999999999997 109.446 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.53 143.61 46.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.743 1.277 . . . . 73.5 110.336 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.4 135.01 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.515 1.126 . . . . 73.140000000000001 108.73 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -158.36 161.57 37.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.935 0.894 . . . . 65.319999999999993 110.716 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.8 p -135.37 -178.87 5.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.178 1.791 . . . . 73.319999999999993 108.297 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -139.3 -76.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 64.5 109.284 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -133.4 -50.2 0.86 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.72 1.608 . . . . 75.140000000000001 109.406 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -148.29 1.86 0.64 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 75.109999999999999 111.923 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 115' ' ' LEU . 58.5 mt -105.76 120.46 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.841 1.656 . . . . 63.210000000000001 107.155 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -108.27 113.46 26.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.818 1.247 . . . . 53.130000000000003 108.661 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -113.26 129.41 56.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.842 1.339 . . . . 70.420000000000002 109.835 -174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.97 120.2 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.98 -1.119 . . . . 63.200000000000003 107.98 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.9 m -102.74 156.15 17.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.794 1.238 . . . . 75.430000000000007 109.205 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.82 142.25 38.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.7 2.0 . . . . 73.420000000000002 108.812 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 3' ' ' PHE . 4.0 tt -120.48 119.8 34.03 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.451 -1.685 . . . . 75.109999999999999 106.451 171.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -129.45 83.56 2.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.535 1.534 . . . . 74.430000000000007 107.156 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.85 -111.88 3.95 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.913 1.244 . . . . 71.310000000000002 110.538 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -79.59 -24.2 42.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.18 1.392 . . . . 74.010000000000005 112.974 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -87.62 136.75 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.126 0.97 . . . . 64.109999999999999 110.709 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.23 107.62 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.895 1.278 . . . . 71.120000000000005 107.83 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -99.02 151.74 20.6 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 124.214 0.946 . . . . 75.510000000000005 109.328 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -146.7 141.46 26.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.926 1.29 . . . . 72.519999999999996 108.288 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 93.1 m -132.5 132.23 42.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.012 1.725 . . . . 71.420000000000002 108.239 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.2 mtp -131.12 119.07 21.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.444 1.497 . . . . 63.210000000000001 108.911 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -104.26 110.41 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.257 0.973 . . . . 43.549999999999997 109.116 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 98' ' ' ILE . 19.8 tp -116.16 98.55 6.67 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 106.816 -1.55 . . . . 64.310000000000002 106.816 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.49 -130.59 40.69 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 109.768 -1.333 . . . . 61.130000000000003 109.768 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.45 8.74 20.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 74.430000000000007 114.013 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 74.3 mt -108.88 123.0 64.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 108.511 -0.922 . . . . 44.240000000000002 108.511 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.57 85.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.524 1.14 . . . . 72.049999999999997 108.366 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.32 137.81 58.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.821 1.248 . . . . 63.229999999999997 111.753 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -134.03 148.5 51.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.012 1.325 . . . . 61.439999999999998 109.715 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -143.78 141.54 30.46 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.633 1.173 . . . . 72.200000000000003 108.83 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.91 134.1 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.665 -1.235 . . . . 74.430000000000007 107.665 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.5 m -133.1 161.02 35.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.782 1.633 . . . . 71.200000000000003 109.516 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.73 142.73 33.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.467 1.107 . . . . 73.219999999999999 110.741 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -63.44 138.39 58.5 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.222 1.809 . . . . 75.519999999999996 113.681 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 104.595 -2.372 . . . . 74.439999999999998 104.595 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 . . . . . 0 CA--C 1.539 0.537 0 N-CA-C 112.913 0.708 . . . . 61.340000000000003 112.913 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -60.44 112.78 2.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.296 1.839 . . . . 73.099999999999994 112.69 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.96 173.44 32.63 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.092 -1.603 . . . . 70.140000000000001 109.092 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 127' ' ' ILE . 16.9 ttmt -127.03 138.96 53.32 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.875 0.87 . . . . 73.450000000000003 109.322 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -134.55 139.94 45.76 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.463 1.505 . . . . 71.040000000000006 109.634 -168.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.99 152.8 18.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.46 1.104 . . . . 74.200000000000003 109.36 171.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.34 140.82 57.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.839 0.856 . . . . 53.020000000000003 110.031 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -118.18 -48.1 2.54 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.95 1.3 . . . . 73.230000000000004 110.887 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -152.15 152.23 32.03 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.761 1.224 . . . . 60.009999999999998 109.868 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -149.6 136.58 19.62 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.356 1.062 . . . . 74.329999999999998 110.142 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -128.64 147.07 50.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.965 1.706 . . . . 74.049999999999997 110.046 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 55.94 24.91 8.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.305 1.842 . . . . 73.450000000000003 112.712 -167.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.61 -62.66 1.63 Allowed 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.556 1.142 . . . . 74.310000000000002 112.136 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.87 -43.1 99.52 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.298 0.998 . . . . 62.299999999999997 113.173 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.31 75.82 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.685 1.194 . . . . 64.439999999999998 113.602 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.06 -46.93 76.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.456 1.502 . . . . 72.239999999999995 113.271 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.92 -40.05 79.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.563 1.145 . . . . 55.299999999999997 113.183 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.65 -37.67 88.38 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 73.319999999999993 112.419 169.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.6 74.03 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.235 1.198 . . . . 70.25 114.235 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.9 pt -79.72 -5.19 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.262 0.838 . . . . 74.230000000000004 113.262 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.34 22.52 26.75 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.239 -1.312 . . . . 54.200000000000003 113.79 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -69.96 146.11 94.85 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.478 1.639 . . . . 71.319999999999993 111.38 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 146.96 77.12 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.474 2.116 . . . . 64.409999999999997 111.864 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -30.23 64.04 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.829 1.418 . . . . 71.150000000000006 114.829 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.2 -51.52 69.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.387 1.075 . . . . 75.200000000000003 112.995 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.8 -24.42 67.75 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.616 1.167 . . . . 71.150000000000006 113.207 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.99 -45.55 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 118.005 -0.998 . . . . 63.409999999999997 111.073 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -67.28 -33.19 74.78 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.498 1.295 . . . . 73.040000000000006 114.498 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.8 -11.15 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.123 0.969 . . . . 61.25 112.56 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 -28.0 8.82 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.75 -1.028 . . . . 51.5 111.549 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -32.68 37.53 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.49 1.145 . . . . 73.420000000000002 113.366 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -83.61 -51.9 6.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.783 0.833 . . . . 73.219999999999999 111.301 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.26 113.04 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.411 1.084 . . . . 53.409999999999997 108.854 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -67.55 130.35 42.77 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.584 1.178 . . . . 71.209999999999994 110.561 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.63 31.25 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 124.834 1.334 . . . . 34.229999999999997 111.403 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 t -141.02 154.09 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.398 -1.334 . . . . 73.420000000000002 107.398 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -142.72 120.19 11.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.351 1.061 . . . . 61.43 109.922 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -99.8 131.27 45.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 124.302 1.001 . . . . 53.229999999999997 108.704 167.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.1 133.58 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.669 -1.604 . . . . 73.420000000000002 106.669 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.4 128.56 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 123.485 0.49 . . . . 70.040000000000006 109.823 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -88.94 128.6 35.69 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.725 -1.213 . . . . 74.349999999999994 107.725 165.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.83 53.11 1.4 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.896 1.278 . . . . 73.010000000000005 109.942 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.26 -119.82 5.27 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.035 -2.026 . . . . 72.230000000000004 108.035 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -77.2 -29.82 54.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.441 0.696 . . . . 74.420000000000002 111.923 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -69.37 164.25 23.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.417 1.087 . . . . 74.349999999999994 112.266 169.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -156.32 140.96 16.93 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.133 -1.803 . . . . 75.010000000000005 106.133 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -118.07 134.05 55.35 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.75 1.22 . . . . 72.319999999999993 109.957 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.59 112.93 18.59 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 125.115 1.509 . . . . 73.219999999999999 107.485 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -114.15 124.78 52.92 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.145 -1.428 . . . . 72.25 107.145 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.46 143.52 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.517 1.127 . . . . 74.010000000000005 108.601 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -133.74 153.86 51.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 63.329999999999998 110.821 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.94 139.66 19.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.096 1.758 . . . . 75.439999999999998 108.807 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.44 -98.66 0.68 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.057 -1.617 . . . . 72.420000000000002 109.057 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -149.66 39.05 0.78 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.897 1.279 . . . . 51.210000000000001 111.314 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -142.2 135.47 28.95 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.121 0.968 . . . . 74.540000000000006 110.921 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.61 144.63 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.269 1.428 . . . . 72.310000000000002 109.938 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.51 139.32 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.683 1.593 . . . . 63.310000000000002 108.095 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.55 132.36 55.13 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.805 1.242 . . . . 71.209999999999994 108.075 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.37 158.45 42.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.887 1.275 . . . . 74.129999999999995 109.952 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -137.9 148.56 45.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 125.181 1.551 . . . . 64.340000000000003 108.853 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.46 157.52 41.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.329 1.452 . . . . 72.140000000000001 109.867 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.11 53.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.637 1.175 . . . . 74.120000000000005 108.084 171.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.76 113.06 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.648 1.179 . . . . 72.439999999999998 110.494 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.02 -11.45 60.52 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.118 -1.379 . . . . 55.350000000000001 112.994 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -97.62 144.02 27.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.248 1.524 . . . . 70.230000000000004 110.08 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -73.67 134.59 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.572 1.149 . . . . 64.109999999999999 110.74 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.0 p -164.62 160.0 19.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.979 1.312 . . . . 70.349999999999994 109.619 -171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.44 114.97 28.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.376 1.07 . . . . 62.109999999999999 109.972 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.65 136.22 43.76 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.797 1.639 . . . . 63.25 110.339 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.56 154.88 26.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.869 1.268 . . . . 41.409999999999997 111.267 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -117.17 169.34 9.52 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.647 1.979 . . . . 73.140000000000001 109.286 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -54.13 -32.75 56.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.145 1.535 . . . . 71.129999999999995 115.145 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 p -77.6 -11.15 59.83 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.293 2.237 . . . . 73.340000000000003 113.976 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.36 81.2 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.431 -1.205 . . . . 72.120000000000005 112.361 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.81 126.23 27.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.276 1.83 . . . . 62.439999999999998 110.668 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -112.89 119.33 37.58 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.165 0.916 . . . . 62.240000000000002 108.931 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.78 130.09 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.118 1.367 . . . . 74.430000000000007 111.928 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -73.93 142.19 45.95 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.194 1.397 . . . . 75.409999999999997 113.536 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -174.35 177.11 2.29 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 125.394 1.684 . . . . 71.099999999999994 110.615 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.95 148.72 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.773 2.029 . . . . 75.140000000000001 107.866 166.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.2 t -112.66 139.43 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.707 -0.849 . . . . 72.030000000000001 108.707 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -128.31 155.76 44.11 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.452 1.501 . . . . 70.340000000000003 111.102 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.666 HD13 ' H ' ' A' ' 87' ' ' GLY . 2.3 tm? -114.18 117.48 31.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 65.519999999999996 107.148 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.67 14.15 4.96 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.058 1.503 . . . . 63.229999999999997 115.058 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.666 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 82.11 -7.0 64.86 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.423 1.487 . . . . 62.210000000000001 113.816 174.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -110.78 38.1 2.59 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.004 1.721 . . . . 73.409999999999997 111.568 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.312 0.2 OUTLIER 52.75 40.65 30.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.275 1.83 . . . . 72.329999999999998 112.96 -177.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -137.95 127.07 24.33 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.438 1.495 . . . . 70.409999999999997 109.553 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.1 mt -91.64 144.4 25.57 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.71 1.256 . . . . 73.5 109.11 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -130.97 138.39 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.204 1.402 . . . . 73.140000000000001 108.61 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -160.01 159.57 32.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.479 1.111 . . . . 65.319999999999993 109.971 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 73.9 p -130.85 -179.25 5.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 73.319999999999993 108.443 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -143.53 -55.02 0.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.645 0.657 . . . . 64.5 111.621 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -157.02 -54.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.524 1.13 . . . . 75.140000000000001 109.003 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -146.68 2.58 0.83 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.687 1.595 . . . . 75.109999999999999 111.699 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.31 102.08 13.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 C-N-CA 125.591 1.557 . . . . 63.210000000000001 107.582 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -76.01 144.69 40.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.525 -0.916 . . . . 53.130000000000003 108.525 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -143.31 106.61 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.312 1.045 . . . . 70.420000000000002 108.466 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -115.12 110.0 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 124.866 1.354 . . . . 63.200000000000003 108.018 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -97.67 152.48 19.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.845 1.258 . . . . 75.430000000000007 109.539 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.14 146.89 39.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.997 1.719 . . . . 73.420000000000002 109.697 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -119.78 137.8 53.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.093 2.157 . . . . 75.109999999999999 107.788 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -138.35 64.46 1.5 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.122 2.169 . . . . 74.430000000000007 106.561 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.47 -105.0 1.32 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.795 1.188 . . . . 71.310000000000002 111.014 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.01 -7.95 59.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.784 1.234 . . . . 74.010000000000005 113.095 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.39 146.46 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.579 1.152 . . . . 64.109999999999999 109.146 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.4 mm -130.39 143.61 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.478 1.511 . . . . 71.120000000000005 108.39 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -127.94 148.76 50.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.398 1.061 . . . . 75.510000000000005 108.315 168.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -140.17 117.27 11.18 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.347 -1.723 . . . . 72.519999999999996 106.347 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.2 m -120.95 102.01 8.07 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.858 1.349 . . . . 71.420000000000002 107.845 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 mtm -93.76 155.39 17.25 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.25 0.969 . . . . 63.210000000000001 110.45 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -134.6 97.2 3.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.507 1.123 . . . . 43.549999999999997 108.846 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt -85.99 95.06 9.38 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.526 1.13 . . . . 64.310000000000002 108.047 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.55 -108.57 1.73 Allowed Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.678 1.132 . . . . 61.130000000000003 111.523 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.53 -2.72 57.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.871 2.068 . . . . 74.430000000000007 115.5 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.34 137.46 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.079 -1.082 . . . . 44.240000000000002 108.079 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.65 88.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 123.944 0.778 . . . . 72.049999999999997 109.298 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -67.4 139.58 57.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.217 1.007 . . . . 63.229999999999997 112.073 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -133.61 148.83 51.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.564 1.545 . . . . 61.439999999999998 109.955 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -157.32 108.88 2.35 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.811 1.244 . . . . 72.200000000000003 108.715 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -100.98 135.09 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.304 1.442 . . . . 74.430000000000007 107.773 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.7 m -136.11 159.01 43.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 71.200000000000003 109.971 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -143.66 144.12 31.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.982 0.913 . . . . 73.219999999999999 110.697 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -65.48 136.92 57.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.704 2.002 . . . . 75.519999999999996 113.933 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 6' ' ' LYS . 3.1 mt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 124.915 2.293 . . . . 74.439999999999998 107.798 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' ILE . 38.4 m-85 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 117.101 2.26 . . . . 61.340000000000003 117.101 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -63.18 147.42 50.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.114 1.524 . . . . 73.099999999999994 115.114 -170.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.66 168.0 12.14 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.467 1.508 . . . . 70.140000000000001 110.646 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -89.71 152.86 21.12 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.902 1.281 . . . . 73.450000000000003 112.369 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -143.78 134.71 25.37 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.963 1.705 . . . . 71.040000000000006 107.782 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.25 154.02 22.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.919 0.781 . . . . 74.200000000000003 109.458 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.24 130.17 40.16 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.615 0.572 . . . . 53.020000000000003 109.649 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -103.57 -61.38 1.43 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.292 1.037 . . . . 73.230000000000004 110.797 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 m -143.62 155.08 44.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.384 1.073 . . . . 60.009999999999998 110.902 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.57 147.66 48.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 74.329999999999998 109.062 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -129.85 136.98 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.829 1.652 . . . . 74.049999999999997 108.333 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 56.44 28.18 13.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.861 1.665 . . . . 73.450000000000003 112.54 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.78 -63.33 1.28 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.514 1.126 . . . . 74.310000000000002 112.608 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -64.02 -37.49 87.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.543 1.152 . . . . 62.299999999999997 113.128 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.21 -44.31 88.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.414 1.086 . . . . 64.439999999999998 113.171 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.12 -43.46 67.59 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.241 1.416 . . . . 72.239999999999995 114.032 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.4 mmt -67.83 -38.27 82.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.177 0.991 . . . . 55.299999999999997 112.683 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.8 mptt -64.79 -40.38 95.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.867 0.867 . . . . 73.319999999999993 112.721 167.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.28 -27.92 64.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.963 1.468 . . . . 70.25 114.963 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -84.97 -8.3 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.104 0.779 . . . . 74.230000000000004 113.104 171.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.7 24.73 22.62 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.07 -1.406 . . . . 54.200000000000003 113.54 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.98 149.75 97.77 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.675 1.737 . . . . 71.319999999999993 111.29 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.96 152.22 62.91 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.329 2.019 . . . . 64.409999999999997 111.847 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -52.66 -34.45 51.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.025 1.33 . . . . 71.150000000000006 114.31 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -49.55 -54.83 15.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.73 2.012 . . . . 75.200000000000003 113.258 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.11 -26.13 62.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.506 1.523 . . . . 71.150000000000006 112.857 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 20' ' ' LYS . 62.2 mt -75.13 -45.94 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.125 0.97 . . . . 63.409999999999997 111.849 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.24 -37.41 74.97 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.307 1.225 . . . . 73.040000000000006 114.307 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -18.25 49.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.648 -0.692 . . . . 61.25 112.506 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -38.0 11.07 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.732 -1.038 . . . . 51.5 111.517 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -36.02 61.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.592 1.196 . . . . 73.420000000000002 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.81 -65.74 0.79 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.104 1.361 . . . . 73.219999999999999 110.661 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -76.83 121.36 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.563 1.165 . . . . 53.409999999999997 109.234 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -78.42 127.91 32.86 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.231 0.957 . . . . 71.209999999999994 109.716 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.06 -156.86 28.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.791 1.307 . . . . 34.229999999999997 111.127 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.89 164.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.865 1.266 . . . . 73.420000000000002 108.745 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.12 155.75 47.65 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.017 1.727 . . . . 61.43 107.819 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.13 145.53 31.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.905 -1.517 . . . . 53.229999999999997 106.905 167.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 3' ' ' PHE . 98.8 mt -126.78 135.74 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.505 -1.665 . . . . 73.420000000000002 106.505 166.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.2 87.06 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.965 -1.124 . . . . 70.040000000000006 107.965 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -71.5 131.23 43.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 109.205 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.65 74.16 1.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.36 -1.348 . . . . 73.010000000000005 107.36 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.54 -125.27 9.22 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 108.993 -1.643 . . . . 72.230000000000004 108.993 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -72.22 -29.14 63.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.216 1.406 . . . . 74.420000000000002 114.266 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.95 152.63 42.37 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.117 0.885 . . . . 74.349999999999994 110.975 169.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -152.94 133.87 14.0 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.354 -1.35 . . . . 75.010000000000005 107.354 -171.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -119.29 148.06 43.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.106 1.362 . . . . 72.319999999999993 108.245 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.7 102.8 3.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.94 -1.504 . . . . 73.219999999999999 106.94 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.2 m -109.48 92.26 3.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.762 0.825 . . . . 72.25 109.397 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.6 mt -102.85 129.61 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.07 0.948 . . . . 74.010000000000005 109.093 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -126.29 150.07 48.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.501 1.12 . . . . 63.329999999999998 110.745 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.64 -152.32 0.4 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.374 1.87 . . . . 75.439999999999998 109.812 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.12 -0.92 82.53 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.98 -1.456 . . . . 72.420000000000002 113.191 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -157.93 9.3 0.16 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.681 1.74 . . . . 51.210000000000001 114.094 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -167.41 155.27 9.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.943 0.897 . . . . 74.540000000000006 111.928 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.75 144.78 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.598 1.559 . . . . 72.310000000000002 109.512 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -119.2 140.44 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.371 1.868 . . . . 63.310000000000002 106.48 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.2 123.85 39.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.742 0.817 . . . . 71.209999999999994 109.323 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -120.98 150.43 41.12 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.144 1.378 . . . . 74.129999999999995 108.983 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -147.56 143.14 27.56 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.707 1.255 . . . . 64.340000000000003 108.713 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.65 167.56 29.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.021 1.328 . . . . 72.140000000000001 110.55 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -119.25 128.34 54.09 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.419 -1.326 . . . . 74.120000000000005 107.419 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.36 103.78 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.436 1.094 . . . . 72.439999999999998 110.281 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.0 -7.07 11.97 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 117.85 -1.528 . . . . 55.350000000000001 112.621 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -123.95 156.66 35.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.374 1.587 . . . . 70.230000000000004 111.518 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -74.36 123.09 23.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.614 1.565 . . . . 64.109999999999999 110.717 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.9 m -142.02 156.34 45.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.333 1.453 . . . . 70.349999999999994 108.4 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.95 124.24 42.31 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.004 0.921 . . . . 62.109999999999999 110.14 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 81' ' ' THR . 3.9 mm? -107.26 125.42 51.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.985 1.714 . . . . 63.25 108.981 -172.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -78.89 128.32 33.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.586 1.154 . . . . 41.409999999999997 110.876 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -90.45 166.18 13.4 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.253 1.821 . . . . 73.140000000000001 110.329 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 mtt -49.47 -38.16 28.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.954 1.835 . . . . 71.129999999999995 115.954 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 p -80.71 -7.37 59.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.965 1.706 . . . . 73.340000000000003 113.978 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.05 86.85 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 118.552 -1.138 . . . . 72.120000000000005 111.549 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.94 148.25 50.0 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.033 1.333 . . . . 62.439999999999998 110.043 163.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -135.57 142.96 45.42 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.768 0.668 . . . . 62.240000000000002 109.487 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.96 131.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.576 1.151 . . . . 74.430000000000007 110.826 -173.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -81.91 142.84 32.11 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.383 1.073 . . . . 75.409999999999997 112.004 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -169.86 160.74 8.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.634 1.574 . . . . 71.099999999999994 109.044 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.6 t -104.4 125.21 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.709 -1.219 . . . . 75.140000000000001 107.709 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.03 138.64 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.118 0.886 . . . . 72.030000000000001 108.792 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -125.74 173.85 8.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.023 1.729 . . . . 70.340000000000003 111.204 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.45 127.34 19.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.414 1.485 . . . . 65.519999999999996 107.414 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.02 26.19 2.56 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.618 1.34 . . . . 63.229999999999997 114.618 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.8 -0.29 78.23 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.258 1.409 . . . . 62.210000000000001 114.586 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.05 61.38 1.65 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.35 1.575 . . . . 73.409999999999997 108.519 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.99 34.99 3.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.196 2.198 . . . . 72.329999999999998 115.331 171.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -128.26 109.76 11.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.875 1.67 . . . . 70.409999999999997 108.598 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -83.2 131.4 35.11 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.767 1.292 . . . . 73.5 109.587 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -124.34 137.47 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.761 1.224 . . . . 73.140000000000001 109.143 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -157.3 146.41 19.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.611 0.764 . . . . 65.319999999999993 110.644 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -138.14 110.09 7.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.398 1.479 . . . . 73.319999999999993 107.84 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -72.42 -59.6 2.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.312 1.045 . . . . 64.5 111.79 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -145.97 -61.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.974 1.31 . . . . 75.140000000000001 109.314 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -141.27 7.98 2.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.213 1.805 . . . . 75.109999999999999 111.64 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.43 HG12 HD12 ' A' ' 115' ' ' LEU . 9.5 mt -115.73 113.79 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.021 1.728 . . . . 63.210000000000001 106.795 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.241 0.963 . . . . 53.130000000000003 108.853 168.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -143.31 119.66 10.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.384 -1.339 . . . . 70.420000000000002 107.384 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -127.59 97.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 124.983 1.427 . . . . 63.200000000000003 107.376 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.3 m -78.17 146.35 35.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.614 1.166 . . . . 75.430000000000007 109.257 168.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -138.82 112.14 8.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.915 1.686 . . . . 73.420000000000002 108.193 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.7 tp -83.44 124.17 30.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.521 165.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.45 83.14 2.05 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.301 1.84 . . . . 74.430000000000007 106.135 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.4 -109.73 3.07 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 109.999 -1.241 . . . . 71.310000000000002 109.999 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.3 2.85 56.42 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 74.010000000000005 113.846 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -113.96 136.08 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.03 0.932 . . . . 64.109999999999999 109.326 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mm -118.17 105.09 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.974 1.31 . . . . 71.120000000000005 108.267 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 m -86.17 144.64 27.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.05 -1.093 . . . . 75.510000000000005 108.05 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -144.45 95.6 2.74 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 107.83 -1.174 . . . . 72.519999999999996 107.83 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.1 m -82.17 137.91 34.83 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 125.205 1.566 . . . . 71.420000000000002 109.509 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 mtm -127.56 155.83 43.19 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.275 1.03 . . . . 63.210000000000001 109.562 168.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.1 m -140.34 101.85 4.22 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.097 0.873 . . . . 43.549999999999997 110.03 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD12 HG12 ' A' ' 98' ' ' ILE . 6.4 tt -99.98 110.31 22.63 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.731 1.212 . . . . 64.310000000000002 107.888 171.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.33 -89.68 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.183 1.373 . . . . 61.130000000000003 112.943 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -132.2 36.97 3.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.444 1.898 . . . . 74.430000000000007 109.847 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.4 mm -133.92 137.98 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.947 1.699 . . . . 44.240000000000002 106.972 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.8 90.25 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 124.06 0.85 . . . . 72.049999999999997 108.932 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -78.76 143.79 35.81 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.052 1.341 . . . . 63.229999999999997 111.406 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.79 152.73 51.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.183 0.993 . . . . 61.439999999999998 109.587 164.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -146.08 126.33 13.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.236 1.414 . . . . 72.200000000000003 107.988 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -116.17 128.3 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 125.025 1.453 . . . . 74.430000000000007 107.397 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 56.3 m -127.82 157.68 39.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.755 . . . . 71.200000000000003 108.83 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -141.91 143.23 33.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.277 1.031 . . . . 73.219999999999999 110.875 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -51.32 140.96 16.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.42 2.288 . . . . 75.519999999999996 113.558 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 125.181 2.42 . . . . 74.439999999999998 108.334 -179.446 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 113.914 1.079 . . . . 61.340000000000003 113.914 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.0 p -60.7 110.16 1.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.371 1.868 . . . . 73.099999999999994 114.454 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.81 169.26 34.41 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 110.08 -1.208 . . . . 70.140000000000001 110.08 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -119.0 141.93 48.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.405 1.482 . . . . 73.450000000000003 108.542 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -137.18 159.1 42.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.228 1.811 . . . . 71.040000000000006 110.559 -168.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -121.27 143.41 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.287 1.435 . . . . 74.200000000000003 108.257 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 37' ' ' GLY . 37.5 tp -61.1 139.57 58.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.845 1.258 . . . . 53.020000000000003 111.608 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -122.79 -43.97 2.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.65 1.18 . . . . 73.230000000000004 111.334 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -155.49 156.14 34.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.295 1.038 . . . . 60.009999999999998 111.336 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -135.33 155.25 50.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.103 1.361 . . . . 74.329999999999998 109.332 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -131.31 144.42 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.707 1.203 . . . . 74.049999999999997 108.34 171.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 57.23 22.51 7.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.165 1.786 . . . . 73.450000000000003 114.227 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -56.32 -59.22 5.26 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.518 1.127 . . . . 74.310000000000002 113.478 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.61 -39.28 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.228 0.955 . . . . 62.299999999999997 112.909 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.84 76.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.561 1.144 . . . . 64.439999999999998 112.81 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.65 -49.24 74.0 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.321 1.448 . . . . 72.239999999999995 113.489 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.17 -37.19 85.03 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 124.512 1.132 . . . . 55.299999999999997 113.768 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -73.37 -27.46 61.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.272 -0.87 . . . . 73.319999999999993 112.768 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.67 63.75 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.454 1.102 . . . . 70.25 113.839 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG13 HD23 ' A' ' 24' ' ' LEU . 42.4 pt -80.67 -6.57 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 113.457 0.91 . . . . 74.230000000000004 113.457 170.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.75 28.95 27.78 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 118.759 -1.023 . . . . 54.200000000000003 113.379 167.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -72.84 147.26 88.72 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 118.774 1.287 . . . . 71.319999999999993 110.541 175.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.29 149.55 63.65 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.742 2.295 . . . . 64.409999999999997 112.588 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.74 -35.54 22.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.242 1.817 . . . . 71.150000000000006 114.988 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -51.07 -60.71 2.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.872 1.669 . . . . 75.200000000000003 112.614 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.5 -26.13 67.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.71 1.604 . . . . 71.150000000000006 113.917 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.6 -58.51 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 CA-C-O 118.233 -0.889 . . . . 63.409999999999997 110.691 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -63.98 -34.14 77.31 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.078 1.51 . . . . 73.040000000000006 115.078 -173.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -20.23 35.17 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.175 -0.917 . . . . 61.25 112.513 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -34.67 21.05 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.104 -0.831 . . . . 51.5 111.603 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -26.18 42.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.593 1.157 . . . . 73.420000000000002 112.769 170.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.67 -67.53 0.63 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.28 1.032 . . . . 73.219999999999999 110.52 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.79 108.74 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.572 1.17 . . . . 53.409999999999997 109.794 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -63.84 116.2 5.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.425 1.89 . . . . 71.209999999999994 109.908 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' H ' HD23 ' A' ' 9' ' ' LEU . . . -75.68 171.98 54.11 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 124.557 1.161 . . . . 34.229999999999997 111.834 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.96 149.24 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.189 -1.412 . . . . 73.420000000000002 107.189 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.2 t -142.66 149.65 39.17 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.566 0.746 . . . . 61.43 109.71 -172.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.56 140.54 26.19 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.215 1.006 . . . . 53.229999999999997 108.298 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -140.4 140.28 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.583 -1.636 . . . . 73.420000000000002 106.583 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.4 t -141.69 120.94 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.661 -0.866 . . . . 70.040000000000006 108.661 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -95.46 136.35 35.95 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.069 0.856 . . . . 74.349999999999994 108.987 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.72 49.57 2.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.155 1.382 . . . . 73.010000000000005 110.251 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -70.99 3.0 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.835 1.207 . . . . 72.230000000000004 110.858 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -120.74 -34.39 3.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.861 1.664 . . . . 74.420000000000002 110.794 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.99 165.45 24.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.316 1.046 . . . . 74.349999999999994 111.28 169.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -158.98 136.58 10.13 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.095 -1.446 . . . . 75.010000000000005 107.095 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -118.49 152.2 36.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.035 1.334 . . . . 72.319999999999993 110.795 168.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.24 137.69 39.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.394 -2.076 . . . . 73.219999999999999 105.394 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -143.35 127.13 17.15 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.667 1.187 . . . . 72.25 107.916 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.6 122.43 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.641 -0.874 . . . . 74.010000000000005 108.641 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -95.66 114.35 26.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.449 1.5 . . . . 63.329999999999998 109.67 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.83 -179.73 6.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.455 1.502 . . . . 75.439999999999998 110.487 167.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 17.6 1.59 Allowed Glycine 0 CA--C 1.545 1.939 0 C-N-CA 125.27 1.414 . . . . 72.420000000000002 114.99 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -150.03 -40.13 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 51.210000000000001 112.261 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 170.56 17.5 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.838 1.255 . . . . 74.540000000000006 110.749 -161.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.8 130.43 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.516 1.135 . . . . 72.310000000000002 108.825 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.67 144.01 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.525 1.13 . . . . 63.310000000000002 108.257 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.42 149.41 45.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 71.209999999999994 110.618 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -135.67 163.14 30.82 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.335 1.454 . . . . 74.129999999999995 109.44 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -145.39 139.09 26.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.263 -1.335 . . . . 64.340000000000003 108.539 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.73 167.18 31.23 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 124.229 0.956 . . . . 72.140000000000001 111.343 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.2 126.66 54.84 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.706 1.254 . . . . 74.120000000000005 108.271 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.44 123.8 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.093 0.957 . . . . 72.439999999999998 111.02 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.5 73.18 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.163 -1.354 . . . . 55.350000000000001 113.243 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -125.93 153.17 44.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.01 1.405 . . . . 70.230000000000004 109.825 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -72.76 136.92 45.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.096 0.959 . . . . 64.109999999999999 112.561 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 m -152.8 153.18 32.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.115 1.766 . . . . 70.349999999999994 108.343 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.66 113.55 25.64 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.244 0.965 . . . . 62.109999999999999 110.641 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.27 146.72 23.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.573 1.549 . . . . 63.25 109.267 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -112.44 130.58 55.93 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.262 1.025 . . . . 41.409999999999997 110.463 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.9 m -78.09 158.91 28.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.47 1.908 . . . . 73.140000000000001 110.747 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.38 -18.29 58.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.785 1.772 . . . . 71.129999999999995 115.785 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.9 p -76.23 -40.4 52.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.489 1.515 . . . . 73.340000000000003 112.38 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.38 2.26 13.49 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.535 -1.703 . . . . 72.120000000000005 112.052 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.36 125.72 26.52 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.291 2.046 . . . . 62.439999999999998 110.119 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -107.95 120.24 41.73 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.617 1.198 . . . . 62.240000000000002 108.617 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.49 127.95 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.337 1.455 . . . . 74.430000000000007 111.278 -167.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -80.1 141.42 35.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.091 1.357 . . . . 75.409999999999997 112.656 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -167.89 170.94 10.25 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.28 1.432 . . . . 71.099999999999994 110.034 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -108.84 137.78 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.454 1.502 . . . . 75.140000000000001 108.459 170.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.72 142.15 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 124.082 0.864 . . . . 72.030000000000001 108.912 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -126.98 173.04 9.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.811 2.044 . . . . 70.340000000000003 111.213 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.39 132.2 35.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 65.519999999999996 107.275 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.07 16.73 6.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.706 1.203 . . . . 63.229999999999997 113.889 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.29 5.73 77.87 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.042 1.782 . . . . 62.210000000000001 114.019 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -131.32 50.53 2.22 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.843 1.322 . . . . 73.409999999999997 109.625 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.32 0.4 OUTLIER 41.43 35.95 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 72.329999999999998 115.694 -174.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -137.92 122.84 18.95 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 126.021 1.728 . . . . 70.409999999999997 107.859 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.86 152.04 22.39 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.35 1.031 . . . . 73.5 109.586 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.53 139.28 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.928 1.291 . . . . 73.140000000000001 107.834 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -154.7 165.37 36.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.515 0.726 . . . . 65.319999999999993 109.703 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 95' ' ' PHE . 2.5 m -139.06 -176.57 4.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.956 1.302 . . . . 73.319999999999993 108.476 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' H ' HG22 ' A' ' 94' ' ' THR . 93.7 m-85 -135.62 -106.47 0.21 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.128 -1.804 . . . . 64.5 106.128 165.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.84 -40.16 6.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.775 1.23 . . . . 75.140000000000001 111.259 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -149.11 5.4 0.65 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.144 1.378 . . . . 75.109999999999999 112.78 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -124.16 107.79 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.59 -1.263 . . . . 63.210000000000001 107.59 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -80.09 165.07 22.86 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 123.975 0.797 . . . . 53.130000000000003 110.209 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.4 t -152.74 133.17 13.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.225 1.81 . . . . 70.420000000000002 108.483 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -139.03 105.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.941 1.697 . . . . 63.200000000000003 106.791 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.8 m -88.52 154.8 20.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.008 1.323 . . . . 75.430000000000007 109.746 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -137.19 143.32 42.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.863 1.265 . . . . 73.420000000000002 108.786 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.6 tp -120.39 117.46 27.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.33 1.852 . . . . 75.109999999999999 106.375 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 86.93 2.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.715 -1.587 . . . . 74.430000000000007 106.715 173.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.99 -106.43 2.02 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.385 -1.486 . . . . 71.310000000000002 109.385 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -96.7 -19.68 18.8 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 74.010000000000005 112.605 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -80.76 133.16 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.475 1.11 . . . . 64.109999999999999 109.776 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mm -121.29 103.49 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.03 -1.1 . . . . 71.120000000000005 108.03 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.5 m -104.53 97.37 7.29 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.169 0.918 . . . . 75.510000000000005 109.845 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.21 143.96 25.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.852 1.261 . . . . 72.519999999999996 110.226 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.1 m -145.67 122.8 11.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.655 1.182 . . . . 71.420000000000002 109.493 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.04 162.56 16.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.366 1.466 . . . . 63.210000000000001 110.091 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 m -144.85 92.2 2.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.566 0.746 . . . . 43.549999999999997 110.812 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.6 tp -88.36 114.17 24.71 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 124.28 1.032 . . . . 64.310000000000002 109.135 168.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.59 -103.06 0.23 Allowed Glycine 0 CA--C 1.535 1.29 0 O-C-N 125.158 1.536 . . . . 61.130000000000003 111.904 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.95 -13.24 25.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.901 2.08 . . . . 74.430000000000007 113.835 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.0 mt -119.07 121.98 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.068 0.849 . . . . 44.240000000000002 110.863 -166.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.6 96.48 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 O-C-N 124.727 1.267 . . . . 72.049999999999997 109.089 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.61 145.63 43.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.444 1.098 . . . . 63.229999999999997 111.853 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 154.33 51.27 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 123.411 0.684 . . . . 61.439999999999998 110.925 168.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -139.87 125.47 19.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.336 1.454 . . . . 72.200000000000003 108.384 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.72 133.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.924 1.289 . . . . 74.430000000000007 107.96 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.41 162.5 35.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.979 1.312 . . . . 71.200000000000003 110.2 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -138.87 146.93 41.77 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.308 1.443 . . . . 73.219999999999999 109.449 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -60.25 145.02 48.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.473 1.509 . . . . 75.519999999999996 114.239 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 105.818 -1.919 . . . . 74.439999999999998 105.818 174.743 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 CA--C 1.54 0.591 0 N-CA-C 114.823 1.416 . . . . 61.340000000000003 114.823 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 m -65.53 120.69 13.34 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.846 1.259 . . . . 73.099999999999994 113.352 -174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.94 175.98 28.49 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.398 0.999 . . . . 70.140000000000001 110.701 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 23.8 ttmt -115.7 144.72 43.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.958 1.303 . . . . 73.450000000000003 109.951 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -139.84 141.17 36.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.158 1.783 . . . . 71.040000000000006 110.207 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -97.72 152.58 18.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.037 1.335 . . . . 74.200000000000003 109.66 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.614 HD21 ' HE ' ' A' ' 122' ' ' ARG . 4.7 mt -64.85 143.5 57.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.248 0.619 . . . . 53.020000000000003 111.782 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -119.21 -61.45 1.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.383 1.473 . . . . 73.230000000000004 108.767 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 m -135.5 158.69 43.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.669 1.188 . . . . 60.009999999999998 110.521 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -144.12 162.42 36.32 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.779 1.632 . . . . 74.329999999999998 108.589 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.75 138.48 14.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.422 -0.585 . . . . 74.049999999999997 109.422 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.93 30.05 19.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.475 1.91 . . . . 73.450000000000003 112.559 -165.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.97 -57.17 13.76 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.106 0.962 . . . . 74.310000000000002 112.433 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.77 -43.68 95.64 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.606 1.191 . . . . 62.299999999999997 112.253 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.73 -47.67 76.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.827 1.251 . . . . 64.439999999999998 113.491 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.72 -47.0 73.7 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.005 1.322 . . . . 72.239999999999995 113.348 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.0 mmt -67.91 -35.56 78.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.909 1.077 . . . . 55.299999999999997 113.909 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -71.03 -30.67 66.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.282 -0.866 . . . . 73.319999999999993 112.115 171.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.71 -37.77 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.515 1.126 . . . . 70.25 113.605 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.4 pt -83.86 -1.25 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 113.623 0.972 . . . . 74.230000000000004 113.623 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 27.96 50.46 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.738 -1.034 . . . . 54.200000000000003 114.088 164.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 147.32 99.0 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.683 1.242 . . . . 71.319999999999993 111.055 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.26 141.3 81.57 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 64.409999999999997 111.556 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -55.21 -30.41 59.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.909 1.284 . . . . 71.150000000000006 114.194 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -51.72 -54.04 32.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 75.200000000000003 113.568 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.31 -25.84 66.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.422 1.489 . . . . 71.150000000000006 113.004 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.9 mt -75.18 -49.73 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.02 0.928 . . . . 63.409999999999997 111.168 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -62.61 -42.78 99.78 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.972 0.909 . . . . 73.040000000000006 113.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.18 -13.49 58.55 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.37 1.044 . . . . 61.25 113.057 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.99 -18.83 45.36 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-O 118.263 -1.298 . . . . 51.5 112.183 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -35.01 11.2 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 116.913 -1.518 . . . . 73.420000000000002 113.549 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -78.15 -56.04 4.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.72 1.145 . . . . 73.219999999999999 111.085 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.4 124.99 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.436 1.494 . . . . 53.409999999999997 107.725 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.52 131.22 34.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 124.461 1.101 . . . . 71.209999999999994 109.375 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.06 -176.35 34.4 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 124.697 1.248 . . . . 34.229999999999997 111.574 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.96 156.38 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.816 1.646 . . . . 73.420000000000002 107.283 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -148.56 141.39 24.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.054 0.941 . . . . 61.43 109.162 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -124.24 144.0 50.21 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.242 -1.021 . . . . 53.229999999999997 108.242 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -129.54 139.01 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 106.442 -1.688 . . . . 73.420000000000002 106.442 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.07 112.32 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 107.321 -1.363 . . . . 70.040000000000006 107.321 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.32 121.47 40.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.153 1.381 . . . . 74.349999999999994 109.116 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -122.56 44.01 2.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 73.010000000000005 110.36 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -117.52 5.37 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.963 -2.055 . . . . 72.230000000000004 107.963 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -73.84 -29.52 62.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.555 1.317 . . . . 74.420000000000002 114.555 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 154.51 35.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.524 0.602 . . . . 74.349999999999994 110.526 169.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -151.94 137.76 18.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.575 -1.268 . . . . 75.010000000000005 107.575 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -125.01 150.4 46.77 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 124.587 1.18 . . . . 72.319999999999993 110.128 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 128.24 20.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.491 -1.67 . . . . 73.219999999999999 106.491 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 m -111.05 129.91 55.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.291 -1.374 . . . . 72.25 107.291 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.61 109.38 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.974 -1.861 . . . . 74.010000000000005 105.974 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 47.4 m -113.87 105.45 13.28 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.375 1.047 . . . . 63.329999999999998 109.414 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.04 -173.21 0.99 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 75.439999999999998 111.931 169.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.6 46.38 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.277 1.417 . . . . 72.420000000000002 114.915 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.1 p -159.04 20.2 0.19 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.201 1.4 . . . . 51.210000000000001 113.101 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 153.67 41.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.204 1.402 . . . . 74.540000000000006 109.562 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.54 129.81 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.331 1.052 . . . . 72.310000000000002 108.302 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -124.23 131.15 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.928 1.691 . . . . 63.310000000000002 107.404 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.06 130.54 50.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.252 1.021 . . . . 71.209999999999994 109.312 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.79 145.07 39.7 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.183 1.393 . . . . 74.129999999999995 109.46 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 146.35 51.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.763 1.625 . . . . 64.340000000000003 109.041 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -160.21 162.08 33.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.312 1.045 . . . . 72.140000000000001 111.663 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.2 m -96.84 128.28 43.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.564 1.165 . . . . 74.120000000000005 108.448 168.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.4 t -66.08 134.02 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.725 1.61 . . . . 72.439999999999998 110.737 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.13 -13.14 60.39 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.04 1.305 . . . . 55.350000000000001 113.049 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -105.67 145.93 30.4 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.461 1.504 . . . . 70.230000000000004 109.639 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.55 139.38 58.26 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.727 1.211 . . . . 64.109999999999999 112.244 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.08 161.53 42.38 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 124.792 1.307 . . . . 70.349999999999994 109.728 -170.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.84 118.05 30.98 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 124.358 1.036 . . . . 62.109999999999999 108.628 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.04 148.64 29.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.66 1.584 . . . . 63.25 109.097 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.67 125.25 43.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.588 1.155 . . . . 41.409999999999997 110.257 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -74.83 162.82 28.31 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.817 1.647 . . . . 73.140000000000001 110.626 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.05 -26.83 62.99 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.253 1.575 . . . . 71.129999999999995 115.253 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 -13.46 61.11 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.224 1.81 . . . . 73.340000000000003 113.901 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.98 -3.15 82.6 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.122 -1.377 . . . . 72.120000000000005 111.773 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.24 116.07 8.42 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 119.541 1.67 . . . . 62.439999999999998 111.087 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -87.12 123.77 32.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 124.809 1.318 . . . . 62.240000000000002 110.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.59 129.37 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.071 1.748 . . . . 74.430000000000007 109.966 -168.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -74.4 141.61 45.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.355 1.062 . . . . 75.409999999999997 111.741 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 t -166.07 166.65 17.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.185 1.394 . . . . 71.099999999999994 110.015 -168.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.07 146.54 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 75.140000000000001 107.643 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.75 145.41 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.23 1.012 . . . . 72.030000000000001 108.92 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.82 149.85 51.4 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.414 1.485 . . . . 70.340000000000003 109.837 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.5 tt -106.21 124.63 49.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.24 1.416 . . . . 65.519999999999996 107.524 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -86.55 12.44 10.44 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.945 1.298 . . . . 63.229999999999997 114.428 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.638 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 82.5 -10.49 55.25 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.224 1.869 . . . . 62.210000000000001 113.872 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.9 49.77 1.14 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.517 1.527 . . . . 73.409999999999997 110.973 -169.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.291 0.6 OUTLIER 46.9 43.12 13.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.003 2.121 . . . . 72.329999999999998 114.054 -177.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -143.39 141.17 30.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.324 1.85 . . . . 70.409999999999997 108.642 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -115.94 148.07 40.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.539 1.535 . . . . 73.5 108.14 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -130.03 133.56 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.867 -1.16 . . . . 73.140000000000001 107.867 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -148.77 143.95 26.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.36 1.064 . . . . 65.319999999999993 111.219 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 p -139.51 127.91 22.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.363 1.465 . . . . 73.319999999999993 108.834 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.5 -98.88 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.495 1.918 . . . . 64.5 108.588 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -106.01 -53.13 2.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.827 1.251 . . . . 75.140000000000001 110.51 167.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -143.06 13.94 1.86 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.878 1.271 . . . . 75.109999999999999 112.7 -170.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 115' ' ' LEU . 72.0 mt -113.65 99.15 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.074 -1.454 . . . . 63.210000000000001 107.074 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -87.83 105.58 17.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.071 0.948 . . . . 53.130000000000003 109.236 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 t -112.79 117.72 32.96 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.172 1.389 . . . . 70.420000000000002 110.631 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.34 128.31 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.227 -1.397 . . . . 63.200000000000003 107.227 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 m -109.11 146.19 34.45 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.624 -1.25 . . . . 75.430000000000007 107.624 168.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -142.24 148.41 38.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.808 0.843 . . . . 73.420000000000002 110.743 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.89 122.47 38.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.992 2.117 . . . . 75.109999999999999 107.486 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.14 79.74 1.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 74.430000000000007 107.376 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.67 -116.85 6.27 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 109.402 -1.479 . . . . 71.310000000000002 109.402 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.1 -10.09 51.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.319 1.448 . . . . 74.010000000000005 114.187 172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.25 139.86 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.698 0.799 . . . . 64.109999999999999 109.052 175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.31 144.72 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.283 1.433 . . . . 71.120000000000005 108.599 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -127.21 148.79 50.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.442 1.897 . . . . 75.510000000000005 108.23 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.94 145.79 33.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.922 0.889 . . . . 72.519999999999996 109.121 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.7 m -144.77 86.73 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.674 1.59 . . . . 71.420000000000002 107.927 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mtm -84.66 139.34 32.11 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.016 0.927 . . . . 63.210000000000001 109.747 170.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.1 m -130.82 103.08 6.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.662 1.185 . . . . 43.549999999999997 108.277 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 98' ' ' ILE . 35.5 tp -118.36 119.56 34.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.334 1.454 . . . . 64.310000000000002 108.775 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.79 -105.49 1.34 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.138 -1.585 . . . . 61.130000000000003 109.138 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.4 0.05 10.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.681 1.993 . . . . 74.430000000000007 112.292 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.6 mt -99.3 142.59 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.96 1.704 . . . . 44.240000000000002 109.291 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -121.67 92.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.791 0.837 . . . . 72.049999999999997 109.574 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.87 112.09 7.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 63.229999999999997 112.307 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -94.5 146.6 23.98 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.289 1.435 . . . . 61.439999999999998 110.62 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 9' ' ' LEU . 72.0 mtp180 -134.85 148.93 50.26 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.816 1.322 . . . . 72.200000000000003 108.019 161.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.82 131.06 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 105.954 -1.869 . . . . 74.430000000000007 105.954 169.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.2 m -131.93 165.3 24.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.16 1.384 . . . . 71.200000000000003 109.682 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -147.64 143.11 27.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.823 0.849 . . . . 73.219999999999999 110.799 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -54.5 140.09 35.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.629 2.372 . . . . 75.519999999999996 113.133 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.3 mt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 124.605 2.145 . . . . 74.439999999999998 107.263 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 115.083 1.512 . . . . 61.340000000000003 115.083 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -59.83 116.25 3.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.165 1.786 . . . . 73.099999999999994 113.715 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.82 170.86 29.32 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.627 -0.989 . . . . 70.140000000000001 110.627 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HD2' HD12 ' A' ' 127' ' ' ILE . 6.1 ttmt -112.92 140.46 47.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.981 1.312 . . . . 73.450000000000003 107.993 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.41 125.52 26.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.165 1.386 . . . . 71.040000000000006 110.34 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.58 152.36 30.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.973 0.909 . . . . 74.200000000000003 110.318 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.67 126.64 30.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.712 0.805 . . . . 53.020000000000003 109.033 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -95.79 -56.52 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.37 1.068 . . . . 73.230000000000004 110.917 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -156.89 163.36 39.26 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.079 1.352 . . . . 60.009999999999998 110.39 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -160.09 151.12 19.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.518 1.127 . . . . 74.329999999999998 109.59 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.59 143.95 43.86 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.204 1.401 . . . . 74.049999999999997 109.18 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.11 16.84 10.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.555 1.942 . . . . 73.450000000000003 114.783 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.79 -50.65 69.91 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.669 1.588 . . . . 74.310000000000002 113.189 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.17 -59.51 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.296 1.838 . . . . 62.299999999999997 112.782 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.5 83.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.213 1.405 . . . . 64.439999999999998 113.787 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.69 -52.71 49.26 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.987 1.315 . . . . 72.239999999999995 112.835 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 mmt -68.08 -35.35 78.05 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.373 1.046 . . . . 55.299999999999997 113.702 -176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.534 ' HD3' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.0 -44.42 97.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.644 0.777 . . . . 73.319999999999993 112.314 168.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.45 79.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.322 1.23 . . . . 70.25 114.322 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 pt -80.95 -5.0 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.043 1.127 . . . . 74.230000000000004 114.043 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.99 19.33 26.81 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.229 -1.317 . . . . 54.200000000000003 114.646 161.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.25 142.63 97.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 119.54 1.67 . . . . 71.319999999999993 110.319 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.54 141.18 59.92 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.143 1.895 . . . . 64.409999999999997 111.65 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' HD12 ' A' ' 29' ' ' ILE 0.31 27.3 tt0 -65.93 -14.3 61.3 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.668 1.729 . . . . 71.150000000000006 115.668 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.04 -53.17 61.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.616 1.167 . . . . 75.200000000000003 112.556 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.47 -26.01 66.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.563 1.545 . . . . 71.150000000000006 112.86 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.534 HD13 ' HD3' ' A' ' 20' ' ' LYS . 47.7 mt -78.85 -47.43 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 117.55 -1.214 . . . . 63.409999999999997 111.161 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -65.36 -39.48 92.38 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 113.731 1.011 . . . . 73.040000000000006 113.731 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -16.67 57.78 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.256 -0.878 . . . . 61.25 112.472 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.18 -37.74 10.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.974 -0.903 . . . . 51.5 111.35 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -26.27 34.73 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.465 1.106 . . . . 73.420000000000002 113.584 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -84.95 -62.82 1.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 124.163 0.914 . . . . 73.219999999999999 110.304 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.56 120.15 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.866 0.866 . . . . 53.409999999999997 108.914 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -66.33 127.58 32.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.051 0.94 . . . . 71.209999999999994 111.334 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.3 -172.57 48.87 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 124.712 1.258 . . . . 34.229999999999997 110.554 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.0 t -137.59 152.97 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.6 1.56 . . . . 73.420000000000002 107.389 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -135.77 155.61 50.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.257 1.023 . . . . 61.43 109.112 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -137.72 140.4 40.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.178 -0.675 . . . . 53.229999999999997 109.178 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' A' ' 48' ' ' PHE . 84.6 mt -123.61 129.61 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.863 1.352 . . . . 73.420000000000002 107.477 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.92 90.53 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.087 -1.079 . . . . 70.040000000000006 108.087 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -74.29 136.46 42.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.698 0.799 . . . . 74.349999999999994 110.223 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.07 86.22 1.43 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.233 1.013 . . . . 73.010000000000005 109.845 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.64 -114.29 4.06 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 109.526 -1.429 . . . . 72.230000000000004 109.526 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -91.58 -15.81 28.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.998 1.319 . . . . 74.420000000000002 111.874 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -86.15 147.65 26.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.322 1.449 . . . . 74.349999999999994 112.49 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.531 ' CE2' HD11 ' A' ' 91' ' ' LEU . 12.7 t80 -133.33 118.99 19.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.793 1.637 . . . . 75.010000000000005 107.828 176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -87.6 131.93 34.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.046 1.338 . . . . 72.319999999999993 108.567 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.24 109.36 12.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.162 -1.792 . . . . 73.219999999999999 106.162 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -106.15 141.88 36.78 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.158 1.383 . . . . 72.25 109.536 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.91 107.41 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.145 1.378 . . . . 74.010000000000005 108.016 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.5 m -87.64 132.04 34.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.566 1.546 . . . . 63.329999999999998 109.068 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.88 4.64 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.653 . . . . 75.439999999999998 110.225 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.83 -86.93 0.86 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 109.674 -1.37 . . . . 72.420000000000002 109.674 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 t -150.25 21.56 0.85 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.996 1.318 . . . . 51.210000000000001 111.781 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmm? -129.25 149.39 51.06 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.475 1.51 . . . . 74.540000000000006 109.818 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.91 111.68 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 124.198 0.936 . . . . 72.310000000000002 109.567 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.2 mt -84.19 144.61 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.77 1.228 . . . . 63.310000000000002 107.988 166.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.29 141.68 23.34 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 123.955 0.784 . . . . 71.209999999999994 110.762 165.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.79 158.52 41.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.455 1.902 . . . . 74.129999999999995 107.817 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.37 145.83 39.47 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 124.081 0.863 . . . . 64.340000000000003 109.909 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -139.62 149.91 44.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.829 1.331 . . . . 72.140000000000001 110.175 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -94.03 126.1 39.05 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.915 1.384 . . . . 74.120000000000005 108.094 168.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.23 130.45 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.862 0.865 . . . . 72.439999999999998 111.675 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.74 -5.47 81.84 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.21 -1.328 . . . . 55.350000000000001 113.672 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.49 157.03 21.6 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.122 1.461 . . . . 70.230000000000004 109.71 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.62 143.75 46.21 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.057 0.848 . . . . 64.109999999999999 111.794 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.11 -173.01 3.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.633 2.373 . . . . 70.349999999999994 107.576 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.69 129.47 38.8 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.146 -0.687 . . . . 62.109999999999999 109.146 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mp -104.71 161.42 14.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.877 1.671 . . . . 63.25 109.448 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.22 142.58 39.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.233 1.413 . . . . 41.409999999999997 109.013 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 m -109.03 142.89 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.562 1.145 . . . . 73.140000000000001 108.035 168.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.1 mtt -44.53 -32.07 1.31 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 118.769 2.877 . . . . 71.129999999999995 118.769 -163.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -71.05 -22.43 62.13 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.12 1.368 . . . . 73.340000000000003 114.262 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.27 5.57 10.38 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.209 -1.328 . . . . 72.120000000000005 112.298 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.18 147.03 52.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.448 1.624 . . . . 62.439999999999998 111.923 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 124.39 44.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.442 1.497 . . . . 62.240000000000002 107.732 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.33 128.62 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.196 0.998 . . . . 74.430000000000007 111.928 -169.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 148.4 48.9 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.89 1.276 . . . . 75.409999999999997 111.791 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -169.46 162.87 10.34 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.548 1.155 . . . . 71.099999999999994 111.039 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.06 150.62 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 126.047 1.739 . . . . 75.140000000000001 107.465 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.03 139.65 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.847 -0.798 . . . . 72.030000000000001 108.847 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -125.35 152.03 45.29 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.73 1.612 . . . . 70.340000000000003 110.86 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.75 118.11 35.26 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 65.519999999999996 106.513 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.05 11.65 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.22 1.563 . . . . 63.229999999999997 115.22 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.76 11.16 85.7 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.04 1.305 . . . . 62.210000000000001 112.596 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -134.04 35.78 3.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.391 1.476 . . . . 73.409999999999997 109.702 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.318 0.5 OUTLIER 53.51 27.08 6.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.469 1.908 . . . . 72.329999999999998 114.785 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -124.93 126.35 45.37 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.834 1.654 . . . . 70.409999999999997 108.832 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 48' ' ' PHE . 45.6 mt -94.05 127.51 39.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.157 0.983 . . . . 73.5 109.639 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.69 134.89 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 73.140000000000001 108.684 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 t -160.9 151.26 17.92 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.222 1.009 . . . . 65.319999999999993 111.362 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -161.23 141.24 10.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.74 1.216 . . . . 73.319999999999993 110.861 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -83.65 -61.32 1.86 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.227 0.954 . . . . 64.5 109.18 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -129.72 -52.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.75 1.62 . . . . 75.140000000000001 110.241 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -147.56 -5.98 0.47 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.089 -0.958 . . . . 75.109999999999999 113.341 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG12 HD23 ' A' ' 115' ' ' LEU . 56.2 mt -78.43 85.65 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.787 1.235 . . . . 63.210000000000001 109.761 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.06 93.91 1.45 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.745 1.618 . . . . 53.130000000000003 111.725 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 t -85.28 128.41 34.68 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.496 1.123 . . . . 70.420000000000002 108.952 169.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.56 96.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.877 -1.527 . . . . 63.200000000000003 106.877 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -77.53 150.34 34.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.471 1.108 . . . . 75.430000000000007 109.665 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -132.6 128.85 38.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.733 2.013 . . . . 73.420000000000002 107.643 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.37 123.18 43.43 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.459 -1.312 . . . . 75.109999999999999 107.459 165.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.58 69.31 1.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.148 -1.797 . . . . 74.430000000000007 106.148 170.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.51 8.8 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.852 -1.299 . . . . 71.310000000000002 109.852 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.06 7.36 5.04 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.223 1.564 . . . . 74.010000000000005 115.223 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.44 138.05 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.141 0.976 . . . . 64.109999999999999 108.983 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 mm -123.62 98.52 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.05 1.34 . . . . 71.120000000000005 108.024 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -88.36 154.67 20.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.137 -0.69 . . . . 75.510000000000005 109.137 167.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -154.21 143.27 21.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.788 1.235 . . . . 72.519999999999996 108.343 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.8 m -130.56 126.76 37.58 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.832 1.332 . . . . 71.420000000000002 108.672 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mmm -119.08 105.55 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.266 2.227 . . . . 63.210000000000001 108.929 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.0 m -101.3 115.76 31.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.667 0.787 . . . . 43.549999999999997 110.275 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -126.96 110.16 12.7 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.422 1.889 . . . . 64.310000000000002 107.203 177.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.33 -135.74 47.95 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 109.893 -1.283 . . . . 61.130000000000003 109.893 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.73 3.38 37.66 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.845 1.258 . . . . 74.430000000000007 113.733 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.4 mt -93.63 132.75 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.402 -0.962 . . . . 44.240000000000002 108.402 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.88 95.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.439 -0.948 . . . . 72.049999999999997 108.439 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -78.48 136.15 37.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.472 1.909 . . . . 63.229999999999997 111.279 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.8 146.1 46.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.566 1.146 . . . . 61.439999999999998 109.698 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -130.9 140.79 50.24 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.881 1.672 . . . . 72.200000000000003 108.213 168.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.74 131.12 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.076 -1.824 . . . . 74.430000000000007 106.076 169.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m -136.71 159.05 42.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.79 1.636 . . . . 71.200000000000003 108.745 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -140.39 140.42 35.51 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.933 0.893 . . . . 73.219999999999999 110.381 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.73 136.51 57.02 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.308 2.243 . . . . 75.519999999999996 111.463 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 6' ' ' LYS . 19.1 mt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.339 -2.467 . . . . 74.439999999999998 104.339 -175.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.06 0 N-CA-C 104.269 -2.493 . . . . 50.049999999999997 104.269 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 58.63 61.86 2.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.198 2.199 . . . . 75.540000000000006 111.594 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -156.85 173.5 16.9 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.834 1.654 . . . . 64.310000000000002 109.739 -173.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 66.94 76.9 0.28 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.435 1.894 . . . . 70.329999999999998 111.766 174.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -78.74 72.79 5.28 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.652 1.581 . . . . 74.239999999999995 110.703 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 46.8 m170 65.46 18.24 11.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 127.466 2.306 . . . . 62.119999999999997 114.376 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 10.1 m -140.94 123.19 15.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.982 1.313 . . . . 64.25 109.936 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -141.16 168.62 19.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.76 1.624 . . . . 75.329999999999998 110.101 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mmm 70.44 145.5 0.06 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 127.805 2.442 . . . . 75.420000000000002 112.286 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.3 p -150.87 115.35 5.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.804 -0.634 . . . . 70.030000000000001 110.689 -170.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -66.6 -14.42 62.37 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.591 1.556 . . . . 61.340000000000003 114.568 174.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.0 p -66.54 115.7 6.7 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.992 1.317 . . . . 73.099999999999994 112.359 172.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.18 173.4 35.38 Favored Glycine 0 CA--C 1.536 1.352 0 N-CA-C 110.283 -1.127 . . . . 70.140000000000001 110.283 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 ttmm -117.62 145.45 44.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.044 0.937 . . . . 73.450000000000003 109.046 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -135.82 172.77 12.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.144 2.178 . . . . 71.040000000000006 110.579 -169.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -151.69 119.66 6.23 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.582 1.153 . . . . 74.200000000000003 108.04 -164.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.43 HD13 ' HE ' ' A' ' 122' ' ' ARG . 46.7 tp -57.57 122.98 14.02 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.975 1.31 . . . . 53.020000000000003 112.177 -177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -100.22 -49.69 4.19 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 124.921 1.388 . . . . 73.230000000000004 110.436 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 m -161.41 159.77 28.61 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.57 1.148 . . . . 60.009999999999998 110.6 -172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -160.56 142.37 12.48 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.34 1.056 . . . . 74.329999999999998 110.661 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -127.65 148.59 50.38 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.233 1.813 . . . . 74.049999999999997 108.799 -174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.17 16.13 6.93 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.886 1.675 . . . . 73.450000000000003 113.509 -171.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -56.54 -56.68 18.27 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.188 1.395 . . . . 74.310000000000002 112.909 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -60.99 -48.23 82.8 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 124.397 1.061 . . . . 62.299999999999997 112.767 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.85 -42.64 76.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.727 1.211 . . . . 64.439999999999998 113.794 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -68.6 -46.86 68.22 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.256 1.422 . . . . 72.239999999999995 113.241 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 3.8 mmt -66.13 -41.23 90.77 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.646 1.178 . . . . 55.299999999999997 113.144 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.5 mptm? -60.89 -40.78 94.34 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.39 1.076 . . . . 73.319999999999993 112.226 169.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.24 -30.59 66.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.885 1.439 . . . . 70.25 114.885 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 pt -86.84 0.96 6.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 113.214 0.82 . . . . 74.230000000000004 113.214 172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.91 22.57 38.43 Favored Glycine 0 CA--C 1.536 1.353 0 CA-C-O 118.381 -1.233 . . . . 54.200000000000003 113.774 166.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.8 mt -78.16 145.93 70.07 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 119.278 1.539 . . . . 71.319999999999993 110.859 172.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.15 149.65 58.45 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.25 . . . . 64.409999999999997 111.998 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' HD12 ' A' ' 29' ' ' ILE . 51.8 tt0 -55.52 -29.18 58.41 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.366 1.466 . . . . 71.150000000000006 114.693 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.31 -54.08 51.04 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.475 1.51 . . . . 75.200000000000003 113.257 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.69 -22.75 66.65 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.892 1.277 . . . . 71.150000000000006 113.698 176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.571 HD13 ' HD2' ' A' ' 20' ' ' LYS . 66.2 mt -78.25 -49.56 20.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.444 1.098 . . . . 63.409999999999997 111.366 176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -65.74 -36.56 83.92 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.247 1.203 . . . . 73.040000000000006 114.247 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -27.67 55.9 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 118.524 -0.75 . . . . 61.25 112.28 171.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.3 -29.38 56.32 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-O 118.754 -1.026 . . . . 51.5 112.361 -177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.19 -30.12 18.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.436 1.095 . . . . 73.420000000000002 112.797 175.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -78.34 -59.86 2.61 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.738 0.815 . . . . 73.219999999999999 110.436 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.9 mm -73.64 109.94 6.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 124.451 1.094 . . . . 53.409999999999997 108.822 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.14 115.77 8.82 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 124.12 0.887 . . . . 71.209999999999994 110.191 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -77.43 179.66 50.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 124.974 1.421 . . . . 34.229999999999997 111.674 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.5 t -116.93 160.01 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 C-N-CA 125.613 1.565 . . . . 73.420000000000002 106.81 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 t -148.15 149.83 32.7 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 108.713 -0.847 . . . . 61.43 108.713 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -147.07 139.56 24.81 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.628 -0.878 . . . . 53.229999999999997 108.628 -173.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 80.5 mt -136.29 140.41 43.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 107.306 -1.368 . . . . 73.420000000000002 107.306 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.25 107.56 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 108.192 -1.04 . . . . 70.040000000000006 108.192 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -76.89 131.6 38.67 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.309 -0.997 . . . . 74.349999999999994 108.309 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -130.41 51.21 2.13 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.988 1.315 . . . . 73.010000000000005 108.79 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.25 -115.56 5.17 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 108.667 -1.773 . . . . 72.230000000000004 108.667 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -34.22 75.92 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.785 1.234 . . . . 74.420000000000002 112.908 173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -73.33 155.29 39.57 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.972 1.309 . . . . 74.349999999999994 112.134 173.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -147.36 128.27 14.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.621 1.569 . . . . 75.010000000000005 107.78 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -106.26 136.0 46.76 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.657 1.583 . . . . 72.319999999999993 108.707 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.74 134.48 55.22 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.083 -1.451 . . . . 73.219999999999999 107.083 175.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.89 122.94 15.58 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.059 1.343 . . . . 72.25 107.991 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.22 113.7 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.873 -1.158 . . . . 74.010000000000005 107.873 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.7 m -90.94 104.77 17.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.552 1.141 . . . . 63.329999999999998 109.695 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.61 174.99 11.02 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.644 1.178 . . . . 75.439999999999998 110.658 166.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.79 21.15 0.98 Allowed Glycine 0 CA--C 1.544 1.859 0 C-N-CA 125.714 1.626 . . . . 72.420000000000002 115.174 -175.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 97.8 p -158.22 -30.68 0.07 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.578 1.689 . . . . 51.210000000000001 113.459 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -151.23 165.07 35.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.195 0.998 . . . . 74.540000000000006 110.742 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.8 t -108.73 139.72 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 124.462 1.101 . . . . 72.310000000000002 108.723 174.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.1 mp -106.79 117.33 52.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 106.666 -1.605 . . . . 63.310000000000002 106.666 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -107.66 140.91 39.97 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.348 1.03 . . . . 71.209999999999994 109.016 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -144.42 158.97 43.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.954 1.702 . . . . 74.129999999999995 109.043 175.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -145.35 146.82 31.74 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.273 0.983 . . . . 64.340000000000003 109.563 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -148.4 171.27 16.3 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.436 1.494 . . . . 72.140000000000001 109.474 173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.2 m -118.07 132.7 56.34 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.46 -1.311 . . . . 74.120000000000005 107.46 169.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.91 129.87 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.313 1.045 . . . . 72.439999999999998 110.876 -176.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.21 -7.96 49.16 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-O 118.179 -1.345 . . . . 55.350000000000001 113.821 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -101.62 152.37 20.89 Favored 'General case' 0 C--N 1.347 0.476 0 CA-C-N 119.202 1.501 . . . . 70.230000000000004 109.032 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.63 104.41 16.34 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.098 0.959 . . . . 64.109999999999999 110.879 -169.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 70.7 m -125.18 -162.91 1.14 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.483 1.913 . . . . 70.349999999999994 109.067 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.06 155.74 49.76 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.707 1.203 . . . . 62.109999999999999 111.522 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.9 mt -132.03 139.04 48.44 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.792 1.637 . . . . 63.25 108.647 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -99.03 132.86 44.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.069 1.347 . . . . 41.409999999999997 109.892 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.1 m -83.72 162.41 20.71 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.432 1.493 . . . . 73.140000000000001 110.439 173.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.8 mtt -56.75 -30.1 63.22 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.94 1.459 . . . . 71.129999999999995 114.94 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.9 t -71.84 -11.33 60.75 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.427 1.491 . . . . 73.340000000000003 114.211 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.49 1.97 70.87 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.88 1.229 . . . . 72.120000000000005 112.028 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.89 132.52 47.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.303 1.441 . . . . 62.439999999999998 110.881 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -101.29 128.64 47.35 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.431 1.492 . . . . 62.240000000000002 108.375 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.97 126.15 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 O-C-N 124.038 0.836 . . . . 74.430000000000007 111.228 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -76.24 144.52 40.33 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.827 1.651 . . . . 75.409999999999997 111.729 172.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -171.88 179.59 2.69 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.113 1.365 . . . . 71.099999999999994 111.069 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.49 145.8 28.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 126.52 1.928 . . . . 75.140000000000001 107.557 169.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.21 143.33 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.111 0.964 . . . . 72.030000000000001 109.474 176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -125.06 166.44 16.38 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.305 1.842 . . . . 70.340000000000003 111.216 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.11 135.77 41.43 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.659 1.584 . . . . 65.519999999999996 107.112 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -92.71 18.99 7.97 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.642 1.177 . . . . 63.229999999999997 113.74 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.48 9.18 64.27 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 125.991 1.758 . . . . 62.210000000000001 113.893 177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -132.05 46.09 2.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.88 1.272 . . . . 73.409999999999997 109.574 -166.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.288 0.9 OUTLIER 49.65 32.06 4.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.071 2.148 . . . . 72.329999999999998 114.884 179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -137.48 119.82 15.79 Favored 'General case' 0 C--N 1.344 0.359 0 C-N-CA 126.044 1.738 . . . . 70.409999999999997 108.572 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.6 mt -92.22 146.42 23.73 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.204 0.94 . . . . 73.5 109.496 171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.72 138.0 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.914 1.286 . . . . 73.140000000000001 108.501 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.7 t -153.43 146.38 24.48 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.964 0.906 . . . . 65.319999999999993 109.51 171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.9 p -120.14 174.29 6.58 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.758 1.223 . . . . 73.319999999999993 109.007 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -133.85 -85.43 0.43 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.412 -0.958 . . . . 64.5 108.412 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -51.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.809 1.244 . . . . 75.140000000000001 109.11 172.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -145.6 12.87 1.34 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.128 1.771 . . . . 75.109999999999999 111.601 -175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.7 mt -112.21 118.98 59.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.451 1.9 . . . . 63.210000000000001 106.683 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -111.08 102.08 10.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.611 1.164 . . . . 53.130000000000003 108.736 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 70.7 m -99.48 129.18 45.64 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.293 1.437 . . . . 70.420000000000002 110.344 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.6 t -133.06 108.59 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.589 1.156 . . . . 63.200000000000003 108.608 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.7 m -85.92 148.49 25.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.456 1.102 . . . . 75.430000000000007 109.221 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.85 118.01 7.79 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.999 1.32 . . . . 73.420000000000002 109.262 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.9 tt -95.92 127.28 41.8 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.522 -0.918 . . . . 75.109999999999999 108.522 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.14 81.52 2.03 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.279 1.832 . . . . 74.430000000000007 107.729 175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.95 -110.38 3.45 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.927 1.251 . . . . 71.310000000000002 110.922 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -96.81 21.24 9.79 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.562 1.545 . . . . 74.010000000000005 111.99 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -129.4 141.38 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.747 1.219 . . . . 64.109999999999999 108.646 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 17.9 mm -117.07 107.97 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.941 1.296 . . . . 71.120000000000005 107.89 172.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 m -85.9 144.2 27.79 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.835 1.254 . . . . 75.510000000000005 108.283 165.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -149.3 122.43 8.89 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 107.209 -1.404 . . . . 72.519999999999996 107.209 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 94.2 m -129.93 120.33 24.69 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 124.513 1.133 . . . . 71.420000000000002 108.87 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.4 mtp -118.43 142.59 47.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.894 1.678 . . . . 63.210000000000001 109.216 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 85.0 m -133.71 95.74 3.53 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 43.549999999999997 109.905 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tt -96.08 106.37 18.54 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 125.038 1.335 . . . . 64.310000000000002 108.287 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.47 -109.84 3.08 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 110.218 -1.153 . . . . 61.130000000000003 110.218 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -102.78 -9.06 20.3 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.527 1.531 . . . . 74.430000000000007 112.014 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.8 mt -88.24 130.87 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.05 1.34 . . . . 44.240000000000002 108.956 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -122.49 82.24 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 O-C-N 124.168 0.918 . . . . 72.049999999999997 109.621 -174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -66.96 131.91 46.84 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.434 1.093 . . . . 63.229999999999997 112.534 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -127.97 152.24 48.15 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.038 1.335 . . . . 61.439999999999998 109.577 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HE ' HD13 ' A' ' 9' ' ' LEU . 50.6 ttt-85 -155.79 130.22 8.93 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.605 1.162 . . . . 72.200000000000003 109.401 -175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -120.43 131.69 71.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.096 1.358 . . . . 74.430000000000007 107.497 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m -131.02 159.29 37.94 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.412 1.485 . . . . 71.200000000000003 108.924 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -129.2 131.57 47.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.558 1.143 . . . . 73.219999999999999 110.016 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -69.33 119.96 14.4 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.852 2.061 . . . . 75.519999999999996 110.535 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 124.098 1.904 . . . . 74.439999999999998 108.425 -173.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 67.8 t60 . . . . . 0 N--CA 1.504 2.251 0 N-CA-C 104.777 -2.305 . . . . 50.049999999999997 104.777 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -149.4 123.39 9.4 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 118.97 0.804 . . . . 75.540000000000006 109.296 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -170.64 -56.62 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.102 1.761 . . . . 64.310000000000002 108.479 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 45.06 32.47 0.88 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 128.641 2.776 . . . . 70.329999999999998 115.658 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.33 -28.15 67.92 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 116.355 1.983 . . . . 74.239999999999995 116.355 -165.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 58.81 42.59 19.68 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.144 1.778 . . . . 62.119999999999997 113.294 170.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 17.4 m -102.81 -25.57 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 64.25 113.495 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -171.17 149.44 2.85 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 125.249 1.419 . . . . 75.329999999999998 109.649 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mmt -96.8 143.11 28.02 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 124.472 1.107 . . . . 75.420000000000002 109.507 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.2 p -151.66 116.85 5.27 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 124.3 1.0 . . . . 70.030000000000001 109.957 -173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.65 -6.88 40.23 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.993 1.717 . . . . 61.340000000000003 114.447 -177.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -57.01 120.78 8.57 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.329 2.252 . . . . 73.099999999999994 112.837 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.62 169.8 21.02 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 109.944 -1.262 . . . . 70.140000000000001 109.944 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.3 ttmt -121.22 133.03 55.15 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.974 1.309 . . . . 73.450000000000003 108.88 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -134.04 122.92 23.68 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.198 1.399 . . . . 71.040000000000006 110.217 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.68 153.31 37.23 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.264 1.025 . . . . 74.200000000000003 110.061 171.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.521 HD21 ' HG2' ' A' ' 122' ' ' ARG . 1.3 mt -70.65 137.02 49.52 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 123.195 0.309 . . . . 53.020000000000003 110.726 170.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -109.17 -48.57 3.24 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 124.744 1.277 . . . . 73.230000000000004 110.095 175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.55 160.24 25.74 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 124.255 0.972 . . . . 60.009999999999998 111.786 -177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.27 153.45 50.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.826 1.65 . . . . 74.329999999999998 107.628 172.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -129.87 142.03 50.73 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.968 0.907 . . . . 74.049999999999997 109.613 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 58.86 25.37 13.52 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.346 1.858 . . . . 73.450000000000003 113.495 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -53.83 -55.15 29.19 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.159 1.384 . . . . 74.310000000000002 112.794 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.37 -45.24 76.87 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 124.791 1.307 . . . . 62.299999999999997 112.946 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.9 -39.75 86.44 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.359 1.064 . . . . 64.439999999999998 113.577 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -69.98 -45.4 67.43 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.698 1.199 . . . . 72.239999999999995 112.815 174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 16.3 mmt -65.82 -40.44 91.83 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.514 1.134 . . . . 55.299999999999997 112.945 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.4 mptt -59.34 -39.48 83.3 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.436 1.094 . . . . 73.319999999999993 113.014 168.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.08 -37.68 72.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.614 1.339 . . . . 70.25 114.614 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.571 HG13 HD23 ' A' ' 24' ' ' LEU . 45.9 pt -77.16 -1.54 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 N-CA-C 113.682 0.993 . . . . 74.230000000000004 113.682 171.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.56 38.07 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.83 -0.983 . . . . 54.200000000000003 113.146 167.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.571 HD23 HG13 ' A' ' 22' ' ' ILE . 1.1 mm? -74.57 142.65 77.86 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 118.581 1.19 . . . . 71.319999999999993 109.276 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -68.02 149.49 77.18 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.58 2.187 . . . . 64.409999999999997 111.565 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 29' ' ' ILE . 59.2 tt0 -59.74 -24.85 64.37 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.1 1.519 . . . . 71.150000000000006 115.1 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.97 -46.39 78.22 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.575 0.954 . . . . 75.200000000000003 113.575 171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.5 mt -67.97 -25.7 65.56 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 118.352 -0.832 . . . . 71.150000000000006 113.001 174.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 26' ' ' GLU . 56.2 mt -72.73 -53.16 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 117.86 -1.067 . . . . 63.409999999999997 111.009 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.3 mm-40 -62.96 -43.13 99.64 Favored 'General case' 0 C--N 1.35 0.59 0 N-CA-C 114.025 1.12 . . . . 73.040000000000006 114.025 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.8 -23.22 63.3 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 123.735 0.647 . . . . 61.25 111.926 173.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.57 -28.36 47.8 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 118.127 -1.374 . . . . 51.5 112.469 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -92.37 -28.34 16.96 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 116.756 -1.592 . . . . 73.420000000000002 113.79 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -80.35 -34.95 36.12 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.865 1.212 . . . . 73.219999999999999 110.942 177.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.3 mt -93.47 122.51 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.361 1.065 . . . . 53.409999999999997 108.883 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.71 144.91 29.05 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.983 0.802 . . . . 71.209999999999994 110.668 165.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.3 -162.75 26.42 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 124.603 1.19 . . . . 34.229999999999997 110.725 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.3 t -143.86 152.64 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 126.607 1.963 . . . . 73.420000000000002 107.5 175.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -132.88 149.21 52.27 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.841 0.856 . . . . 61.43 109.598 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -123.14 136.91 54.98 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.023 -1.103 . . . . 53.229999999999997 108.023 166.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.4 mt -125.63 128.42 72.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.509 -2.034 . . . . 73.420000000000002 105.509 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.92 99.11 2.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 124.162 0.914 . . . . 70.040000000000006 108.738 -163.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -78.51 120.31 23.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.574 1.15 . . . . 74.349999999999994 109.685 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -117.45 54.83 0.87 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.381 1.472 . . . . 73.010000000000005 109.831 -175.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -118.1 6.47 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.526 -1.83 . . . . 72.230000000000004 108.526 -174.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -75.45 -31.58 60.35 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.262 1.025 . . . . 74.420000000000002 112.829 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.52 161.92 29.83 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.339 1.056 . . . . 74.349999999999994 111.078 169.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -155.55 138.31 15.24 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.584 -1.265 . . . . 75.010000000000005 107.584 -175.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -120.98 144.7 48.37 Favored 'General case' 0 CA--C 1.533 0.288 0 C-N-CA 125.53 1.532 . . . . 72.319999999999993 109.894 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.59 123.41 27.85 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.864 -1.902 . . . . 73.219999999999999 105.864 174.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -116.6 135.52 53.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.313 1.845 . . . . 72.25 108.525 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.52 105.26 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.325 -0.991 . . . . 74.010000000000005 108.325 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.3 m -97.02 114.84 26.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.824 1.649 . . . . 63.329999999999998 109.125 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -159.86 147.97 17.08 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.584 0.754 . . . . 75.439999999999998 110.977 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.63 -105.58 1.96 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 107.608 -2.197 . . . . 72.420000000000002 107.608 -173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.2 m -147.79 34.2 0.84 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.017 1.327 . . . . 51.210000000000001 110.912 170.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -142.03 164.4 30.26 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.0 1.72 . . . . 74.540000000000006 109.644 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.31 129.91 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 O-C-N 123.977 0.798 . . . . 72.310000000000002 109.0 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -96.27 133.8 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.396 -1.335 . . . . 63.310000000000002 107.396 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.82 124.38 43.17 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.245 -1.391 . . . . 71.209999999999994 107.245 173.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.528 HD21 ' HB3' ' A' ' 72' ' ' GLU . 25.3 m120 -123.33 150.71 43.27 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 124.645 1.216 . . . . 74.129999999999995 109.014 172.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.66 142.27 41.15 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 125.205 1.566 . . . . 64.340000000000003 108.99 176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.81 162.3 40.55 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.063 1.345 . . . . 72.140000000000001 109.756 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.5 m -109.51 135.46 50.48 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.309 -1.367 . . . . 74.120000000000005 107.309 166.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.5 130.46 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 123.953 0.901 . . . . 72.439999999999998 111.032 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.88 -7.97 64.48 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 117.941 -1.477 . . . . 55.350000000000001 114.092 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -98.75 136.09 39.29 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 119.538 1.669 . . . . 70.230000000000004 110.08 176.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -72.66 136.12 45.58 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.364 1.04 . . . . 64.109999999999999 111.068 174.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.8 p -167.63 159.17 11.76 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.853 1.261 . . . . 70.349999999999994 109.403 -169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -100.94 124.23 46.33 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.236 0.96 . . . . 62.109999999999999 110.915 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD23 HG22 ' A' ' 81' ' ' THR . 4.5 mm? -105.67 168.66 8.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.941 2.096 . . . . 63.25 109.787 -176.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.528 ' HB3' HD21 ' A' ' 61' ' ' ASN . 35.0 tt0 -129.79 157.96 40.74 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.954 1.301 . . . . 41.409999999999997 110.545 178.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.6 p -124.11 173.09 8.52 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.093 1.757 . . . . 73.140000000000001 109.703 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -59.82 -20.39 56.61 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.509 1.67 . . . . 71.129999999999995 115.509 -177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.556 HG22 HD21 ' A' ' 24' ' ' LEU . 54.3 p -78.57 -14.88 59.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.159 1.783 . . . . 73.340000000000003 113.842 172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.15 -2.08 83.35 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 124.996 1.284 . . . . 72.120000000000005 112.653 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -65.2 135.74 55.8 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 119.121 1.46 . . . . 62.439999999999998 112.559 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -103.93 143.14 33.26 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 125.126 1.516 . . . . 62.240000000000002 110.93 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.48 123.22 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.747 1.219 . . . . 74.430000000000007 111.272 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -71.43 137.92 48.66 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.738 1.215 . . . . 75.409999999999997 111.582 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 71' ' ' LEU . 13.8 t -167.41 169.67 12.07 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.677 1.236 . . . . 71.099999999999994 110.315 -172.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.8 t -125.71 132.2 71.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.866 1.266 . . . . 75.140000000000001 107.998 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.2 t -99.41 140.88 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 124.11 0.881 . . . . 72.030000000000001 109.524 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -131.59 168.58 17.45 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 70.340000000000003 111.373 173.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -122.44 127.2 49.35 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.006 -1.479 . . . . 65.519999999999996 107.006 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -84.9 18.55 2.4 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.596 1.332 . . . . 63.229999999999997 114.596 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.79 18.16 78.69 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.98 1.276 . . . . 62.210000000000001 113.719 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -143.43 48.14 1.46 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.605 1.162 . . . . 73.409999999999997 109.47 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.29 0.7 OUTLIER 47.21 37.58 5.79 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.695 1.998 . . . . 72.329999999999998 114.178 -179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -137.47 121.34 17.61 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.862 1.665 . . . . 70.409999999999997 109.072 -171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 71.8 mt -90.58 140.77 29.44 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.556 1.16 . . . . 73.5 109.725 171.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.22 138.68 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.326 1.45 . . . . 73.140000000000001 108.476 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -160.11 143.62 13.99 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.959 0.787 . . . . 65.319999999999993 110.85 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.4 p -129.17 117.35 20.63 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.243 1.417 . . . . 73.319999999999993 107.343 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -69.33 -52.3 28.63 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.268 1.027 . . . . 64.5 110.604 177.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -149.26 -101.71 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 104.828 -2.286 . . . . 75.140000000000001 104.828 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -76.72 -20.23 56.79 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.481 2.312 . . . . 75.109999999999999 113.674 173.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.564 HG12 HD13 ' A' ' 115' ' ' LEU . 68.5 mt -81.69 102.31 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.312 1.045 . . . . 63.210000000000001 108.636 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.84 146.89 24.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.105 1.362 . . . . 53.130000000000003 109.838 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.1 m -138.71 126.89 22.73 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.462 1.505 . . . . 70.420000000000002 107.43 -178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.59 97.71 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 107.173 -1.418 . . . . 63.200000000000003 107.173 -178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.5 m -94.54 152.91 18.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.157 1.383 . . . . 75.430000000000007 110.156 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -141.32 139.48 33.62 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.7 2.0 . . . . 73.420000000000002 108.545 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.7 tp -109.11 137.38 47.1 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.634 1.574 . . . . 75.109999999999999 107.556 162.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -142.11 77.22 1.57 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.927 1.691 . . . . 74.430000000000007 106.8 169.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.88 -98.31 0.48 Allowed Glycine 0 C--N 1.346 1.115 0 C-N-CA 125.435 1.493 . . . . 71.310000000000002 110.752 174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -87.76 -13.69 41.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.335 1.454 . . . . 74.010000000000005 113.133 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.89 140.23 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 119.798 1.181 . . . . 64.109999999999999 110.754 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.7 mm -119.5 107.66 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.088 1.355 . . . . 71.120000000000005 107.855 168.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -96.04 138.23 33.97 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.154 -1.054 . . . . 75.510000000000005 108.154 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -147.0 91.45 2.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.389 0.676 . . . . 72.519999999999996 109.252 -170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.3 m -82.97 144.24 30.12 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.7 1.25 . . . . 71.420000000000002 110.616 173.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 92.9 mtp -130.64 153.09 49.3 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.519 1.527 . . . . 63.210000000000001 108.491 168.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.7 m -141.03 114.03 8.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.842 0.857 . . . . 43.549999999999997 108.737 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.564 HD13 HG12 ' A' ' 98' ' ' ILE . 9.3 tp -123.95 125.08 43.97 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 125.568 1.547 . . . . 64.310000000000002 107.915 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.22 -101.44 0.38 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 124.983 1.427 . . . . 61.130000000000003 110.674 172.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.2 0.18 12.23 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.586 1.955 . . . . 74.430000000000007 112.951 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.3 mp -114.76 137.79 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.878 1.271 . . . . 44.240000000000002 109.817 -172.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.16 102.24 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.544 1.138 . . . . 72.049999999999997 109.324 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -84.85 150.99 24.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.539 1.536 . . . . 63.229999999999997 111.515 173.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -136.52 157.24 47.25 Favored 'General case' 0 C--N 1.344 0.369 0 C-N-CA 123.946 0.898 . . . . 61.439999999999998 110.199 167.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.521 ' HG2' HD21 ' A' ' 9' ' ' LEU . 5.3 ttp180 -137.46 143.64 41.88 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.531 1.533 . . . . 72.200000000000003 108.645 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.72 123.25 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.428 -1.693 . . . . 74.430000000000007 106.428 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -130.32 152.56 49.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.365 1.466 . . . . 71.200000000000003 108.988 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tmmt? -133.29 138.28 46.35 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.85 0.86 . . . . 73.219999999999999 110.665 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.4 ttp85 -64.27 135.99 56.76 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.856 2.062 . . . . 75.519999999999996 112.526 -171.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.59 HD12 ' HD2' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 C--N 1.343 0.319 0 N-CA-C 103.369 -2.826 . . . . 74.439999999999998 103.369 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 8.9 m170 . . . . . 0 N--CA 1.501 2.117 0 N-CA-C 104.116 -2.549 . . . . 50.049999999999997 104.116 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -170.56 -43.26 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 128.353 2.661 . . . . 75.540000000000006 107.956 167.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -65.74 162.69 18.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.821 1.648 . . . . 64.310000000000002 112.324 168.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -163.08 156.0 19.06 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.305 1.442 . . . . 70.329999999999998 108.948 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -155.51 149.27 25.3 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.195 0.998 . . . . 74.239999999999995 109.968 -173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -170.06 -12.85 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.238 1.415 . . . . 62.119999999999997 112.495 -174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.0 m -75.19 78.47 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 126.059 1.744 . . . . 64.25 112.05 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -148.86 166.63 27.94 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.308 1.843 . . . . 75.329999999999998 109.624 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.7 mmm 64.12 -175.62 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.446 1.899 . . . . 75.420000000000002 113.501 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -173.23 136.35 0.62 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.443 1.897 . . . . 70.030000000000001 107.444 170.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -88.91 64.37 7.16 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.213 1.005 . . . . 61.340000000000003 109.581 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 96.3 p -128.56 124.86 37.0 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.763 1.225 . . . . 73.099999999999994 109.05 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.42 174.21 27.82 Favored Glycine 0 CA--C 1.536 1.356 0 N-CA-C 109.63 -1.388 . . . . 70.140000000000001 109.63 -177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 4.2 ttmt -130.25 134.01 46.93 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 73.450000000000003 108.98 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -136.27 130.7 33.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.509 1.524 . . . . 71.040000000000006 110.04 -165.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -88.73 152.47 21.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.273 1.029 . . . . 74.200000000000003 110.009 171.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.2 tp -65.62 149.3 50.31 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.838 1.255 . . . . 53.020000000000003 112.011 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -125.99 -46.11 1.69 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.697 1.199 . . . . 73.230000000000004 111.126 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -162.43 155.71 20.27 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.303 1.041 . . . . 60.009999999999998 111.405 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -137.48 140.38 41.16 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.239 1.415 . . . . 74.329999999999998 108.522 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -116.33 149.33 39.48 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.084 0.954 . . . . 74.049999999999997 109.208 167.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 58.93 26.22 14.7 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.321 1.848 . . . . 73.450000000000003 113.302 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -58.34 -61.4 2.6 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 124.583 1.153 . . . . 74.310000000000002 113.373 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.43 -32.99 74.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.151 -0.928 . . . . 62.299999999999997 113.284 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.38 -44.78 95.65 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.101 0.961 . . . . 64.439999999999998 113.112 173.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -68.56 -51.01 47.42 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.419 1.488 . . . . 72.239999999999995 113.42 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.4 mmt -63.37 -42.74 98.88 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.006 1.322 . . . . 55.299999999999997 112.966 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -74.91 -26.54 59.71 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.036 -0.983 . . . . 73.319999999999993 113.071 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.28 66.47 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 118.21 -0.9 . . . . 70.25 113.327 174.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.24 -13.31 14.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 O-C-N 123.968 0.792 . . . . 74.230000000000004 112.77 170.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.34 17.88 27.91 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 117.998 -1.446 . . . . 54.200000000000003 113.849 164.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 26.3 mt -61.56 142.22 94.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-N 119.694 1.747 . . . . 71.319999999999993 112.112 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.15 143.51 90.26 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.502 2.135 . . . . 64.409999999999997 111.742 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -59.73 -24.43 64.01 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.839 1.422 . . . . 71.150000000000006 114.839 -172.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -58.09 -47.39 83.38 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.418 1.487 . . . . 75.200000000000003 113.397 168.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.6 -27.43 66.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.83 1.252 . . . . 71.150000000000006 112.642 176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -67.15 -54.72 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 117.764 -1.112 . . . . 63.409999999999997 111.085 168.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -60.96 -42.92 99.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.6 1.333 . . . . 73.040000000000006 114.6 -175.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -13.23 59.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 118.36 -0.829 . . . . 61.25 112.986 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.09 -35.67 9.58 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.847 -0.974 . . . . 51.5 111.443 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -33.39 23.79 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 118.451 1.125 . . . . 73.420000000000002 112.874 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -71.96 -60.1 2.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.833 0.853 . . . . 73.219999999999999 110.542 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.8 mm -79.48 114.99 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 O-C-N 124.339 1.024 . . . . 53.409999999999997 109.371 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.97 110.82 3.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.68 1.592 . . . . 71.209999999999994 109.415 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.29 -178.68 45.54 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.756 1.169 . . . . 34.229999999999997 111.893 -175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.97 158.3 38.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.241 1.416 . . . . 73.420000000000002 108.846 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 m -144.32 146.39 32.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.107 1.363 . . . . 61.43 109.76 176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -128.38 138.22 52.24 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.75 1.22 . . . . 53.229999999999997 108.318 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -126.46 130.9 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 106.671 -1.603 . . . . 73.420000000000002 106.671 -174.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.3 t -140.31 90.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 123.844 0.715 . . . . 70.040000000000006 109.729 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 67.0 tt0 -76.36 136.32 39.53 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.325 0.65 . . . . 74.349999999999994 110.241 167.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -140.98 79.07 1.68 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.617 1.567 . . . . 73.010000000000005 107.477 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.41 -126.05 12.53 Favored Glycine 0 CA--C 1.533 1.195 0 N-CA-C 109.28 -1.528 . . . . 72.230000000000004 109.28 -175.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -68.4 -29.35 68.02 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.558 1.318 . . . . 74.420000000000002 114.558 173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.78 151.5 39.11 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 123.913 0.758 . . . . 74.349999999999994 111.493 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.06 137.35 23.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.164 1.786 . . . . 75.010000000000005 107.382 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -121.75 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.547 1.154 . . . . 72.319999999999993 108.85 174.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.61 103.4 5.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.75 -1.945 . . . . 73.219999999999999 105.75 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.6 m -92.93 138.7 31.25 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.698 1.199 . . . . 72.25 108.466 169.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.78 111.88 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.786 1.234 . . . . 74.010000000000005 107.774 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 96.1 m -86.64 107.3 18.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.873 1.269 . . . . 63.329999999999998 108.59 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.09 -173.63 1.68 Allowed 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.825 1.65 . . . . 75.439999999999998 111.872 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -57.66 -31.54 63.98 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 124.783 1.182 . . . . 72.420000000000002 114.621 -173.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.3 t -162.11 46.84 0.17 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.99 1.316 . . . . 51.210000000000001 109.324 167.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -150.34 160.85 43.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.495 1.518 . . . . 74.540000000000006 108.53 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.48 128.79 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 108.311 -0.996 . . . . 72.310000000000002 108.311 173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.6 mt -127.71 141.89 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.748 -1.575 . . . . 63.310000000000002 106.748 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.32 137.52 37.47 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 123.898 0.749 . . . . 71.209999999999994 110.766 175.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -124.17 158.13 33.09 Favored 'General case' 0 N--CA 1.457 -0.09 0 O-C-N 125.475 1.734 . . . . 74.129999999999995 108.872 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -145.62 141.71 28.4 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 124.759 1.287 . . . . 64.340000000000003 108.972 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -147.69 160.67 42.44 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.48 1.112 . . . . 72.140000000000001 110.635 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 m -109.48 130.61 55.49 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.869 -1.16 . . . . 74.120000000000005 107.869 170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.4 117.21 5.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 123.893 0.877 . . . . 72.439999999999998 110.242 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.89 -5.68 56.58 Favored Glycine 0 CA--C 1.536 1.351 0 CA-C-O 117.74 -1.589 . . . . 55.350000000000001 112.759 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -119.16 150.77 39.48 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 119.502 1.651 . . . . 70.230000000000004 110.063 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.8 122.09 24.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.766 1.226 . . . . 64.109999999999999 110.732 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 88.7 m -144.97 151.9 39.33 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.966 1.306 . . . . 70.349999999999994 109.712 -172.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -100.09 134.4 43.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.665 1.186 . . . . 62.109999999999999 110.857 -165.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.1 mt -128.48 106.65 9.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.013 1.325 . . . . 63.25 109.67 -165.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.78 125.75 30.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.494 1.518 . . . . 41.409999999999997 111.664 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.7 m -82.3 166.38 19.56 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.728 1.611 . . . . 73.140000000000001 111.179 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.3 mtt -52.12 -27.42 14.14 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.579 1.952 . . . . 71.129999999999995 115.488 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.2 t -86.44 -17.19 34.91 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.266 1.826 . . . . 73.340000000000003 114.255 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.34 -16.08 45.69 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.785 1.183 . . . . 72.120000000000005 112.123 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -62.19 136.7 58.05 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 125.501 1.52 . . . . 62.439999999999998 110.4 170.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -133.65 153.76 51.43 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 124.382 1.051 . . . . 62.240000000000002 111.25 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -150.58 140.79 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 126.565 1.946 . . . . 74.430000000000007 108.517 -168.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -109.17 134.57 51.56 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.485 1.116 . . . . 75.409999999999997 109.867 -174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 t -168.21 161.05 12.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.327 1.051 . . . . 71.099999999999994 111.124 -173.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.2 t -89.78 117.94 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.867 1.267 . . . . 75.140000000000001 109.302 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.52 138.15 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.906 0.883 . . . . 72.030000000000001 108.818 171.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -129.92 153.93 47.84 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.979 1.312 . . . . 70.340000000000003 111.821 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.9 tt -97.74 132.41 43.4 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.929 1.292 . . . . 65.519999999999996 109.565 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -93.54 27.28 2.68 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.757 1.623 . . . . 63.229999999999997 113.607 -170.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 69.9 6.13 54.96 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.88 1.705 . . . . 62.210000000000001 115.304 171.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.26 57.36 0.89 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.329 1.565 . . . . 73.409999999999997 109.012 -174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.341 0.0 OUTLIER 49.4 32.6 4.72 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.337 1.855 . . . . 72.329999999999998 114.92 178.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -124.43 138.62 54.34 Favored 'General case' 0 C--N 1.343 0.285 0 C-N-CA 126.532 1.933 . . . . 70.409999999999997 108.641 -174.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.5 mt -114.34 125.15 53.54 Favored 'General case' 0 C--N 1.343 0.289 0 O-C-N 124.342 1.026 . . . . 73.5 108.896 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.0 141.7 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.425 1.49 . . . . 73.140000000000001 108.718 173.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.8 t -150.78 140.53 21.76 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 124.212 0.945 . . . . 65.319999999999993 110.141 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 76.6 p -135.74 160.09 39.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.347 1.859 . . . . 73.319999999999993 108.743 178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -127.71 -56.81 1.28 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.005 -0.739 . . . . 64.5 109.005 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -140.62 -63.1 0.48 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.697 1.599 . . . . 75.140000000000001 109.414 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -127.13 -26.36 3.13 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 124.633 1.208 . . . . 75.109999999999999 112.068 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.1 mt -74.07 100.58 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 C-N-CA 124.032 0.933 . . . . 63.210000000000001 109.58 -175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -74.57 148.97 40.35 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.595 1.184 . . . . 53.130000000000003 109.01 165.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.4 t -149.75 125.11 10.19 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.812 -1.551 . . . . 70.420000000000002 106.812 174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.2 t -127.06 100.43 6.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 106.82 -1.548 . . . . 63.200000000000003 106.82 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 96.1 m -77.99 147.75 34.73 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.463 1.102 . . . . 75.430000000000007 108.578 165.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.8 tt0 -149.33 114.61 5.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.555 1.142 . . . . 73.420000000000002 109.498 -174.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.6 tp -94.7 124.25 38.62 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.439 1.496 . . . . 75.109999999999999 109.145 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -129.78 67.65 1.45 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.235 -1.765 . . . . 74.430000000000007 106.235 169.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.78 -106.4 1.55 Allowed Glycine 0 C--N 1.348 1.202 0 C-N-CA 125.394 1.474 . . . . 71.310000000000002 110.278 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -75.72 -10.82 59.76 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.459 1.281 . . . . 74.010000000000005 114.459 176.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.58 137.0 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.199 1.0 . . . . 64.109999999999999 109.847 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 29.9 mm -124.77 104.82 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 125.023 1.329 . . . . 71.120000000000005 107.861 171.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.5 m -94.74 135.31 36.37 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 107.564 -1.273 . . . . 75.510000000000005 107.564 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -142.73 95.74 2.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 108.81 -0.811 . . . . 72.519999999999996 108.81 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.1 m -88.96 138.89 31.0 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.618 1.199 . . . . 71.420000000000002 109.653 172.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.7 mtp -130.67 154.37 47.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.425 1.49 . . . . 63.210000000000001 109.195 174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 16.1 m -147.64 88.17 1.68 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.819 0.447 . . . . 43.549999999999997 111.474 -176.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.09 107.48 16.46 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.502 1.121 . . . . 64.310000000000002 108.373 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.23 -99.14 0.22 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.782 1.182 . . . . 61.130000000000003 111.685 173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -110.33 -3.81 15.98 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.22 1.808 . . . . 74.430000000000007 111.95 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 mt -102.71 102.29 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 125.159 1.383 . . . . 44.240000000000002 109.075 -171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.0 t -92.69 84.34 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 124.498 1.119 . . . . 72.049999999999997 109.681 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -70.8 148.55 47.77 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.633 1.173 . . . . 63.229999999999997 112.261 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.28 156.02 49.17 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.722 0.809 . . . . 61.439999999999998 110.323 167.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -141.26 136.46 31.68 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.045 1.738 . . . . 72.200000000000003 107.339 168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.38 132.77 70.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.129 -1.804 . . . . 74.430000000000007 106.129 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -139.64 155.26 47.52 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.616 1.567 . . . . 71.200000000000003 109.284 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -142.15 145.57 34.36 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.069 0.948 . . . . 73.219999999999999 110.883 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 tpt85 -51.4 141.09 16.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.023 2.929 . . . . 75.519999999999996 113.993 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.1 mt . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 104.103 -2.555 . . . . 74.439999999999998 104.103 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 102.696 -3.076 . . . . 50.049999999999997 102.696 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.8 119.12 8.96 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 125.231 1.412 . . . . 75.540000000000006 109.112 176.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -69.84 158.17 36.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.5 1.52 . . . . 64.310000000000002 111.975 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -116.4 125.56 52.22 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.292 1.037 . . . . 70.329999999999998 108.517 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -129.43 146.04 51.34 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.673 1.189 . . . . 74.239999999999995 110.151 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -158.52 -32.12 0.07 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.245 1.818 . . . . 62.119999999999997 111.042 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 16.9 t 61.43 53.1 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 C-N-CA 126.966 2.106 . . . . 64.25 109.935 -171.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -168.4 151.32 5.44 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.758 1.623 . . . . 75.329999999999998 109.54 -174.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmt -75.29 138.16 41.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 124.225 0.953 . . . . 75.420000000000002 111.216 171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.1 t -164.29 142.71 7.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.49 1.516 . . . . 70.030000000000001 108.72 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' HA ' HD22 ' A' ' 104' ' ' LEU . 66.3 m-85 -75.72 -2.75 31.09 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 115.504 1.668 . . . . 61.340000000000003 115.504 -177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.6 m -59.01 127.2 31.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.929 1.692 . . . . 73.099999999999994 113.725 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.11 174.58 27.0 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.9 -0.88 . . . . 70.140000000000001 110.9 177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.524 ' HD2' HD12 ' A' ' 127' ' ' ILE . 10.8 ttmm -125.23 137.01 54.11 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.863 1.665 . . . . 73.450000000000003 108.094 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -137.47 127.88 26.5 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.397 1.479 . . . . 71.040000000000006 110.527 -166.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.96 152.0 28.23 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.734 0.814 . . . . 74.200000000000003 110.046 168.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.39 146.94 50.08 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.194 0.598 . . . . 53.020000000000003 110.409 168.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -120.39 -60.63 1.66 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.442 1.097 . . . . 73.230000000000004 109.779 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 m -143.17 157.28 44.65 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.69 1.196 . . . . 60.009999999999998 110.982 -172.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -142.86 149.97 39.24 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.289 1.435 . . . . 74.329999999999998 109.36 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -125.7 148.96 48.87 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.059 0.944 . . . . 74.049999999999997 109.38 165.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 54.33 33.1 17.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.819 2.048 . . . . 73.450000000000003 112.402 -173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -61.51 -64.61 0.89 Allowed 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.572 1.149 . . . . 74.310000000000002 111.318 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -61.85 -38.99 90.31 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 124.446 1.091 . . . . 62.299999999999997 113.062 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.96 -46.45 78.57 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.546 1.139 . . . . 64.439999999999998 113.476 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -74.39 -40.79 61.84 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.541 1.136 . . . . 72.239999999999995 113.322 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.1 mmt -68.08 -36.64 80.16 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.492 1.117 . . . . 55.299999999999997 113.395 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -65.0 -40.66 95.27 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.846 0.858 . . . . 73.319999999999993 112.313 167.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.85 -33.18 70.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.081 1.511 . . . . 70.25 115.081 -175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -75.87 -14.12 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 N-CA-C 113.371 0.878 . . . . 74.230000000000004 113.371 172.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.7 20.69 39.43 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 118.593 -1.115 . . . . 54.200000000000003 112.719 174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.7 135.55 96.42 Favored Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 118.909 1.354 . . . . 71.319999999999993 109.296 170.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -64.77 153.25 78.73 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.338 2.025 . . . . 64.409999999999997 112.268 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HA ' HD12 ' A' ' 29' ' ' ILE . 45.1 tt0 -56.97 -27.66 61.51 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.131 1.53 . . . . 71.150000000000006 115.131 -174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.78 -52.99 61.96 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.087 -0.958 . . . . 75.200000000000003 112.546 169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.5 mt -64.62 -22.9 67.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.643 1.177 . . . . 71.150000000000006 114.059 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 26' ' ' GLU . 49.2 mt -75.04 -56.65 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.031 0.932 . . . . 63.409999999999997 110.197 171.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -66.08 -36.38 83.03 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.702 1.371 . . . . 73.040000000000006 114.702 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.03 -13.78 49.44 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.722 0.638 . . . . 61.25 112.263 174.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.74 -21.5 76.65 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-O 118.698 -1.056 . . . . 51.5 111.424 173.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -103.35 -22.33 13.7 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 116.365 -1.778 . . . . 73.420000000000002 113.86 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . 0.25 20.0 p-10 -70.46 -51.68 27.45 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.127 1.33 . . . . 73.219999999999999 110.778 -173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.4 mm -97.96 122.98 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.606 1.562 . . . . 53.409999999999997 107.418 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.1 126.46 29.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 124.392 1.057 . . . . 71.209999999999994 109.553 168.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.79 -168.76 10.31 Favored Glycine 0 CA--C 1.537 1.464 0 O-C-N 124.598 1.186 . . . . 34.229999999999997 112.172 -178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -138.2 153.86 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 107.801 -1.185 . . . . 73.420000000000002 107.801 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.4 m -135.98 148.99 48.68 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.11 1.364 . . . . 61.43 108.79 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -138.47 135.78 35.51 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.9 0.88 . . . . 53.229999999999997 108.727 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.96 130.84 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.358 -1.349 . . . . 73.420000000000002 107.358 -170.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.4 t -136.23 97.81 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.329 -0.989 . . . . 70.040000000000006 108.329 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -76.28 143.12 41.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.873 0.869 . . . . 74.349999999999994 109.808 168.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -145.24 83.07 1.67 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.87 -1.159 . . . . 73.010000000000005 107.87 171.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.72 -120.3 10.92 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 109.292 -1.523 . . . . 72.230000000000004 109.292 -175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -77.67 -24.79 49.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.259 1.424 . . . . 74.420000000000002 114.243 175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -75.69 154.13 36.68 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.305 1.042 . . . . 74.349999999999994 111.678 173.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -151.78 119.8 6.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.775 1.23 . . . . 75.010000000000005 108.39 -173.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -99.69 137.48 38.1 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.413 1.071 . . . . 72.319999999999993 108.901 168.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.71 140.86 51.78 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 106.336 -1.727 . . . . 73.219999999999999 106.336 175.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 m -140.09 136.95 34.13 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.966 1.706 . . . . 72.25 107.929 172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mp -136.26 114.15 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.635 1.574 . . . . 74.010000000000005 106.806 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.3 m -96.8 130.63 44.03 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.296 1.439 . . . . 63.329999999999998 109.608 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -122.39 172.55 8.25 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.615 1.566 . . . . 75.439999999999998 109.365 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.23 7.5 8.02 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 118.249 -1.306 . . . . 72.420000000000002 114.638 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -36.9 1.85 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.23 1.515 . . . . 51.210000000000001 112.062 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.5 168.92 22.77 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.967 1.307 . . . . 74.540000000000006 110.401 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -111.73 138.31 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 O-C-N 124.56 1.163 . . . . 72.310000000000002 108.242 170.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.4 mt -115.58 127.41 73.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.197 1.799 . . . . 63.310000000000002 106.778 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.18 144.3 30.79 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.737 0.648 . . . . 71.209999999999994 111.41 178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -146.45 161.18 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.597 1.959 . . . . 74.129999999999995 108.857 -176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -133.81 144.46 49.0 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.033 0.933 . . . . 64.340000000000003 109.88 171.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -153.08 171.41 18.46 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.24 1.416 . . . . 72.140000000000001 110.122 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.8 m -112.83 132.09 55.42 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.59 1.156 . . . . 74.120000000000005 108.204 172.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.3 t -68.39 133.28 31.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 124.163 0.985 . . . . 72.439999999999998 110.307 -177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.15 -26.84 13.11 Favored Glycine 0 CA--C 1.538 1.521 0 CA-C-O 118.59 -1.117 . . . . 55.350000000000001 111.593 -174.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.37 153.12 21.44 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 124.972 1.309 . . . . 70.230000000000004 110.172 170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.26 158.0 24.96 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.408 1.067 . . . . 64.109999999999999 110.721 170.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -162.33 165.01 27.13 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.755 1.222 . . . . 70.349999999999994 110.145 -165.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.99 117.23 30.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.736 1.214 . . . . 62.109999999999999 109.187 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.2 mp -110.06 166.36 11.0 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 63.25 110.645 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -115.38 148.13 39.69 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.5 1.92 . . . . 41.409999999999997 109.481 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.3 p -111.79 173.88 6.14 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.715 1.606 . . . . 73.140000000000001 110.361 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -55.3 -28.73 55.53 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 116.52 2.044 . . . . 71.129999999999995 116.52 -174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.7 p -85.75 -15.87 40.73 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.371 1.068 . . . . 73.340000000000003 113.411 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.03 1.16 65.35 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 118.339 -1.256 . . . . 72.120000000000005 111.542 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -62.18 129.69 41.94 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 119.261 1.531 . . . . 62.439999999999998 109.868 164.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -108.43 150.4 27.46 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 124.792 1.308 . . . . 62.240000000000002 110.5 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.31 127.11 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.088 -1.415 . . . . 74.430000000000007 109.317 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -74.87 143.14 43.98 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 124.084 0.865 . . . . 75.409999999999997 110.663 166.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.5 t -160.74 161.0 32.05 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.12 1.368 . . . . 71.099999999999994 109.588 -166.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.5 t -133.36 144.61 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.918 -1.141 . . . . 75.140000000000001 107.918 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG12 HD22 ' A' ' 91' ' ' LEU . 40.2 t -130.18 132.64 65.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.098 0.959 . . . . 72.030000000000001 109.472 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -134.53 150.73 50.79 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.232 1.413 . . . . 70.340000000000003 110.751 173.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 12.9 tp -80.05 137.85 36.88 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.275 1.03 . . . . 65.519999999999996 110.267 171.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -85.59 6.49 27.07 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.769 1.228 . . . . 63.229999999999997 112.441 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.479 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 73.6 5.07 67.29 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 125.695 1.617 . . . . 62.210000000000001 113.42 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -127.41 42.31 3.35 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.356 1.862 . . . . 73.409999999999997 108.922 -169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.337 0.2 OUTLIER 47.15 38.52 6.87 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.456 1.902 . . . . 72.329999999999998 113.904 -172.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -134.14 138.94 45.55 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.677 1.991 . . . . 70.409999999999997 108.993 -175.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.407 HD22 HG12 ' A' ' 83' ' ' VAL . 59.8 mt -101.28 143.42 31.37 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 124.632 1.207 . . . . 73.5 108.618 164.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.6 t -121.84 134.38 65.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.098 -1.445 . . . . 73.140000000000001 107.098 170.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -151.09 150.17 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 65.319999999999993 110.898 -175.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.1 p -140.87 126.28 18.75 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.241 1.416 . . . . 73.319999999999993 108.216 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.54 -87.74 0.07 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 124.885 1.366 . . . . 64.5 109.493 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -126.19 -43.44 1.79 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.245 1.418 . . . . 75.140000000000001 111.181 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -157.22 26.5 0.3 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.588 1.155 . . . . 75.109999999999999 111.533 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 36.6 mt -130.41 102.74 7.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.489 -1.3 . . . . 63.210000000000001 107.489 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -65.55 132.85 49.89 Favored 'General case' 0 C--N 1.348 0.528 0 O-C-N 123.819 0.7 . . . . 53.130000000000003 109.518 167.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.9 m -142.27 108.81 5.33 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 124.683 1.239 . . . . 70.420000000000002 108.129 -169.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -116.98 131.53 69.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.669 1.188 . . . . 63.200000000000003 108.67 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 89.6 m -113.53 151.83 31.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.251 1.821 . . . . 75.430000000000007 108.713 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -139.87 144.34 37.17 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.853 1.661 . . . . 73.420000000000002 108.534 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.9 tp -117.92 124.29 47.9 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.789 2.035 . . . . 75.109999999999999 106.725 167.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.17 85.44 2.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.28 1.832 . . . . 74.430000000000007 106.844 174.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.28 -106.69 2.09 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 109.767 -1.333 . . . . 71.310000000000002 109.767 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.46 -20.68 19.47 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.92 1.288 . . . . 74.010000000000005 112.452 171.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -80.18 135.02 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.231 1.013 . . . . 64.109999999999999 110.52 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mm -119.54 95.1 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.01 1.324 . . . . 71.120000000000005 107.707 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.5 m -86.26 127.36 34.75 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.182 0.926 . . . . 75.510000000000005 108.858 175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -127.11 141.26 51.81 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.732 -0.84 . . . . 72.519999999999996 108.732 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.3 m -140.93 120.6 13.36 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.715 1.206 . . . . 71.420000000000002 108.723 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 83.3 mtp -116.53 156.27 27.22 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.6 1.56 . . . . 63.210000000000001 109.289 174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.4 m -143.76 114.26 7.54 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.319 1.048 . . . . 43.549999999999997 109.557 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.67 105.03 11.17 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 126.506 1.922 . . . . 64.310000000000002 107.162 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.01 -128.91 43.13 Favored Glycine 0 CA--C 1.536 1.361 0 N-CA-C 110.483 -1.047 . . . . 61.130000000000003 110.483 -177.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -73.75 -13.83 61.02 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.83 1.652 . . . . 74.430000000000007 114.139 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.4 mt -97.69 132.71 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.854 1.262 . . . . 44.240000000000002 109.469 -171.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.63 85.63 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 O-C-N 124.383 1.052 . . . . 72.049999999999997 109.458 -175.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -68.47 139.6 55.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.078 1.351 . . . . 63.229999999999997 113.052 176.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 152.45 50.27 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.62 1.168 . . . . 61.439999999999998 111.104 173.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -130.45 151.18 51.22 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.663 1.585 . . . . 72.200000000000003 108.659 161.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.78 124.44 63.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 105.246 -2.131 . . . . 74.430000000000007 105.246 160.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.1 m -122.86 157.45 32.47 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 71.200000000000003 108.332 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -134.49 142.08 46.94 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.862 0.865 . . . . 73.219999999999999 110.45 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.7 ttp85 -61.73 138.21 58.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.692 1.997 . . . . 75.519999999999996 112.627 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.524 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.8 mt . . . . . 0 N--CA 1.474 0.755 0 CA-C-O 125.04 2.352 . . . . 74.439999999999998 107.996 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 104.063 -2.569 . . . . 50.049999999999997 104.063 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 48.49 56.5 7.43 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.648 2.379 . . . . 75.540000000000006 114.075 165.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -66.86 144.74 56.09 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.388 1.075 . . . . 64.310000000000002 111.224 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -67.52 149.01 50.72 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 124.306 1.004 . . . . 70.329999999999998 112.54 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -161.95 159.13 26.2 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.703 2.001 . . . . 74.239999999999995 108.313 -171.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -82.59 36.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.451 1.1 . . . . 62.119999999999997 113.324 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 57.7 t -134.39 120.3 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.142 1.777 . . . . 64.25 108.032 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -82.27 167.02 19.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.107 1.363 . . . . 75.329999999999998 111.426 171.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt 64.92 -169.53 0.2 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.479 1.911 . . . . 75.420000000000002 113.404 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -144.24 117.0 8.72 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.777 1.631 . . . . 70.030000000000001 107.603 172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 104' ' ' LEU . 81.5 m-85 -78.38 46.24 0.61 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.529 1.532 . . . . 61.340000000000003 112.175 175.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.5 p -132.77 114.1 13.72 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.172 1.789 . . . . 73.099999999999994 109.183 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.75 165.97 18.6 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 109.187 -1.565 . . . . 70.140000000000001 109.187 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HD2' HD12 ' A' ' 127' ' ' ILE . 3.8 tmmt? -120.29 138.46 53.67 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.351 1.06 . . . . 73.450000000000003 109.744 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -133.64 151.35 51.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.337 1.855 . . . . 71.040000000000006 110.59 -164.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.38 149.98 30.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.936 1.294 . . . . 74.200000000000003 109.086 173.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 132.26 49.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.883 0.873 . . . . 53.020000000000003 110.398 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -102.48 -67.86 0.86 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.849 1.26 . . . . 73.230000000000004 109.117 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -141.56 167.88 21.09 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.649 1.18 . . . . 60.009999999999998 111.397 -175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.805 1.242 . . . . 74.329999999999998 110.133 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.85 146.46 50.27 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.681 1.592 . . . . 74.049999999999997 108.694 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 59.3 20.56 8.74 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.909 1.684 . . . . 73.450000000000003 113.679 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -57.96 -62.07 2.08 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.735 1.214 . . . . 74.310000000000002 112.793 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.89 -36.33 82.97 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.332 1.02 . . . . 62.299999999999997 112.987 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.22 -49.16 78.71 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.368 1.067 . . . . 64.439999999999998 113.057 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -66.79 -47.06 73.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.266 1.426 . . . . 72.239999999999995 113.618 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 6.6 mmt -66.19 -36.58 83.44 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.874 1.269 . . . . 55.299999999999997 113.346 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -75.7 -28.99 58.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.383 1.073 . . . . 73.319999999999993 112.746 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.22 -38.96 71.99 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.134 0.973 . . . . 70.25 113.135 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.1 pt -80.16 -9.73 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 113.174 0.805 . . . . 74.230000000000004 113.174 172.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.37 30.34 22.36 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-O 118.48 -1.178 . . . . 54.200000000000003 113.968 164.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.7 mt -67.46 152.73 95.93 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 119.135 1.467 . . . . 71.319999999999993 111.367 169.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.11 145.74 68.0 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.516 2.144 . . . . 64.409999999999997 112.221 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -33.14 20.7 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.333 1.853 . . . . 71.150000000000006 114.801 -177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -53.54 -55.46 25.33 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.979 1.712 . . . . 75.200000000000003 113.18 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.2 mt -66.64 -28.48 68.51 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.827 1.251 . . . . 71.150000000000006 113.87 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.6 mp -71.56 -52.06 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 118.085 -0.96 . . . . 63.409999999999997 111.526 170.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -67.02 -36.41 82.08 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.696 1.369 . . . . 73.040000000000006 114.696 -176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -23.93 49.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 118.183 -0.913 . . . . 61.25 111.809 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.03 -32.43 32.24 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.765 -1.02 . . . . 51.5 111.972 -178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -29.11 30.87 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 118.442 1.121 . . . . 73.420000000000002 112.96 174.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -85.12 -60.36 2.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.062 0.945 . . . . 73.219999999999999 109.98 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 24.4 mm -85.21 128.24 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 124.141 0.976 . . . . 53.409999999999997 109.31 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -81.79 138.57 35.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.339 1.056 . . . . 71.209999999999994 110.737 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.32 -171.09 47.58 Favored Glycine 0 CA--C 1.535 1.34 0 O-C-N 124.586 1.179 . . . . 34.229999999999997 111.065 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.1 t -136.78 152.6 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.852 1.661 . . . . 73.420000000000002 107.123 176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.9 m -144.23 147.63 33.85 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.515 0.726 . . . . 61.43 109.794 178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -128.57 146.15 50.92 Favored 'General case' 0 CA--C 1.522 -0.102 0 N-CA-C 108.348 -0.982 . . . . 53.229999999999997 108.348 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 17.3 mt -123.2 138.01 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 105.667 -1.975 . . . . 73.420000000000002 105.667 170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.3 t -130.84 137.97 54.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.099 -1.074 . . . . 70.040000000000006 108.099 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -129.04 128.9 44.54 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.988 1.315 . . . . 74.349999999999994 108.601 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -137.57 78.63 1.7 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.816 1.322 . . . . 73.010000000000005 107.759 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.05 -126.64 13.76 Favored Glycine 0 CA--C 1.534 1.25 0 N-CA-C 109.212 -1.555 . . . . 72.230000000000004 109.212 -176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -66.8 -24.73 66.21 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.512 1.525 . . . . 74.420000000000002 114.535 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.21 146.4 37.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.349 1.06 . . . . 74.349999999999994 112.036 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -138.11 136.69 36.98 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.65 1.98 . . . . 75.010000000000005 107.801 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt -125.42 149.22 48.38 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.67 1.988 . . . . 72.319999999999993 108.298 176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -146.92 101.11 3.4 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.391 0.676 . . . . 73.219999999999999 109.544 -174.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.8 m -83.44 135.53 34.65 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.209 1.404 . . . . 72.25 109.878 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.7 mt -137.73 99.1 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.615 -1.254 . . . . 74.010000000000005 107.615 176.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.8 m -92.97 138.15 31.74 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.861 2.064 . . . . 63.329999999999998 110.373 -179.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -113.13 -145.96 0.4 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 75.439999999999998 109.401 173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.46 -33.2 85.79 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 119.2 -0.778 . . . . 72.420000000000002 112.52 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -140.9 -62.03 0.48 Allowed 'General case' 0 C--N 1.344 0.361 0 C-N-CA 125.055 1.342 . . . . 51.210000000000001 109.477 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -61.68 143.74 55.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.516 1.526 . . . . 74.540000000000006 114.157 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.5 t -131.89 144.15 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 124.767 1.292 . . . . 72.310000000000002 108.886 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.5 mt -122.57 127.07 74.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 106.868 -1.53 . . . . 63.310000000000002 106.868 178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.8 91.36 3.27 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.903 0.881 . . . . 71.209999999999994 110.433 -176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -84.48 155.01 22.38 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.126 1.37 . . . . 74.129999999999995 111.42 176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -143.99 138.91 28.76 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 124.851 1.345 . . . . 64.340000000000003 110.09 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -152.91 167.98 27.32 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.624 1.17 . . . . 72.140000000000001 111.032 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.7 m -118.89 128.36 54.36 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 124.704 1.253 . . . . 74.120000000000005 107.797 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.92 128.93 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.135 0.974 . . . . 72.439999999999998 111.801 -171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.2 -3.38 86.19 Favored Glycine 0 CA--C 1.539 1.59 0 CA-C-O 117.979 -1.456 . . . . 55.350000000000001 113.303 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -117.42 147.05 43.04 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 119.304 1.552 . . . . 70.230000000000004 110.936 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -70.37 119.5 14.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.317 1.847 . . . . 64.109999999999999 111.901 -175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 97.0 m -140.13 169.57 17.44 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.047 1.739 . . . . 70.349999999999994 109.254 -176.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.6 127.71 55.82 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.146 0.978 . . . . 62.109999999999999 110.33 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD23 HG22 ' A' ' 81' ' ' THR . 3.8 mm? -115.39 141.86 47.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.695 1.598 . . . . 63.25 110.002 -170.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -122.27 142.09 50.83 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.466 1.907 . . . . 41.409999999999997 110.383 -173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 p -116.7 -178.96 3.55 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.638 1.575 . . . . 73.140000000000001 111.132 -175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.3 mtt -65.94 -24.23 66.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.423 1.489 . . . . 71.129999999999995 114.983 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 68.3 p -81.47 -11.58 59.17 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 125.261 1.424 . . . . 73.340000000000003 112.045 170.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.09 4.85 88.09 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.114 1.34 . . . . 72.120000000000005 112.615 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -61.89 120.18 10.24 Favored 'General case' 0 C--N 1.35 0.598 0 C-N-CA 125.401 1.481 . . . . 62.439999999999998 111.364 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -97.8 126.94 43.43 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 124.953 1.408 . . . . 62.240000000000002 110.37 173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.53 123.57 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.924 1.69 . . . . 74.430000000000007 108.801 -176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -76.01 137.11 40.03 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 124.206 0.941 . . . . 75.409999999999997 111.495 174.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.425 HG22 HD23 ' A' ' 71' ' ' LEU . 12.7 t -165.24 -175.94 3.85 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 124.993 1.433 . . . . 71.099999999999994 109.834 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.18 144.61 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.716 1.606 . . . . 75.140000000000001 107.765 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.02 133.09 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 123.861 0.864 . . . . 72.030000000000001 108.707 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -115.34 174.96 5.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.193 1.797 . . . . 70.340000000000003 111.509 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 87' ' ' GLY . 13.2 tp -124.96 136.04 53.37 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 65.519999999999996 107.178 167.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -89.0 9.23 25.92 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.231 1.197 . . . . 63.229999999999997 114.231 176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.474 ' H ' ' HG ' ' A' ' 85' ' ' LEU . . . 84.79 3.3 88.17 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-O 118.147 -1.363 . . . . 62.210000000000001 113.86 173.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -124.64 50.28 1.73 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 119.08 1.44 . . . . 73.409999999999997 108.817 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.333 0.1 OUTLIER 51.19 27.3 3.37 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.648 1.979 . . . . 72.329999999999998 115.297 177.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -121.73 111.97 17.82 Favored 'General case' 0 C--N 1.344 0.328 0 C-N-CA 126.329 1.852 . . . . 70.409999999999997 109.446 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.53 143.61 46.44 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 124.743 1.277 . . . . 73.5 110.336 171.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.3 t -136.4 135.01 49.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.515 1.126 . . . . 73.140000000000001 108.73 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.6 t -158.36 161.57 37.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.935 0.894 . . . . 65.319999999999993 110.716 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 31.8 p -135.37 -178.87 5.31 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.178 1.791 . . . . 73.319999999999993 108.297 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -139.3 -76.38 0.35 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 64.5 109.284 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -133.4 -50.2 0.86 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.72 1.608 . . . . 75.140000000000001 109.406 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -148.29 1.86 0.64 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.359 1.864 . . . . 75.109999999999999 111.923 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.403 HG12 HD13 ' A' ' 115' ' ' LEU . 58.5 mt -105.76 120.46 56.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.841 1.656 . . . . 63.210000000000001 107.155 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 18.4 tttp -108.27 113.46 26.57 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.818 1.247 . . . . 53.130000000000003 108.661 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -113.26 129.41 56.53 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 124.842 1.339 . . . . 70.420000000000002 109.835 -174.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.5 t -132.97 120.2 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.98 -1.119 . . . . 63.200000000000003 107.98 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.9 m -102.74 156.15 17.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.794 1.238 . . . . 75.430000000000007 109.205 172.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.82 142.25 38.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.7 2.0 . . . . 73.420000000000002 108.812 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 3' ' ' PHE . 4.0 tt -120.48 119.8 34.03 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.451 -1.685 . . . . 75.109999999999999 106.451 171.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -129.45 83.56 2.15 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.535 1.534 . . . . 74.430000000000007 107.156 173.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.85 -111.88 3.95 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.913 1.244 . . . . 71.310000000000002 110.538 175.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -79.59 -24.2 42.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.18 1.392 . . . . 74.010000000000005 112.974 173.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.3 mm -87.62 136.75 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.126 0.97 . . . . 64.109999999999999 110.709 -174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.7 mm -122.23 107.62 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.895 1.278 . . . . 71.120000000000005 107.83 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 m -99.02 151.74 20.6 Favored 'General case' 0 CA--C 1.543 0.673 0 O-C-N 124.214 0.946 . . . . 75.510000000000005 109.328 174.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -146.7 141.46 26.83 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.926 1.29 . . . . 72.519999999999996 108.288 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 93.1 m -132.5 132.23 42.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.012 1.725 . . . . 71.420000000000002 108.239 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 80.2 mtp -131.12 119.07 21.39 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.444 1.497 . . . . 63.210000000000001 108.911 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.4 m -104.26 110.41 22.61 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.257 0.973 . . . . 43.549999999999997 109.116 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 98' ' ' ILE . 19.8 tp -116.16 98.55 6.67 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 106.816 -1.55 . . . . 64.310000000000002 106.816 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.49 -130.59 40.69 Favored Glycine 0 CA--C 1.536 1.375 0 N-CA-C 109.768 -1.333 . . . . 61.130000000000003 109.768 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.45 8.74 20.58 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.171 1.388 . . . . 74.430000000000007 114.013 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 74.3 mt -108.88 123.0 64.38 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 108.511 -0.922 . . . . 44.240000000000002 108.511 174.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 63.5 t -114.57 85.48 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.524 1.14 . . . . 72.049999999999997 108.366 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.32 137.81 58.11 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.821 1.248 . . . . 63.229999999999997 111.753 170.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -134.03 148.5 51.09 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.012 1.325 . . . . 61.439999999999998 109.715 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -143.78 141.54 30.46 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.633 1.173 . . . . 72.200000000000003 108.83 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.91 134.1 62.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 107.665 -1.235 . . . . 74.430000000000007 107.665 178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.5 m -133.1 161.02 35.51 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.782 1.633 . . . . 71.200000000000003 109.516 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.73 142.73 33.29 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.467 1.107 . . . . 73.219999999999999 110.741 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -63.44 138.39 58.5 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.222 1.809 . . . . 75.519999999999996 113.681 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.497 HD12 ' HD2' ' A' ' 6' ' ' LYS . 5.4 mt . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 104.595 -2.372 . . . . 74.439999999999998 104.595 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 101.822 -3.399 . . . . 50.049999999999997 101.822 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -174.71 19.63 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.762 2.025 . . . . 75.540000000000006 111.311 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -153.76 175.62 13.08 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.364 1.466 . . . . 64.310000000000002 109.799 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -135.05 -87.71 0.37 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.441 -1.318 . . . . 70.329999999999998 107.441 170.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -148.68 115.51 6.02 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 107.307 -1.368 . . . . 74.239999999999995 107.307 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -157.75 119.77 3.72 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.834 -1.173 . . . . 62.119999999999997 107.834 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 86.8 t -123.48 86.19 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 124.696 1.247 . . . . 64.25 107.885 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -162.8 152.71 15.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.133 1.773 . . . . 75.329999999999998 108.561 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -123.28 148.81 45.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.954 1.302 . . . . 75.420000000000002 110.124 -176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.8 m -139.25 118.61 12.83 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 124.728 1.267 . . . . 70.030000000000001 109.701 -171.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -68.06 -29.14 68.04 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 124.041 0.838 . . . . 61.340000000000003 112.913 168.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.5 p -60.44 112.78 2.1 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.296 1.839 . . . . 73.099999999999994 112.69 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.96 173.44 32.63 Favored Glycine 0 CA--C 1.537 1.434 0 N-CA-C 109.092 -1.603 . . . . 70.140000000000001 109.092 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HD2' HD12 ' A' ' 127' ' ' ILE . 16.9 ttmt -127.03 138.96 53.32 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.875 0.87 . . . . 73.450000000000003 109.322 175.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -134.55 139.94 45.76 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.463 1.505 . . . . 71.040000000000006 109.634 -168.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.99 152.8 18.19 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.46 1.104 . . . . 74.200000000000003 109.36 171.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.34 140.82 57.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.839 0.856 . . . . 53.020000000000003 110.031 172.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -118.18 -48.1 2.54 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.95 1.3 . . . . 73.230000000000004 110.887 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 m -152.15 152.23 32.03 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.761 1.224 . . . . 60.009999999999998 109.868 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -149.6 136.58 19.62 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.356 1.062 . . . . 74.329999999999998 110.142 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -128.64 147.07 50.71 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.965 1.706 . . . . 74.049999999999997 110.046 -174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 55.94 24.91 8.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.305 1.842 . . . . 73.450000000000003 112.712 -167.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -57.61 -62.66 1.63 Allowed 'General case' 0 C--N 1.351 0.654 0 C-N-CA 124.556 1.142 . . . . 74.310000000000002 112.136 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.87 -43.1 99.52 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.298 0.998 . . . . 62.299999999999997 113.173 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.31 -47.31 75.82 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.685 1.194 . . . . 64.439999999999998 113.602 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.06 -46.93 76.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.456 1.502 . . . . 72.239999999999995 113.271 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.92 -40.05 79.3 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.563 1.145 . . . . 55.299999999999997 113.183 -175.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -64.65 -37.67 88.38 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.352 1.061 . . . . 73.319999999999993 112.419 169.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.2 -35.6 74.03 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 114.235 1.198 . . . . 70.25 114.235 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.9 pt -79.72 -5.19 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 N-CA-C 113.262 0.838 . . . . 74.230000000000004 113.262 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.34 22.52 26.75 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.239 -1.312 . . . . 54.200000000000003 113.79 164.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -69.96 146.11 94.85 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.478 1.639 . . . . 71.319999999999993 111.38 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.33 146.96 77.12 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.474 2.116 . . . . 64.409999999999997 111.864 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -30.23 64.04 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.829 1.418 . . . . 71.150000000000006 114.829 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -59.2 -51.52 69.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.387 1.075 . . . . 75.200000000000003 112.995 172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.6 mt -63.8 -24.42 67.75 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.616 1.167 . . . . 71.150000000000006 113.207 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.9 mt -78.99 -45.55 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 118.005 -0.998 . . . . 63.409999999999997 111.073 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -67.28 -33.19 74.78 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.498 1.295 . . . . 73.040000000000006 114.498 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.8 -11.15 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.123 0.969 . . . . 61.25 112.56 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.4 -28.0 8.82 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.75 -1.028 . . . . 51.5 111.549 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 -32.68 37.53 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 118.49 1.145 . . . . 73.420000000000002 113.366 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -83.61 -51.9 6.91 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.783 0.833 . . . . 73.219999999999999 111.301 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -77.26 113.04 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.411 1.084 . . . . 53.409999999999997 108.854 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -67.55 130.35 42.77 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.584 1.178 . . . . 71.209999999999994 110.561 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.67 -173.63 31.25 Favored Glycine 0 CA--C 1.537 1.414 0 O-C-N 124.834 1.334 . . . . 34.229999999999997 111.403 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 t -141.02 154.09 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.398 -1.334 . . . . 73.420000000000002 107.398 176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.1 m -142.72 120.19 11.68 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.351 1.061 . . . . 61.43 109.922 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -99.8 131.27 45.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 124.302 1.001 . . . . 53.229999999999997 108.704 167.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.1 mt -128.1 133.58 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 106.669 -1.604 . . . . 73.420000000000002 106.669 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 t -146.4 128.56 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 123.485 0.49 . . . . 70.040000000000006 109.823 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -88.94 128.6 35.69 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.725 -1.213 . . . . 74.349999999999994 107.725 165.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -123.83 53.11 1.4 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.896 1.278 . . . . 73.010000000000005 109.942 -173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.26 -119.82 5.27 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 108.035 -2.026 . . . . 72.230000000000004 108.035 -173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -77.2 -29.82 54.48 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.441 0.696 . . . . 74.420000000000002 111.923 171.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -69.37 164.25 23.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.417 1.087 . . . . 74.349999999999994 112.266 169.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -156.32 140.96 16.93 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 106.133 -1.803 . . . . 75.010000000000005 106.133 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -118.07 134.05 55.35 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.75 1.22 . . . . 72.319999999999993 109.957 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.59 112.93 18.59 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 125.115 1.509 . . . . 73.219999999999999 107.485 171.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.8 m -114.15 124.78 52.92 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.145 -1.428 . . . . 72.25 107.145 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.46 143.52 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.517 1.127 . . . . 74.010000000000005 108.601 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.1 t -133.74 153.86 51.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.092 1.357 . . . . 63.329999999999998 110.821 173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -151.94 139.66 19.82 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.096 1.758 . . . . 75.439999999999998 108.807 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.44 -98.66 0.68 Allowed Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.057 -1.617 . . . . 72.420000000000002 109.057 -174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 m -149.66 39.05 0.78 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.897 1.279 . . . . 51.210000000000001 111.314 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 ptmt -142.2 135.47 28.95 Favored 'General case' 0 C--N 1.347 0.488 0 C-N-CA 124.121 0.968 . . . . 74.540000000000006 110.921 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.61 144.63 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 125.269 1.428 . . . . 72.310000000000002 109.938 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.51 139.32 52.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.683 1.593 . . . . 63.310000000000002 108.095 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.55 132.36 55.13 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.805 1.242 . . . . 71.209999999999994 108.075 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -133.37 158.45 42.99 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.887 1.275 . . . . 74.129999999999995 109.952 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -137.9 148.56 45.45 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 125.181 1.551 . . . . 64.340000000000003 108.853 173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.46 157.52 41.3 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.329 1.452 . . . . 72.140000000000001 109.867 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.21 131.11 53.84 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.637 1.175 . . . . 74.120000000000005 108.084 171.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.76 113.06 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.648 1.179 . . . . 72.439999999999998 110.494 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.02 -11.45 60.52 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.118 -1.379 . . . . 55.350000000000001 112.994 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -97.62 144.02 27.71 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.248 1.524 . . . . 70.230000000000004 110.08 174.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -73.67 134.59 43.63 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.572 1.149 . . . . 64.109999999999999 110.74 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.0 p -164.62 160.0 19.61 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.979 1.312 . . . . 70.349999999999994 109.619 -171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -110.44 114.97 28.83 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.376 1.07 . . . . 62.109999999999999 109.972 -171.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.65 136.22 43.76 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 125.797 1.639 . . . . 63.25 110.339 -171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.56 154.88 26.0 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.869 1.268 . . . . 41.409999999999997 111.267 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 27.3 m -117.17 169.34 9.52 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.647 1.979 . . . . 73.140000000000001 109.286 176.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -54.13 -32.75 56.03 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 115.145 1.535 . . . . 71.129999999999995 115.145 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.7 p -77.6 -11.15 59.83 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.293 2.237 . . . . 73.340000000000003 113.976 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.95 0.36 81.2 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.431 -1.205 . . . . 72.120000000000005 112.361 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.81 126.23 27.83 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.276 1.83 . . . . 62.439999999999998 110.668 174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -112.89 119.33 37.58 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.165 0.916 . . . . 62.240000000000002 108.931 -172.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -133.78 130.09 55.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.118 1.367 . . . . 74.430000000000007 111.928 -168.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -73.93 142.19 45.95 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.194 1.397 . . . . 75.409999999999997 113.536 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.1 t -174.35 177.11 2.29 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 125.394 1.684 . . . . 71.099999999999994 110.615 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -116.95 148.72 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 126.773 2.029 . . . . 75.140000000000001 107.866 166.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.2 t -112.66 139.43 37.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.707 -0.849 . . . . 72.030000000000001 108.707 170.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -128.31 155.76 44.11 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.452 1.501 . . . . 70.340000000000003 111.102 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.666 HD13 ' H ' ' A' ' 87' ' ' GLY . 2.3 tm? -114.18 117.48 31.31 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.715 1.606 . . . . 65.519999999999996 107.148 179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -84.67 14.15 4.96 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 115.058 1.503 . . . . 63.229999999999997 115.058 -173.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.666 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 82.11 -7.0 64.86 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 125.423 1.487 . . . . 62.210000000000001 113.816 174.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -110.78 38.1 2.59 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.004 1.721 . . . . 73.409999999999997 111.568 -175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.312 0.2 OUTLIER 52.75 40.65 30.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.275 1.83 . . . . 72.329999999999998 112.96 -177.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -137.95 127.07 24.33 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 125.438 1.495 . . . . 70.409999999999997 109.553 -172.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.1 mt -91.64 144.4 25.57 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 124.71 1.256 . . . . 73.5 109.11 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -130.97 138.39 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.204 1.402 . . . . 73.140000000000001 108.61 178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -160.01 159.57 32.26 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.479 1.111 . . . . 65.319999999999993 109.971 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 73.9 p -130.85 -179.25 5.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.141 1.776 . . . . 73.319999999999993 108.443 172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -143.53 -55.02 0.38 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.645 0.657 . . . . 64.5 111.621 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -157.02 -54.22 0.08 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.524 1.13 . . . . 75.140000000000001 109.003 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -146.68 2.58 0.83 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.687 1.595 . . . . 75.109999999999999 111.699 173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.31 102.08 13.05 Favored 'Isoleucine or valine' 0 C--N 1.346 0.416 0 C-N-CA 125.591 1.557 . . . . 63.210000000000001 107.582 176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -76.01 144.69 40.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.525 -0.916 . . . . 53.130000000000003 108.525 161.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -143.31 106.61 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.312 1.045 . . . . 70.420000000000002 108.466 -174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.4 t -115.12 110.0 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 O-C-N 124.866 1.354 . . . . 63.200000000000003 108.018 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -97.67 152.48 19.04 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.845 1.258 . . . . 75.430000000000007 109.539 176.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -140.14 146.89 39.39 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.997 1.719 . . . . 73.420000000000002 109.697 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.3 tp -119.78 137.8 53.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.093 2.157 . . . . 75.109999999999999 107.788 171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -138.35 64.46 1.5 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 127.122 2.169 . . . . 74.430000000000007 106.561 170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.47 -105.0 1.32 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.795 1.188 . . . . 71.310000000000002 111.014 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -82.01 -7.95 59.64 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.784 1.234 . . . . 74.010000000000005 113.095 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.2 mm -107.39 146.46 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 124.579 1.152 . . . . 64.109999999999999 109.146 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.4 mm -130.39 143.61 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.478 1.511 . . . . 71.120000000000005 108.39 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 21.5 m -127.94 148.76 50.51 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 124.398 1.061 . . . . 75.510000000000005 108.315 168.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -140.17 117.27 11.18 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.347 -1.723 . . . . 72.519999999999996 106.347 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.2 m -120.95 102.01 8.07 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.858 1.349 . . . . 71.420000000000002 107.845 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 22.2 mtm -93.76 155.39 17.25 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.25 0.969 . . . . 63.210000000000001 110.45 171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.7 m -134.6 97.2 3.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.507 1.123 . . . . 43.549999999999997 108.846 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 tt -85.99 95.06 9.38 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.526 1.13 . . . . 64.310000000000002 108.047 168.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 59.55 -108.57 1.73 Allowed Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.678 1.132 . . . . 61.130000000000003 111.523 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -91.53 -2.72 57.08 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.871 2.068 . . . . 74.430000000000007 115.5 176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 56.7 mt -103.34 137.46 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.079 -1.082 . . . . 44.240000000000002 108.079 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 66.6 t -121.65 88.54 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 123.944 0.778 . . . . 72.049999999999997 109.298 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -67.4 139.58 57.15 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.217 1.007 . . . . 63.229999999999997 112.073 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -133.61 148.83 51.59 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.564 1.545 . . . . 61.439999999999998 109.955 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -157.32 108.88 2.35 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.811 1.244 . . . . 72.200000000000003 108.715 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -100.98 135.09 38.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.304 1.442 . . . . 74.430000000000007 107.773 176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.7 m -136.11 159.01 43.03 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.241 1.417 . . . . 71.200000000000003 109.971 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -143.66 144.12 31.74 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.982 0.913 . . . . 73.219999999999999 110.697 -177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -65.48 136.92 57.04 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.704 2.002 . . . . 75.519999999999996 113.933 -169.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.623 HD12 ' HD2' ' A' ' 6' ' ' LYS . 3.1 mt . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 124.915 2.293 . . . . 74.439999999999998 107.798 178.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 1.7 m80 . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 108.346 -0.983 . . . . 50.049999999999997 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -73.61 146.6 44.52 Favored 'General case' 0 C--N 1.348 0.501 0 C-N-CA 124.392 1.077 . . . . 75.540000000000006 111.562 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 42.0 p-80 -158.59 -55.73 0.07 Allowed 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.694 1.246 . . . . 64.310000000000002 109.837 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 68.32 -15.68 0.22 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.924 2.489 . . . . 70.329999999999998 115.095 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -164.64 158.91 18.41 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.831 2.852 . . . . 74.239999999999995 107.563 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -77.88 145.42 36.24 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 123.586 0.554 . . . . 62.119999999999997 110.545 169.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.64 14.1 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.114 1.366 . . . . 64.25 111.744 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 67.79 177.26 0.25 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.724 2.409 . . . . 75.329999999999998 112.179 -168.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtm -76.12 151.34 37.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 111.888 0.329 . . . . 75.420000000000002 111.888 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.5 m -89.59 107.23 18.96 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.591 1.557 . . . . 70.030000000000001 110.483 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' HG21 ' A' ' 41' ' ' ILE . 38.4 m-85 -65.7 -25.21 67.21 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 117.101 2.26 . . . . 61.340000000000003 117.101 -174.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -63.18 147.42 50.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 115.114 1.524 . . . . 73.099999999999994 115.114 -170.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 130.66 168.0 12.14 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.467 1.508 . . . . 70.140000000000001 110.646 176.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -89.71 152.86 21.12 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.902 1.281 . . . . 73.450000000000003 112.369 172.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -143.78 134.71 25.37 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.963 1.705 . . . . 71.040000000000006 107.782 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -85.25 154.02 22.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.919 0.781 . . . . 74.200000000000003 109.458 170.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.24 130.17 40.16 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.615 0.572 . . . . 53.020000000000003 109.649 172.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 86.0 mm-40 -103.57 -61.38 1.43 Allowed 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.292 1.037 . . . . 73.230000000000004 110.797 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.5 m -143.62 155.08 44.15 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.384 1.073 . . . . 60.009999999999998 110.902 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -135.57 147.66 48.81 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.767 1.227 . . . . 74.329999999999998 109.062 172.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -129.85 136.98 50.19 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.829 1.652 . . . . 74.049999999999997 108.333 178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 56.44 28.18 13.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.861 1.665 . . . . 73.450000000000003 112.54 -170.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -57.78 -63.33 1.28 Allowed 'General case' 0 C--N 1.348 0.538 0 C-N-CA 124.514 1.126 . . . . 74.310000000000002 112.608 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -64.02 -37.49 87.63 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 124.543 1.152 . . . . 62.299999999999997 113.128 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.21 -44.31 88.1 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.414 1.086 . . . . 64.439999999999998 113.171 173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -71.12 -43.46 67.59 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 125.241 1.416 . . . . 72.239999999999995 114.032 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 8.4 mmt -67.83 -38.27 82.99 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.177 0.991 . . . . 55.299999999999997 112.683 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.8 mptt -64.79 -40.38 95.16 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.867 0.867 . . . . 73.319999999999993 112.721 167.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.28 -27.92 64.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 114.963 1.468 . . . . 70.25 114.963 -177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -84.97 -8.3 11.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 N-CA-C 113.104 0.779 . . . . 74.230000000000004 113.104 171.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.7 24.73 22.62 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.07 -1.406 . . . . 54.200000000000003 113.54 168.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.2 mt -68.98 149.75 97.77 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.675 1.737 . . . . 71.319999999999993 111.29 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.96 152.22 62.91 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.329 2.019 . . . . 64.409999999999997 111.847 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -52.66 -34.45 51.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.025 1.33 . . . . 71.150000000000006 114.31 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -49.55 -54.83 15.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.73 2.012 . . . . 75.200000000000003 113.258 173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.0 mp -72.11 -26.13 62.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.506 1.523 . . . . 71.150000000000006 112.857 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.401 HD13 ' HD2' ' A' ' 20' ' ' LYS . 62.2 mt -75.13 -45.94 40.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.125 0.97 . . . . 63.409999999999997 111.849 178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -70.24 -37.41 74.97 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.307 1.225 . . . . 73.040000000000006 114.307 -177.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -18.25 49.64 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 118.648 -0.692 . . . . 61.25 112.506 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -38.0 11.07 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.732 -1.038 . . . . 51.5 111.517 178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -36.02 61.32 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 118.592 1.196 . . . . 73.420000000000002 112.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.81 -65.74 0.79 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.104 1.361 . . . . 73.219999999999999 110.661 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 36.3 mt -76.83 121.36 28.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.563 1.165 . . . . 53.409999999999997 109.234 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -78.42 127.91 32.86 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.231 0.957 . . . . 71.209999999999994 109.716 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.06 -156.86 28.47 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 124.791 1.307 . . . . 34.229999999999997 111.127 -177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.5 t -137.89 164.12 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.865 1.266 . . . . 73.420000000000002 108.745 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.12 155.75 47.65 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.017 1.727 . . . . 61.43 107.819 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -145.13 145.53 31.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.905 -1.517 . . . . 53.229999999999997 106.905 167.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 3' ' ' PHE . 98.8 mt -126.78 135.74 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 106.505 -1.665 . . . . 73.420000000000002 106.505 166.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.5 t -136.2 87.06 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.965 -1.124 . . . . 70.040000000000006 107.965 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -71.5 131.23 43.0 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.511 -0.768 . . . . 74.349999999999994 109.205 166.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -135.65 74.16 1.5 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.36 -1.348 . . . . 73.010000000000005 107.36 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.54 -125.27 9.22 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 108.993 -1.643 . . . . 72.230000000000004 108.993 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -72.22 -29.14 63.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.216 1.406 . . . . 74.420000000000002 114.266 174.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -71.95 152.63 42.37 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 124.117 0.885 . . . . 74.349999999999994 110.975 169.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -152.94 133.87 14.0 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.354 -1.35 . . . . 75.010000000000005 107.354 -171.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 tttm -119.29 148.06 43.58 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.106 1.362 . . . . 72.319999999999993 108.245 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.7 102.8 3.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 106.94 -1.504 . . . . 73.219999999999999 106.94 -176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.2 m -109.48 92.26 3.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.762 0.825 . . . . 72.25 109.397 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 91.6 mt -102.85 129.61 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.07 0.948 . . . . 74.010000000000005 109.093 -177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -126.29 150.07 48.7 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.501 1.12 . . . . 63.329999999999998 110.745 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.64 -152.32 0.4 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.374 1.87 . . . . 75.439999999999998 109.812 175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -88.12 -0.92 82.53 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.98 -1.456 . . . . 72.420000000000002 113.191 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.9 t -157.93 9.3 0.16 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 119.681 1.74 . . . . 51.210000000000001 114.094 -172.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 ptmt -167.41 155.27 9.12 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.943 0.897 . . . . 74.540000000000006 111.928 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.3 t -110.75 144.78 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 125.598 1.559 . . . . 72.310000000000002 109.512 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 mt -119.2 140.44 43.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.371 1.868 . . . . 63.310000000000002 106.48 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.2 123.85 39.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.742 0.817 . . . . 71.209999999999994 109.323 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -120.98 150.43 41.12 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.144 1.378 . . . . 74.129999999999995 108.983 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -147.56 143.14 27.56 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 124.707 1.255 . . . . 64.340000000000003 108.713 168.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -157.65 167.56 29.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.021 1.328 . . . . 72.140000000000001 110.55 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -119.25 128.34 54.09 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.419 -1.326 . . . . 74.120000000000005 107.419 171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.5 t -70.36 103.78 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.436 1.094 . . . . 72.439999999999998 110.281 -175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.0 -7.07 11.97 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 117.85 -1.528 . . . . 55.350000000000001 112.621 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -123.95 156.66 35.98 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.374 1.587 . . . . 70.230000000000004 111.518 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -74.36 123.09 23.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.614 1.565 . . . . 64.109999999999999 110.717 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.9 m -142.02 156.34 45.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.333 1.453 . . . . 70.349999999999994 108.4 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -97.95 124.24 42.31 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.004 0.921 . . . . 62.109999999999999 110.14 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.476 HD23 HG22 ' A' ' 81' ' ' THR . 3.9 mm? -107.26 125.42 51.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.985 1.714 . . . . 63.25 108.981 -172.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.3 tt0 -78.89 128.32 33.18 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.586 1.154 . . . . 41.409999999999997 110.876 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 26.8 m -90.45 166.18 13.4 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.253 1.821 . . . . 73.140000000000001 110.329 175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 31.7 mtt -49.47 -38.16 28.78 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 115.954 1.835 . . . . 71.129999999999995 115.954 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 p -80.71 -7.37 59.32 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.965 1.706 . . . . 73.340000000000003 113.978 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.37 0.05 86.85 Favored Glycine 0 CA--C 1.54 1.63 0 CA-C-O 118.552 -1.138 . . . . 72.120000000000005 111.549 -172.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.94 148.25 50.0 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 125.033 1.333 . . . . 62.439999999999998 110.043 163.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -135.57 142.96 45.42 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.768 0.668 . . . . 62.240000000000002 109.487 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.96 131.63 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.576 1.151 . . . . 74.430000000000007 110.826 -173.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 7.6 mtmt -81.91 142.84 32.11 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 124.383 1.073 . . . . 75.409999999999997 112.004 173.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.476 HG22 HD23 ' A' ' 71' ' ' LEU . 12.5 t -169.86 160.74 8.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.634 1.574 . . . . 71.099999999999994 109.044 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 83.6 t -104.4 125.21 59.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.709 -1.219 . . . . 75.140000000000001 107.709 169.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.6 t -93.03 138.64 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 124.118 0.886 . . . . 72.030000000000001 108.792 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -125.74 173.85 8.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.023 1.729 . . . . 70.340000000000003 111.204 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.45 127.34 19.32 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.414 1.485 . . . . 65.519999999999996 107.414 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -92.02 26.19 2.56 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.618 1.34 . . . . 63.229999999999997 114.618 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.8 -0.29 78.23 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.258 1.409 . . . . 62.210000000000001 114.586 171.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -136.05 61.38 1.65 Allowed 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.35 1.575 . . . . 73.409999999999997 108.519 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.301 0.4 OUTLIER 46.99 34.99 3.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.196 2.198 . . . . 72.329999999999998 115.331 171.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -128.26 109.76 11.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.875 1.67 . . . . 70.409999999999997 108.598 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 mp -83.2 131.4 35.11 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.767 1.292 . . . . 73.5 109.587 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.3 t -124.34 137.47 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 124.761 1.224 . . . . 73.140000000000001 109.143 -177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -157.3 146.41 19.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.611 0.764 . . . . 65.319999999999993 110.644 173.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.4 p -138.14 110.09 7.23 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.398 1.479 . . . . 73.319999999999993 107.84 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -72.42 -59.6 2.65 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.312 1.045 . . . . 64.5 111.79 -175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -145.97 -61.59 0.32 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.974 1.31 . . . . 75.140000000000001 109.314 -175.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -141.27 7.98 2.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.213 1.805 . . . . 75.109999999999999 111.64 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.43 HG12 HD12 ' A' ' 115' ' ' LEU . 9.5 mt -115.73 113.79 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 126.021 1.728 . . . . 63.210000000000001 106.795 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 28.9 tttp -79.32 149.16 31.83 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.241 0.963 . . . . 53.130000000000003 108.853 168.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 44.5 t -143.31 119.66 10.91 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 107.384 -1.339 . . . . 70.420000000000002 107.384 172.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -127.59 97.96 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 O-C-N 124.983 1.427 . . . . 63.200000000000003 107.376 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.3 m -78.17 146.35 35.09 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.614 1.166 . . . . 75.430000000000007 109.257 168.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -138.82 112.14 8.1 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.915 1.686 . . . . 73.420000000000002 108.193 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 3' ' ' PHE . 19.7 tp -83.44 124.17 30.42 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.624 1.17 . . . . 75.109999999999999 108.521 165.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -132.45 83.14 2.05 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.301 1.84 . . . . 74.430000000000007 106.135 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.4 -109.73 3.07 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 109.999 -1.241 . . . . 71.310000000000002 109.999 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -93.3 2.85 56.42 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.914 1.686 . . . . 74.010000000000005 113.846 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -113.96 136.08 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.03 0.932 . . . . 64.109999999999999 109.326 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mm -118.17 105.09 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.974 1.31 . . . . 71.120000000000005 108.267 173.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.5 m -86.17 144.64 27.38 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.05 -1.093 . . . . 75.510000000000005 108.05 163.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -144.45 95.6 2.74 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 107.83 -1.174 . . . . 72.519999999999996 107.83 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.1 m -82.17 137.91 34.83 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 125.205 1.566 . . . . 71.420000000000002 109.509 171.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 mtm -127.56 155.83 43.19 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.275 1.03 . . . . 63.210000000000001 109.562 168.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 88.1 m -140.34 101.85 4.22 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.097 0.873 . . . . 43.549999999999997 110.03 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD12 HG12 ' A' ' 98' ' ' ILE . 6.4 tt -99.98 110.31 22.63 Favored 'General case' 0 C--N 1.346 0.424 0 C-N-CA 124.731 1.212 . . . . 64.310000000000002 107.888 171.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.33 -89.68 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.183 1.373 . . . . 61.130000000000003 112.943 168.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -132.2 36.97 3.59 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.444 1.898 . . . . 74.430000000000007 109.847 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 20.4 mm -133.92 137.98 51.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.947 1.699 . . . . 44.240000000000002 106.972 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.4 t -127.8 90.25 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 O-C-N 124.06 0.85 . . . . 72.049999999999997 108.932 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -78.76 143.79 35.81 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.052 1.341 . . . . 63.229999999999997 111.406 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.79 152.73 51.96 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.183 0.993 . . . . 61.439999999999998 109.587 164.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -146.08 126.33 13.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.236 1.414 . . . . 72.200000000000003 107.988 177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -116.17 128.3 73.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 125.025 1.453 . . . . 74.430000000000007 107.397 -176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 56.3 m -127.82 157.68 39.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.755 . . . . 71.200000000000003 108.83 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -141.91 143.23 33.19 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.277 1.031 . . . . 73.219999999999999 110.875 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -51.32 140.96 16.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.42 2.288 . . . . 75.519999999999996 113.558 -176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 125.181 2.42 . . . . 74.439999999999998 108.334 -179.446 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 78.7 t60 . . . . . 0 N--CA 1.499 2.022 0 N-CA-C 103.464 -2.791 . . . . 50.049999999999997 103.464 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -117.36 148.39 41.78 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.61 1.564 . . . . 75.540000000000006 109.159 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -159.2 79.75 0.75 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.838 0.855 . . . . 64.310000000000002 109.583 -167.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -148.49 157.49 43.5 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.308 1.043 . . . . 70.329999999999998 111.26 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . 0.482 ' CG ' ' H ' ' A' ' -2' ' ' HIS . 7.2 p80 -105.23 -66.51 0.97 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.561 1.945 . . . . 74.239999999999995 109.879 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . 0.482 ' H ' ' CG ' ' A' ' -3' ' ' HIS . 48.1 t-80 -152.07 84.49 1.27 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.703 2.001 . . . . 62.119999999999997 106.221 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 2.5 m -155.95 -52.7 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.208 1.403 . . . . 64.25 109.825 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 61.32 165.53 0.09 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.839 2.056 . . . . 75.329999999999998 112.224 -160.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.43 177.36 0.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.311 1.444 . . . . 75.420000000000002 114.356 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t -169.99 141.37 2.17 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.454 1.901 . . . . 70.030000000000001 107.67 169.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -86.24 3.01 44.95 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.919 1.288 . . . . 61.340000000000003 113.914 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 97.0 p -60.7 110.16 1.23 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.371 1.868 . . . . 73.099999999999994 114.454 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.81 169.26 34.41 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 110.08 -1.208 . . . . 70.140000000000001 110.08 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -119.0 141.93 48.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.405 1.482 . . . . 73.450000000000003 108.542 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -137.18 159.1 42.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.228 1.811 . . . . 71.040000000000006 110.559 -168.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -121.27 143.41 49.18 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.287 1.435 . . . . 74.200000000000003 108.257 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.451 HD23 ' H ' ' A' ' 37' ' ' GLY . 37.5 tp -61.1 139.57 58.06 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.845 1.258 . . . . 53.020000000000003 111.608 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -122.79 -43.97 2.23 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.65 1.18 . . . . 73.230000000000004 111.334 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 m -155.49 156.14 34.7 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.295 1.038 . . . . 60.009999999999998 111.336 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -135.33 155.25 50.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.103 1.361 . . . . 74.329999999999998 109.332 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -131.31 144.42 51.25 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.707 1.203 . . . . 74.049999999999997 108.34 171.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 57.23 22.51 7.7 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.165 1.786 . . . . 73.450000000000003 114.227 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -56.32 -59.22 5.26 Favored 'General case' 0 C--N 1.348 0.54 0 C-N-CA 124.518 1.127 . . . . 74.310000000000002 113.478 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.61 -39.28 93.44 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 124.228 0.955 . . . . 62.299999999999997 112.909 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.44 -49.84 76.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.561 1.144 . . . . 64.439999999999998 112.81 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -63.65 -49.24 74.0 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.321 1.448 . . . . 72.239999999999995 113.489 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.4 mmt -66.17 -37.19 85.03 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 124.512 1.132 . . . . 55.299999999999997 113.768 -176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -73.37 -27.46 61.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 118.272 -0.87 . . . . 73.319999999999993 112.768 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.22 -34.67 63.75 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.454 1.102 . . . . 70.25 113.839 175.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG13 HD23 ' A' ' 24' ' ' LEU . 42.4 pt -80.67 -6.57 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 113.457 0.91 . . . . 74.230000000000004 113.457 170.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.75 28.95 27.78 Favored Glycine 0 CA--C 1.536 1.386 0 CA-C-O 118.759 -1.023 . . . . 54.200000000000003 113.379 167.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD23 HG13 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -72.84 147.26 88.72 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 118.774 1.287 . . . . 71.319999999999993 110.541 175.039 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.29 149.55 63.65 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.742 2.295 . . . . 64.409999999999997 112.588 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.74 -35.54 22.55 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.242 1.817 . . . . 71.150000000000006 114.988 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -51.07 -60.71 2.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.872 1.669 . . . . 75.200000000000003 112.614 169.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.5 -26.13 67.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.71 1.604 . . . . 71.150000000000006 113.917 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mp -70.6 -58.51 5.16 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 CA-C-O 118.233 -0.889 . . . . 63.409999999999997 110.691 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -63.98 -34.14 77.31 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.078 1.51 . . . . 73.040000000000006 115.078 -173.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.14 -20.23 35.17 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.175 -0.917 . . . . 61.25 112.513 172.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -34.67 21.05 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 119.104 -0.831 . . . . 51.5 111.603 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -26.18 42.74 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.593 1.157 . . . . 73.420000000000002 112.769 170.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.67 -67.53 0.63 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.28 1.032 . . . . 73.219999999999999 110.52 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.9 mt -72.79 108.74 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 124.572 1.17 . . . . 53.409999999999997 109.794 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -63.84 116.2 5.56 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.425 1.89 . . . . 71.209999999999994 109.908 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' H ' HD23 ' A' ' 9' ' ' LEU . . . -75.68 171.98 54.11 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 124.557 1.161 . . . . 34.229999999999997 111.834 -176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.96 149.24 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 107.189 -1.412 . . . . 73.420000000000002 107.189 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.2 t -142.66 149.65 39.17 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 123.566 0.746 . . . . 61.43 109.71 -172.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -146.56 140.54 26.19 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 124.215 1.006 . . . . 53.229999999999997 108.298 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -140.4 140.28 34.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 106.583 -1.636 . . . . 73.420000000000002 106.583 -174.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 37.4 t -141.69 120.94 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 108.661 -0.866 . . . . 70.040000000000006 108.661 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -95.46 136.35 35.95 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.069 0.856 . . . . 74.349999999999994 108.987 167.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -130.72 49.57 2.3 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.155 1.382 . . . . 73.010000000000005 110.251 -172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -70.99 3.0 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.835 1.207 . . . . 72.230000000000004 110.858 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -120.74 -34.39 3.58 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.861 1.664 . . . . 74.420000000000002 110.794 175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.99 165.45 24.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.316 1.046 . . . . 74.349999999999994 111.28 169.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -158.98 136.58 10.13 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.095 -1.446 . . . . 75.010000000000005 107.095 -176.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 mttt -118.49 152.2 36.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.035 1.334 . . . . 72.319999999999993 110.795 168.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.24 137.69 39.33 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 105.394 -2.076 . . . . 73.219999999999999 105.394 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 94.8 m -143.35 127.13 17.15 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.667 1.187 . . . . 72.25 107.916 175.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.4 mp -134.6 122.43 39.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 108.641 -0.874 . . . . 74.010000000000005 108.641 -173.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.4 m -95.66 114.35 26.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.449 1.5 . . . . 63.329999999999998 109.67 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.83 -179.73 6.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.455 1.502 . . . . 75.439999999999998 110.487 167.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -72.81 17.6 1.59 Allowed Glycine 0 CA--C 1.545 1.939 0 C-N-CA 125.27 1.414 . . . . 72.420000000000002 114.99 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 m -150.03 -40.13 0.14 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.714 1.606 . . . . 51.210000000000001 112.261 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.06 170.56 17.5 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.838 1.255 . . . . 74.540000000000006 110.749 -161.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.8 130.43 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.516 1.135 . . . . 72.310000000000002 108.825 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.3 mt -113.67 144.01 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 124.525 1.13 . . . . 63.310000000000002 108.257 167.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.42 149.41 45.48 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.86 1.264 . . . . 71.209999999999994 110.618 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -135.67 163.14 30.82 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.335 1.454 . . . . 74.129999999999995 109.44 176.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -145.39 139.09 26.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 114.263 -1.335 . . . . 64.340000000000003 108.539 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -156.73 167.18 31.23 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 124.229 0.956 . . . . 72.140000000000001 111.343 -176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.2 126.66 54.84 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 124.706 1.254 . . . . 74.120000000000005 108.271 174.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -66.44 123.8 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.093 0.957 . . . . 72.439999999999998 111.02 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.5 73.18 Favored Glycine 0 CA--C 1.536 1.389 0 CA-C-O 118.163 -1.354 . . . . 55.350000000000001 113.243 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -125.93 153.17 44.62 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.01 1.405 . . . . 70.230000000000004 109.825 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -72.76 136.92 45.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.096 0.959 . . . . 64.109999999999999 112.561 -176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.7 m -152.8 153.18 32.61 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.115 1.766 . . . . 70.349999999999994 108.343 174.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -90.66 113.55 25.64 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 124.244 0.965 . . . . 62.109999999999999 110.641 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -92.27 146.72 23.49 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.573 1.549 . . . . 63.25 109.267 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -112.44 130.58 55.93 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.262 1.025 . . . . 41.409999999999997 110.463 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 29.9 m -78.09 158.91 28.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.47 1.908 . . . . 73.140000000000001 110.747 176.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.5 mtm -61.38 -18.29 58.04 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.785 1.772 . . . . 71.129999999999995 115.785 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.9 p -76.23 -40.4 52.18 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.489 1.515 . . . . 73.340000000000003 112.38 168.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.38 2.26 13.49 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.535 -1.703 . . . . 72.120000000000005 112.052 -175.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.36 125.72 26.52 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 120.291 2.046 . . . . 62.439999999999998 110.119 167.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -107.95 120.24 41.73 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.617 1.198 . . . . 62.240000000000002 108.617 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.49 127.95 43.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.337 1.455 . . . . 74.430000000000007 111.278 -167.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -80.1 141.42 35.81 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.091 1.357 . . . . 75.409999999999997 112.656 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.2 t -167.89 170.94 10.25 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.28 1.432 . . . . 71.099999999999994 110.034 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -108.84 137.78 39.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.454 1.502 . . . . 75.140000000000001 108.459 170.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.72 142.15 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 O-C-N 124.082 0.864 . . . . 72.030000000000001 108.912 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -126.98 173.04 9.95 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.811 2.044 . . . . 70.340000000000003 111.213 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 tt -136.39 132.2 35.21 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.485 1.514 . . . . 65.519999999999996 107.275 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -89.07 16.73 6.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.706 1.203 . . . . 63.229999999999997 113.889 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.29 5.73 77.87 Favored Glycine 0 CA--C 1.539 1.548 0 C-N-CA 126.042 1.782 . . . . 62.210000000000001 114.019 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -131.32 50.53 2.22 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 118.843 1.322 . . . . 73.409999999999997 109.625 -167.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.32 0.4 OUTLIER 41.43 35.95 0.49 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 128.238 2.615 . . . . 72.329999999999998 115.694 -174.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -137.92 122.84 18.95 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 126.021 1.728 . . . . 70.409999999999997 107.859 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.2 mt -87.86 152.04 22.39 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 124.35 1.031 . . . . 73.5 109.586 172.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.53 139.28 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.928 1.291 . . . . 73.140000000000001 107.834 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -154.7 165.37 36.77 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.515 0.726 . . . . 65.319999999999993 109.703 169.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 95' ' ' PHE . 2.5 m -139.06 -176.57 4.55 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.956 1.302 . . . . 73.319999999999993 108.476 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' H ' HG22 ' A' ' 94' ' ' THR . 93.7 m-85 -135.62 -106.47 0.21 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.128 -1.804 . . . . 64.5 106.128 165.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -104.84 -40.16 6.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.775 1.23 . . . . 75.140000000000001 111.259 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -149.11 5.4 0.65 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.144 1.378 . . . . 75.109999999999999 112.78 -169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.5 mt -124.16 107.79 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.59 -1.263 . . . . 63.210000000000001 107.59 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -80.09 165.07 22.86 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 123.975 0.797 . . . . 53.130000000000003 110.209 173.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.4 t -152.74 133.17 13.69 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.225 1.81 . . . . 70.420000000000002 108.483 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -139.03 105.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.941 1.697 . . . . 63.200000000000003 106.791 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.8 m -88.52 154.8 20.06 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.008 1.323 . . . . 75.430000000000007 109.746 174.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -137.19 143.32 42.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.863 1.265 . . . . 73.420000000000002 108.786 172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.6 tp -120.39 117.46 27.79 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.33 1.852 . . . . 75.109999999999999 106.375 166.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.75 86.93 2.54 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 106.715 -1.587 . . . . 74.430000000000007 106.715 173.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.99 -106.43 2.02 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 109.385 -1.486 . . . . 71.310000000000002 109.385 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -96.7 -19.68 18.8 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.603 1.561 . . . . 74.010000000000005 112.605 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.9 mm -80.76 133.16 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.475 1.11 . . . . 64.109999999999999 109.776 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 38.8 mm -121.29 103.49 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 108.03 -1.1 . . . . 71.120000000000005 108.03 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.5 m -104.53 97.37 7.29 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.169 0.918 . . . . 75.510000000000005 109.845 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.21 143.96 25.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.852 1.261 . . . . 72.519999999999996 110.226 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.1 m -145.67 122.8 11.47 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.655 1.182 . . . . 71.420000000000002 109.493 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 90.9 mtp -114.04 162.56 16.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.366 1.466 . . . . 63.210000000000001 110.091 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 58.6 m -144.85 92.2 2.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.566 0.746 . . . . 43.549999999999997 110.812 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.6 tp -88.36 114.17 24.71 Favored 'General case' 0 C--N 1.344 0.367 0 C-N-CA 124.28 1.032 . . . . 64.310000000000002 109.135 168.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.59 -103.06 0.23 Allowed Glycine 0 CA--C 1.535 1.29 0 O-C-N 125.158 1.536 . . . . 61.130000000000003 111.904 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -94.95 -13.24 25.53 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.901 2.08 . . . . 74.430000000000007 113.835 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 73.0 mt -119.07 121.98 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-N 119.068 0.849 . . . . 44.240000000000002 110.863 -166.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 47.3 t -98.6 96.48 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 O-C-N 124.727 1.267 . . . . 72.049999999999997 109.089 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.61 145.63 43.14 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.444 1.098 . . . . 63.229999999999997 111.853 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.12 154.33 51.27 Favored 'General case' 0 C--N 1.346 0.435 0 C-N-CA 123.411 0.684 . . . . 61.439999999999998 110.925 168.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -139.87 125.47 19.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.336 1.454 . . . . 72.200000000000003 108.384 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -114.72 133.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.924 1.289 . . . . 74.430000000000007 107.96 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.41 162.5 35.18 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.979 1.312 . . . . 71.200000000000003 110.2 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.2 tttm -138.87 146.93 41.77 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.308 1.443 . . . . 73.219999999999999 109.449 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.7 ttp180 -60.25 145.02 48.86 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.473 1.509 . . . . 75.519999999999996 114.239 -176.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 105.818 -1.919 . . . . 74.439999999999998 105.818 174.743 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 69.0 m80 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 103.454 -2.795 . . . . 50.049999999999997 103.454 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -144.99 143.94 30.78 Favored 'General case' 0 C--N 1.344 0.353 0 C-N-CA 126.027 1.731 . . . . 75.540000000000006 108.688 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 67.99 169.85 0.27 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.796 2.038 . . . . 64.310000000000002 112.624 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -168.55 157.44 8.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.173 0.989 . . . . 70.329999999999998 110.661 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 40.4 p-80 -146.69 119.22 8.48 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.119 1.368 . . . . 74.239999999999995 107.874 176.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -167.67 150.05 5.79 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.484 1.113 . . . . 62.119999999999997 110.031 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 66.8 t -109.84 76.7 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 106.83 -1.544 . . . . 64.25 106.83 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -170.84 176.76 4.03 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.608 1.963 . . . . 75.329999999999998 109.49 -174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -117.58 165.32 13.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.953 1.301 . . . . 75.420000000000002 110.194 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t -165.58 142.84 5.66 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.065 1.346 . . . . 70.030000000000001 108.634 165.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.823 1.416 . . . . 61.340000000000003 114.823 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 m -65.53 120.69 13.34 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.846 1.259 . . . . 73.099999999999994 113.352 -174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 156.94 175.98 28.49 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.398 0.999 . . . . 70.140000000000001 110.701 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 127' ' ' ILE . 23.8 ttmt -115.7 144.72 43.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.958 1.303 . . . . 73.450000000000003 109.951 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -139.84 141.17 36.68 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.158 1.783 . . . . 71.040000000000006 110.207 -170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -97.72 152.58 18.97 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.037 1.335 . . . . 74.200000000000003 109.66 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.614 HD21 ' HE ' ' A' ' 122' ' ' ARG . 4.7 mt -64.85 143.5 57.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.248 0.619 . . . . 53.020000000000003 111.782 170.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -119.21 -61.45 1.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.383 1.473 . . . . 73.230000000000004 108.767 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 m -135.5 158.69 43.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.669 1.188 . . . . 60.009999999999998 110.521 -176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -144.12 162.42 36.32 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.779 1.632 . . . . 74.329999999999998 108.589 173.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -156.75 138.48 14.2 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.422 -0.585 . . . . 74.049999999999997 109.422 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 59.93 30.05 19.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.475 1.91 . . . . 73.450000000000003 112.559 -165.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -60.97 -57.17 13.76 Favored 'General case' 0 C--N 1.348 0.536 0 C-N-CA 124.106 0.962 . . . . 74.310000000000002 112.433 176.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.77 -43.68 95.64 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 124.606 1.191 . . . . 62.299999999999997 112.253 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.73 -47.67 76.53 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.827 1.251 . . . . 64.439999999999998 113.491 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.72 -47.0 73.7 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.005 1.322 . . . . 72.239999999999995 113.348 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.0 mmt -67.91 -35.56 78.68 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.909 1.077 . . . . 55.299999999999997 113.909 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -71.03 -30.67 66.94 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 118.282 -0.866 . . . . 73.319999999999993 112.115 171.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.71 -37.77 67.69 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.515 1.126 . . . . 70.25 113.605 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.4 pt -83.86 -1.25 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 N-CA-C 113.623 0.972 . . . . 74.230000000000004 113.623 171.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 80.26 27.96 50.46 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.738 -1.034 . . . . 54.200000000000003 114.088 164.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.49 147.32 99.0 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.683 1.242 . . . . 71.319999999999993 111.055 174.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.26 141.3 81.57 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.235 1.957 . . . . 64.409999999999997 111.556 173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -55.21 -30.41 59.92 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.909 1.284 . . . . 71.150000000000006 114.194 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -51.72 -54.04 32.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 75.200000000000003 113.568 169.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.8 mp -67.31 -25.84 66.23 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.422 1.489 . . . . 71.150000000000006 113.004 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.9 mt -75.18 -49.73 26.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 124.02 0.928 . . . . 63.409999999999997 111.168 172.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -62.61 -42.78 99.78 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.972 0.909 . . . . 73.040000000000006 113.218 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.18 -13.49 58.55 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.37 1.044 . . . . 61.25 113.057 176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -90.99 -18.83 45.36 Favored Glycine 0 CA--C 1.538 1.477 0 CA-C-O 118.263 -1.298 . . . . 51.5 112.183 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.62 -35.01 11.2 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 116.913 -1.518 . . . . 73.420000000000002 113.549 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -78.15 -56.04 4.79 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.72 1.145 . . . . 73.219999999999999 111.085 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.6 mt -78.4 124.99 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.436 1.494 . . . . 53.409999999999997 107.725 172.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -85.52 131.22 34.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 124.461 1.101 . . . . 71.209999999999994 109.375 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.06 -176.35 34.4 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 124.697 1.248 . . . . 34.229999999999997 111.574 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.96 156.38 37.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.816 1.646 . . . . 73.420000000000002 107.283 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -148.56 141.39 24.67 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.054 0.941 . . . . 61.43 109.162 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -124.24 144.0 50.21 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.242 -1.021 . . . . 53.229999999999997 108.242 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.7 mt -129.54 139.01 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 106.442 -1.688 . . . . 73.420000000000002 106.442 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 t -140.07 112.32 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 107.321 -1.363 . . . . 70.040000000000006 107.321 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -98.32 121.47 40.3 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.153 1.381 . . . . 74.349999999999994 109.116 -178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -122.56 44.01 2.75 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.797 1.239 . . . . 73.010000000000005 110.36 -171.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.99 -117.52 5.37 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 107.963 -2.055 . . . . 72.230000000000004 107.963 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -73.84 -29.52 62.17 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.555 1.317 . . . . 74.420000000000002 114.555 173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -76.3 154.51 35.04 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.524 0.602 . . . . 74.349999999999994 110.526 169.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -151.94 137.76 18.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.575 -1.268 . . . . 75.010000000000005 107.575 -173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -125.01 150.4 46.77 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 124.587 1.18 . . . . 72.319999999999993 110.128 174.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.17 128.24 20.76 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 106.491 -1.67 . . . . 73.219999999999999 106.491 -177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 m -111.05 129.91 55.77 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.291 -1.374 . . . . 72.25 107.291 165.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.61 109.38 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.974 -1.861 . . . . 74.010000000000005 105.974 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 47.4 m -113.87 105.45 13.28 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.375 1.047 . . . . 63.329999999999998 109.414 -172.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.04 -173.21 0.99 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.088 1.355 . . . . 75.439999999999998 111.931 169.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.1 -27.6 46.38 Favored Glycine 0 CA--C 1.543 1.789 0 C-N-CA 125.277 1.417 . . . . 72.420000000000002 114.915 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.1 p -159.04 20.2 0.19 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.201 1.4 . . . . 51.210000000000001 113.101 174.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 153.67 41.08 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.204 1.402 . . . . 74.540000000000006 109.562 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -134.54 129.81 52.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.331 1.052 . . . . 72.310000000000002 108.302 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.3 mt -124.23 131.15 73.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.928 1.691 . . . . 63.310000000000002 107.404 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.06 130.54 50.13 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.252 1.021 . . . . 71.209999999999994 109.312 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -138.79 145.07 39.7 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.183 1.393 . . . . 74.129999999999995 109.46 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -130.31 146.35 51.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.763 1.625 . . . . 64.340000000000003 109.041 176.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -160.21 162.08 33.7 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.312 1.045 . . . . 72.140000000000001 111.663 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.2 m -96.84 128.28 43.64 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.564 1.165 . . . . 74.120000000000005 108.448 168.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.4 t -66.08 134.02 30.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 125.725 1.61 . . . . 72.439999999999998 110.737 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.13 -13.14 60.39 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 125.04 1.305 . . . . 55.350000000000001 113.049 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -105.67 145.93 30.4 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.461 1.504 . . . . 70.230000000000004 109.639 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.55 139.38 58.26 Favored 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.727 1.211 . . . . 64.109999999999999 112.244 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 32.1 p -153.08 161.53 42.38 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 124.792 1.307 . . . . 70.349999999999994 109.728 -170.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -117.84 118.05 30.98 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 124.358 1.036 . . . . 62.109999999999999 108.628 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.04 148.64 29.47 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.66 1.584 . . . . 63.25 109.097 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.67 125.25 43.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.588 1.155 . . . . 41.409999999999997 110.257 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.6 m -74.83 162.82 28.31 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.817 1.647 . . . . 73.140000000000001 110.626 171.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.05 -26.83 62.99 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 115.253 1.575 . . . . 71.129999999999995 115.253 176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 81.7 p -73.34 -13.46 61.11 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.224 1.81 . . . . 73.340000000000003 113.901 171.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 89.98 -3.15 82.6 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-O 118.122 -1.377 . . . . 72.120000000000005 111.773 -174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -68.24 116.07 8.42 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 119.541 1.67 . . . . 62.439999999999998 111.087 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -87.12 123.77 32.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 124.809 1.318 . . . . 62.240000000000002 110.601 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.59 129.37 68.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.071 1.748 . . . . 74.430000000000007 109.966 -168.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -74.4 141.61 45.07 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.355 1.062 . . . . 75.409999999999997 111.741 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 t -166.07 166.65 17.03 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.185 1.394 . . . . 71.099999999999994 110.015 -168.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 t -139.07 146.54 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.643 -1.243 . . . . 75.140000000000001 107.643 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.2 t -117.75 145.41 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.23 1.012 . . . . 72.030000000000001 108.92 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.82 149.85 51.4 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.414 1.485 . . . . 70.340000000000003 109.837 166.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.638 HD23 ' H ' ' A' ' 87' ' ' GLY . 4.5 tt -106.21 124.63 49.88 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.24 1.416 . . . . 65.519999999999996 107.524 175.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -86.55 12.44 10.44 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.945 1.298 . . . . 63.229999999999997 114.428 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.638 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 82.5 -10.49 55.25 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 126.224 1.869 . . . . 62.210000000000001 113.872 173.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -116.9 49.77 1.14 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.517 1.527 . . . . 73.409999999999997 110.973 -169.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.291 0.6 OUTLIER 46.9 43.12 13.14 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.003 2.121 . . . . 72.329999999999998 114.054 -177.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -143.39 141.17 30.79 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.324 1.85 . . . . 70.409999999999997 108.642 -175.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 18.0 mt -115.94 148.07 40.46 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.539 1.535 . . . . 73.5 108.14 170.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 82.5 t -130.03 133.56 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.867 -1.16 . . . . 73.140000000000001 107.867 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 t -148.77 143.95 26.71 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.36 1.064 . . . . 65.319999999999993 111.219 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.2 p -139.51 127.91 22.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.363 1.465 . . . . 73.319999999999993 108.834 -177.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -87.5 -98.88 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.495 1.918 . . . . 64.5 108.588 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -106.01 -53.13 2.69 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.827 1.251 . . . . 75.140000000000001 110.51 167.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -143.06 13.94 1.86 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.878 1.271 . . . . 75.109999999999999 112.7 -170.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 115' ' ' LEU . 72.0 mt -113.65 99.15 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 107.074 -1.454 . . . . 63.210000000000001 107.074 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -87.83 105.58 17.5 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.071 0.948 . . . . 53.130000000000003 109.236 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 t -112.79 117.72 32.96 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.172 1.389 . . . . 70.420000000000002 110.631 -171.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.34 128.31 55.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 107.227 -1.397 . . . . 63.200000000000003 107.227 165.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.8 m -109.11 146.19 34.45 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 107.624 -1.25 . . . . 75.430000000000007 107.624 168.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -142.24 148.41 38.07 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.808 0.843 . . . . 73.420000000000002 110.743 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -122.89 122.47 38.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.992 2.117 . . . . 75.109999999999999 107.486 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -129.14 79.74 1.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 74.430000000000007 107.376 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.67 -116.85 6.27 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 109.402 -1.479 . . . . 71.310000000000002 109.402 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -88.1 -10.09 51.19 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.319 1.448 . . . . 74.010000000000005 114.187 172.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.25 139.86 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 123.698 0.799 . . . . 64.109999999999999 109.052 175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.31 144.72 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.283 1.433 . . . . 71.120000000000005 108.599 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 m -127.21 148.79 50.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.442 1.897 . . . . 75.510000000000005 108.23 179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.94 145.79 33.35 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.922 0.889 . . . . 72.519999999999996 109.121 172.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.7 m -144.77 86.73 1.81 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.674 1.59 . . . . 71.420000000000002 107.927 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 4.2 mtm -84.66 139.34 32.11 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 124.016 0.927 . . . . 63.210000000000001 109.747 170.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.1 m -130.82 103.08 6.37 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.662 1.185 . . . . 43.549999999999997 108.277 -176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 HG12 ' A' ' 98' ' ' ILE . 35.5 tp -118.36 119.56 34.98 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.334 1.454 . . . . 64.310000000000002 108.775 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.79 -105.49 1.34 Allowed Glycine 0 CA--C 1.534 1.271 0 N-CA-C 109.138 -1.585 . . . . 61.130000000000003 109.138 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.4 0.05 10.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.681 1.993 . . . . 74.430000000000007 112.292 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.6 mt -99.3 142.59 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.96 1.704 . . . . 44.240000000000002 109.291 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 93.5 t -121.67 92.04 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.791 0.837 . . . . 72.049999999999997 109.574 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.87 112.09 7.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.649 1.18 . . . . 63.229999999999997 112.307 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -94.5 146.6 23.98 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.289 1.435 . . . . 61.439999999999998 110.62 173.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.614 ' HE ' HD21 ' A' ' 9' ' ' LEU . 72.0 mtp180 -134.85 148.93 50.26 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 124.816 1.322 . . . . 72.200000000000003 108.019 161.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -133.82 131.06 56.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 105.954 -1.869 . . . . 74.430000000000007 105.954 169.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.2 m -131.93 165.3 24.22 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.16 1.384 . . . . 71.200000000000003 109.682 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -147.64 143.11 27.44 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.823 0.849 . . . . 73.219999999999999 110.799 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -54.5 140.09 35.6 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.629 2.372 . . . . 75.519999999999996 113.133 -174.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 ' HD2' ' A' ' 6' ' ' LYS . 9.3 mt . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 124.605 2.145 . . . . 74.439999999999998 107.263 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 58.8 m170 . . . . . 0 N--CA 1.503 2.183 0 N-CA-C 105.215 -2.142 . . . . 50.049999999999997 105.215 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -125.45 83.88 2.21 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 125.096 1.358 . . . . 75.540000000000006 107.864 173.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 51.4 m80 65.51 -82.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.856 2.462 . . . . 64.310000000000002 113.521 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -151.89 158.94 43.89 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.13 0.972 . . . . 70.329999999999998 110.789 -172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -156.08 77.13 0.94 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.701 1.2 . . . . 74.239999999999995 108.57 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.61 179.03 7.48 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.725 1.21 . . . . 62.119999999999997 111.236 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 30.6 m -122.28 18.58 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 125.588 1.555 . . . . 64.25 112.926 -175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -67.67 139.81 56.79 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.664 1.186 . . . . 75.329999999999998 111.844 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.4 mmt -97.85 97.78 9.26 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.33 1.052 . . . . 75.420000000000002 109.072 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.7 m -118.87 118.81 32.55 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 125.201 1.563 . . . . 70.030000000000001 109.167 -173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -68.53 -25.62 65.02 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 115.083 1.512 . . . . 61.340000000000003 115.083 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.2 p -59.83 116.25 3.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.165 1.786 . . . . 73.099999999999994 113.715 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.82 170.86 29.32 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.627 -0.989 . . . . 70.140000000000001 110.627 177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.553 ' HD2' HD12 ' A' ' 127' ' ' ILE . 6.1 ttmt -112.92 140.46 47.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.981 1.312 . . . . 73.450000000000003 107.993 173.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -135.41 125.52 26.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.165 1.386 . . . . 71.040000000000006 110.34 -168.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.58 152.36 30.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.973 0.909 . . . . 74.200000000000003 110.318 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.67 126.64 30.22 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.712 0.805 . . . . 53.020000000000003 109.033 170.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -95.79 -56.52 2.64 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.37 1.068 . . . . 73.230000000000004 110.917 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.0 m -156.89 163.36 39.26 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.079 1.352 . . . . 60.009999999999998 110.39 -172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -160.09 151.12 19.17 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.518 1.127 . . . . 74.329999999999998 109.59 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -136.59 143.95 43.86 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.204 1.401 . . . . 74.049999999999997 109.18 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.11 16.84 10.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.555 1.942 . . . . 73.450000000000003 114.783 -178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.79 -50.65 69.91 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.669 1.588 . . . . 74.310000000000002 113.189 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.17 -59.51 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.296 1.838 . . . . 62.299999999999997 112.782 177.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.59 -42.5 83.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.213 1.405 . . . . 64.439999999999998 113.787 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -65.69 -52.71 49.26 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.987 1.315 . . . . 72.239999999999995 112.835 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.1 mmt -68.08 -35.35 78.05 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.373 1.046 . . . . 55.299999999999997 113.702 -176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.534 ' HD3' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -61.0 -44.42 97.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.644 0.777 . . . . 73.319999999999993 112.314 168.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.45 79.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 114.322 1.23 . . . . 70.25 114.322 -179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 pt -80.95 -5.0 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 N-CA-C 114.043 1.127 . . . . 74.230000000000004 114.043 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.99 19.33 26.81 Favored Glycine 0 CA--C 1.536 1.371 0 CA-C-O 118.229 -1.317 . . . . 54.200000000000003 114.646 161.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.25 142.63 97.8 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-N 119.54 1.67 . . . . 71.319999999999993 110.319 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.54 141.18 59.92 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.143 1.895 . . . . 64.409999999999997 111.65 170.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' HA ' HD12 ' A' ' 29' ' ' ILE 0.31 27.3 tt0 -65.93 -14.3 61.3 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.668 1.729 . . . . 71.150000000000006 115.668 -173.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.04 -53.17 61.22 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.616 1.167 . . . . 75.200000000000003 112.556 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.1 mp -66.47 -26.01 66.99 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.563 1.545 . . . . 71.150000000000006 112.86 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.534 HD13 ' HD3' ' A' ' 20' ' ' LYS . 47.7 mt -78.85 -47.43 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 117.55 -1.214 . . . . 63.409999999999997 111.161 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 -65.36 -39.48 92.38 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 113.731 1.011 . . . . 73.040000000000006 113.731 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -16.67 57.78 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 118.256 -0.878 . . . . 61.25 112.472 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.18 -37.74 10.86 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-O 118.974 -0.903 . . . . 51.5 111.35 178.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 -26.27 34.73 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.465 1.106 . . . . 73.420000000000002 113.584 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -84.95 -62.82 1.45 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 124.163 0.914 . . . . 73.219999999999999 110.304 178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -85.56 120.15 35.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 123.866 0.866 . . . . 53.409999999999997 108.914 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -66.33 127.58 32.82 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.051 0.94 . . . . 71.209999999999994 111.334 172.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.3 -172.57 48.87 Favored Glycine 0 CA--C 1.536 1.389 0 O-C-N 124.712 1.258 . . . . 34.229999999999997 110.554 174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.0 t -137.59 152.97 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 125.6 1.56 . . . . 73.420000000000002 107.389 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.2 m -135.77 155.61 50.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.257 1.023 . . . . 61.43 109.112 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -137.72 140.4 40.7 Favored 'General case' 0 C--N 1.338 0.098 0 N-CA-C 109.178 -0.675 . . . . 53.229999999999997 109.178 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' A' ' 48' ' ' PHE . 84.6 mt -123.61 129.61 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 124.863 1.352 . . . . 73.420000000000002 107.477 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.6 t -133.92 90.53 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.087 -1.079 . . . . 70.040000000000006 108.087 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -74.29 136.46 42.62 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.698 0.799 . . . . 74.349999999999994 110.223 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -150.07 86.22 1.43 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.233 1.013 . . . . 73.010000000000005 109.845 -174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.64 -114.29 4.06 Favored Glycine 0 CA--C 1.532 1.152 0 N-CA-C 109.526 -1.429 . . . . 72.230000000000004 109.526 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -91.58 -15.81 28.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.998 1.319 . . . . 74.420000000000002 111.874 173.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -86.15 147.65 26.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.322 1.449 . . . . 74.349999999999994 112.49 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.531 ' CE2' HD11 ' A' ' 91' ' ' LEU . 12.7 t80 -133.33 118.99 19.15 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.793 1.637 . . . . 75.010000000000005 107.828 176.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -87.6 131.93 34.24 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.046 1.338 . . . . 72.319999999999993 108.567 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.24 109.36 12.74 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 106.162 -1.792 . . . . 73.219999999999999 106.162 175.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.8 m -106.15 141.88 36.78 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.158 1.383 . . . . 72.25 109.536 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.91 107.41 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.145 1.378 . . . . 74.010000000000005 108.016 177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 98.5 m -87.64 132.04 34.22 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.566 1.546 . . . . 63.329999999999998 109.068 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.88 4.64 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.334 0.653 . . . . 75.439999999999998 110.225 -175.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.83 -86.93 0.86 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 109.674 -1.37 . . . . 72.420000000000002 109.674 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.8 t -150.25 21.56 0.85 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.996 1.318 . . . . 51.210000000000001 111.781 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmm? -129.25 149.39 51.06 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.475 1.51 . . . . 74.540000000000006 109.818 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -127.91 111.68 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 124.198 0.936 . . . . 72.310000000000002 109.567 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.2 mt -84.19 144.61 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.77 1.228 . . . . 63.310000000000002 107.988 166.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.29 141.68 23.34 Favored 'General case' 0 C--N 1.339 0.145 0 O-C-N 123.955 0.784 . . . . 71.209999999999994 110.762 165.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -131.79 158.52 41.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.455 1.902 . . . . 74.129999999999995 107.817 177.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -139.37 145.83 39.47 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 124.081 0.863 . . . . 64.340000000000003 109.909 169.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -139.62 149.91 44.35 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 124.829 1.331 . . . . 72.140000000000001 110.175 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -94.03 126.1 39.05 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 124.915 1.384 . . . . 74.120000000000005 108.094 168.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.9 t -64.23 130.45 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.862 0.865 . . . . 72.439999999999998 111.675 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.74 -5.47 81.84 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 118.21 -1.328 . . . . 55.350000000000001 113.672 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -112.49 157.03 21.6 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-N 119.122 1.461 . . . . 70.230000000000004 109.71 173.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -73.62 143.75 46.21 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.057 0.848 . . . . 64.109999999999999 111.794 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 26.3 p -141.11 -173.01 3.61 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.633 2.373 . . . . 70.349999999999994 107.576 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -132.69 129.47 38.8 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.146 -0.687 . . . . 62.109999999999999 109.146 168.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.4 mp -104.71 161.42 14.16 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.877 1.671 . . . . 63.25 109.448 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.22 142.58 39.84 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.233 1.413 . . . . 41.409999999999997 109.013 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.5 m -109.03 142.89 39.07 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.562 1.145 . . . . 73.140000000000001 108.035 168.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.1 mtt -44.53 -32.07 1.31 Allowed 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 118.769 2.877 . . . . 71.129999999999995 118.769 -163.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 t -71.05 -22.43 62.13 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.12 1.368 . . . . 73.340000000000003 114.262 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.27 5.57 10.38 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.209 -1.328 . . . . 72.120000000000005 112.298 177.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.18 147.03 52.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.448 1.624 . . . . 62.439999999999998 111.923 172.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.23 124.39 44.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.442 1.497 . . . . 62.240000000000002 107.732 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.33 128.62 10.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.196 0.998 . . . . 74.430000000000007 111.928 -169.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.02 148.4 48.9 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.89 1.276 . . . . 75.409999999999997 111.791 174.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.5 t -169.46 162.87 10.34 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 124.548 1.155 . . . . 71.099999999999994 111.039 176.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.2 t -116.06 150.62 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 126.047 1.739 . . . . 75.140000000000001 107.465 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.5 t -120.03 139.65 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.847 -0.798 . . . . 72.030000000000001 108.847 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -125.35 152.03 45.29 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 125.73 1.612 . . . . 70.340000000000003 110.86 176.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -110.75 118.11 35.26 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 65.519999999999996 106.513 173.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -76.05 11.65 1.39 Allowed 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 115.22 1.563 . . . . 63.229999999999997 115.22 -173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.76 11.16 85.7 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.04 1.305 . . . . 62.210000000000001 112.596 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -134.04 35.78 3.28 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.391 1.476 . . . . 73.409999999999997 109.702 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.318 0.5 OUTLIER 53.51 27.08 6.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.469 1.908 . . . . 72.329999999999998 114.785 177.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -124.93 126.35 45.37 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.834 1.654 . . . . 70.409999999999997 108.832 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 48' ' ' PHE . 45.6 mt -94.05 127.51 39.89 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.157 0.983 . . . . 73.5 109.639 176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.69 134.89 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.97 1.308 . . . . 73.140000000000001 108.684 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 t -160.9 151.26 17.92 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.222 1.009 . . . . 65.319999999999993 111.362 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.4 t -161.23 141.24 10.75 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.74 1.216 . . . . 73.319999999999993 110.861 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -83.65 -61.32 1.86 Allowed 'General case' 0 CA--C 1.538 0.498 0 O-C-N 124.227 0.954 . . . . 64.5 109.18 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? -129.72 -52.56 1.15 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.75 1.62 . . . . 75.140000000000001 110.241 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -147.56 -5.98 0.47 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 118.089 -0.958 . . . . 75.109999999999999 113.341 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG12 HD23 ' A' ' 115' ' ' LEU . 56.2 mt -78.43 85.65 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.787 1.235 . . . . 63.210000000000001 109.761 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -72.06 93.91 1.45 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.745 1.618 . . . . 53.130000000000003 111.725 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.8 t -85.28 128.41 34.68 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 124.496 1.123 . . . . 70.420000000000002 108.952 169.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -131.56 96.17 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.877 -1.527 . . . . 63.200000000000003 106.877 171.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 86.3 m -77.53 150.34 34.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.471 1.108 . . . . 75.430000000000007 109.665 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -132.6 128.85 38.06 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.733 2.013 . . . . 73.420000000000002 107.643 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 15.4 tp -99.37 123.18 43.43 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 107.459 -1.312 . . . . 75.109999999999999 107.459 165.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.58 69.31 1.24 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 106.148 -1.797 . . . . 74.430000000000007 106.148 170.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.53 -116.51 8.8 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.852 -1.299 . . . . 71.310000000000002 109.852 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -77.06 7.36 5.04 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 115.223 1.564 . . . . 74.010000000000005 115.223 175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -116.44 138.05 48.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.141 0.976 . . . . 64.109999999999999 108.983 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 mm -123.62 98.52 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.05 1.34 . . . . 71.120000000000005 108.024 174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 m -88.36 154.67 20.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 109.137 -0.69 . . . . 75.510000000000005 109.137 167.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -154.21 143.27 21.17 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.788 1.235 . . . . 72.519999999999996 108.343 175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.8 m -130.56 126.76 37.58 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.832 1.332 . . . . 71.420000000000002 108.672 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mmm -119.08 105.55 11.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.266 2.227 . . . . 63.210000000000001 108.929 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.0 m -101.3 115.76 31.24 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.667 0.787 . . . . 43.549999999999997 110.275 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD23 HG12 ' A' ' 98' ' ' ILE . 0.7 OUTLIER -126.96 110.16 12.7 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.422 1.889 . . . . 64.310000000000002 107.203 177.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.33 -135.74 47.95 Favored Glycine 0 CA--C 1.538 1.513 0 N-CA-C 109.893 -1.283 . . . . 61.130000000000003 109.893 -172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.73 3.38 37.66 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.845 1.258 . . . . 74.430000000000007 113.733 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 19.4 mt -93.63 132.75 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.402 -0.962 . . . . 44.240000000000002 108.402 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.2 t -126.88 95.6 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.439 -0.948 . . . . 72.049999999999997 108.439 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -78.48 136.15 37.53 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.472 1.909 . . . . 63.229999999999997 111.279 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.8 146.1 46.89 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.566 1.146 . . . . 61.439999999999998 109.698 174.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -130.9 140.79 50.24 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 125.881 1.672 . . . . 72.200000000000003 108.213 168.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.74 131.12 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.076 -1.824 . . . . 74.430000000000007 106.076 169.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 m -136.71 159.05 42.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.79 1.636 . . . . 71.200000000000003 108.745 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -140.39 140.42 35.51 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.933 0.893 . . . . 73.219999999999999 110.381 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -64.73 136.51 57.02 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.308 2.243 . . . . 75.519999999999996 111.463 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 6' ' ' LYS . 19.1 mt . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.339 -2.467 . . . . 74.439999999999998 104.339 -175.124 . . . . . . . . 1 1 . 1 stop_ save_